TW202009235A - 1,2-dithiolone compounds and use thereof - Google Patents

1,2-dithiolone compounds and use thereof Download PDF

Info

Publication number
TW202009235A
TW202009235A TW108129373A TW108129373A TW202009235A TW 202009235 A TW202009235 A TW 202009235A TW 108129373 A TW108129373 A TW 108129373A TW 108129373 A TW108129373 A TW 108129373A TW 202009235 A TW202009235 A TW 202009235A
Authority
TW
Taiwan
Prior art keywords
chloro
amino
dithiol
methyl
benzyl
Prior art date
Application number
TW108129373A
Other languages
Chinese (zh)
Inventor
桑迪普 阿帕基 普賈里
羅希特 薩克斯納
桑巴吉 舒夫納斯 托克
桑卡 德巴斯
盧佩許 庫瑪 米什拉
魯奇 賈克
桑陶許 斯里達 奧卡爾
哈佳拉瓦迪M 凡卡泰沙
亞歷山大Gm 克勞森納
Original Assignee
印度商皮埃企業有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 印度商皮埃企業有限公司 filed Critical 印度商皮埃企業有限公司
Publication of TW202009235A publication Critical patent/TW202009235A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D339/00Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02Five-membered rings
    • C07D339/04Five-membered rings having the hetero atoms in positions 1 and 2, e.g. lipoic acid
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • A01N43/24Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with two or more hetero atoms
    • A01N43/26Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with two or more hetero atoms five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

The present invention discloses 1,2-dithiolone compounds of the formula (I),
Figure 108129373-A0101-11-0001-2
wherein, A, Cy, R, R1 , R2a and R2b have the same meanings as defined in the description. The present invention further discloses methods for their preparation and the use of 1,2-dithiolone compounds of formula (I) and/or composition thereof for the protection of crops against undesired phytopathogenic microorganisms.

Description

1,2-二硫醇酮化合物及其用途1,2-dithiol ketone compound and its use

本發明涉及式(I)的1,2-二硫醇酮化合物。更具體地,本發明涉及式(I)的1,2-二硫醇酮化合物及其製備方法。本發明還涉及式(I)的1,2-二硫醇化合物作為疾病控制劑的用途。The present invention relates to 1,2-dithiol compounds of formula (I). More specifically, the present invention relates to a 1,2-dithiol compound of formula (I) and a method for preparing the same. The invention also relates to the use of the 1,2-dithiol compound of formula (I) as a disease control agent.

控制植物病原微生物和病蟲害對作物的危害對於實現作物高產是極其重要的。例如,植物病害可導致觀賞植物、蔬菜、牧場、穀類和水果作物的生產力的顯著降低,從而增加消費者的成本。許多產品在商業上可以控制這種損害。但是還是需要更有效、成本更低、毒性更小、環境更安全和/或具有不同作用方式的新化合物。Controlling the damage of plant pathogenic microorganisms and pests to crops is extremely important for achieving high crop yields. For example, plant diseases can lead to a significant reduction in the productivity of ornamental plants, vegetables, pastures, cereals, and fruit crops, thereby increasing consumer costs. Many products can control this damage commercially. However, there is still a need for new compounds that are more effective, less costly, less toxic, safer in the environment, and/or have different modes of action.

某些1,2-二硫醇酮化合物在文獻中公開為殺蟲劑中的殺微生物活性成分。例如,DE1278701、FR2541680、GB1136793、US3527867公開了1,2-二硫醇酮化合物作為殺真菌劑(單獨或作為組合物的一部分)的用途。Certain 1,2-dithiol compounds are disclosed in the literature as microbicidal active ingredients in insecticides. For example, DE1278701, FR2541680, GB1136793, US3527867 disclose the use of 1,2-dithiol compounds as fungicides (alone or as part of a composition).

先前技術化合物的缺點是這些化合物的殺真菌活性(特別是在低施用率下)是不令人滿意的。因此,還是需要更有效、成本更低、毒性更小、環境更安全和/或具有不同作用方式的新化合物。The disadvantage of the prior art compounds is that the fungicidal activity of these compounds (especially at low application rates) is unsatisfactory. Therefore, there is still a need for new compounds that are more efficient, less costly, less toxic, safer in the environment, and/or have different modes of action.

鑒於上述情況,本發明設想了能夠克服與先前技術相關的缺點的化合物。In view of the foregoing, the present invention contemplates compounds that can overcome the disadvantages associated with the prior art.

本發明的目的是提供對植物病原性有害真菌具有增強功效和/或更廣泛活性譜的化合物。The object of the present invention is to provide compounds with enhanced efficacy and/or a broader spectrum of activity against phytopathogenic harmful fungi.

本發明公開的某些1,2-二硫醇酮類化合物具有優秀的對植物致病真菌的殺真菌活性,可以出人意料地實現該目的。Certain 1,2-dithiol ketone compounds disclosed in the present invention have excellent fungicidal activity against phytopathogenic fungi, and this objective can be achieved unexpectedly.

因此,本發明提供式(I)的1,2-二硫醇酮化合物,

Figure 02_image001
其中,A、Cy、R、R1 、R2a 和R2b 如詳述中所定義。Therefore, the present invention provides a 1,2-dithiol compound of formula (I),
Figure 02_image001
Among them, A, Cy, R, R 1 , R 2a and R 2b are as defined in the detailed description.

本發明還涉及式(I)化合物的農業上可接受的鹽、結構異構體、立體異構體、非對映異構體、對映異構體、互變異構體、金屬絡合物、多晶型物、S-氧化物或N-氧化物。The present invention also relates to agriculturally acceptable salts, structural isomers, stereoisomers, diastereomers, enantiomers, tautomers, metal complexes of compounds of formula (I), Polymorph, S-oxide or N-oxide.

本發明進一步涉及包含至少一種式(I)化合物和任選至少一種選自殺真菌劑、殺蟲劑、殺線蟲劑、殺蟎劑、生物殺蟲劑、除草劑、植物生長調節劑、抗生素、肥料和/或其混合物的活性化合物的組合物。The invention further relates to comprising at least one compound of formula (I) and optionally at least one selected from fungicides, insecticides, nematicides, acaricides, biological insecticides, herbicides, plant growth regulators, antibiotics, fertilizers And/or a mixture of active compounds thereof.

在一個實施方案中,本發明提供式(I)的1,2-二硫醇酮化合物或其農業上可接受的鹽作為作物保護劑用於防治不想要的植物致病微生物(優選真菌病原體)的用途。In one embodiment, the present invention provides a 1,2-dithiol compound of formula (I) or an agriculturally acceptable salt thereof as a crop protection agent for controlling unwanted phytopathogenic microorganisms (preferably fungal pathogens) the use of.

本發明詳細描述 定義Detailed description of the invention definition

本文提供的用於本公開中使用的術語的定義僅用於說明目的,並且決不限制本發明公開的本發明的範圍。The definitions of the terms used in this disclosure provided herein are for illustrative purposes only, and in no way limit the scope of the invention disclosed by the invention.

本文所用的“包含”、“包括”、“具有”、“擁有”、“以...為特徵”或其任何其他變體旨在涵蓋非排他性包含,但須受明確指明的除外。例如,組合、混合、過程或方法包含的要素表的不一定局限於這些要素,但可以包括沒有明確列出的該組合、混合、步驟或方法固有的其他要素。As used herein, "comprising", "including", "having", "having", "characterized by" or any other variants thereof are intended to cover non-exclusive inclusions, unless expressly stated otherwise. For example, the list of elements included in a combination, mixture, process, or method is not necessarily limited to these elements, but may include other elements inherent to the combination, mixture, step, or method that are not explicitly listed.

過渡詞“由...組成”排除任何未指定的元素、步驟或成分。如果在申請專利範圍中(除了通常與之相關的雜項之外),這樣的申請專利範圍將包含除所述材料之外的材料。當“由…組成”一詞出現在申請專利範圍正文的一個條款中,而不是緊接在序言之後時,它只限制該條款所規定的要素;其他因素也未從整個申請專利範圍中排除。The transitional word "consisting of" excludes any unspecified elements, steps or ingredients. If it is within the scope of the patent application (except for the miscellaneous items usually associated with it), such a patent application will include materials other than those mentioned. When the term "consisting of" appears in a clause in the main body of the patent application rather than immediately after the preamble, it only restricts the elements specified in the clause; other factors have not been excluded from the entire scope of the patent application.

過渡詞“基本上由...組成”用於定義包括材料、步驟、特徵、成分或要素的組合物或方法,條件是這些附加材料、步驟、特徵、成分或要素不實質上影響申請專利範圍保護的發明的基本要素和新穎特徵。術語“基本上由......組成”佔據“包含”和“由......組成”之間的中間地帶。The transitional word "consisting essentially of" is used to define a composition or method that includes materials, steps, features, ingredients or elements, provided that these additional materials, steps, features, ingredients or elements do not substantially affect the scope of the patent application The essential elements and novel features of the protected invention. The term "consisting essentially of" occupies the middle ground between "contains" and "consists of".

此外,除非有相反的明確說明,否則“或”是指包含性的“或”而不是排他性的“或”。例如,條件A“或”B滿足以下任何一個:A為真(或存在)且B為假(或不存在),A為假(或不存在)且B為真(或現在),A和B都為真(或存在)。In addition, unless expressly stated to the contrary, "or" refers to an inclusive "or" rather than an exclusive "or". For example, the condition A "or" B meets any of the following: A is true (or exists) and B is false (or does not exist), A is false (or does not exist) and B is true (or present), A and B Are true (or exist).

此外,在本發明的要素或成分之前的不定冠詞“a”和“an”不限制該要素或成分的實例(即出現次數)的數量。因此,“a”或“an”應該被理解為包括一個或至少一個,並且要素或成分的單數單詞形式也包括複數,除非該數明顯是單數的。In addition, the indefinite articles "a" and "an" preceding an element or component of the present invention do not limit the number of instances (ie, the number of occurrences) of the element or component. Therefore, "a" or "an" should be understood to include one or at least one, and the singular word form of an element or component also includes a plural, unless the number is clearly singular.

本公開中所提到的術語“農藥”在每種情況下也總是包括術語“作物保護劑”。The term "pesticide" referred to in this disclosure also always includes the term "crop protection agent" in each case.

術語“有害微生物”或“植物病原微生物”如真菌或細菌病原體包括包括瘧原蟲菌類、卵菌類、壺菌菌類、接合菌類、子囊菌類、擔子菌類和申菌類,以及假單胞菌科、根瘤菌科、腸桿菌科、棒狀桿菌科和鏈黴菌科。The term "harmful microorganisms" or "plant pathogenic microorganisms" such as fungi or bacterial pathogens include Plasmodium fungi, oomycetes, chytridiomycetes, Zygomycetes, Ascomycetes, Basidiomycetes and Shenmycetes, as well as Pseudomonasceae, Rhizobia Mycobacteriaceae, Enterobacteriaceae, Corynebacteriaceae, and Streptomycesceae.

術語“農業的”一詞是指農作物如食物和纖維的生產,包括種植玉米、大豆和其他豆類、大米、穀物(如小麥、燕麥、大麥、黑麥、水稻、玉米)、綠葉蔬菜(如生菜、捲心菜和其他油菜作物)、果實蔬菜(如番茄、胡椒、茄子、十字花科植物和葫蘆)、土豆、紅薯、葡萄、棉花、樹木果實(如梨果和柑橘),小水果(草莓、櫻桃)和其他特種作物(如油菜、向日葵、橄欖)。The term "agricultural" refers to the production of crops such as food and fiber, including growing corn, soybeans and other legumes, rice, cereals (such as wheat, oats, barley, rye, rice, corn), green leafy vegetables (such as lettuce) , Cabbage and other rape crops), fruits and vegetables (such as tomatoes, peppers, eggplants, crucifers and gourds), potatoes, sweet potatoes, grapes, cotton, tree fruits (such as pears and citrus), small fruits (strawberries, cherries ) And other special crops (eg rape, sunflower, olive).

術語“非農的”一詞指的非農作物,例如園藝作物(例如,未在田間生長的溫室,苗圃或觀賞植物),住宅、農業、商業和工業結構、草皮(例如,草皮農場、牧場、高爾夫球場、草坪、運動場等)、木製品、儲藏物、農林業和植被管理、公共衛生(即人類)和動物(例如寵物、牲畜和家禽等馴養動物、非馴養動物等野生動物)健康應用。The term "non-agricultural" refers to non-agricultural crops, such as horticultural crops (eg, greenhouses, nurseries or ornamental plants that are not grown in the field), residential, agricultural, commercial and industrial structures, turf (eg, turf farms, pastures, Golf courses, lawns, sports fields, etc.), wood products, storage, agroforestry and vegetation management, public health (ie humans) and animals (such as domestic animals such as pets, livestock and poultry, and wild animals such as non-domestic animals) for health applications.

非農學應用包括通過將生物有效量的本發明化合物(通常以獸醫用組合物的形式)給予待保護的動物來保護動物免受微生物的侵害。Non-agricultural applications include protecting animals from microorganisms by administering a biologically effective amount of a compound of the invention (usually in the form of a veterinary composition) to the animal to be protected.

通常,術語“取代的”,無論其前面是否有“任選地”一詞,是指基團上存在的至少一個氫(例如,碳或氮原子等)被允許的取代基{例如,在取代後產生穩定的化合物[例如在正常條件(溫度,壓力,空氣等)下不會自發地(例如通過重排、環化、消除或其它反應)進行轉化的化合物]的取代基}取代。除非另有說明,否則“取代的”基團可以在該基團的一個或多個可取代的位置具有取代基,並且當在任何給定結構中有多個位置被取代時,每個位置上的取代基可以相同或不同。In general, the term "substituted", whether or not preceded by the word "optionally", refers to a substituent on which at least one hydrogen (eg, carbon or nitrogen atom, etc.) present on the group is allowed {eg, in substitution Substances that produce stable compounds [such as compounds that do not undergo spontaneous conversion (such as by rearrangement, cyclization, elimination, or other reactions) under normal conditions (temperature, pressure, air, etc.)]. Unless otherwise stated, a "substituted" group may have a substituent at one or more substitutable positions of the group, and when multiple positions are substituted in any given structure, each position May have the same or different substituents.

下面就本說明中使用的各種術語的含義給予說明:The following explains the meaning of the various terms used in this description:

本文使用的術語“脂族化合物”或“脂族基團”是碳原子以直鏈、支鏈或非芳族環連接的有機化合物。The term "aliphatic compound" or "aliphatic group" as used herein is an organic compound in which carbon atoms are connected in a straight chain, branched chain, or non-aromatic ring.

術語“烷基”(獨立使用或在“烷基硫”或“鹵代烷基”或-N(烷基)或烷基羰基烷基或烷基磺醯胺基等複合詞中使用)包括直鏈或支鏈C1 到C24 烷基,優選C1 到C15 烷基,優選C1 到C10 烷基,優選C1 到C6 烷基。烷基的非限制性例子包括甲基、乙基、丙基、1-甲基乙基、1-甲基乙基、戊基、1-甲基丁基、1-甲基丁基、2-甲基丁基、2-甲基丙基、1-甲基戊基、1-甲基戊基、1-甲基戊基、2-甲基戊基、3-甲基戊基、4-甲基戊基、1,1-二甲基丁基、1,2-二甲基丁基、2,3-二甲基丁基、3,3-二甲基丁基、1-乙基丁基、2-乙基丁基、1,1,2-三甲基丙基、1,2,2-三甲基丙基,1-乙基1-甲基丙基和l-乙基2-甲基丙基或不同異構體。如果烷基在複合取代基的末端,例如,在烷基環烷基中,起始的複合取代基的部分,例如環烷基,可以以相同或不同方式且獨立地被烷基單取代或多取代。這同樣適用於其他自由基如烯基、烷基、羥基、鹵素、羰基、羰基氧基等位於末端的複合取代基。The term "alkyl" (used independently or in compound words such as "alkylsulfide" or "haloalkyl" or -N(alkyl) or alkylcarbonylalkyl or alkylsulfonamide) includes straight chain or branched The chain C 1 to C 24 alkyl, preferably C 1 to C 15 alkyl, preferably C 1 to C 10 alkyl, preferably C 1 to C 6 alkyl. Non-limiting examples of alkyl groups include methyl, ethyl, propyl, 1-methylethyl, 1-methylethyl, pentyl, 1-methylbutyl, 1-methylbutyl, 2- Methylbutyl, 2-methylpropyl, 1-methylpentyl, 1-methylpentyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methyl Amylpentyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1-ethylbutyl , 2-ethylbutyl, 1,1,2-trimethylpropyl, 1,2,2-trimethylpropyl, 1-ethyl 1-methylpropyl and l-ethyl 2-methyl Propyl or different isomers. If the alkyl group is at the end of the composite substituent, for example, in an alkylcycloalkyl, the portion of the initial composite substituent, such as cycloalkyl, can be mono-substituted or multiply substituted with alkyl in the same or different manners and independently replace. The same applies to other free radicals such as alkenyl, alkyl, hydroxyl, halogen, carbonyl, carbonyloxy and other compound substituents at the end.

術語“烯基”(獨立使用或在複合詞中使用)包括直鏈或C2 到C24 烯烴、優選C2 到C15 烯烴、更優選C2 到C10 烯烴、更優選C2 到C6 烯烴的支鏈。烯烴的非限制性例子包括乙烯基、1-丙烯基、2-丙烯基、1-丁烯基、2-丁烯基、1-甲基-1-丙烯基、2-甲基-2-丙烯基、2-甲基-1-丁烯基、1-甲基-1-丁烯基、2-甲基-1-丁烯基、3-甲基-2-丁烯基、3-甲基-3-丁烯基、2-甲基-3-丁烯基、3-甲基-3-丁烯基、1-1-二甲-2-丁烯基、1,2-二甲基-2-丙烯、1-乙基-1-丙烯、1-乙基-2-丙烯、1-乙基-2-戊烯、3-甲基-1-戊烯、2-甲基-1-戊烯、3-甲基-2-戊烯、3-甲基-2-戊烯、3-甲基-3-戊烯、3-甲基-3-戊烯、4-甲基-4-戊烯、3-甲基-4-戊烯、3-甲基-4-戊烯、1,1-二甲基-2-丁烯基、l,l-二甲基-3-丁烯基、1,2-二甲基-2-丁烯基、1,2-二甲基-3-丁烯基、1,3-二甲基-3-丁烯基、2,3-二甲基-3-丁烯基、2,3-二甲基-3-丁烯基、2,3-二甲基-3-丁烯基、3,3-二甲基-3-丁烯基、1-乙基-1-丁烯基、1-乙基-2-丁烯基、2-乙基-2-丁烯基、2-乙基-2-丁烯基、2-乙基-2-丁烯基、2-乙基-2-丁烯基、2-乙基-2-丁烯基、1-乙基-2-丁烯基、l-乙基-2-甲基-l-丙烯和l-乙基-2-甲基-2-丙烯及其異構體。烯烴也包括多烯,如1,2-丙二烯和2,4-己二烯。除非在其他地方有明確的定義,否則這個定義也適用於烯烴作為一部分的複合取代基,例如鹵代烯烴等。The term "alkenyl" (used independently or in compound words) includes linear or C 2 to C 24 olefins, preferably C 2 to C 15 olefins, more preferably C 2 to C 10 olefins, more preferably C 2 to C 6 olefins Branch. Non-limiting examples of olefins include vinyl, 1-propenyl, 2-propenyl, 1-butenyl, 2-butenyl, 1-methyl-1-propenyl, 2-methyl-2-propenyl Group, 2-methyl-1-butenyl, 1-methyl-1-butenyl, 2-methyl-1-butenyl, 3-methyl-2-butenyl, 3-methyl -3-butenyl, 2-methyl-3-butenyl, 3-methyl-3-butenyl, 1--1-dimethyl-2-butenyl, 1,2-dimethyl- 2-propene, 1-ethyl-1-propene, 1-ethyl-2-propene, 1-ethyl-2-pentene, 3-methyl-1-pentene, 2-methyl-1-pentene Ene, 3-methyl-2-pentene, 3-methyl-2-pentene, 3-methyl-3-pentene, 3-methyl-3-pentene, 4-methyl-4-pentene Ene, 3-methyl-4-pentene, 3-methyl-4-pentene, 1,1-dimethyl-2-butenyl, 1,1-dimethyl-3-butenyl, 1,2-dimethyl-2-butenyl, 1,2-dimethyl-3-butenyl, 1,3-dimethyl-3-butenyl, 2,3-dimethyl- 3-butenyl, 2,3-dimethyl-3-butenyl, 2,3-dimethyl-3-butenyl, 3,3-dimethyl-3-butenyl, 1- Ethyl-1-butenyl, 1-ethyl-2-butenyl, 2-ethyl-2-butenyl, 2-ethyl-2-butenyl, 2-ethyl-2-butenyl Alkenyl, 2-ethyl-2-butenyl, 2-ethyl-2-butenyl, 1-ethyl-2-butenyl, 1-ethyl-2-methyl-1-propene and l-ethyl-2-methyl-2-propene and its isomers. Alkenes also include polyenes, such as 1,2-propadiene and 2,4-hexadiene. Unless there is a clear definition elsewhere, this definition also applies to compound substituents as part of olefins, such as halogenated olefins.

術語“炔基”(單獨使用或在複合詞中使用)包括支鏈或直鏈C2 到C24 炔烴、優選C2 到C15 炔烴、更優選C2 到C10 炔烴、最優選C2 到C6 炔烴。炔的非限制性例子包括乙炔基、1-丙炔基、2-丙炔基、1-丁炔基、2-丁炔基、3-丁炔基、1-甲基-2-丙炔基、1-戊炔基、2-戊炔基、3-戊炔基,4-戊炔基、1-甲基-2-丁炔基、1-甲基-3-丁炔基、2-甲基-3-丁炔基、3-甲基-1-丁炔基、1,1-二甲基-2-丙炔基、1-乙基-2-丙炔基、1-己炔基、2-己炔基、3-己炔基、4-己炔基、5-己炔基、1-甲基-2-戊炔基、1-甲基-3-戊炔基、1-甲基-4-戊炔基、2-甲基-3-戊炔基、2-甲基-4-戊炔基、3-甲基-1-戊炔基、3-甲基-4-戊炔基、4-甲基-1-戊炔基、4-甲基-2-戊炔基、1,1-二甲基-2-丁炔基、1,1-二甲基-3-丁炔基、1,2-二甲基-3-丁炔基、2,2-二甲基-3-丁炔基、3,3-二甲基-1-丁炔基、1-乙基-2-丁炔基、1-乙基-3-丁炔基、2-乙基-3-丁炔基和1-乙基-1-甲基-2-丙炔基和不同的異構體。除非在別處具體限定,否則定義也適用於作為複合取代基的一部分的炔基,例如鹵代炔基等。術語“炔基”還可包括由多個三鍵組成的部分,例如2,5-己二炔基。The term "alkynyl" (used alone or in compound words) includes branched or straight chain C 2 to C 24 alkyne, preferably C 2 to C 15 alkyne, more preferably C 2 to C 10 alkyne, most preferably C 2 to C 6 alkynes. Non-limiting examples of alkynes include ethynyl, 1-propynyl, 2-propynyl, 1-butynyl, 2-butynyl, 3-butynyl, 1-methyl-2-propynyl , 1-pentynyl, 2-pentynyl, 3-pentynyl, 4-pentynyl, 1-methyl-2-butynyl, 1-methyl-3-butynyl, 2-methyl Yl-3-butynyl, 3-methyl-1-butynyl, 1,1-dimethyl-2-propynyl, 1-ethyl-2-propynyl, 1-hexynyl, 2-hexynyl, 3-hexynyl, 4-hexynyl, 5-hexynyl, 1-methyl-2-pentynyl, 1-methyl-3-pentynyl, 1-methyl -4-pentynyl, 2-methyl-3-pentynyl, 2-methyl-4-pentynyl, 3-methyl-1-pentynyl, 3-methyl-4-pentynyl , 4-methyl-1-pentynyl, 4-methyl-2-pentynyl, 1,1-dimethyl-2-butynyl, 1,1-dimethyl-3-butynyl , 1,2-dimethyl-3-butynyl, 2,2-dimethyl-3-butynyl, 3,3-dimethyl-1-butynyl, 1-ethyl-2- Butynyl, 1-ethyl-3-butynyl, 2-ethyl-3-butynyl and 1-ethyl-1-methyl-2-propynyl and different isomers. Unless specifically defined elsewhere, the definition also applies to alkynyl groups that are part of a composite substituent, such as haloalkynyl and the like. The term "alkynyl" may also include moieties composed of multiple triple bonds, such as 2,5-hexadiynyl.

術語“環烷基”是指閉合形成環的烷基。非限制性實例包括但不限於環丙基、環丁基、環戊基和環己基。除非在別處明確限定,否則該定義也適用於作為複合取代基的一部分的環烷基,例如環烷基烷基等。The term "cycloalkyl" refers to an alkyl group closed to form a ring. Non-limiting examples include, but are not limited to cyclopropyl, cyclobutyl, cyclopentyl, and cyclohexyl. Unless explicitly defined elsewhere, this definition also applies to cycloalkyl as part of a composite substituent, such as cycloalkylalkyl and the like.

術語“環烯基”指閉合形成環烯基,包括單環,部分不飽和的烴基。非限制性實例包括但不限於環戊烯基和環己烯基。除非在別處明確限定,否則該定義也適用於作為複合取代基的一部分的環烯基,例如環烯基烷基等。The term "cycloalkenyl" refers to the formation of cycloalkenyl groups, including monocyclic, partially unsaturated hydrocarbon groups. Non-limiting examples include, but are not limited to cyclopentenyl and cyclohexenyl. Unless clearly defined elsewhere, this definition also applies to cycloalkenyl as part of a composite substituent, such as cycloalkenylalkyl and the like.

術語“環炔基”是指閉合形成環的炔基,包括單環、部分不飽和的基團。除非在別處具體限定,該定義也適用於作為複合取代基的一部分的環炔基,例如環炔基烷基等。The term "cycloalkynyl" refers to an alkynyl group that is closed to form a ring and includes monocyclic, partially unsaturated groups. Unless specifically defined elsewhere, this definition also applies to cycloalkynyl as part of a composite substituent, such as cycloalkynylalkyl and the like.

“環烷氧基”,“環烯氧基”等類似詞具有類似的定義。環烷氧基的非限制性實例包括環丙氧基,環戊氧基和環己氧基。除非在別處明確限定,否則該定義也適用於環烷氧基作為複合取代基的一部分,例如環烷氧基烷基等。"Cycloalkoxy", "cycloalkenyloxy" and similar words have similar definitions. Non-limiting examples of cycloalkoxy include cyclopropoxy, cyclopentyloxy and cyclohexyloxy. Unless explicitly defined elsewhere, this definition also applies to cycloalkoxy as part of a composite substituent, such as cycloalkoxyalkyl.

術語“鹵素”(獨立或以複合詞如“鹵代烷基”使用)包括氟、氯、溴或碘。此外,當用於諸如“鹵代烷基”的複合詞時,所述烷基可以部分或完全被鹵素原子取代,所述鹵素原子可以相同或不同。“鹵代烷基”的非限制性實例包括氯甲基、溴甲基、二氯甲基、三氯甲基、氟甲基、二氟甲基、三氟甲基、氯氟甲基、二氯氟甲基、氯二氟甲基、1-氯乙基、1-溴乙基、1-氟乙基、2-氟乙基、2,2-二氟乙基 2,2,2-三氟乙基、2-氯-2-氟乙基、2-氯-2,2-二氟乙基、2,2-二氯-2-氟乙基、2,2,2-三氯乙基、五氟乙基、1,1-二氯-2,2,2-三氟乙基和1,1,1-三氟丙-2-基。除非在別處明確限定,否則這個定義也適用於鹵代烷基作為複合取代基的一部分,例如鹵代烷基氨基烷基等。The term "halogen" (independently or used in compound words such as "haloalkyl") includes fluorine, chlorine, bromine or iodine. In addition, when used for compound words such as "haloalkyl", the alkyl group may be partially or completely substituted with a halogen atom, and the halogen atoms may be the same or different. Non-limiting examples of "haloalkyl" include chloromethyl, bromomethyl, dichloromethyl, trichloromethyl, fluoromethyl, difluoromethyl, trifluoromethyl, chlorofluoromethyl, dichlorofluoro Methyl, chlorodifluoromethyl, 1-chloroethyl, 1-bromoethyl, 1-fluoroethyl, 2-fluoroethyl, 2,2-difluoroethyl 2,2,2-trifluoroethyl Group, 2-chloro-2-fluoroethyl, 2-chloro-2,2-difluoroethyl, 2,2-dichloro-2-fluoroethyl, 2,2,2-trichloroethyl, penta Fluoroethyl, 1,1-dichloro-2,2,2-trifluoroethyl and 1,1,1-trifluoroprop-2-yl. Unless clearly defined elsewhere, this definition also applies to haloalkyl as part of a composite substituent, such as haloalkylaminoalkyl.

術語“鹵代烯基”和“鹵代炔基”的定義類似,不同的是烯基和炔基代替烷基作為取代基的一部分存在。The terms "haloalkenyl" and "haloalkynyl" are defined similarly, except that alkenyl and alkynyl exist as part of the substituent instead of alkyl.

術語“鹵代烷氧基”是指直鏈或支鏈烷氧基,其中這些基團中的一些或所有氫原子可以被如上所述的鹵素原子取代。鹵代烷氧基的非限制性實例包括氯甲氧基,溴甲氧基,二氯甲氧基,三氯甲氧基,氟甲氧基,二氟甲氧基,三氟甲氧基,氯氟甲氧基,二氯氟甲氧基,氯二氟甲氧基,1-氯乙氧基,1-溴乙氧基,1-氟乙氧基,2-氟乙氧基,2,2-二氟乙氧基,2,2,2-三氟乙氧基,2-氯-2-氟乙氧基,2-氯-2,2-二氟乙氧基,2,2-二氯-2-氟乙氧基,2,2,2-三氯乙氧基,五氟乙氧基和1,1,1-三氟丙-2-氧基。除非在別處明確限定,否則該定義也適用於鹵代烷氧基作為複合取代基的一部分的基團,例如鹵代烷氧基烷基等。The term "haloalkoxy" refers to a straight-chain or branched-chain alkoxy group in which some or all of the hydrogen atoms in these groups may be replaced by halogen atoms as described above. Non-limiting examples of haloalkoxy include chloromethoxy, bromomethoxy, dichloromethoxy, trichloromethoxy, fluoromethoxy, difluoromethoxy, trifluoromethoxy, chlorofluoro Methoxy, dichlorofluoromethoxy, chlorodifluoromethoxy, 1-chloroethoxy, 1-bromoethoxy, 1-fluoroethoxy, 2-fluoroethoxy, 2,2- Difluoroethoxy, 2,2,2-trifluoroethoxy, 2-chloro-2-fluoroethoxy, 2-chloro-2,2-difluoroethoxy, 2,2-dichloro- 2-fluoroethoxy, 2,2,2-trichloroethoxy, pentafluoroethoxy and 1,1,1-trifluoroprop-2-oxy. Unless clearly defined elsewhere, this definition also applies to groups where haloalkoxy is part of a composite substituent, such as haloalkoxyalkyl and the like.

術語“鹵代烷硫基”是指直鏈或支鏈烷硫基,其中這些基團中的一些或所有氫原子可以被如上所述的鹵素原子取代。鹵代烷硫基的非限制性實例包括氯甲硫基,溴甲硫基,二氯甲硫基,三氯甲硫基,氟甲硫基,二氟甲硫基,三氟甲硫基,氯氟甲硫基,二氯氟甲硫基,氯二氟甲硫基,1-氯乙硫基,1-溴乙硫基,1-氟乙硫基,2-氟乙硫基,2,2-二氟乙硫基,2,2,2-三氟乙硫基,2-氯-2-氟乙硫基,2-氯-2,2-二氟乙硫基,2,2-二氯-2-氟乙硫基,2,2,2-三氯乙硫基,五氟乙硫基和1,1,1-三氟丙-2-基硫基。除非在別處具體限定,否則該定義也適用於鹵代烷硫基作為複合取代基的一部分的,例如鹵代烷硫基烷基等。The term "haloalkylthio" refers to a straight-chain or branched-chain alkylthio group in which some or all of the hydrogen atoms in these groups may be replaced by halogen atoms as described above. Non-limiting examples of haloalkylthio groups include chloromethylthio, bromomethylthio, dichloromethylthio, trichloromethylthio, fluoromethylthio, difluoromethylthio, trifluoromethylthio, chlorofluoro Methylthio, dichlorofluoromethylthio, chlorodifluoromethylthio, 1-chloroethylthio, 1-bromoethylthio, 1-fluoroethylthio, 2-fluoroethylthio, 2,2- Difluoroethylthio, 2,2,2-trifluoroethylthio, 2-chloro-2-fluoroethylthio, 2-chloro-2,2-difluoroethylthio, 2,2-dichloro- 2-fluoroethylthio, 2,2,2-trichloroethylthio, pentafluoroethylthio and 1,1,1-trifluoroprop-2-ylthio. Unless specifically defined elsewhere, this definition also applies to halogenated alkylthio groups as part of the composite substituent, such as halogenated alkylthioalkyl groups.

“鹵代烷基亞磺醯基”的非限制性實例包括CF3 S(O)、CCl3 S(O)、CF3 CH2 S(O)。“鹵代烷基磺醯基”的非限制性實例包括CF3 S(O)2 、CCl3 S(O)2 、CF3 CH2 S(O)2 和CF3 CF2 S(O)2Non-limiting examples of "haloalkylsulfinyl" include CF 3 S(O), CCl 3 S(O), CF 3 CH 2 S(O). Non-limiting examples of "haloalkylsulfonyl" include CF 3 S(O) 2 , CCl 3 S(O) 2 , CF 3 CH 2 S(O) 2 and CF 3 CF 2 S(O) 2 .

術語“羥基”表示-OH,氨基表示-NRR,其中R可以是H或任何可能的取代基,例如烷基。羰基表示-C(O)-,羰基氧基表示-OC(O)-,亞磺醯基表示SO,磺醯基表示S(O)2The term "hydroxyl" means -OH and amino means -NRR, where R may be H or any possible substituent, such as alkyl. Carbonyl represents -C(O)-, carbonyloxy represents -OC(O)-, sulfinyl represents SO, and sulfonyl represents S(O) 2 .

術語“烷氧基”(單獨使用或以複合詞的形式使用)包括C1 至C1 烷氧基、優選C1 至C15 烷氧基、更優選C1 至C10 烷氧基、最優選C1 至C6烷氧基。烷氧基的實例包括甲氧基、乙氧基、丙氧基、1-甲基乙氧基、丁氧基、1-甲基丙氧基、2-甲基丙氧基、1,1-二甲基乙氧基、戊氧基、1-甲基丁氧基、2-甲基丁氧基、3-甲基丁氧基、2,2-二甲基丙氧基、1-乙基丙氧基、己氧基、1,1-二甲基丙氧基、1,2-二甲基丙氧基、1-甲基戊氧基、2-甲基戊氧基、3-甲基戊氧基、4-甲基戊氧基、1,1-二甲基丁氧基、1,2-二甲基丁氧基、1,3-二甲基丁氧基、2,2-二甲基丁氧基、2,3-二甲基丁氧基、3,3-二甲基丁氧基、1-乙基丁氧基、2-乙基丁氧基、1,1,2-三甲基丙氧基、1,2,2-三甲基丙氧基、1-乙基-1-甲基丙氧基和1-乙基-2-甲基丙氧基和不同的異構體。除非在別處具體限定,否則該定義也適用於烷氧基作為複合取代基的一部分,例如鹵代烷氧基、炔基烷氧基等。The term "alkoxy" (used alone or in compound form) includes C 1 to C 1 alkoxy, preferably C 1 to C 15 alkoxy, more preferably C 1 to C 10 alkoxy, most preferably C 1 to C6 alkoxy. Examples of alkoxy groups include methoxy, ethoxy, propoxy, 1-methylethoxy, butoxy, 1-methylpropoxy, 2-methylpropoxy, 1,1- Dimethylethoxy, pentyloxy, 1-methylbutoxy, 2-methylbutoxy, 3-methylbutoxy, 2,2-dimethylpropoxy, 1-ethyl Propoxy, hexyloxy, 1,1-dimethylpropoxy, 1,2-dimethylpropoxy, 1-methylpentoxy, 2-methylpentoxy, 3-methyl Pentoxy, 4-methylpentoxy, 1,1-dimethylbutoxy, 1,2-dimethylbutoxy, 1,3-dimethylbutoxy, 2,2-bis Methylbutoxy, 2,3-dimethylbutoxy, 3,3-dimethylbutoxy, 1-ethylbutoxy, 2-ethylbutoxy, 1,1,2- Trimethylpropoxy, 1,2,2-trimethylpropoxy, 1-ethyl-1-methylpropoxy and 1-ethyl-2-methylpropoxy and different isomers body. Unless specifically defined elsewhere, this definition also applies to alkoxy as part of a composite substituent, such as haloalkoxy, alkynylalkoxy, and the like.

術語“烷氧基烷基”表示烷基被烷氧基取代。“烷氧基烷基”的非限制性實例包括CH3 OCH2 , CH3 OCH2 CH2 , CH3 CH2 OCH2 , CH3 CH2 CH2 CH2 OCH2 和CH3 CH2 OCH2 CH2The term "alkoxyalkyl" means that the alkyl group is substituted with an alkoxy group. Non-limiting examples of "alkoxyalkyl" include CH 3 OCH 2 , CH 3 OCH 2 CH 2 , CH 3 CH 2 OCH 2 , CH 3 CH 2 CH 2 CH 2 OCH 2 and CH 3 CH 2 OCH 2 CH 2 .

術語“烷氧基烷氧基”表示烷氧基被烷氧基取代。The term "alkoxyalkoxy" means that alkoxy is replaced by alkoxy.

術語“C6 -C16 芳氧基團”包括(例如)苯氧基,1-萘氧基,2-萘氧基,1-苊烯氧基,1-菲氧基,9-蒽氧基,和1-吡苯氧基。The term "C 6 -C 16 aryloxy group" includes, for example, phenoxy, 1-naphthyloxy, 2-naphthyloxy, 1-acenaphthenyloxy, 1-phenanthrenyloxy, 9-anthraceneoxy , And 1-pyrphenoxy.

術語“烷硫基”包括支鏈或直鏈烷硫基部分,例如甲硫基、乙硫基、丙硫基、1-甲硫基硫基、丁硫基、1-甲基丙硫基、2-甲基丙硫基、1,1-二甲基乙硫基、戊硫基、1-甲基丁硫基、2-甲基丁硫基 、3-甲基丁硫基、2,2-二甲基丙硫基、1-乙基丙硫基、己硫基、1,1-二甲基丙硫基、1,2-二甲基丙硫基、1-甲基戊硫基、2-甲基戊硫基、3-甲基戊硫基、4-甲基戊硫基、1,1-二甲基丁硫基 1,2-二甲基丁硫基、1,3-二甲基丁硫基、2,2-二甲基丁硫基、2,3-二甲基丁硫基、3,3-二甲基丁硫基、1-乙基丁硫基、2-乙基丁硫基、1,1,2-三甲基丙硫基、1,2,2-二甲基丁硫基、2-三甲基丙硫基、1-乙基-1-甲基丙硫基和1-乙基-2-甲基丙硫基以及不同的異構體。The term "alkylthio" includes branched or straight chain alkylthio moieties such as methylthio, ethylthio, propylthio, 1-methylthiothio, butylthio, 1-methylpropylthio, 2-methylpropylthio, 1,1-dimethylethylthio, pentylthio, 1-methylbutylthio, 2-methylbutylthio, 3-methylbutylthio, 2,2 -Dimethylpropylthio, 1-ethylpropylthio, hexylthio, 1,1-dimethylpropylthio, 1,2-dimethylpropylthio, 1-methylpentylthio, 2-methylpentylthio, 3-methylpentylthio, 4-methylpentylthio, 1,1-dimethylbutylthio1,2-dimethylbutylthio, 1,3-bis Methylbutylthio, 2,2-dimethylbutylthio, 2,3-dimethylbutylthio, 3,3-dimethylbutylthio, 1-ethylbutylthio, 2-ethyl Butylthio, 1,1,2-trimethylpropylthio, 1,2.2-dimethylbutylthio, 2-trimethylpropylthio, 1-ethyl-1-methylpropyl Thio and 1-ethyl-2-methylpropylthio and different isomers.

鹵代環烷基、鹵代環烯基、烷基環烷基、環烷基烷基、環烷氧基烷基、烷基亞磺醯基烷基、烷基磺醯基烷基、鹵代烷基羰基、環烷基羰基、鹵代烷氧基烷基等的定義與上述例子類似。Halocycloalkyl, halocycloalkenyl, alkylcycloalkyl, cycloalkylalkyl, cycloalkoxyalkyl, alkylsulfinylalkyl, alkylsulfonylalkyl, haloalkyl The definition of carbonyl, cycloalkylcarbonyl, haloalkoxyalkyl, etc. is similar to the above examples.

術語“烷基硫代烷基”表示烷基被烷硫基取代。“烷基硫代烷基”的非限制性實例包括-CH2 SCH2 、-CH2 SCH2 CH2 、CH3 CH2 SCH2 、CH3 CH2 CH2 CH2 SCH2 和CH3 CH2 SCH2 CH2 。“烷基硫代烷氧基”表示烷氧基被烷硫基取代。“環烷基代烷基氨基”表示烷基氨基被環烷基取代。The term "alkylthioalkyl" means that the alkyl group is substituted with an alkylthio group. Non-limiting examples of "alkylthioalkyl" include -CH 2 SCH 2 , -CH 2 SCH 2 CH 2 , CH 3 CH 2 SCH 2 , CH 3 CH 2 CH 2 CH 2 SCH 2 and CH 3 CH 2 SCH 2 CH 2 . "Alkylthioalkoxy" means that the alkoxy group is substituted with an alkylthio group. "Cycloalkylalkylamino" means that the alkylamino is substituted with cycloalkyl.

烷氧基烷氧基烷基、烷基氨基烷基、二烷基氨基烷基、環烷基氨基烷基、環烷基氨基羰基等的定義與“烷基硫代烷基”或“環烷基代烷基氨基”類似。The definition of alkoxyalkoxyalkyl, alkylaminoalkyl, dialkylaminoalkyl, cycloalkylaminoalkyl, cycloalkylaminocarbonyl, etc. is the same as "alkylthioalkyl" or "cycloalkane" "Alkylalkylamino" is similar.

“烷氧基羰基”是通過羰基(-CO-)與骨架鍵合的烷氧基。除非在別處具體限定,否則該定義也適用於烷氧基羰基作為複合取代基的一部分,例如環烷基烷氧基羰基等。"Alkoxycarbonyl" is an alkoxy group bonded to a skeleton through a carbonyl group (-CO-). Unless specifically defined elsewhere, this definition also applies to alkoxycarbonyl as part of a composite substituent, such as cycloalkylalkoxycarbonyl and the like.

術語“烷氧基羰基烷基氨基”表示烷基氨基被烷氧基羰基取代。“烷基羰基烷基氨基”表示烷基氨基被烷基羰基取代。 術語烷硫基烷氧基羰基、環烷基烷基氨基烷基等的定義與此類似。The term "alkoxycarbonylalkylamino" means that the alkylamino group is substituted with an alkoxycarbonyl group. "Alkylcarbonylalkylamino" means that the alkylamino group is substituted with an alkylcarbonyl group. The terms alkylthioalkoxycarbonyl, cycloalkylalkylaminoalkyl, etc. are defined similarly.

“烷基亞磺醯基”的非限制性例子包括但不限於甲基亞磺醯基、乙基亞磺醯基、丙基亞磺醯基、1-甲基乙基亞磺醯基、丁基亞磺醯基、1-甲基丙基亞磺醯基、2-甲基丁基亞磺醯基、1-甲基丁基亞磺醯基、2-甲基丁基亞磺醯基、2-甲基丁基亞磺醯基、1-乙基丙基亞磺醯基、1-乙基丙基亞磺醯基、1-2-二甲基丙基亞磺醯基、2-甲基戊基磺醯、3-甲基戊基磺醯、4-甲基戊基磺醯、1,1-二甲基丁基磺醯、1,3-二甲基丁基磺醯、2,3-二甲基丁基磺醯、3,3-二甲基丁基磺醯、1-乙基丁基磺醯、1,1,2-三甲基丙基磺醯、1-乙基1-甲基丙基磺醯和1-乙基2-甲基丙基磺醯及其異構體。“芳基亞磺醯基”一詞包括Ar-S(O),其中Ar可以是任何羧基或雜環。除非另有專門定義,否則這一定義也適用於烷基亞磺醯基作為複合取代基的一部分,例如鹵代烷基亞磺醯基等。Non-limiting examples of "alkylsulfinyl" include, but are not limited to, methylsulfinyl, ethylsulfinyl, propylsulfinyl, 1-methylethylsulfinyl, butyl Sulfenyl, 1-methylpropylsulfinyl, 2-methylbutylsulfinyl, 1-methylbutylsulfinyl, 2-methylbutylsulfinyl, 2-methylbutylsulfinyl, 1-ethylpropylsulfinyl, 1-ethylpropylsulfinyl, 1-2-dimethylpropylsulfinyl, 2-methyl Amylpentylsulfonamide, 3-methylpentylsulfonamide, 4-methylpentylsulfonamide, 1,1-dimethylbutylsulfonamide, 1,3-dimethylbutylsulfonamide, 2, 3-dimethylbutylsulfonamide, 3,3-dimethylbutylsulfonamide, 1-ethylbutylsulfonamide, 1,1,2-trimethylpropylsulfonamide, 1-ethyl 1 -Methyl propyl sulfonamide and 1-ethyl 2-methyl propyl sulfonamide and their isomers. The term "arylsulfinyl" includes Ar-S(O), where Ar may be any carboxyl or heterocyclic ring. Unless otherwise specifically defined, this definition also applies to alkylsulfinyl as part of a composite substituent, such as haloalkylsulfinyl and the like.

“烷基磺醯基”的非限制性例子包括但不限於甲基磺醯基、乙基磺醯基、丙基磺醯基、1-甲基乙基磺醯基、丁基磺醯基、1-甲基丙基磺醯基、2-甲基丁基磺醯基、1-甲基丁基磺醯基、2-甲基丁基磺醯基、3-甲基丁基磺醯基、2,2-甲基丙基磺醯基、1-乙基丙基磺醯基、1-乙基丙基磺醯基、1,2-二甲基丙基磺醯基、1-甲基磺醯基、2-甲基戊基磺基、3-甲基戊基磺基、4-甲基戊基磺基、1,1-二甲基丁基磺基、1,2-二甲基丁基磺基、2,2-二甲基丁基磺基、2,3-二甲基丁基磺基、3,3-二甲基丁基磺基、1-乙基丁基磺基、1,1,2-三甲基丙基磺基、1-乙基1-甲基丙基磺基、l-乙基2-甲基丙基磺基及其異構體。“芳基磺醯基”一詞包括Ar-S(O)2 ,其中Ar可以是任何羧基或雜環。除非另有定義,這個定義也適用於烷基磺醯基作為複合取代基的一部分,例如烷基磺基烷基等。Non-limiting examples of "alkylsulfonyl" include, but are not limited to, methylsulfonyl, ethylsulfonyl, propylsulfonyl, 1-methylethylsulfonyl, butylsulfonyl, 1-methylpropylsulfonyl, 2-methylbutylsulfonyl, 1-methylbutylsulfonyl, 2-methylbutylsulfonyl, 3-methylbutylsulfonyl, 2,2-methylpropylsulfonyl, 1-ethylpropylsulfonyl, 1-ethylpropylsulfonyl, 1,2-dimethylpropylsulfonyl, 1-methylsulfonate Acyl, 2-methylpentylsulfo, 3-methylpentylsulfo, 4-methylpentylsulfo, 1,1-dimethylbutylsulfo, 1,2-dimethylbutane Sulfo, 2,2-dimethylbutylsulfo, 2,3-dimethylbutylsulfo, 3,3-dimethylbutylsulfo, 1-ethylbutylsulfo, 1 , 1,2-trimethylpropylsulfo, 1-ethyl 1-methylpropylsulfo, 1-ethyl 2-methylpropylsulfo and its isomers. The term "arylsulfonyl" includes Ar-S(O) 2 , where Ar may be any carboxyl or heterocyclic ring. Unless otherwise defined, this definition also applies to alkylsulfonyl as part of a composite substituent, such as alkylsulfoalkyl and the like.

“烷基胺基”、“二烷基胺基”等術語的定義與上述示例類似。Definitions of terms such as "alkylamino" and "dialkylamino" are similar to the above examples.

術語“環”或“環系”或“Cy”作為式I的組分為碳環基或雜環基。術語“環系統”表示一個或多個環。“雙環或環系”是指由兩個或兩個以上常見原子組成的環系。The term "ring" or "ring system" or "Cy" as a component of formula I is carbocyclic or heterocyclic. The term "ring system" means one or more rings. "Bicyclic or ring system" refers to a ring system composed of two or more common atoms.

術語“碳環”或“碳環的”或“碳環基的”包括“芳族碳環系統”和“非芳族碳環系統”或多環或雙環(螺環、稠合、橋連、非稠合)環化合物,其中環可以是芳族的或 非芳香族(其中芳香族表示符合休克爾規則,非芳香族表示不滿足休克爾規則)。非芳族碳環系統的非限制性實例是環丙基、環丁基、環戊基、降莰基等。芳族碳環系統的非限制性實例是苯基、萘基等。The term "carbocyclic" or "carbocyclic" or "carbocyclic" includes "aromatic carbocyclic systems" and "non-aromatic carbocyclic systems" or polycyclic or bicyclic (spiro, fused, bridged, Non-fused) ring compounds, where the ring may be aromatic or non-aromatic (where aromatic means that the Huckel rule is met, and non-aromatic means that the Huckel rule is not met). Non-limiting examples of non-aromatic carbocyclic systems are cyclopropyl, cyclobutyl, cyclopentyl, norbornyl and the like. Non-limiting examples of aromatic carbocyclic systems are phenyl, naphthyl and the like.

術語“芳基”是指任何含碳基芳香族的基團,包括但不限於苯基、萘、聯苯、蒽等。芳基可以取代也可以不取代。此外,芳基可以是單環結構,也可以由多個環結構組成,這些環結構可以是熔合環結構,也可以通過一個或多個橋接基團(如碳碳鍵)連接。The term "aryl" refers to any aromatic group containing a carbon group, including but not limited to phenyl, naphthalene, biphenyl, anthracene, and the like. The aryl group may or may not be substituted. In addition, the aryl group may be a single ring structure, or may be composed of multiple ring structures, and these ring structures may be fused ring structures, or may be connected by one or more bridging groups (such as carbon-carbon bonds).

“芳烷基”是指芳基烴基,包括上文定義的烷基部分。實例包括苯甲基,苯乙基和6-萘基己基。本文所用“芳烯基”是指芳基烴基,包括上文定義的烯基部分和文定義的芳基部分。實例包括苯乙烯基,3-(苯甲基)丙-2-烯基和6-萘基己-2-烯基。"Aralkyl" refers to an aryl hydrocarbon group, including the alkyl moiety defined above. Examples include benzyl, phenethyl and 6-naphthylhexyl. As used herein, "arylalkenyl" refers to an aryl hydrocarbon group, including the alkenyl moiety defined above and the aryl moiety defined herein. Examples include styryl, 3-(benzyl)prop-2-enyl and 6-naphthylhex-2-enyl.

與環相關的術語“雜”是指其中至少一個環原子不是碳並且可以含有1至4個獨立地選自氮、氧和硫的雜原子的環,條件是每個環不超過4個氮,不超過2個氧和不超過2個硫。The term "hetero" in relation to a ring refers to a ring in which at least one ring atom is not carbon and may contain 1 to 4 heteroatoms independently selected from nitrogen, oxygen, and sulfur, provided that each ring does not exceed 4 nitrogens, No more than 2 oxygen and no more than 2 sulfur.

術語“芳香”表示滿足休克爾規則,“非芳香”表示不滿足休克爾規則。The term "aromatic" means that the Huckel rule is satisfied, and "non-aromatic" means that the Huckel rule is not satisfied.

“雜環”或“雜環的”包括“芳香雜環”或“雜芳基環系統”和“非芳香雜環系統”或多環或雙環(螺環,稠合,橋連,非稠合)環化合物,環可以是芳香族的 或非芳香族,其中雜環含有至少一個選自N、O、S(O)0-2 的雜原子,和/或雜環的C環成員可以被C(=O)、C(=S)、C(=CR*R*)和C=NR*取代(*表示整數)。"Heterocycle" or "heterocyclic" includes "aromatic heterocycle" or "heteroaryl ring system" and "non-aromatic heterocyclic system" or polycyclic or bicyclic (spiro ring, fused, bridged, non-fused) ) Ring compounds, the ring may be aromatic or non-aromatic, wherein the heterocycle contains at least one heteroatom selected from N, O, S(O) 0-2 , and/or the C ring member of the heterocycle may be C (=O), C(=S), C(=CR*R*) and C=NR* (* represents an integer).

術語“非芳族雜環”或“非芳族雜環”是指含有1至4個選自氧、氮和硫的雜原子的三至十五元(優選三至十二元)飽和或部分不飽和的雜環:單環,雙環或三環雜環,除碳環成員外,還含有1-3個氮原子和/或一個氧或硫原子或一個或兩個氧和/或硫原子;如果環含有多個氧原子,則它們不直接相鄰;例如(但不限於)環氧乙烷基、氮丙啶基、氧雜環丁烷基、氮雜環丁烷基、硫雜環丁基、2-四氫呋喃基、3-四氫呋喃基、2-四氫噻吩基、3-四氫噻吩基、1-吡咯烷基、2-吡咯烷基、3-吡咯烷基、3-異惡唑烷基、4-異惡唑烷基、5-異惡唑烷基、3-異噻唑烷基、4-異噻唑烷基、5-異噻唑烷基、1-吡唑烷基、3-吡唑烷基、4-吡唑烷基、5-吡唑烷基、2-惡唑烷基、4-惡唑烷基、5-惡唑烷基、2-噻唑烷基、4-噻唑烷基、5-噻唑烷基、1-咪唑烷基、2-咪唑烷基、4-咪唑烷基、1,2,4-惡二唑烷-3-基、1,2,4-惡二唑烷-5-基、1,2,4-噻二唑烷-3-基、1,2,4-噻二唑烷-5-基、1,2,4-三唑烷-1-基、1,2,4-三唑烷-3-基、1,3,4-惡二唑烷-2-基、1,3,4-噻二唑烷-2-基、1,3,4-三唑烷-1-基、1,3,4-三唑烷-2-基、2,3-二氫呋喃-2-基、2,3-二氫呋喃-3-基、2,4-二氫呋喃-2-基、2,4-二氫呋喃-3-基、2,3-二氫噻吩-2-基、2,3-二氫噻吩-3-基、2,4-二氫噻吩-2-基、2,4-二氫噻吩-3-基、吡咯啉基、2-吡咯啉-2-基、2-吡咯-3-基、3-吡咯-2-基、3-吡咯-3-基、2-異惡唑啉-3-基、3-異惡唑啉-3-基、4-異惡唑啉-3-基、2-異惡唑啉-4-基、3-異惡唑啉-4-基、4-異惡唑啉-4-基、2-異惡唑啉-5-基、3-異惡唑啉-5-基、4-異惡唑啉-5-基、2-異噻唑啉-3-基、3-異噻唑啉-3-、4-異噻唑啉-3-基、2-異噻唑啉-4-基、3-異噻唑啉-4-基、4-異噻唑啉-4-基、2-異噻唑啉-5-基、3-異噻唑啉-5-基、4-異噻唑啉-5-基、2,3-二氫吡唑-1-基、2,3-二氫吡唑-2-基、2,3-二氫吡唑-3-基、2,3-二氫吡唑-4-基、2 、3-二氫吡唑-5-基、3,4-二氫吡唑-1-基、3,4-二氫吡唑-3-基、3,4-二氫吡唑-4-基、3,4-二氫吡唑-5-基、4,5-二氫吡唑-1-基、4,5-二氫吡唑-3-基、4,5-二氫吡唑-4-基、4,5-二氫吡唑-5-基、2,3-二氫惡唑-2-基、2,3-二氫惡唑-3-基、2,3-二氫惡唑-4-基、2,3-二氫惡唑-5-基、3,4-二氫惡唑-2-基、3,4-二氫惡唑-3-基、3,4-二氫惡唑-4-基、3,4-二氫惡唑-5-基、3,4-二氫惡唑-2-基、3,4-二氫惡唑-3-基、3,4-二氫惡唑-4-基、呱啶基、2點二乙烯基、3-呱啶基、4-呱啶基、吡嗪基、嗎啉基、硫代嗎啉基、1,3-二惡烷-5-基、2-四氫吡喃基、4-四氫吡喃基、2-四氫噻吩基、3-六氫噠嗪基、4-六氫噠嗪基、2-六氫嘧啶基、4-六氫嘧啶基、5-六氫嘧啶基、2-呱嗪基、1,3,5-六氫三嗪-2-基、1,2,4-六氫三嗪-3-基、環絲氨酸、2,3,4,5-四氫[1H]氮雜卓-1-或-2-或-3-或-4-或-5-或-6-或-7-基、3,4,5,6-四氫[2H]氮雜卓-2-或-3-或-4-或-5-或-6-或-7-基、2,3,4,7-四氫[1H]氮雜卓-1-或-2-或-3-或-4-或-5-或-6-或-7-基、2,3,6,7-四氫[1H]氮雜卓-1-或-2-或-3-或-4-或-5-或-6-或-7-基、六氫氮雜-1-或-2-或-3-或-4-基、四-和六氫氧雜環庚烯基、如2,3,4,5-四氫[1 H]氧雜環庚烷-2-或-3-或-4-或-5-或-6-或-7-基、2,3,4,7-四氫[1H]氧雜-2-酮或-3-或-4-或-5-或-6-或-7-基、2,3,6,7-四氫[1H]氧雜-2-酮或-3-或-4-或-5-或-6-或-7-基、六氫氮雜-1-或-2--或-3-或-4-基、四-和六氫-1,3-二氮雜基、四-和六氫-1,4-二氮雜基、四-和六氫-1,3-氧氮雜基、四-和六氫-1,4-氧氮雜基、四-和六氫-1,3-二氧雜環庚烯基、四氫和六氫-1,4-二氧雜環庚烯基。除非在別處具體限定,否則該定義也適用於雜環烷基作為複合取代基的一部分,例如雜環基烷基等。The term "non-aromatic heterocyclic ring" or "non-aromatic heterocyclic ring" means a three to fifteen-membered (preferably three to twelve-membered) saturated or partially containing 1 to 4 heteroatoms selected from oxygen, nitrogen and sulfur Unsaturated heterocycle: monocyclic, bicyclic or tricyclic heterocycle, in addition to carbocyclic members, it also contains 1-3 nitrogen atoms and/or one oxygen or sulfur atom or one or two oxygen and/or sulfur atoms; If the ring contains multiple oxygen atoms, they are not directly adjacent; for example (but not limited to) oxirane, aziridinyl, oxetane, azetidine, thietane Group, 2-tetrahydrofuranyl, 3-tetrahydrofuranyl, 2-tetrahydrothienyl, 3-tetrahydrothienyl, 1-pyrrolidinyl, 2-pyrrolidinyl, 3-pyrrolidinyl, 3-isoxazolidine Group, 4-isoxazolidinyl, 5-isoxazolidinyl, 3-isothiazolidinyl, 4-isothiazolidinyl, 5-isothiazolidinyl, 1-pyrazolidinyl, 3-pyrazole Alkyl, 4-pyrazolidinyl, 5-pyrazolidinyl, 2-oxazolidinyl, 4-oxazolidinyl, 5-oxazolidinyl, 2-thiazolidinyl, 4-thiazolidinyl, 5-thiazolidinyl, 1-imidazolidinyl, 2-imidazolidinyl, 4-imidazolidinyl, 1,2,4-oxadiazolidin-3-yl, 1,2,4-oxadiazolidinyl- 5-yl, 1,2,4-thiadiazolidin-3-yl, 1,2,4-thiadiazolidin-5-yl, 1,2,4-triazolidin-1-yl, 1, 2,4-triazolidin-3-yl, 1,3,4-oxadiazolidin-2-yl, 1,3,4-thiadiazolidin-2-yl, 1,3,4-triazole Alkan-1-yl, 1,3,4-triazolidin-2-yl, 2,3-dihydrofuran-2-yl, 2,3-dihydrofuran-3-yl, 2,4-dihydro Furan-2-yl, 2,4-dihydrofuran-3-yl, 2,3-dihydrothiophen-2-yl, 2,3-dihydrothiophen-3-yl, 2,4-dihydrothiophene- 2-yl, 2,4-dihydrothiophen-3-yl, pyrrolinyl, 2-pyrrolin-2-yl, 2-pyrrol-3-yl, 3-pyrrol-2-yl, 3-pyrrol-3 -Yl, 2-isoxazolin-3-yl, 3-isoxazolin-3-yl, 4-isoxazolin-3-yl, 2-isoxazolin-4-yl, 3-iso Oxazolin-4-yl, 4-isoxazolin-4-yl, 2-isoxazolin-5-yl, 3-isoxazolin-5-yl, 4-isoxazolin-5-yl Group, 2-isothiazolin-3-yl, 3-isothiazolin-3-yl, 4-isothiazolin-3-yl, 2-isothiazolin-4-yl, 3-isothiazolin-4-yl , 4-isothiazolin-4-yl, 2-isothiazolin-5-yl, 3-isothiazolin-5-yl, 4-isothiazolin-5-yl, 2,3-dihydropyrazole- 1-yl, 2,3-dihydropyrazol-2-yl, 2,3-dihydropyrazol-3-yl, 2,3-dihydropyrazol-4-yl, 2, 3-dihydropyridine Azole-5-yl, 3,4-dihydropyrazol-1-yl, 3,4-dihydropyrazol-3-yl, 3,4-dihydropyrazol-4-yl, 3,4-di Pyrazol-5-yl, 4,5-dihydropyrazol-1-yl, 4,5-dihydropyrazol-3-yl, 4 ,5-dihydropyrazol-4-yl, 4,5-dihydropyrazol-5-yl, 2,3-dihydrooxazol-2-yl, 2,3-dihydrooxazol-3-yl , 2,3-dihydrooxazol-4-yl, 2,3-dihydrooxazol-5-yl, 3,4-dihydrooxazol-2-yl, 3,4-dihydrooxazol-3 -Yl, 3,4-dihydrooxazol-4-yl, 3,4-dihydrooxazol-5-yl, 3,4-dihydrooxazol-2-yl, 3,4-dihydrooxazole -3-yl, 3,4-dihydrooxazol-4-yl, pyridyl, 2-point divinyl, 3-pyridyl, 4-pyridyl, pyrazinyl, morpholinyl, thio Morpholinyl, 1,3-dioxan-5-yl, 2-tetrahydropyranyl, 4-tetrahydropyranyl, 2-tetrahydrothienyl, 3-hexahydropyridazinyl, 4-hexa Hydropyridazinyl, 2-hexahydropyrimidinyl, 4-hexahydropyrimidinyl, 5-hexahydropyrimidinyl, 2-pentazinyl, 1,3,5-hexahydrotriazin-2-yl, 1,2 ,4-hexahydrotriazin-3-yl, cycloserine, 2,3,4,5-tetrahydro[1H]azaaza-1- or -2- or -3- or -4- or -5- Or -6- or -7-yl, 3,4,5,6-tetrahydro[2H]aza-2- or -3- or -4- or -5- or -6- or -7-yl , 2,3,4,7-tetrahydro[1H]aza-1- or -2- or -3- or -4- or -5- or -6- or -7-yl, 2,3, 6,7-tetrahydro[1H]aza-1- or -2- or -3- or -4- or -5- or -6- or -7-yl, hexahydroaza-1- or- 2- or -3- or -4-yl, tetra- and hexahydrooxepanyl, such as 2,3,4,5-tetrahydro[1 H]oxepan-2- or -3 -Or -4- or -5- or -6- or -7-yl, 2, 3, 4, 7-tetrahydro [1H] oxa-2-one or -3- or -4- or -5- Or -6- or -7-yl, 2,3,6,7-tetrahydro[1H]oxa-2-one or -3- or -4- or -5- or -6- or -7-yl , Hexahydroaza-1- or -2-- or -3- or -4-yl, tetra- and hexahydro-1,3-diaza, tetra- and hexahydro-1,4-diazepine Hetero, tetra- and hexahydro-1,3-oxaza, tetra- and hexahydro-1,4-oxaza, tetra- and hexahydro-1,3-dioxanyl , Tetrahydro and hexahydro-1,4-dioxanyl. Unless specifically defined elsewhere, this definition also applies to heterocycloalkyl as part of a composite substituent, such as heterocyclylalkyl and the like.

術語“雜芳基”是指包含氧、氮和硫族中的一至四個雜原子的5或6元全不飽和單環系;如果該環含有一個以上的氧原子,它們並不直接相鄰;5元雜芳基包含一至四個氮原子或一至三個氮原子及一個硫或氧原子:除了碳原子外,五元雜芳基還可含有一至四個氮原子或一至三個氮原子及一個硫或氧原子作為環成員,例如(但不限於)呋喃基、噻吩基、吡咯基、異惡唑基、異噻唑基、吡唑基、惡唑基、噻唑基、咪唑基、1,2,4-惡二唑基、1,2,4-噻二唑基1,2,4,4-三唑基、1,3,4-惡二唑基、1,3,4-噻二唑基、1,3,4-三唑基、四唑基;含有一至四個氮原子的氮鍵合的5-元雜芳基,或含有一至三個氮原子的苯並稠合的氮鍵合的5-元雜芳基:除碳原子外,可含有一至四個氮原子的五元雜芳基或者一至三個氮原子作為環成員並且其中兩個相鄰的碳環成員或一個氮和一個相鄰的碳環成員可以通過丁-1,3-二烯-1,4-二基橋接,其中一個或兩個碳原子可被氮原子取代,其中這些環通過一個氮環成員與骨架連接,例如(但不限於)1-吡咯基、1-吡唑基、1,2,4-三唑基、1-咪唑基、1,2,3-三唑基和1,3,4-三唑基。The term "heteroaryl" refers to a 5- or 6-membered fully unsaturated monocyclic ring system containing one to four heteroatoms in oxygen, nitrogen and chalcogenide; if the ring contains more than one oxygen atom, they are not directly adjacent ; 5-membered heteroaryl groups contain one to four nitrogen atoms or one to three nitrogen atoms and one sulfur or oxygen atom: in addition to carbon atoms, five-membered heteroaryl groups can also contain one to four nitrogen atoms or one to three nitrogen atoms and A sulfur or oxygen atom as a ring member, such as (but not limited to) furanyl, thienyl, pyrrolyl, isoxazolyl, isothiazolyl, pyrazolyl, oxazolyl, thiazolyl, imidazolyl, 1,2 ,4-oxadiazolyl, 1,2,4-thiadiazolyl 1,2,4,4-triazolyl, 1,3,4-oxadiazolyl, 1,3,4-thiadiazole Radical, 1,3,4-triazolyl, tetrazolyl; nitrogen-bonded 5-membered heteroaryl containing one to four nitrogen atoms, or benzo-fused nitrogen bond containing one to three nitrogen atoms 5-membered heteroaryl: in addition to carbon atoms, a five-membered heteroaryl that may contain one to four nitrogen atoms or one to three nitrogen atoms as ring members and two adjacent carbocyclic members or one nitrogen and one Adjacent carbocyclic members can be bridged through but-1,3-diene-1,4-diyl, where one or two carbon atoms can be replaced by nitrogen atoms, where these rings are connected to the backbone through a nitrogen ring member, For example (but not limited to) 1-pyrrolyl, 1-pyrazolyl, 1,2,4-triazolyl, 1-imidazolyl, 1,2,3-triazolyl and 1,3,4-triazole base.

含有1-4個氮原子的6-元雜芳基:6-元雜芳基,其除碳原子外,還可分別含有1-3個和1-4個氮原子作為環成員,例如(但不限於)2-吡啶基、3-吡啶基、4-吡啶基、3-噠嗪基、4-噠嗪基、2-嘧啶基、4-嘧啶基、5-嘧啶基、2-吡嗪基、1,3,5-三嗪-2-基、1,2,4-三嗪-3-基和1,2,4,5-四嗪-3-基;含有一至三個氮原子或一個氮原子和一個氧或硫原子的苯並稠合的5-元雜芳基:例如(但不限於)吲哚-1-基、吲哚-2-基、吲哚-3-基、吲哚-4-基、吲哚-5-基、吲哚-6-基、吲哚-7-基、苯並咪唑-1-基、苯並咪唑-2-基、苯並咪唑-4-基、苯並咪唑-5-基、吲唑-l-基、吲唑-3-基、吲唑-4-基、吲唑-5-基、吲唑-6-基、吲唑-7-基、吲唑-2-基、1-苯並呋喃-2-基、1-苯並呋喃-3-基、1-苯並呋喃-4-基、1-苯並呋喃-5-基、1-苯並呋喃-6-基、1-苯並呋喃-7-基、1-苯並噻吩-2-基、1-苯並噻吩-3-基基團、1-苯並噻吩-4-基、1-苯並噻吩-5-基、1-苯並噻吩-6-基、1-苯並噻吩-7-基、1,3-苯並噻唑-2-基、1,3-苯並噻唑-4-基、1,3-苯並噻唑-5-基、1,3-苯並噻唑-6-基、1,3-苯並噻唑-7-基、1,3-苯並惡唑-2-基、1,3-苯並惡唑-4-基、1,3-苯並惡唑-5-基、1,3-苯並惡唑-6-基和1,3-苯並惡唑-7-基;含有一至三個氮原子的苯並稠合的6-元雜芳基:例如(但不限於)喹啉-2-基、喹啉-3-基、喹啉-4-基、喹啉-5-基、喹啉-6-基、喹啉-7-基、喹啉-8-基、異喹啉-1-基、異喹啉-3-基、異喹啉-4-基、異喹啉-5-基、異喹啉-6-基、異喹啉-7-基和異喹啉啉-8-基。6-membered heteroaryl groups containing 1-4 nitrogen atoms: 6-membered heteroaryl groups, in addition to carbon atoms, can also contain 1-3 and 1-4 nitrogen atoms as ring members, for example (but Not limited to) 2-pyridyl, 3-pyridyl, 4-pyridyl, 3-pyridazinyl, 4-pyridazinyl, 2-pyrimidinyl, 4-pyrimidinyl, 5-pyrimidinyl, 2-pyrazinyl , 1,3,5-triazin-2-yl, 1,2,4-triazin-3-yl and 1,2,4,5-tetrazin-3-yl; contains one to three nitrogen atoms or one A benzo-fused 5-membered heteroaryl group of a nitrogen atom and an oxygen or sulfur atom: for example (but not limited to) indol-1-yl, indol-2-yl, indol-3-yl, indole -4-yl, indol-5-yl, indol-6-yl, indol-7-yl, benzimidazol-1-yl, benzimidazol-2-yl, benzimidazol-4-yl, Benzimidazol-5-yl, indazol-1-yl, indazol-3-yl, indazol-4-yl, indazol-5-yl, indazol-6-yl, indazol-7-yl, Indazol-2-yl, 1-benzofuran-2-yl, 1-benzofuran-3-yl, 1-benzofuran-4-yl, 1-benzofuran-5-yl, 1-benzene Benzofuran-6-yl, 1-benzofuran-7-yl, 1-benzothiophen-2-yl, 1-benzothiophen-3-yl, 1-benzothiophen-4-yl, 1 -Benzothiophen-5-yl, 1-benzothiophen-6-yl, 1-benzothiophen-7-yl, 1,3-benzothiazol-2-yl, 1,3-benzothiazole-4 -Yl, 1,3-benzothiazol-5-yl, 1,3-benzothiazol-6-yl, 1,3-benzothiazol-7-yl, 1,3-benzoxazol-2- Group, 1,3-benzoxazol-4-yl, 1,3-benzoxazol-5-yl, 1,3-benzoxazol-6-yl and 1,3-benzoxazol- 7-yl; benzo-fused 6-membered heteroaryl containing one to three nitrogen atoms: for example (but not limited to) quinolin-2-yl, quinolin-3-yl, quinolin-4-yl, Quinolin-5-yl, quinolin-6-yl, quinolin-7-yl, quinolin-8-yl, isoquinolin-1-yl, isoquinolin-3-yl, isoquinolin-4- Group, isoquinolin-5-yl, isoquinolin-6-yl, isoquinolin-7-yl and isoquinolin-8-yl.

稠合的6-5-元雜芳基的非限制性實例包括吲嗪基;吡唑並[1,5-a]吡啶基;咪唑並[1,2-a]吡啶基;吡咯並[1,2-a]嘧啶基;吡唑並[1,5-a]嘧啶基;咪唑並[1,2-a]嘧啶基;吡咯並[1,2-a]吡嗪基;吡唑並[1,5-a]吡嗪基;咪唑並[1,2-a]吡嗪基等。除非在別處具體限定,否則該定義也適用於雜芳基作為複合取代基的一部分的,例如雜芳基烷基等。Non-limiting examples of fused 6-5-membered heteroaryl groups include indolizinyl; pyrazolo[1,5-a]pyridyl; imidazo[1,2-a]pyridyl; pyrrolo[1 ,2-a]pyrimidinyl; pyrazolo[1,5-a]pyrimidinyl; imidazo[1,2-a]pyrimidinyl; pyrrolo[1,2-a]pyrazinyl; pyrazolo[ 1,5-a]pyrazinyl; imidazo[1,2-a]pyrazinyl and the like. Unless specifically defined elsewhere, this definition also applies to heteroaryl groups as part of a composite substituent, such as heteroarylalkyl.

術語“三烷基甲矽烷基”包括3個支鏈和/或直鏈烷基自由基,它們附屬於並連接在矽原子上,例如三甲基甲矽烷基,三乙基甲矽烷基和叔丁基二甲基甲矽烷基。“鹵代烷基甲矽烷基”表示三個烷基中的至少一個被鹵素原子部分或完全取代,所述鹵素原子可以相同或不同。“烷氧基三烷基甲矽烷基”表示三個烷基中的至少一個被一個或多個可以相同或不同的烷氧基取代。“三烷基甲矽烷氧基”表示通過氧連接的三烷基甲矽烷基部分。The term "trialkylsilyl" includes 3 branched and/or linear alkyl radicals which are attached to and attached to silicon atoms, such as trimethylsilyl, triethylsilyl and tertiary Butyldimethylsilyl. "Haloalkylsilyl" means that at least one of the three alkyl groups is partially or completely substituted with halogen atoms, which may be the same or different. "Alkoxytrialkylsilyl" means that at least one of the three alkyl groups is substituted with one or more alkoxy groups which may be the same or different. "Trialkylsilyloxy" means a trialkylsilyl moiety linked by oxygen.

“烷基羰基”的非限制性實例包括C(O)CH3 、C(O)CH2 CH2 CH3 和C(O)CH(CH3 )2 。“烷氧基羰基”的實例包括CH3 OC(=O)、CH3 CH2 OC(=O)、CH3 CH2 CH2 OC(=O)、(CH3 )2 CHOC(=O)和不同的丁氧基或戊氧基羰基異構體。“烷基氨基羰基”的實例包括CH3 NHC(=O)、CH3 CH2 NHC(=O)、CH3 CH2 CH2 NHC(=O)、(CH3 )2 CHNHC(=O)和不同的丁氨基-或戊基氨基羰基異構體。“二烷基氨基羰基”的實例包括(CH3 )2 NC(=O)、(CH3 CH2 )2 NC(=O)、CH3 CH2 (CH3 )NC(=O)、CH3 CH2 CH2 (CH3 )NC(=O)和(CH3 )2 CHN(CH3 )C(=O)“烷氧基烷基羰基”的實例包括CH3 OCH2 C(=O)、CH3 OCH2 CH2 C(=O)、CH3 CH2 OCH2 C(=O)、CH3 CH2 CH2 CH2 OCH2 C(=O)和CH3 CH2 OCH2 CH2 C(=O)。“烷基硫代烷基羰基”的實例包括CH3 SCH2 C(=O)、CH3 SCH2 CH2 C(=O)、CH3 CH2 SCH2 C(=O)、CH3 CH2 CH2 CH2 SCH2 C(=O)和CH3 CH2 SCH2 CH2 C(=O)。鹵代烷基磺醯基羰基、烷基磺醯基氨基羰基、烷基硫代烷氧基羰基、烷氧基羰基烷基氨基等的定義與此類似。Non-limiting examples of "alkylcarbonyl" include C (O) CH 3, C (O) CH 2 CH 2 CH 3 and C (O) CH (CH 3 ) 2. Examples of "alkoxycarbonyl" include CH 3 OC(=O), CH 3 CH 2 OC(=O), CH 3 CH 2 CH 2 OC(=O), (CH 3 ) 2 CHOC(=O) and Different butoxy or pentoxycarbonyl isomers. Examples of "alkylaminocarbonyl" include CH 3 NHC (=O), CH 3 CH 2 NHC (=O), CH 3 CH 2 CH 2 NHC (=O), (CH 3 ) 2 CHNHC (=O) and Different butylamino- or pentylaminocarbonyl isomers. Examples of "dialkylaminocarbonyl" include (CH 3 ) 2 NC(=O), (CH 3 CH 2 ) 2 NC(=O), CH 3 CH 2 (CH 3 )NC(=O), CH 3 Examples of "CH 2 CH 2 (CH 3 )NC(=O) and (CH 3 ) 2 CHN(CH 3 )C(=O)"alkoxyalkylcarbonyl" include CH 3 OCH 2 C(=O), CH 3 OCH 2 CH 2 C (=O), CH 3 CH 2 OCH 2 C (=O), CH 3 CH 2 CH 2 CH 2 OCH 2 C (=O) and CH 3 CH 2 OCH 2 CH 2 C ( =O). Examples of "alkylthioalkylcarbonyl" include CH 3 SCH 2 C(=O), CH 3 SCH 2 CH 2 C(=O), CH 3 CH 2 SCH 2 C(=O), CH 3 CH 2 CH 2 CH 2 SCH 2 C (=O) and CH 3 CH 2 SCH 2 CH 2 C (=O). The definitions of haloalkylsulfonylcarbonylcarbonyl, alkylsulfonylaminocarbonyl, alkylthioalkoxycarbonyl, alkoxycarbonylalkylamino, etc. are similar to this.

“烷基氨基烷基羰基”的非限制性實例包括CH3 NHCH2 C(=O)、CH3 NHCH2 CH2 C(=O)、CH3 CH2 NHCH2 C(=O)、CH3 CH2 CH2 CH2 NHCH2 C(=O)和CH3 CH2 NHCH2 CH2 C(=O)。Non-limiting examples of "alkylaminoalkylcarbonyl" include CH 3 NHCH 2 C(=O), CH 3 NHCH 2 CH 2 C(=O), CH 3 CH 2 NHCH 2 C(=O), CH 3 CH 2 CH 2 CH 2 NHCH 2 C (=O) and CH 3 CH 2 NHCH 2 CH 2 C (=O).

“醯胺”指的是A-R'C = ONR''-B,其中R'和R''表示取代基,A和B表示任何基團。"Acetylamine" refers to A-R'C = ONR''-B, where R'and R'' represent substituents, and A and B represent any group.

“硫代醯胺”是指A-R'C=SNR''-B,其中R'和R''表示取代基,A和B表示任何基團。"Thiamidamide" means A-R'C=SNR''-B, where R'and R'' represent substituents, and A and B represent any group.

取代基中的碳原子總數由“Ci -Cj ”首碼表示,其中i和j是1至21的數。例如,C1 -C3 烷基磺醯基表示甲基磺醯基至丙基磺醯基;C2 烷氧基烷基表示CH3 OCH2 ;C3 烷氧基烷基表示例如CH3 CH(OCH3 )、CH3 OCH2 CH2 或CH3 CH2 OCH2 ;C4 烷氧基烷基表示被含有總共四個碳原子的烷氧基取代的烷基的各種異構體,實例包括CH3 CH2 CH2 OCH2 和CH3 CH2 OCH2 CH2 。在上述敘述中,當式(I)化合物由一個或多個雜環組成時,所有取代基通過任何可用的碳或氮通過取代所述碳或氮上的氫而連接到這些環上。The total number of carbon atoms in the substituent is represented by the "C i -C j "prefix, where i and j are numbers from 1 to 21. For example, C 1 -C 3 alkylsulfonyl represents methylsulfonyl to propylsulfonyl; C 2 alkoxyalkyl represents CH 3 OCH 2 ; C 3 alkoxyalkyl represents for example CH 3 CH (OCH 3 ), CH 3 OCH 2 CH 2 or CH 3 CH 2 OCH 2 ; C 4 alkoxyalkyl represents various isomers of alkyl substituted with alkoxy containing a total of four carbon atoms, examples include CH 3 CH 2 CH 2 OCH 2 and CH 3 CH 2 OCH 2 CH 2 . In the above description, when the compound of formula (I) consists of one or more heterocycles, all substituents are attached to these rings through any available carbon or nitrogen by substituting hydrogen on the carbon or nitrogen.

當化合物被帶有下標的取代基取代時,所述取代基表示所述取代基的數目可以超過1,所述取代基(當它們超過1時)獨立地選自所定義的取代基。此外,當(R)m 中的下標m表示範圍從例如0到4的整數時,則取代基的數目可以從0和4之間的整數中選擇。When the compound is substituted with a subscripted substituent, the substituent means that the number of the substituent may exceed 1, and the substituent (when they exceed 1) is independently selected from the defined substituents. Furthermore, when the subscript m in (R) m represents an integer ranging from, for example, 0 to 4, then the number of substituents can be selected from integers between 0 and 4.

當基團含有可以是氫的取代基時,則當該取代基被認為是氫時,可以認為所述基團未被取代。When the group contains a substituent which may be hydrogen, then when the substituent is considered to be hydrogen, the group may be considered unsubstituted.

本文中的實施例及其各種特徵和有利的細節將參照描述中的非限制性實施例進行說明。為避免不必要地模糊本文實施例,省略了對已知組件和處理技術的描述。這裡使用的示例僅旨在便於理解可以實踐本文的實施例的方式,並且進一步使本領域技術人員能夠實踐本文的實施例。因此,這些實施例不應被解釋為限制本文實施方案的範圍。The embodiments herein and their various features and advantageous details will be explained with reference to the non-limiting embodiments in the description. To avoid unnecessarily obscuring the embodiments herein, descriptions of known components and processing techniques are omitted. The examples used herein are merely intended to facilitate understanding of the manner in which the embodiments of this document can be practiced, and to further enable those skilled in the art to practice the embodiments of this document. Therefore, these examples should not be construed as limiting the scope of the embodiments herein.

具體實施方案的描述將充分地揭示本文實施方案的大致性質,使其他人可以通過應用當前知識,能夠修改和/或適應應用這些具體實施方式而不脫離一般概念,因此,這種適應和修改, 應被理解為具有本發明同樣地意義和範圍。需要理解的是,這裡使用的片語或術語是為了描述的目的,而不是為了限制。因此,雖然這裡的實施例是以首選實施例的形式描述的,但那些精通該技術的人將認識到,在這裡描述的實施例的精神和範圍內,通過修改可以實踐這裡的實施例。The description of specific embodiments will fully reveal the general nature of the embodiments herein so that others can apply current knowledge to modify and/or adapt to apply these specific embodiments without departing from the general concept. Therefore, such adaptation and modification, It should be understood that it has the same meaning and scope of the present invention. It should be understood that the phrases or terms used here are for the purpose of description, not for limitation. Therefore, although the embodiments herein are described in the form of preferred embodiments, those skilled in the art will recognize that within the spirit and scope of the embodiments described herein, the embodiments herein can be practiced through modification.

在本詳述中包含的對文檔、步驟、材料、裝置、物品等的任何討論僅僅是為了提供本發明的背景。不得視為承認這些事項構成現有技術基礎的一部分,或是與本申請的最先日期存在的本發明領域的一般常識。Any discussion of documents, steps, materials, devices, articles, etc. contained in this detailed description is merely to provide a background to the present invention. It should not be taken as an admission that these matters form part of the basis of the prior art, or are common general knowledge in the field of the invention as of the earliest date of this application.

儘管在描述和描述/申請專利範圍中提到的數值可能構成本發明的本發明的關鍵部分,但是如果該偏差遵循相同的科學,則與這些數值的任何偏差仍然是本發明的範圍內。如果合適,本發明的發明化合物可以作為不同可能的異構形式的混合物存在,尤其是立體異構體的混合物,例如E和Z、蘇式和赤型、光學異構體,還有互變異構體(如果合適)。E和Z異構體以及蘇型和赤型異構體和光學異構體的任何所需混合物和可能的互變異構形式都被是本公開和申請專利範圍的範圍。Although the numerical values mentioned in the description and description/patent application may constitute a key part of the invention of the present invention, if the deviation follows the same science, any deviation from these values is still within the scope of the invention. If appropriate, the inventive compounds of the present invention may exist as a mixture of different possible isomeric forms, especially mixtures of stereoisomers, such as E and Z, threo and erythroforms, optical isomers, and tautomerism Body (if appropriate). The E and Z isomers as well as any desired mixtures and possible tautomeric forms of threo and erythro isomers and optical isomers are within the scope of this disclosure and patent application.

用於本發明目的的術語“害蟲”包括但不限於真菌、原生藻菌(卵菌綱)、細菌、線蟲、蟎蟲、蜱蟲、昆蟲和齧齒動物。害蟲也包括對人類或人類關切點(包括農作物、牲畜和林業)有害的動物或植物。The term "pest" for the purposes of the present invention includes, but is not limited to, fungi, protozoan (Oomycetes), bacteria, nematodes, mites, ticks, insects, and rodents. Pests also include animals or plants that are harmful to humans or human concerns (including crops, livestock, and forestry).

術語“植物”在此應理解為意指所有植物和植物種群,例如需要的和不需要的野生植物或作物植物(包括天然存在的作物植物)。作物植物可以是通過常規育種和優化方法或通過生物技術和基因工程方法或這些方法的組合獲得的植物,包括轉基因植物和植物育種者權利受保護和不受保護的植物栽培種。The term "plant" is understood here to mean all plants and plant populations, such as required and undesired wild plants or crop plants (including naturally occurring crop plants). Crop plants can be plants obtained by conventional breeding and optimization methods or by biotechnology and genetic engineering methods or a combination of these methods, including transgenic plants and plant cultivars with protected and unprotected rights of plant breeders.

為了本發明的目的,術語“植物”包括以樹木、灌木、草本植物、草、蕨類植物和苔蘚這些通常在田間生長,通過其根部吸收水和所需物質,以及通過光合作用合成葉片中的營養成分的活生物體。For the purposes of the present invention, the term "plants" includes trees, shrubs, herbs, grasses, ferns, and mosses that normally grow in the field, absorb water and required substances through their roots, and synthesize Nutritional components of living organisms.

用於本發明目的的“植物”的實例包括但不限於農作物,例如小麥、黑麥、大麥、黑小麥、燕麥或大米;甜菜;水果和果樹,例如梨果、核果或軟果,例如蘋果、梨、李子、桃子、杏仁、櫻桃、草莓、覆盆子、黑莓或醋栗;豆科植物,如扁豆、豌豆、苜蓿或大豆;油菜、芥菜、橄欖、向日葵、椰子、可哥豆、蓖麻油植物、油棕櫚、花生或大豆等油料植物;葫蘆,如南瓜、黃瓜或甜瓜;纖維植物,如棉花、亞麻、大麻或黃麻;柑橘類水果和柑橘樹,如柳丁、檸檬、葡萄柚或柑橘;任何園藝植物、蔬菜,如菠菜、生菜、蘆筍、捲心菜、胡蘿蔔、洋蔥、番茄、土豆、葫蘆或辣椒粉;月桂科屬植物,如鱷梨、肉桂或樟腦;葫蘆科植物;含油植物;能源和原料植物,如穀物、玉米、大豆、其他豆科植物、油菜、甘蔗或油棕;煙草;堅果;咖啡;茶;可哥;香蕉;胡椒;葡萄藤(鮮食葡萄和葡萄汁、葡萄藤);跳;草皮;甜葉(也稱甜葉菊);天然橡膠植物或觀賞植物和林業植物,例如花、灌木、闊葉樹或常綠植物,例如針葉樹;以及植物繁殖材料,例如種子,以及這些植物的作物材料。Examples of "plants" for the purposes of the present invention include, but are not limited to, agricultural crops such as wheat, rye, barley, triticale, oats or rice; sugar beets; fruits and fruit trees such as pear fruit, stone fruit or soft fruit such as apples, Pears, plums, peaches, almonds, cherries, strawberries, raspberries, blackberries or gooseberries; legumes such as lentils, peas, alfalfa or soybeans; rape, mustard, olives, sunflower, coconut, cocoa, castor oil plants , Oil palms such as oil palm, peanut or soybean; gourds such as pumpkin, cucumber or melon; fibrous plants such as cotton, flax, hemp or jute; citrus fruits and citrus trees such as orange, lemon, grapefruit or citrus; Any horticultural plant, vegetable, such as spinach, lettuce, asparagus, cabbage, carrot, onion, tomato, potato, gourd or paprika; laurel plant, such as avocado, cinnamon or camphor; cucurbitaceous plant; oily plant; energy and Raw plants, such as grains, corn, soybeans, other legumes, rape, sugar cane or oil palm; tobacco; nuts; coffee; tea; cocoa; bananas; peppers; vines (fresh grapes and grape juice, vines); Jump; turf; sweet leaves (also called stevia); natural rubber plants or ornamental plants and forestry plants, such as flowers, shrubs, broad-leaved trees or evergreen plants, such as conifers; and plant propagation materials, such as seeds, and crop materials of these plants .

優選地,用於本發明目的的植物包括但不限於穀類、玉米、大米、大豆和其他豆科植物、水果和果樹、葡萄、堅果和堅果樹、柑橘和柑橘樹、任何園藝植物、葫蘆科、含油植物、煙草、咖啡、茶、可哥、甜菜、甘蔗、棉花、馬鈴薯、番茄、洋蔥、辣椒和蔬菜、觀賞植物、任何供人類和動物使用的花卉植物和其他植物。Preferably, plants used for the purposes of the present invention include but are not limited to cereals, corn, rice, soybeans and other legumes, fruits and fruit trees, grapes, nuts and nut trees, citrus and citrus trees, any horticultural plants, cucurbitaceae, Oily plants, tobacco, coffee, tea, cocoa, sugar beets, sugar cane, cotton, potatoes, tomatoes, onions, peppers and vegetables, ornamental plants, any flower plants for humans and animals, and other plants.

術語“植物部分”應理解為是指植物地上和地下的所有部分和器官。為了本發明的目的,術語植物部分包括但不限於插條、葉、枝、塊莖、花、種子、分枝、根,包括主根、側根、根毛、根尖、根冠、根狀莖、幼枝、芽、果實、子實體、樹皮、莖、芽、輔助芽、分生組織、節和節間。The term "plant part" is understood to mean all parts and organs above and below the plant. For the purposes of the present invention, the term plant part includes but is not limited to cuttings, leaves, branches, tubers, flowers, seeds, branches, roots, including main roots, lateral roots, root hairs, root tips, root crowns, rhizomes, young shoots , Buds, fruits, fruiting bodies, bark, stems, buds, auxiliary buds, meristems, nodes and internodes.

術語“其軌跡”包括土壤、植物或植物部分的周圍環境以及在播種/種植植物或植物部分之前、期間或之後使用的設備或工具。The term "its trajectory" includes the surrounding environment of soil, plants or plant parts and equipment or tools used before, during or after sowing/planting of plants or plant parts.

本發明化合物或組合物(由本發明化合物和任意其它相容化合物組成的)中的本發明化合物在植物或植物材料或其所在位點上的應用包括通過本領域技術人員已知的技術施用,包括但不限於噴塗、塗料、浸漬、薰蒸、浸漬、注射和撒粉。The use of the compounds of the invention in the compounds or compositions of the invention (composed of the compounds of the invention and any other compatible compounds) on plants or plant materials or their locus includes application by techniques known to those skilled in the art, including But not limited to spraying, coating, dipping, fumigation, dipping, injection and dusting.

術語“施用”是指物理或化學性黏附於植物或植物部分,包括浸漬。The term "application" refers to physical or chemical adhesion to plants or plant parts, including impregnation.

鑒於上述,本發明提供式(I)的1,2-二硫醇酮化合物,

Figure 02_image001
其中, R選自基團鹵素、羥基、氰基、硝基、C1 -C6 -烷基、C1 -C6 -鹵代烷基、C1 -C6 ­烷氧基、C3 -C6 -環烷基、C(=O)R3 、C(=O)OR3 和S(O)n R3 ; R1 選自氫、羥基、C1 -C6 -烷基、C2 -C6 -烯基、C2 -C6 -炔基、C2 -C6 -烯基-C1 -C3 -烷基、C2 -C6 -炔基-C1 -C3 -烷基、C1 -C6 -鹵代烷基、C2 -C8 -鹵代烯基、C1 -C6 ­烷氧基、C1 -C6 -鹵代烷氧基、C3 -C6 -環烷基、C3 -C6 -鹵代環烷基、C3 -C6 -環烷基-C1 -C3 -烷基、苄基、C(=O)R3 、C(=O)OR3 和S(O)n R3 基團; A代表O、NR1a 或S; R1a 選自氫、羥基、C1 -C6 -烷基、C1 -C6 ­烷氧基、C3 -C6 -環烷基、C3 -C6 -環烷基-C1 -C3 -烷基、苄基、C(=O)R3 、C(=O)OR3 和S(O)n R3 基團; R2a 和R2b 獨立地選自氫、鹵素、羥基、C1 -C6 -烷基、C1 -C6 ­烷氧基、C3 -C6 -環烷基、C3 -C6 -環烷基-C1 -C3 -烷基、C(=O)R3 、C(=O)OR3 和S(O)n R3 基團;或者 R2a 和R2b 與它們所連接的原子一起或與選自C、N、O和S的其他原子一起可以形成3-至5-元環, 其本身可以被一個或多個R3 取代; R3 選自氫、羥基、C1 -C6 -烷基、C1 -C6 -鹵代烷基、C3 -C10 -環烷基、C3 -C10 -鹵代環烷基和N(R6 R7 )基團; R6 和R7 獨立地選自氫、羥基、C1 -C6 -烷基、C1 -C6 -鹵代烷基、C3 -C10 -環烷基和 S(O)n R3 基團; R1 、R2 和R3 中定義的所有上述基團可帶有一個、兩個、三個或四個相同或不同的取代基,所述取代基選自鹵素、氰基、硝基、氨基、羥基、C1 -C6 -烷基、C1 -C6 -鹵代烷基、C1 -C6 ­烷氧基和C1 -C6 -鹵代烷氧基; Cy代表稠合或非稠合的C3 -C10 -碳環基或C3 -C10 -雜環基團,其可任選地被一個或多個R4 取代; R4 獨立地選自氫、鹵素、羥基、氰基、硝基、C1 -C6 -烷基、C2 -C8 -烯基、C2 -C8 -炔基、C1 -C6 -鹵代烷基、C2 -C8 -鹵代烯基、C1 -C6 -烷氧基、C2 -C8 -烯氧基、C2 -C8 -炔氧基、C1 -C6 -鹵代烷氧基、C2 -C8 -烯氧基、C2 -C8 -鹵代炔氧基、C1 -C6 -烷硫基、C2 -C8 -烯硫基、C2 -C8 -炔硫基、C1 -C6 -鹵代烷硫基、C2 -C8 -鹵代烯硫基、C3 -C10 -環烷基、C4 -C10 -環烯基、C3 -C10 -環烷氧基、C4 -C10 -環烯氧基、C3 -C10 -環烷硫基、C4 -C10 -環烯硫基、C3 -C10 -環烷基-C1 -C6 -烷基、C3 -C10 -環烷基-C1 -C6 -烷氧基、C3 -C10 -環烷基-C1 -C6 -烷硫基、C1 -C8 -烷基-S(O)n R3 、N(R6 R7 )、C(=O)R3 、C(=O)OR3 、S(O)n R3 、OS(O)n R3 、S(O)n -C6 -C10 -芳基、S(O)n- C7 -C19 -芳烷基、C6 -C10 -芳氧基、C6 -C10 -芳基和C3 -C10 -雜環基基團;上述所有基團可以被一個或多個選自鹵素R″、CN、OR″、SR″、N(R″)2 、Si(R″)3 、COOR″和CON(R″)2 的基團取代;或者 兩個R4 與它們所連接的原子一起或與其它選自C、N、O、S和任選地包括1至3個選自C(=O)、C(=S)、S(O)m 和Si(R′)2 的環成員的原子一起,可以形成3-至7-元環,其本身可以被一個或多個取代R5 ; R5 獨立地選自氫、鹵素、氰基、硝基、C1 -C6 -烷基、C2 -C8 -烯基、C2 -C8 -炔基、C1 -C6 -鹵代烷基、C2 -C8 -鹵代烯基、C2 -C8 -鹵代炔基、C3 -C6 -環烷基、C(=O)R″、C(=O)OR″、OR″、N(R″)2 和S(O)n R″基團; R″選自氫、C1 -C6 -烷基、C1 -C6 -鹵代烷基、C3 -C8 -環烷基和N(R′)2 基團;其中所述基團可任選被一個或多個選自鹵素、R′、CN、OR′、SR′、NR′2 、Si(R′)3 、COOR′、CONR′2 和C5 -C12 -芳基(其任選被一個或多個R′取代)的基團取代; R′選自氫、鹵素、C1 -C6 -烷基和 C3 -C6 -環烷基基團; n和m代表整數,其中n= 0-2,m= 1-2; 或其農業上可接受的鹽、異構體/結構異構體、立體異構體、非對映異構體、對映異構體、互變異構體、多晶型物、金屬絡合物、S-氧化物或N-氧化物; 條件是:所述式(I)化合物不是5-(苄基氨基)-4-氯-3H-1,2-二硫醇-3-硫酮。In view of the above, the present invention provides 1,2-dithiol ketone compounds of formula (I),
Figure 02_image001
Where R is selected from the group halogen, hydroxy, cyano, nitro, C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, C 1 -C 6 alkoxy, C 3 -C 6- Cycloalkyl, C(=O)R 3 , C(=O)OR 3 and S(O) n R 3 ; R 1 is selected from hydrogen, hydroxyl, C 1 -C 6 -alkyl, C 2 -C 6 -Alkenyl, C 2 -C 6 -alkynyl, C 2 -C 6 -alkenyl-C 1 -C 3 -alkyl, C 2 -C 6 -alkynyl-C 1 -C 3 -alkyl, C 1 -C 6 -haloalkyl, C 2 -C 8 -haloalkenyl, C 1 -C 6 alkoxy, C 1 -C 6 -haloalkoxy, C 3 -C 6 -cycloalkyl, C 3 -C 6 -halocycloalkyl, C 3 -C 6 -cycloalkyl-C 1 -C 3 -alkyl, benzyl, C(=O)R 3 , C(=O)OR 3 and S( O) n R 3 group; A represents O, NR 1a or S; R 1a is selected from hydrogen, hydroxyl, C 1 -C 6 -alkyl, C 1 -C 6 alkoxy, C 3 -C 6 -ring Alkyl, C 3 -C 6 -cycloalkyl-C 1 -C 3 -alkyl, benzyl, C(=O)R 3 , C(=O)OR 3 and S(O) n R 3 groups ; R 2a and R 2b are independently selected from hydrogen, halogen, hydroxy, C 1 -C 6 -alkyl, C 1 -C 6 alkoxy, C 3 -C 6 -cycloalkyl, C 3 -C 6- Cycloalkyl-C 1 -C 3 -alkyl, C(=O)R 3 , C(=O)OR 3 and S(O) n R 3 groups; or R 2a and R 2b to which they are attached Atoms together or with other atoms selected from C, N, O, and S may form a 3- to 5-membered ring, which may itself be substituted with one or more R 3 ; R 3 is selected from hydrogen, hydroxyl, C 1- C 6 -alkyl, C 1 -C 6 -haloalkyl, C 3 -C 10 -cycloalkyl, C 3 -C 10 -halocycloalkyl and N(R 6 R 7 ) group; R 6 and R 7 is independently selected from hydrogen, hydroxyl, C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, C 3 -C 10 -cycloalkyl, and S(O) n R 3 groups; R 1 , R 2 and R 3 all of the above groups may have one, two, three or four same or different substituents selected from halogen, cyano, nitro, amino, hydroxyl , C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, C 1 -C 6 alkoxy and C 1 -C 6 -haloalkoxy; Cy represents fused or non-fused C 3- C 10 -Carbocyclyl or C 3 -C 10 -A heterocyclic group, which may be optionally substituted with one or more R 4 ; R 4 is independently selected from hydrogen, halogen, hydroxyl, cyano, nitro, C 1 -C 6 -alkyl, C 2- C 8 -alkenyl, C 2 -C 8 -alkynyl, C 1 -C 6 -haloalkyl, C 2 -C 8 -haloalkenyl, C 1 -C 6 -alkoxy, C 2 -C 8 -Alkenyloxy, C 2 -C 8 -alkynyloxy, C 1 -C 6 -haloalkoxy, C 2 -C 8 -alkenyloxy, C 2 -C 8 -haloalkynyloxy, C 1- C 6 -alkylthio, C 2 -C 8 -alkenylthio, C 2 -C 8 -alkynylthio, C 1 -C 6 -haloalkylthio, C 2 -C 8 -haloalkenylthio, C 3 -C 10 -cycloalkyl, C 4 -C 10 -cycloalkenyl, C 3 -C 10 -cycloalkoxy, C 4 -C 10 -cycloalkenyloxy, C 3 -C 10 -cycloalkylthio Group, C 4 -C 10 -cycloalkenylthio, C 3 -C 10 -cycloalkyl-C 1 -C 6 -alkyl, C 3 -C 10 -cycloalkyl-C 1 -C 6 -alkoxy Group, C 3 -C 10 -cycloalkyl-C 1 -C 6 -alkylthio, C 1 -C 8 -alkyl-S(O) n R 3 , N(R 6 R 7 ), C(= O)R 3 , C(=O)OR 3 , S(O) n R 3 , OS(O) n R 3 , S(O) n -C 6 -C 10 -aryl, S(O) n- C 7 -C 19 -aralkyl, C 6 -C 10 -aryloxy, C 6 -C 10 -aryl and C 3 -C 10 -heterocyclic groups; all of the above groups can be one or more A group selected from halogen R″, CN, OR″, SR″, N(R″) 2 , Si(R″) 3 , COOR″ and CON(R″) 2 ; or two R 4 and them The attached atoms are taken together or with others selected from C, N, O, S and optionally include 1 to 3 selected from C(=O), C(=S), S(O) m and Si(R′ ) The atoms of the ring members of 2 together may form a 3- to 7-membered ring, which may itself be substituted with one or more R 5 ; R 5 is independently selected from hydrogen, halogen, cyano, nitro, C 1- C 6 -alkyl, C 2 -C 8 -alkenyl, C 2 -C 8 -alkynyl, C 1 -C 6 -haloalkyl, C 2 -C 8 -haloalkenyl, C 2 -C 8- Haloalkynyl, C 3 -C 6 -cycloalkyl, C(=O)R″, C(=O)OR″, OR″, N(R″) 2 and S(O) n R″ groups ; R″ is selected from hydrogen, C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, C 3 -C 8 -cycloalkyl and N(R′) 2 groups; wherein the groups may be optionally selected from one or more of halogen, R′, CN, OR′, SR ′, NR′ 2 , Si(R′) 3 , COOR′, CONR′ 2 and C 5 -C 12 -aryl (which are optionally substituted by one or more R′) groups; R′ is selected from Hydrogen, halogen, C 1 -C 6 -alkyl and C 3 -C 6 -cycloalkyl groups; n and m represent integers, where n = 0-2, m = 1-2; or agriculturally acceptable Salts, isomers/structural isomers, stereoisomers, diastereomers, enantiomers, tautomers, polymorphs, metal complexes, S-oxides or N-oxide; provided that the compound of formula (I) is not 5-(benzylamino)-4-chloro-3H-1,2-dithiol-3-thione.

在一個實施方案中,本發明提供式(I)的1,2-二硫醇酮化合物,其中 A為O; R為鹵素; R2a 和R2b 獨立地選自氫、鹵素、C1 -C6 -烷基、C3 -C6 -環烷基和C3 -C6 -環烷基-C1 -C3 -烷基基團;或者 Cy為芳基,其可任選地被一個或多個R4 取代; R4 獨立地選自鹵素、羥基、氰基、硝基、C1 -C6 -烷基、C2 -C8 -烯基、C2 -C8 -炔基、C1 -C6 -鹵代烷基、C2 -C8 -鹵代烯基、C1 -C6 -烷氧基、C2 -C8 -烯氧基、C2 -C8 -炔氧基、C1 -C6 -鹵代烷氧基、C2 -C8 -烯氧基、C2 -C8 -鹵代炔氧基、C1 -C6 -烷硫基、C2 -C8 -烯硫基、C2 -C8 -炔硫基、C1 -C6 -鹵代烷硫基、C2 -C8 -鹵代烯硫基、C3 -C10 -環烷基、C4 -C10 -環烯基、C3 -C10 -環烷氧基、C4 -C10 -環烯氧基、C3 -C10 -環烷硫基、C4 -C10 -環烯硫基、C3 -C10 -環烷基-C1 -C6 -烷基、C3 -C10 -環烷基-C1 -C6 -烷氧基、C3 -C10 -環烷基-C1 -C6 -烷硫基、C1 -C8 -烷基-S(O)n R3 、N(R6 R7 )、C(=O)R3 、C(=O)OR3 、S(O)n R3 、OS(O)n R3 、OS(O)n R3 、S(O)n -C6 -C10 -芳基、S(O)n- C7 -C19 -芳烷基、C6 -C10 -芳氧基、C6 -C10 -芳基和C3 -C10 -雜環基基團;或者 兩個R4 與它們所連接的原子一起或與選自C、N、O、S的其他原子一起形成3-至5-元環,其本身可以被一個或多個R5 取代; m為1。In one embodiment, the invention provides a 1,2-dithiol compound of formula (I) wherein A is O; R is halogen; R 2a and R 2b are independently selected from hydrogen, halogen, C 1 -C 6 -alkyl, C 3 -C 6 -cycloalkyl and C 3 -C 6 -cycloalkyl-C 1 -C 3 -alkyl groups; or Cy is an aryl group, which may optionally be substituted by one or Multiple R 4 substitutions; R 4 is independently selected from halogen, hydroxyl, cyano, nitro, C 1 -C 6 -alkyl, C 2 -C 8 -alkenyl, C 2 -C 8 -alkynyl, C 1 -C 6 -haloalkyl, C 2 -C 8 -haloalkenyl, C 1 -C 6 -alkoxy, C 2 -C 8 -alkenyloxy, C 2 -C 8 -alkynyloxy, C 1 -C 6 -haloalkoxy, C 2 -C 8 -alkenyloxy, C 2 -C 8 -haloalkynyloxy, C 1 -C 6 -alkylthio, C 2 -C 8 -alkenylthio , C 2 -C 8 -alkynylthio, C 1 -C 6 -haloalkylthio, C 2 -C 8 -haloalkenylthio, C 3 -C 10 -cycloalkyl, C 4 -C 10 -ring Alkenyl, C 3 -C 10 -cycloalkoxy, C 4 -C 10 -cycloalkenyloxy, C 3 -C 10 -cycloalkylthio, C 4 -C 10 -cycloalkenylthio, C 3- C 10 -cycloalkyl-C 1 -C 6 -alkyl, C 3 -C 10 -cycloalkyl-C 1 -C 6 -alkoxy, C 3 -C 10 -cycloalkyl-C 1 -C 6 -alkylthio, C 1 -C 8 -alkyl-S(O) n R 3 , N(R 6 R 7 ), C(=O)R 3 , C(=O)OR 3 , S(O ) n R 3 , OS(O) n R 3 , OS(O) n R 3 , S(O) n -C 6 -C 10 -aryl, S(O) n- C 7 -C 19 -arane Group, C 6 -C 10 -aryloxy group, C 6 -C 10 -aryl group and C 3 -C 10 -heterocyclic group; or two R 4 together with the atom to which they are connected or selected from C , N, O, S and other atoms together form a 3- to 5-membered ring, which may itself be substituted by one or more R 5 ; m is 1.

在另一個實施方案中,本發明提供式(I)的1,2-二硫醇酮化合物,其中 A為O; R為鹵素; R2a 和R2b 獨立地選自氫、鹵素、C1 -C6 -烷基、C3 -C6 -環烷基和C3 -C6 -環烷基-C1 -C3 -烷基基團;或者 Cy為C5 -C6 -雜環基團,其可任選地被一個或多個R4 取代; R4 獨立地選自鹵素、羥基、氰基、硝基、C1 -C6 -烷基、C2 -C8 -烯基、C2 -C8 -炔基、C1 -C6 -鹵代烷基、C2 -C8 -鹵代烯基、C1 -C6 -烷氧基、C2 -C8 -烯氧基、C2 -C8 -炔氧基、C1 -C6 -鹵代烷氧基、C2 -C8 -烯氧基、C2 -C8 -鹵代炔氧基、C1 -C6 -烷硫基、C2 -C8 -烯硫基、C2 -C8 -炔硫基、C1 -C6 -鹵代烷硫基、C2 -C8 -鹵代烯硫基、C3 -C10 -環烷基、C4 -C10 -環烯基、C3 -C10 -環烷氧基、C4 -C10 -環烯氧基、C3 -C10 -環烷硫基、C4 -C10 -環烯硫基、C3 -C10 -環烷基-C1 -C6 -烷基、C3 -C10 -環烷基-C1 -C6 -烷氧基、C3 -C10 -環烷基-C1 -C6 -烷硫基、C1 -C8 -烷基-S(O)n R3 、N(R6 R7 )、C(=O)R3 、C(=O)OR3 、S(O)n R3 、OS(O)n R3 、OS(O)n R3 、S(O)n -C6 -C10 -芳基、S(O)n- C7 -C19 -芳烷基、C6 -C10 -芳氧基、C6 -C10 -芳基和C3 -C10 -雜環基基團;或者 兩個R4 與它們所連接的原子一起或與選自C、N、O、S的其他原子一起形成3-至5-元環,其本身可以被一個或多個R5 取代; m為1。In another embodiment, the present invention provides a 1,2-dithiol compound of formula (I), wherein A is O; R is halogen; R 2a and R 2b are independently selected from hydrogen, halogen, C 1- C 6 -alkyl, C 3 -C 6 -cycloalkyl and C 3 -C 6 -cycloalkyl-C 1 -C 3 -alkyl groups; or Cy is a C 5 -C 6 -heterocyclic group , Which may be optionally substituted with one or more R 4 ; R 4 is independently selected from halogen, hydroxy, cyano, nitro, C 1 -C 6 -alkyl, C 2 -C 8 -alkenyl, C 2 -C 8 -alkynyl, C 1 -C 6 -haloalkyl, C 2 -C 8 -haloalkenyl, C 1 -C 6 -alkoxy, C 2 -C 8 -alkenyloxy, C 2 -C 8 -alkynoxy, C 1 -C 6 -haloalkoxy, C 2 -C 8 -alkenyloxy, C 2 -C 8 -haloalkynyloxy, C 1 -C 6 -alkylthio, C 2 -C 8 -alkenylthio, C 2 -C 8 -alkynylthio, C 1 -C 6 -haloalkylthio, C 2 -C 8 -haloalkenylthio, C 3 -C 10 -cycloalkane Group, C 4 -C 10 -cycloalkenyl, C 3 -C 10 -cycloalkoxy, C 4 -C 10 -cycloalkenyloxy, C 3 -C 10 -cycloalkylthio, C 4 -C 10 -Cycloalkenylthio, C 3 -C 10 -cycloalkyl-C 1 -C 6 -alkyl, C 3 -C 10 -cycloalkyl-C 1 -C 6 -alkoxy, C 3 -C 10 -Cycloalkyl-C 1 -C 6 -alkylthio, C 1 -C 8 -alkyl-S(O) n R 3 , N(R 6 R 7 ), C(=O)R 3 , C( =O)OR 3 , S(O) n R 3 , OS(O) n R 3 , OS(O) n R 3 , S(O) n -C 6 -C 10 -aryl, S(O) n - C 7 -C 19 - aralkyl, C 6 -C 10 - aryloxy, C 6 -C 10 - aryl, and C 3 -C 10 - heterocyclyl group; or two R 4 with which they are The connected atoms together or with other atoms selected from C, N, O, S form a 3- to 5-membered ring, which may itself be substituted with one or more R 5 ; m is 1.

在優選的實施方案中,式(I)的1,2-二硫醇酮化合物選自4-氯-5-((3,4-二甲基苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((3,5-二甲基苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2,5-) 二氟苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((3-乙氧基-4-甲氧基苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(乙基(2-(三氟甲基)苄基)氨基)-3H-1,2-二硫醇-3-酮, 4-氯-5-(乙基((3-甲基噻吩-2-基)甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(甲基(4-苯氧基苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2-氟-4-甲氧基苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮,5-(((3-溴噻吩-2-基)甲基)(甲基)氨基)-4-氯-3H-1,2-二硫醇-3-酮、4-氯-5-(甲基(萘-1-基)甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(甲基(萘-2-基甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((3-甲基苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2-乙氧基苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2,4-二甲氧基苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮,5-(苄基(甲基)氨基)-4-氯-3H-1,2-二硫醇-3-酮、4-氯-5-((4-甲氧基苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((3,4-二氯苄基))氨基)-3H-1,2-二硫醇-3-酮,5-(苄基氨基)-4-氯-3H-1,2-二硫醇-3-酮、4-氯-5-((1-(p-甲苯基)乙基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((4-氯苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((3-(三氟甲氧xy)苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(甲基(2,4,6-三氯苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((4-羥基苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2-氯-5-硝基苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(甲基(2-硝基苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((3-硝基苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(甲基(4-(甲硫基)苄基)氨基)-3H-1,2-二硫醇-3-酮, 5-((3-溴苄基)(甲基)氨基)-4-氯-3H-1,2-二硫醇-3-酮、4-氯-5-((2-氯苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮,5-((4-溴苄基)(甲基)氨基)-4-氯-3H-1,2-二硫醇-3-酮,5-((2-溴-4-)氟代苄基)(甲基)氨基)-4-氯-3H-1,2-二硫醇-3-酮、4-氯-5-((4-甲氧基苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((4-乙氧基苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((3-氯-4-甲氧基苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((4-(2-羥基乙氧基)苄基)(甲基)氨基)-3H-1,2-二硫醇-3-one,4-氯-5-((4-甲氧基-3-甲基苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((4-羥基-3)-甲基苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((4-異丙氧基苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮,5-((3-溴-4-甲氧基苄基)(甲基)氨基)-4-氯-3H-1,2-二硫醇-3-酮、4-氯-5-((4-羥基-3-甲氧基苄基)基)(甲基)氨基)-3H--1,2-二硫醇-3-酮, 5-((4-丁氧基苄基)(甲基)氨基)-4-氯-3H-1,2-二硫醇-3-酮、4-氯-5-((4-羥基-3,5-二甲基苄基)(甲基))氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((3-氯-4-羥基苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮,4-(((4-氯-3-氧代-3H-1,2-二硫醇-5-基)(甲基)氨基)甲基)-2-甲氧基苯基甲磺酸鹽,2-氯-4-(((4-氯)-3-氧代-3H-1,2-二硫醇-5-基)(甲基)氨基)甲基)苯基甲磺酸酯,4-氯-5-((3,4-二甲氧基苄基)(甲基)氨基)-3H-1 ,2-二硫醇-3-酮、4-氯-5-((4-乙氧基-3-甲氧基苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2,5-二甲基苄基)氨基)-3H-1,2-二硫醇-3-酮,5-(苄基(異丁基)氨基)-4-氯-3H-1,2-二硫醇-3-酮,5-(苄基(丙-2-炔-1-基)氨基)-4-氯-3H-1,2-二硫醇-3-酮,5-(苄基(環丙基甲基)氨基)-4-氯-3H-1,2-二硫醇-3-酮,5-(苄基(環丙基)氨基)-4-氯-3H-1,2-二硫醇-3-酮,5-(苄基(乙基)氨基)-4-氯-3H-1,2-二硫醇-3-酮,5-(苄基(異丙基)氨基)-4-氯-3H-1,2-二硫醇-3-酮、4-氯-5-((3-氟-4-)我(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(甲基(4-甲基苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((4-(二甲基氨基)苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2,6-二氟苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((4-(二甲基氨基)苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮,5-(烯丙基(苄基))氨基)-4-氯-3H-1,2-二硫醇-3-酮、4-氯-5-((吡啶-2-基甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((吡啶-3-基甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((吡啶-4-基甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(甲基(吡啶-2-基甲基)氨基)-3H-1,2-二硫醇-3-酮, 4-氯-5-(甲基(吡啶-3-基甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(甲基(吡啶-4-基甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(((6-氯吡啶-3-基)甲基)(丙-2-炔-1-基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(((3-氯吡啶-4-基)甲基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(( (3,5-二氯吡啶-4-基)甲基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(((2-氯吡啶-4-基)甲基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((3-氯苄基)氨基)-3H-1,2-二硫醇-3-酮,5-((3-溴代苄基)氨基)-4-氯-3H-1,2-二硫醇-3-酮、4-氯-5-((3-氯-4-氟苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((3,5-二氟苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(((6-氯吡啶-3-基)甲基 )氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((3,5-二氯苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((3-氟苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((3-氟苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮, 4-氯-5-((4-氯-3-氟苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((3,4-二氟苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((3,4,5-三氟苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((3-(三氟甲基)苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2,6-二氟苄基)氨基)-3H-1,2-二硫醇-3-酮,4-氯-5-((3-氯苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2-氯-6-(三氟甲基)苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((3,5-二氟苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((3,5-二溴苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((3,5-二氯苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(甲基(3-(三氟甲基)苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(甲基(嘧啶-5-基甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(甲基(噻吩-2-基甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((吡嗪-2-基甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((1-(2,4-二氯苯基))乙基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((1-苯乙基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2-羥基-2-)苯乙基)氨基)-3H-1,2-二硫醇-3-酮,5-((2-溴-5-氟苄基)(甲基)氨基)-4-氯-3H-1,2-二硫醇-3-酮, 4-氯-5-((3-羥基苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮,5-((2-溴-3-羥基苄基)(甲基)氨基)-4-氯-3H-1,2-二硫醇-3-酮,3-(((4-氯-3-氧代-3H-1,2-二硫醇-5-基)(甲基)氨基)甲基)苯基甲磺酸鹽,2-溴-3-(((4-氯-3-氧代-3H-1,2-二硫醇-5-基)(甲基)氨基)甲基)苯基甲磺酸鹽,3-(((4-氯-3-氧代)-3H-1,2-二硫醇-5-基)氨基)甲基)苄腈,3-(((4-氯-3-氧代-3H-1,2-二硫醇-5-基)(甲基)氨基)甲基)苄腈,4-(((4-氯-3-氧代-3H-1,2-二硫醇-5-基)氨基)甲基)苄腈,4-(((4-氯-3-氧代-3H-1),2-二硫醇-5-基)(甲基)氨基)甲基)苄腈,4-氯-5-((3-甲氧基苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((3-甲氧基苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((4-氟苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((3-甲基苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((4-甲基苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((3,4-二甲基苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((4-氟-2-甲基苄基))氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((3,5-二甲基苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2-氟苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2,3-二甲基苄基)氨基)-3H-1,2-二硫醇-3-酮, 4-氯-5-(甲基(3-(三氟甲氧基)苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(乙基(3-(三氟甲氧基)苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(甲基(4-(三氟甲氧基)苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-( (4-(三氟甲氧基)苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((環丙基甲基)(3-(三氟甲氧基)苄基)氨基)-3H-1,2-二硫醇-3-酮,5-(烯丙基(3-(三氟甲氧基)苄基)氨基)-4-氯-3H-1,2-二硫醇-3-酮,5-((3-溴苄基)(環丙基甲基)氨基)-4-氯-3H-1,2-二硫醇-3-酮,5-(烯丙基(3-溴苄基)氨基)-4-氯-3H-1,2-二硫醇-3-酮,5-(( 3-溴苄基)(環丙基)氨基)-4-氯-3H-1,2-二硫醇-3-酮,5-((1-(3-溴苯基)乙基)(甲基)氨基)-4-氯-3H-1,2-二硫醇-3-酮,5-((1-(3-溴苯基)乙基)(乙基)氨基)-4-氯-3H-1,2-二硫醇-3-酮,5-(烯丙基)(1-(3-溴苯基)乙基)氨基)-4-氯-3H-1,2-二硫醇-3-酮,5-((1-(3-溴苯基)乙基)(環丙基甲基)氨基)-4-氯-3H-1,2-二硫醇-3-酮、4-氯-5-(甲基(3-((三氟甲氧基)基)硫基)苄基)氨基)-3H-1,2-二硫醇-3-酮, 4-氯-5-(乙基(3-((三氟甲基)硫代)苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(乙基(3-氟苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2,4-二甲氧基苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2,4-二氟苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((4-(三氟甲基)苄基)氨基)-3H-1,2-二硫醇-3-酮,5-((4-溴苄基)氨基)-4-氯-3H-1,2-二硫醇-3-酮、4-氯-5-(乙基(4-甲氧基苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((4-(三氟甲氧基)苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2-氯-4-氟苄基) )氨基)-3H-1,2-二硫醇-3-酮,5-((2-溴苄基)氨基)-4-氯-3H-1,2-二硫醇-3-酮、4-氯-5-((2-氯苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((3,4-二甲氧基苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2,5-二氟苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2,3-二氟苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((3,5-二甲氧基苄基)氨基)-3H-1,2-二硫醇-3-酮, 5-((苯並[d] [1,3]二氧雜環戊烯-5-基甲基)氨基)-4-氯-3H-1,2-二硫醇-3-酮、4-氯-5-((噻吩-2-)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2-甲基苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2,4-二氯苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2-甲氧基苄基)氨基)-3H-1,2-二硫醇-3-酮,4-氯-5-((2,3-二氯苄基)氨基)-3H-1,2-二硫醇-3-酮,5-((4-溴-2-氟苄基)氨基)-4-氯-3H-1,2-二硫醇-3-酮、4-氯-5-((2-甲氧基苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(乙基(2)-甲氧基苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2,4-二氟苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮,4-氯-5-((2,4-二氟苄基)(乙基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(甲基(4-((三氟甲基)硫代)苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2,3-二甲氧基苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2-氯-6-氟苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2,5-二氯苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2,4-二甲基苯)zyl)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((4-(甲硫基)苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(乙基(4-((三氟甲基)硫代)苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((4-氯苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2,4-二氯苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((4-異丙基苄基)氨基)-3H-1,2-二硫醇-3-酮, 4-氯-5-((4-((三氟甲基)硫代)苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((4-乙氧基苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2-氯-3-氟苄基)氨基)-3H-1,2-二硫醇-3-酮,5-((2-溴苄基)(()氨基)-4-氯-3H-1,2-二硫醇-3-酮、4-氯-5-(((5-氯噻吩-2-基)甲基)(甲基)氨基)-3H-1, 2-二硫醇-3-酮、4-氯-5-((2,5-二甲氧基苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(甲基((3-甲基噻吩-2-基)甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2-氟-5-甲氧基苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((3-氯-5-氟苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((3-乙氧基苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2,6-二甲基苄基)(乙基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(甲基(2,3,6-三氯苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(乙基(2,3,6-三氯苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2,3-二氟苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(( 4-氟苄基)(甲基)氨基)-3H--1,2-二硫醇-3-酮、4-氯-5-((2,3-二氯苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((4-(三氟甲基)苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((4-甲氧基-2-甲基苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((3,4-二氯苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((4-異丙基苄基)(甲基)氨基)-3H--1,2-二硫醇-3-酮, 4-氯-5-(甲基(2,4,6-三甲基苄基)氨基)-3H-1,2-二硫醇-3-酮,5-((3,5-雙(三氟甲基)苄基)(甲基)氨基)-4-氯-3H-1,2-二硫醇-3-酮、4-氯-5-((4-氯-2-甲基苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2-氟-5-甲基苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2,6-二甲基苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2-氯-6-氟苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(甲基(4-(三氟甲基)苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((4-(乙基磺醯基)苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(乙基(3-(三氟甲基)苄基)氨基)-3H-1,2-二硫醇-3-酮,5-(([1,1'-聯苯基]-4-基甲基)(甲基)氨基)-4-氯-3H-1,2-二硫醇-3-酮、4-氯-5-((2,3-二氟苄基)(乙基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((4-乙基苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(乙基(4-)氟代苄基)氨基)-3H-1,2-二硫醇-3-酮,5-((4-(叔丁基)苄基)(甲基)氨基)-4-氯-3H-1,2-二硫醇-3-酮、4-氯-5-((2,6-二甲氧基苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(甲基(2-甲基苄基)氨基)-3H-1,2-二硫醇-3-酮和4-氯-5-((2-氟苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮基團。In a preferred embodiment, the 1,2-dithiol compound of formula (I) is selected from 4-chloro-5-((3,4-dimethylbenzyl)(methyl)amino)-3H- 1,2-dithiol-3-one, 4-chloro-5-((3,5-dimethylbenzyl)(methyl)amino)-3H-1,2-dithiol-3-one , 4-chloro-5-((2,5-)difluorobenzyl)(methyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((3- Ethoxy-4-methoxybenzyl) (methyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-(ethyl(2-(trifluoromethyl )Benzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-(ethyl((3-methylthiophen-2-yl)methyl)amino)-3H- 1,2-dithiol-3-one, 4-chloro-5-(methyl(4-phenoxybenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro -5-((2-fluoro-4-methoxybenzyl)(methyl)amino)-3H-1,2-dithiol-3-one, 5-(((3-bromothiophen-2- Yl)methyl)(methyl)amino)-4-chloro-3H-1,2-dithiol-3-one, 4-chloro-5-(methyl(naphthalen-1-yl)methyl)amino )-3H-1,2-dithiol-3-one, 4-chloro-5-(methyl(naphthalene-2-ylmethyl)amino)-3H-1,2-dithiol-3-one , 4-chloro-5-((3-methylbenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((2-ethoxybenzyl) ( Methyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((2,4-dimethoxybenzyl)(methyl)amino)-3H-1, 2-dithiol-3-one, 5-(benzyl(methyl)amino)-4-chloro-3H-1,2-dithiol-3-one, 4-chloro-5-((4- Methoxybenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((3,4-dichlorobenzyl))amino)-3H-1,2- Dithiol-3-one, 5-(benzylamino)-4-chloro-3H-1,2-dithiol-3-one, 4-chloro-5-((1-(p-tolyl) Ethyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((4-chlorobenzyl)amino)-3H-1,2-dithiol-3-one , 4-chloro-5-((3-(trifluoromethoxyxy)benzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-(methyl (2, 4,6-trichlorobenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((4-hydroxybenzyl)(methyl)amino)-3H-1 ,2-dithiol-3-one, 4-chloro-5-((2-chloro-5-nitrobenzyl)(methyl)amino)-3H-1,2-dithiol-3-one , 4-chloro-5-(methyl (2-nitrobenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro -5-((3-nitrobenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-(methyl(4-(methylthio)benzyl)amino )-3H-1,2-dithiol-3-one, 5-((3-bromobenzyl)(methyl)amino)-4-chloro-3H-1,2-dithiol-3-one , 4-chloro-5-((2-chlorobenzyl)(methyl)amino)-3H-1,2-dithiol-3-one, 5-((4-bromobenzyl)(methyl) Amino)-4-chloro-3H-1,2-dithiol-3-one, 5-((2-bromo-4-)fluorobenzyl)(methyl)amino)-4-chloro-3H- 1,2-dithiol-3-one, 4-chloro-5-((4-methoxybenzyl)(methyl)amino)-3H-1,2-dithiol-3-one, 4 -Chloro-5-((4-ethoxybenzyl)(methyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((3-chloro-4- Methoxybenzyl)(methyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((4-(2-hydroxyethoxy)benzyl) (methyl Group) amino)-3H-1,2-dithiol-3-one,4-chloro-5-((4-methoxy-3-methylbenzyl)(methyl)amino)-3H-1 ,2-dithiol-3-one, 4-chloro-5-((4-hydroxy-3)-methylbenzyl)(methyl)amino)-3H-1,2-dithiol-3- Ketone, 4-chloro-5-((4-isopropoxybenzyl)(methyl)amino)-3H-1,2-dithiol-3-one, 5-((3-bromo-4- Methoxybenzyl)(methyl)amino)-4-chloro-3H-1,2-dithiol-3-one, 4-chloro-5-((4-hydroxy-3-methoxybenzyl ) Group) (methyl)amino)-3H--1,2-dithiol-3-one, 5-((4-butoxybenzyl)(methyl)amino)-4-chloro-3H- 1,2-dithiol-3-one, 4-chloro-5-((4-hydroxy-3,5-dimethylbenzyl)(methyl))amino)-3H-1,2-disulfide Alcohol-3-one, 4-chloro-5-((3-chloro-4-hydroxybenzyl)(methyl)amino)-3H-1,2-dithiol-3-one, 4-((( 4-chloro-3-oxo-3H-1,2-dithiol-5-yl) (methyl)amino)methyl)-2-methoxyphenyl methanesulfonate, 2-chloro-4 -(((4-chloro)-3-oxo-3H-1,2-dithiol-5-yl)(methyl)amino)methyl)phenyl methanesulfonate, 4-chloro-5- ((3,4-dimethoxybenzyl)(methyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((4-ethoxy-3- Methoxybenzyl)(methyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((2,5-dimethylbenzyl)amino)-3H- 1,2-dithiol-3-one, 5-(benzyl(isobutyl)amino)-4-chloro-3H-1,2-dithiol-3-one , 5-(benzyl(prop-2-yn-1-yl)amino)-4-chloro-3H-1,2-dithiol-3-one, 5-(benzyl(cyclopropylmethyl) Amino)-4-chloro-3H-1,2-dithiol-3-one, 5-(benzyl(cyclopropyl)amino)-4-chloro-3H-1,2-dithiol-3- Ketone, 5-(benzyl(ethyl)amino)-4-chloro-3H-1,2-dithiol-3-one, 5-(benzyl(isopropyl)amino)-4-chloro-3H -1,2-dithiol-3-one, 4-chloro-5-((3-fluoro-4-)I(methyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-(methyl(4-methylbenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((4-(dimethylamino) Benzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((2,6-difluorobenzyl)(methyl)amino)-3H-1,2- Dithiol-3-one, 4-chloro-5-((4-(dimethylamino)benzyl)(methyl)amino)-3H-1,2-dithiol-3-one, 5- (Allyl(benzyl))amino)-4-chloro-3H-1,2-dithiol-3-one, 4-chloro-5-((pyridin-2-ylmethyl)amino)-3H -1,2-dithiol-3-one, 4-chloro-5-((pyridin-3-ylmethyl)amino)-3H-1,2-dithiol-3-one, 4-chloro- 5-((pyridin-4-ylmethyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-(methyl(pyridin-2-ylmethyl)amino)- 3H-1,2-dithiol-3-one, 4-chloro-5-(methyl(pyridin-3-ylmethyl)amino)-3H-1,2-dithiol-3-one, 4 -Chloro-5-(methyl(pyridin-4-ylmethyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-(((6-chloropyridine-3- Yl)methyl)(prop-2-yn-1-yl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-(((3-chloropyridin-4-yl )Methyl) (methyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-(( (3,5-dichloropyridin-4-yl)methyl) ( Methyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-(((2-chloropyridin-4-yl)methyl)(methyl)amino)-3H- 1,2-dithiol-3-one, 4-chloro-5-((3-chlorobenzyl)amino)-3H-1,2-dithiol-3-one, 5-((3-bromo Substituted benzyl)amino)-4-chloro-3H-1,2-dithiol-3-one, 4-chloro-5-((3-chloro-4-fluorobenzyl)amino)-3H-1, 2-dithiol-3-one, 4-chloro-5-((3,5-difluorobenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5- (((6-chloropyridin-3-yl)methyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((3,5-dichlorobenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((3-fluorobenzyl)amino) -3H-1,2-dithiol-3-one, 4-chloro-5-((3-fluorobenzyl)(methyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((4-chloro-3-fluorobenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((3,4-difluorobenzyl Group) amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((3,4,5-trifluorobenzyl)amino)-3H-1,2-dithiol -3-one, 4-chloro-5-((3-(trifluoromethyl)benzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((2 ,6-difluorobenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((3-chlorobenzyl)(methyl)amino)-3H-1, 2-dithiol-3-one, 4-chloro-5-((2-chloro-6-(trifluoromethyl)benzyl)(methyl)amino)-3H-1,2-dithiol- 3-ketone, 4-chloro-5-((3,5-difluorobenzyl)(methyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-(( 3,5-dibromobenzyl)(methyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((3,5-dichlorobenzyl)(methyl )Amino)-3H-1,2-dithiol-3-one, 4-chloro-5-(methyl(3-(trifluoromethyl)benzyl)amino)-3H-1,2-disulfide Alcohol-3-one, 4-chloro-5-(methyl(pyrimidin-5-ylmethyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-(methyl (Thien-2-ylmethyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((pyrazin-2-ylmethyl)amino)-3H-1, 2-dithiol-3-one, 4-chloro-5-((1-(2,4-dichlorophenyl))ethyl)amino)-3H-1,2-dithiol-3-one , 4-chloro-5-((1-phenethyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((2-hydroxy-2-)phenethyl )Amino)-3H-1,2-dithiol-3-one, 5-((2-bromo-5-fluorobenzyl)(methyl)amino)-4-chloro-3H-1,2-di Thiol-3-one, 4-chloro-5-((3-hydroxybenzyl)(methyl)amino)-3H-1,2-dithiol-3-one, 5-((2-bromo- 3-hydroxybenzyl)(methyl)amino)-4-chloro-3H-1,2-dithiol-3-one, 3-(((4-chloro-3-oxo-3H-1,2 -Dithiol-5-yl)(methyl)amino)methyl)phenyl methanesulfonate, 2-bromo-3-(((4-chloro-3-oxo-3H-1,2-di Thiol-5-yl)(methyl)amino)methyl)phenyl methanesulfonate, 3-(((4-chloro-3-oxo)-3H-1, 2-dithiol-5-yl)amino)methyl)benzonitrile, 3-(((4-chloro-3-oxo-3H-1,2-dithiol-5-yl)(methyl) Amino)methyl)benzonitrile, 4-(((4-chloro-3-oxo-3H-1,2-dithiol-5-yl)amino)methyl)benzonitrile, 4-(((4 -Chloro-3-oxo-3H-1),2-dithiol-5-yl)(methyl)amino)methyl)benzonitrile, 4-chloro-5-((3-methoxybenzyl )Amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((3-methoxybenzyl)(methyl)amino)-3H-1,2-dithiol -3-one, 4-chloro-5-((4-fluorobenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((3-methylbenzyl )Amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((4-methylbenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((3,4-dimethylbenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((4-fluoro-2-methyl Benzyl))amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((3,5-dimethylbenzyl)amino)-3H-1,2-di Thiol-3-one, 4-chloro-5-((2-fluorobenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((2,3- Dimethylbenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-(methyl(3-(trifluoromethoxy)benzyl)amino)-3H- 1,2-dithiol-3-one, 4-chloro-5-(ethyl(3-(trifluoromethoxy)benzyl)amino)-3H-1,2-dithiol-3-one , 4-chloro-5-(methyl(4-(trifluoromethoxy)benzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-( (4- (Trifluoromethoxy)benzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((cyclopropylmethyl)(3-(trifluoromethoxy )Benzyl)amino)-3H-1,2-dithiol-3-one, 5-(allyl(3-(trifluoromethoxy)benzyl)amino)-4-chloro-3H-1 ,2-Dithiol-3-one, 5-((3-bromobenzyl)(cyclopropylmethyl)amino)-4-chloro-3H-1,2-dithiol-3-one, 5 -(Allyl(3-bromobenzyl)amino)-4-chloro-3H-1,2-dithiol-3-one, 5-((3-bromobenzyl)(cyclopropyl)amino) -4-chloro-3H-1,2-dithiol-3-one, 5-((1-(3-bromophenyl)ethyl)(methyl)amino)-4-chloro-3H-1, 2-Dithiol-3-one, 5-((1-(3-bromophenyl)ethyl)(ethyl)amino)-4-chloro-3H-1,2-dithiol-3-one , 5-(allyl)(1-(3-bromophenyl)ethyl)amino)-4-chloro-3H-1,2-dithiol-3-one, 5-(( 1-(3-bromophenyl)ethyl) (cyclopropylmethyl)amino)-4-chloro-3H-1,2-dithiol-3-one, 4-chloro-5-(methyl ( 3-((trifluoromethoxy)yl)thio)benzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-(ethyl(3-((tri Fluoromethyl)thio)benzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-(ethyl(3-fluorobenzyl)amino)-3H-1, 2-dithiol-3-one, 4-chloro-5-((2,4-dimethoxybenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro- 5-((2,4-difluorobenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((4-(trifluoromethyl)benzyl)amino )-3H-1,2-dithiol-3-one, 5-((4-bromobenzyl)amino)-4-chloro-3H-1,2-dithiol-3-one, 4-chloro -5-(ethyl(4-methoxybenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((4-(trifluoromethoxy)benzyl Group) amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((2-chloro-4-fluorobenzyl))amino)-3H-1,2-dithiol -3-one, 5-((2-bromobenzyl)amino)-4-chloro-3H-1,2-dithiol-3-one, 4-chloro-5-((2-chlorobenzyl) Amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((3,4-dimethoxybenzyl)amino)-3H-1,2-dithiol-3 -Ketone, 4-chloro-5-((2,5-difluorobenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((2,3-di Fluorobenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((3,5-dimethoxybenzyl)amino)-3H-1,2-di Thiol-3-one, 5-((benzo[d] [1,3]dioxol-5-ylmethyl)amino)-4-chloro-3H-1,2-dithiol -3-one, 4-chloro-5-((thiophen-2-)(methyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((2-methyl Benzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((2,4-dichlorobenzyl)amino)-3H-1,2-dithiol -3-one, 4-chloro-5-((2-methoxybenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((2,3- Dichlorobenzyl)amino)-3H-1,2-dithiol-3-one, 5-((4-bromo-2-fluorobenzyl)amino)-4-chloro-3H-1,2-di Thiol-3-one, 4-chloro-5-((2-methoxybenzyl)(methyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5- (Ethyl(2)-methoxybenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((2,4-di Fluorobenzyl) (methyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((2,4-difluorobenzyl)(ethyl)amino)-3H -1,2-dithiol-3-one, 4-chloro-5-(methyl(4-((trifluoromethyl)thio)benzyl)amino)-3H-1,2-dithiol -3-one, 4-chloro-5-((2,3-dimethoxybenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((2 -Chloro-6-fluorobenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((2,5-dichlorobenzyl)amino)-3H-1, 2-dithiol-3-one, 4-chloro-5-((2,4-dimethylbenzene) zyl)amino)-3H-1,2-dithiol-3-one, 4-chloro- 5-((4-(methylthio)benzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-(ethyl(4-((trifluoromethyl) Thio)benzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((4-chlorobenzyl)(methyl)amino)-3H-1,2- Dithiol-3-one, 4-chloro-5-((2,4-dichlorobenzyl)(methyl)amino)-3H-1,2-dithiol-3-one, 4-chloro- 5-((4-isopropylbenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((4-((trifluoromethyl)thio)benzyl Group) amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((4-ethoxybenzyl)amino)-3H-1,2-dithiol-3- Ketone, 4-chloro-5-((2-chloro-3-fluorobenzyl)amino)-3H-1,2-dithiol-3-one, 5-((2-bromobenzyl)(() Amino)-4-chloro-3H-1,2-dithiol-3-one, 4-chloro-5-(((5-chlorothiophen-2-yl)methyl)(methyl)amino)-3H -1, 2-dithiol-3-one, 4-chloro-5-((2,5-dimethoxybenzyl)(methyl)amino)-3H-1,2-dithiol-3 -Ketone, 4-chloro-5-(methyl((3-methylthiophen-2-yl)methyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5- ((2-fluoro-5-methoxybenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((3-chloro-5-fluorobenzyl)amino )-3H-1,2-dithiol-3-one, 4-chloro-5-((3-ethoxybenzyl)amino)-3H-1,2-dithiol-3-one, 4 -Chloro-5-((2,6-dimethylbenzyl)(ethyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-(methyl (2, 3,6-trichlorobenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-(ethyl(2,3,6-trichlorobenzyl)amino)- 3H-1,2-dithiol-3-one, 4-chloro-5-((2,3-difluorobenzyl)(methyl)amino)-3H-1, 2-dithiol-3-one, 4-chloro-5-((4-fluorobenzyl)(methyl)amino)-3H--1,2-dithiol-3-one, 4-chloro- 5-((2,3-dichlorobenzyl)(methyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((4-(trifluoromethyl) Benzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((4-methoxy-2-methylbenzyl)amino)-3H-1,2- Dithiol-3-one, 4-chloro-5-((3,4-dichlorobenzyl)(methyl)amino)-3H-1,2-dithiol-3-one, 4-chloro- 5-((4-isopropylbenzyl)(methyl)amino)-3H--1,2-dithiol-3-one, 4-chloro-5-(methyl (2,4,6- Trimethylbenzyl)amino)-3H-1,2-dithiol-3-one, 5-((3,5-bis(trifluoromethyl)benzyl)(methyl)amino)-4- Chloro-3H-1,2-dithiol-3-one, 4-chloro-5-((4-chloro-2-methylbenzyl)amino)-3H-1,2-dithiol-3- Ketone, 4-chloro-5-((2-fluoro-5-methylbenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((2,6- Dimethylbenzyl)(methyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((2-chloro-6-fluorobenzyl)(methyl)amino )-3H-1,2-dithiol-3-one, 4-chloro-5-(methyl(4-(trifluoromethyl)benzyl)amino)-3H-1,2-dithiol- 3-ketone, 4-chloro-5-((4-(ethylsulfonyl)benzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-(ethyl (3-(trifluoromethyl)benzyl)amino)-3H-1,2-dithiol-3-one, 5-(([1,1'-biphenyl]-4-ylmethyl) (Methyl)amino)-4-chloro-3H-1,2-dithiol-3-one, 4-chloro-5-((2,3-difluorobenzyl)(ethyl)amino)-3H -1,2-dithiol-3-one, 4-chloro-5-((4-ethylbenzyl)(methyl)amino)-3H-1,2-dithiol-3-one, 4 -Chloro-5-(ethyl(4-)fluorobenzyl)amino)-3H-1,2-dithiol-3-one, 5-((4-(tert-butyl)benzyl)(methyl Group) amino)-4-chloro-3H-1,2-dithiol-3-one, 4-chloro-5-((2,6-dimethoxybenzyl)(methyl)amino)-3H -1,2-dithiol-3-one, 4-chloro-5-(methyl(2-methylbenzyl)amino)-3H-1,2-dithiol-3-one and 4-chloro -5-((2-fluorobenzyl)(methyl)amino)-3H-1,2-dithiol-3-one group.

本發明化合物可以以純的形式使用或作為不同可能的異構形式(例如立體異構體或結構異構體)的混合物使用。各種立體異構體包括對映異構體、非對映異構體、手性異構體、阻轉異構體、構象異構體、旋轉異構體、互變異構體、光學異構體、多晶型物和幾何異構體。這些異構體的任何所需混合物都是本發明權利請求的範圍內。本領域技術人員可理解,當一種立體異構體與其他異構體富集或與分離時,這種立體異構體可以更具活性和/或可以表現出有益效果。另外,本領域技術人員知道分離,富集和/或選擇性製備所述異構體的步驟或方法或技術。The compounds of the invention can be used in pure form or as a mixture of different possible isomeric forms (eg stereoisomers or structural isomers). Various stereoisomers include enantiomers, diastereomers, chiral isomers, atropisomers, conformational isomers, rotamers, tautomers, optical isomers , Polymorphs and geometric isomers. Any desired mixture of these isomers is within the scope of the claims of the present invention. Those skilled in the art will understand that when one stereoisomer is enriched or separated from other isomers, such stereoisomers may be more active and/or may exhibit beneficial effects. In addition, those skilled in the art are aware of steps, methods or techniques for separating, enriching and/or selectively preparing the isomers.

根據化合物中雙鍵的數目,本發明的任何化合物還可以以一種或多種幾何異構體形式存在。因此,本發明同樣涉及所有幾何異構體和各種比例的所有可能的混合物。幾何異構體可以根據本領域普通技術人員已知的一般方法分離。Depending on the number of double bonds in the compound, any compound of the invention may also exist in the form of one or more geometric isomers. Therefore, the invention also relates to all geometric isomers and all possible mixtures in various ratios. Geometric isomers can be separated according to general methods known to those of ordinary skill in the art.

在每種情況下,如果各個組分具有不同的生物活性,分離或合成生物學上更有效的異構體(例如特定的對映體、非對映體或異構混合物(例如對映體混合物或非對映體混合物))可能會有好處。以游離形式或鹽形式存在的式(I)的化合物和其互變異構體(如果合適)也可以以水合物和/或包括其他溶劑(例如那些被用於化合物的結晶(固體形式存在的)的溶劑)的形式獲得。In each case, if the components have different biological activities, separate or synthesize biologically more effective isomers (such as specific enantiomers, diastereomers, or isomeric mixtures (such as mixtures of enantiomers Or a mixture of diastereomers)) may be beneficial. Compounds of formula (I) and their tautomers (if appropriate) in free form or in salt form can also be hydrated and/or include other solvents (such as those used for crystallization of compounds (in solid form) Solvent).

根據其製備、純化、儲存和各種其他影響因素,本發明的任何化合物也可以以一種或多種無定形或同構或多晶形式存在。因此,本發明涉及各種比例的所有可能的無定形、同構和多晶形式。可以根據本領域普通技術人員本身已知的一般方法製備和/或分離和/或純化無定形、同構和多晶型形式。Depending on its preparation, purification, storage, and various other influencing factors, any compound of the invention may also exist in one or more amorphous or isomorphic or polycrystalline forms. Therefore, the invention relates to all possible amorphous, isomorphic and polycrystalline forms in various proportions. Amorphous, isomorphic and polymorphic forms can be prepared and/or isolated and/or purified according to general methods known per se by those of ordinary skill in the art.

在一個實施方案中,本發明提供了製備式(I)化合物或其農業上可接受的鹽的方法。In one embodiment, the present invention provides a method of preparing a compound of formula (I) or an agriculturally acceptable salt thereof.

有許多合適的已知標準方法(例如烷基化、鹵化、醯化、醯胺化、肟化、氧化和還原)可供選擇。適合的製備方法的選擇取決於中間體中取代基的性質(反應性)。合適的堿的實例是鹼金屬或鹼土金屬氫氧化物、鹼金屬或鹼土金屬氫化物、鹼金屬或鹼土金屬氨化物、鹼金屬或鹼土金屬醇鹽、鹼金屬或鹼土金屬乙酸鹽、鹼金屬或鹼土金屬碳酸鹽、鹼金屬或鹼土金屬二烷基醯胺或鹼金屬或鹼土金屬烷基甲矽烷基醯胺、烷基胺、烷基二胺、游離或N-烷基化的飽和或不飽和環烷基胺、鹼性雜環、氫氧化銨和碳環胺。可能提及的實例有氫氧化鈉、氫化鈉、氨基鈉、甲醇鈉、乙酸鈉、碳酸鈉、叔丁醇鉀、氫氧化鉀、碳酸鉀、氫化鉀、二異丙基氨基化鋰、雙(三甲基甲矽烷基)氨基鉀、氫化鈣、三乙胺、二異丙基乙胺、三亞乙基二胺、環己胺、N-環己基-N,N-二甲基胺、N,N-二乙基苯胺、吡啶、4-(N,N-二甲基氨基)吡啶、奎寧環、N-甲基嗎啉、苄基三甲基氫氧化銨和1,8-二氮雜雙環 [5.4.0]十一烷-7-烯(二氮雜二環)。There are many suitable known standard methods (such as alkylation, halogenation, acylation, amidation, oximation, oxidation and reduction) to choose from. The choice of a suitable preparation method depends on the nature (reactivity) of the substituent in the intermediate. Examples of suitable compounds are alkali metal or alkaline earth metal hydroxides, alkali metal or alkaline earth metal hydrides, alkali metal or alkaline earth metal amides, alkali metal or alkaline earth metal alkoxides, alkali metal or alkaline earth metal acetates, alkali metal or Alkaline earth metal carbonate, alkali metal or alkaline earth metal dialkyl amide or alkali metal or alkaline earth metal alkyl silyl amide, alkyl amine, alkyl diamine, free or N-alkylated saturated or unsaturated Cycloalkylamines, basic heterocycles, ammonium hydroxide and carbocyclic amines. Examples that may be mentioned are sodium hydroxide, sodium hydride, sodium amide, sodium methoxide, sodium acetate, sodium carbonate, potassium t-butoxide, potassium hydroxide, potassium carbonate, potassium hydride, lithium diisopropylamide, bis( Trimethylsilyl) potassium amide, calcium hydride, triethylamine, diisopropylethylamine, triethylenediamine, cyclohexylamine, N-cyclohexyl-N,N-dimethylamine, N, N-diethylaniline, pyridine, 4-(N,N-dimethylamino)pyridine, quinine ring, N-methylmorpholine, benzyltrimethylammonium hydroxide and 1,8-diaza Bicyclic [5.4.0] undecane-7-ene (diazabicyclo).

方案-1的反應優選在當前反應條件下為惰性的標準溶劑中進行。優選脂族、脂環族或芳族烴,例如石油醚、己烷、甲苯;鹵代烴類,如氯苯、二氯甲烷、氯仿、四氯化碳或二氯乙烷;醚類,如二乙醚、二異丙醚、甲基叔丁基醚(MTBE)、二惡烷、四氫呋喃或1,2-二甲氧基乙烷;腈類如乙腈或丙腈,或醯胺類如N, N-二甲基甲醯胺(DMF)、N,N-二甲基乙醯胺、N-甲基甲醯胺、N-甲基吡咯烷酮(NMP)或六亞甲基磷醯三胺;酯類,如乙酸甲酯或乙酸乙酯;亞碸類,如二甲基亞碸(DMSO);碸類,如環丁碸;醇類,如甲醇、乙醇、異丙醇、1,1-、異-、仲-或叔丁醇、乙二醇、丙-1,2-二醇、乙氧基乙醇、甲氧基乙醇、二乙二醇單甲醚、二乙二醇單乙醚或其混合物。The reaction of Scheme-1 is preferably carried out in a standard solvent which is inert under the current reaction conditions. Preferred are aliphatic, cycloaliphatic or aromatic hydrocarbons, such as petroleum ether, hexane, toluene; halogenated hydrocarbons, such as chlorobenzene, methylene chloride, chloroform, carbon tetrachloride, or dichloroethane; ethers, such as Diethyl ether, diisopropyl ether, methyl tert-butyl ether (MTBE), dioxane, tetrahydrofuran or 1,2-dimethoxyethane; nitriles such as acetonitrile or propionitrile, or amides such as N, N-dimethylformamide (DMF), N,N-dimethylacetamide, N-methylformamide, N-methylpyrrolidone (NMP), or hexamethylenephosphoramide; Classes, such as methyl acetate or ethyl acetate; sulfonates, such as dimethyl sulfoxide (DMSO); sulfonates, such as cyclobutane; alcohols, such as methanol, ethanol, isopropanol, 1,1-, Iso-, sec- or tert-butanol, ethylene glycol, propane-1,2-diol, ethoxyethanol, methoxyethanol, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether or mixtures thereof .

反應物可以原樣相互反應,即不添加溶劑或稀釋劑。利於反應的溫度範圍為約-80℃至約+140℃,優選約-30℃至約+100℃,在許多情況下為環境溫度至約+80℃。The reactants can react with each other as they are, that is, without adding a solvent or a diluent. The temperature range favorable for the reaction is about -80°C to about +140°C, preferably about -30°C to about +100°C, and in many cases the ambient temperature to about +80°C.

式(I)化合物可以以本領域技術人員已知方式轉化為式(I)的另一種化合物,方法是用本發明的其他取代基以慣用方式取代式(I)起始化合物的一個或多個取代基。根據在每種情況下適合的反應條件和起始原料的選擇,可以在一個反應步驟中,僅用本發明的一個取代基取代另一個取代基,或者用本發明的多個取代基取代其他取代基。式(I)化合物的鹽可以以本領域技術人員已知的方式製備。因此,例如,通過用合適的酸或合適的離子交換劑試劑處理得到式(I)化合物的酸加成鹽,並通過用合適的堿或用合適的離子交換劑試劑處理得到帶堿的鹽。鹽的選擇取決於其對化合物使用的耐受性,例如農業耐受性或生理耐受性。式(I)化合物的鹽可以以常規方式轉化為游離化合物I,例如,通過用合適的鹼性化合物或用合適的離子交換劑試劑處理得到酸加成鹽,通過用合適的酸或用合適的離子交換劑試劑處理得到帶堿的鹽。式(I)化合物的鹽可以以本領域技術人員已知的方式轉化為式(I)化合物的其它鹽——酸加成鹽,例如在合適的溶劑中通過用合適的酸的金屬鹽(如鈉、鋇或銀鹽),例如乙酸銀,處理無機酸鹽(如鹽酸鹽)轉化為其它酸加成鹽,其中形成的無機鹽(例如氯化銀)是不溶的,因此從反應混合物中沉澱出來。The compound of formula (I) can be converted to another compound of formula (I) in a manner known to those skilled in the art by substituting one or more of the starting compounds of formula (I) with other substituents of the present invention in a conventional manner Substituents. Depending on the suitable reaction conditions and the choice of starting materials in each case, it is possible to substitute only one substituent of the invention for another substituent in one reaction step, or to substitute other substituents with multiple substituents of the invention base. Salts of compounds of formula (I) can be prepared in a manner known to those skilled in the art. Thus, for example, the acid addition salt of the compound of formula (I) is obtained by treatment with a suitable acid or a suitable ion exchanger reagent, and the salt with a bead is obtained by treatment with a suitable benzine or with a suitable ion exchanger reagent. The choice of salt depends on its tolerance to the use of the compound, such as agricultural tolerance or physiological tolerance. The salt of the compound of formula (I) can be converted to the free compound I in a conventional manner, for example, by treatment with a suitable basic compound or with a suitable ion exchanger reagent to obtain an acid addition salt, by using a suitable acid or with a suitable Treatment with ion-exchanger reagents yields a salt with bandage. The salt of the compound of formula (I) can be converted into other salts of the compound of formula (I)-acid addition salts in a manner known to those skilled in the art, for example by using a metal salt of a suitable acid in a suitable solvent (eg Sodium, barium, or silver salts), such as silver acetate, to treat inorganic acid salts (such as hydrochloride) to convert to other acid addition salts, where the inorganic salts formed (such as silver chloride) are insoluble, so from the reaction mixture Precipitate out.

根據本發明的一個特徵,式(I)化合物可以通過方案1或實施例中給出的方法製備。代表性步驟如下所示,但是,本公開不應被解釋為限制本發明製備上文所公開的式(I)化合物的方法的範圍。According to a feature of the invention, the compound of formula (I) can be prepared by the method given in Scheme 1 or the examples. Representative steps are shown below, however, the present disclosure should not be interpreted as limiting the scope of the method of the present invention for preparing the compounds of formula (I) disclosed above.

本發明化合物可以按如下列方案所示製備。在這個方案中,除非另有說明,每個變數的定義與上文對式(I)化合物的定義一致。The compounds of the present invention can be prepared as shown in the following scheme. In this scheme, unless otherwise stated, the definition of each variable is consistent with the definition of the compound of formula (I) above.

由式(I)和/或表1和表2定義的本發明化合物可以使用通用方案1中所述的方法以已知的方式製備。

Figure 02_image005
The compounds of the present invention defined by formula (I) and/or Table 1 and Table 2 can be prepared in a known manner using the method described in General Scheme 1.
Figure 02_image005

式(Ⅰ)化合物可以在0-100℃的溫度下,通過在溶劑(如四氫呋喃)和堿(如三乙胺)中使化合物1(1,2-雙硫腙衍生物)和化合物2(胺衍生物)反應來製備。The compound of formula (I) can be prepared by using compound 1 (1,2-dithizone derivative) and compound 2 (amine) in a solvent (such as tetrahydrofuran) and benzine (such as triethylamine) at a temperature of 0-100°C. Derivatives).

在一個實施方案中,式(IA)和/或表1和2中定義的本發明化合物可以使用通用方案2中所述的方法以已知方式製備。

Figure 02_image007
In one embodiment, the compounds of the present invention as defined in Formula (IA) and/or Tables 1 and 2 can be prepared in a known manner using the method described in General Scheme 2.
Figure 02_image007

步驟1通過使用《抗菌劑和化療》(2004年, 48(8),3093-3102)中公開的類似方法進行。步驟2為在0-100℃的溫度下,在溶劑(如四氫呋喃)和堿(如三乙胺)中使化合物1(1,2-雙硫腙衍生物)和化合物2(胺衍生物)反應。Step 1 is performed by using a similar method disclosed in "Antibacterial Agents and Chemotherapy" (2004, 48(8), 3093-3102). Step 2 is to react compound 1 (1,2-dithizone derivative) and compound 2 (amine derivative) in a solvent (such as tetrahydrofuran) and benzine (such as triethylamine) at a temperature of 0-100°C. .

在一個實施方案中,本發明化合物可用於防治不想要的植物病原微生物,優選植物(特別是在農業、園藝和森林中的有用植物和觀賞植物),或在果實、花、葉、莖、塊莖、種子或根等器官上的真菌病原體,在某些情況下,甚至可以保護後來形成的植物器官免受這些微生物的侵害。In one embodiment, the compounds of the present invention can be used to control unwanted phytopathogenic microorganisms, preferably plants (especially useful plants and ornamental plants in agriculture, horticulture and forests), or in fruits, flowers, leaves, stems, tubers Fungal pathogens on organs such as seeds, seeds or roots, in some cases, can even protect later formed plant organs from these microorganisms.

式(I)化合物可具有有效的殺微生物活性,可在農業或園藝作物保護和材料保護中用於控制有害的微生物,例如真菌和細菌。式(I)化合物具有非常好的殺真菌特性並且可以用於作物保護,例如用於控制瘧原蟲屬、卵菌綱、壺菌綱、接合菌綱、子囊菌綱、擔子菌綱和半知菌綱。The compound of formula (I) can have effective microbicidal activity and can be used to control harmful microorganisms such as fungi and bacteria in the protection of agricultural or horticultural crops and materials. The compounds of formula (I) have very good fungicidal properties and can be used for crop protection, for example for the control of Plasmodium, Oomycetes, Chytridiomycetes, Zygomycetes, Ascomycetes, Basidiomycetes and semi-known Fungi.

式(I)化合物可用作作物保護中的殺菌劑,例如,用於防治假單胞菌科、根瘤菌科、腸桿菌科、棒狀桿菌科和鏈黴菌科。The compounds of formula (I) can be used as fungicides in crop protection, for example, for controlling Pseudomonasceae, Rhizobiaceae, Enterobacteriaceae, Corynebacteriaceae and Streptomycetaceae.

式(I)化合物可用於治療性或保護性控制植物致病真菌。因此,本發明還涉及通過使用本發明的活性成分或組合物控制植物致病真菌的治療和保護方法,所述活性成分或組合物施用於種子、植物或植物部位、果實或植物生長的土壤。The compounds of formula (I) can be used for therapeutic or protective control of phytopathogenic fungi. Therefore, the present invention also relates to a method of treatment and protection of phytopathogenic fungi by using the active ingredients or compositions of the present invention applied to seeds, plants or plant parts, fruits or soil on which plants grow.

式(I)化合物可用於保護農作物和/或園藝作物免受植物病原微生物的侵擾。Compounds of formula (I) can be used to protect crops and/or horticultural crops from phytopathogenic microorganisms.

式(I)化合物可用於作物保護,其中農作物為谷類、玉米、大米、大豆和其他豆科植物、水果和果樹、堅果和堅果樹、柑橘和柑橘樹、園藝植物、 葫蘆科、含油植物、煙草、咖啡、茶、可哥、甜菜、甘蔗、棉花、馬鈴薯、番茄、洋蔥、辣椒和其他蔬菜以及觀賞植物。Compounds of formula (I) can be used for crop protection, where crops are cereals, corn, rice, soybeans and other legumes, fruits and fruit trees, nuts and nut trees, citrus and citrus trees, horticultural plants, cucurbitaceae, oily plants, Tobacco, coffee, tea, cocoa, beets, sugar cane, cotton, potatoes, tomatoes, onions, peppers and other vegetables, and ornamental plants.

在一個實施方案中,本發明提供農業化學組合物,其包含至少一種式(I)化合物或其農業上可接受的鹽。In one embodiment, the present invention provides an agrochemical composition comprising at least one compound of formula (I) or an agriculturally acceptable salt thereof.

在另一個實施方案中,本發明提供了包括用式(I)化合物、農業上可接受的鹽、組合物或其組合處理待保護的植物、土壤、種子或材料對抗植物致病真菌的方法。In another embodiment, the present invention provides a method comprising treating a plant, soil, seed or material to be protected against phytopathogenic fungi with a compound of formula (I), an agriculturally acceptable salt, a composition, or a combination thereof.

在另一個實施方案中,本發明提供了一種控制或預防植物致病微生物侵擾農業作物和/或園藝作物中有用植物的方法,其中所述式(I)化合物、其農業上可接受的鹽、組合物或組合施用於植物、其部分、植物種子或其位點。In another embodiment, the present invention provides a method for controlling or preventing phytopathogenic microorganisms from invading useful plants in agricultural crops and/or horticultural crops, wherein the compound of formula (I), its agriculturally acceptable salts, The composition or combination is applied to plants, parts thereof, plant seeds or their loci.

在另一個實施方案中,本發明提供了使用式(I)化合物、其農業上可接受的鹽、組合物或組合來控制或預防農作物和/或園藝作物中的植物致病微生物的方法,其包括施用有效劑量的該化合物或組合物或組合的步驟,其量為每公頃農業和/或園藝作物施用50g至5kg。In another embodiment, the present invention provides a method for controlling or preventing phytopathogenic microorganisms in agricultural crops and/or horticultural crops using a compound of formula (I), an agriculturally acceptable salt, composition or combination thereof, which It includes the step of applying an effective dose of the compound or composition or combination in an amount of 50 g to 5 kg per hectare of agricultural and/or horticultural crops.

在另一個實施方案中,本發明提供了塗有至少一種式(I)化合物和/或其農業上可接受的鹽或者組合物(其量為每100kg種子0.1-10kg)的種子。In another embodiment, the present invention provides seeds coated with at least one compound of formula (I) and/or an agriculturally acceptable salt or composition thereof in an amount of 0.1-10 kg per 100 kg of seeds.

式(I)化合物及其組合物也分別適用於在儲存產品或收穫物保護和材料保護中防治有害真菌。The compounds of formula (I) and their compositions are also suitable for controlling harmful fungi in the protection of stored products or harvests and the protection of materials, respectively.

術語“材料保護”應理解為表示對技術的以及非活體材料例如黏合劑,膠水,木材,紙和紙板,紡織品,皮革,塗料分散體,塑膠,冷卻潤滑劑,纖維或織物的保護,以防止有害微生物如真菌和細菌的侵擾和破壞。在木材和其他材料的保護方面,特別注意以下有害真菌:蛇孢屬、角孢囊藻屬、普魯蘭金桿菌屬、鞏膜菌屬、毛黴屬、胡米柯拉菌屬、石化菌屬、旋毛蟲屬;擔子菌,如分生孢子菌屬、真皮層菌屬、舌苔菌屬、香菇屬、側耳菌屬、茯苓屬、龍介蟲屬和酪酵母菌屬,半知菌綱,如麯黴屬、枝孢菌屬、青黴屬、木黴菌屬、鏈黴菌屬、擬青黴屬,以及合子菌類,如毛黴屬。此外,在貯藏產品和收穫物的保護方面,值得注意的下列酵母菌:念珠菌屬和酵母菌屬。The term "material protection" is understood to mean the protection of technical and non-living materials such as adhesives, glues, wood, paper and cardboard, textiles, leather, paint dispersions, plastics, cooling lubricants, fibers or fabrics to prevent Harmful microorganisms such as fungi and bacteria invade and destroy. In the protection of wood and other materials, pay special attention to the following harmful fungi: Snake spores, Cercospora spp., Pullulan spp., Scleroderma spp., Mucor spp., Humikola spp., Petrochemical spp. Caterpillars; Basidiomycetes, such as conidia, dermis, genus Coleus, Lentinula, Pleurotus, Poria, Dracunculus, and caseinus, semi-mycetes, such as Aspergillus, Cladosporium, Penicillium, Trichoderma, Streptomyces, Paecilomyces, and Zygomycetes, such as Mucor. In addition, in the protection of stored products and harvest, the following yeasts are worth noting: Candida and Saccharomyces.

式I化合物及其組合物分別特別適用於控制以下植物疾病: 觀賞植物、蔬菜(如念珠菌)和向日葵(如金龜子甲)上的(白銹病);蔬菜、油菜(油菜或芸苔)、甜菜(細鏈格孢)、水果、大米、大豆、馬鈴薯(如龍葵鏈格孢)、番茄(如龍葵鏈格孢)和小麥上的鏈格孢屬;在甜菜和蔬菜上殼二胞菌;穀物和蔬菜上的絲囊黴菌,例如,小麥上的小麥赤黴病(炭疽病)和大麥上的黑麥赤黴病;蠕孢黴和內臍蠕孢屬(異形體:旋孢腔菌屬),例如玉米/穀物上的南方葉枯病(玉米灰斑病菌)或玉米大斑病(玉米圓斑病菌),例如穀物上的葉斑病(麥根腐病)和稻穀和草皮上的稻瘟病;在穀類作物(例如小麥或大麥)的白粉病菌(以前是白粉菌)禾本科植物(白粉病);在水果和漿果(例如草莓)、蔬菜(如萵苣、胡蘿蔔、芹菜和捲心菜)、油菜、花卉、葡萄、林業植物和油菜上的灰黴病菌(異形體:灰葡萄孢黴:灰色黴菌)小麥;萵苣上的霜黴病;闊葉樹和常綠植物上的長喙殼,例如榆樹上的尺蠖(荷蘭榆病);在玉米上(例如灰斑:玉米-玉米斑病)、大米、甜菜(例如檳榔)、甘蔗、蔬菜、咖啡、大豆(例如大豆斑病)菊苣)和大米上的紫斑病;番茄和和穀類上的枝孢黴(例如葉黴),例如小麥上的草莖點黴(黑穗);穀物上的麥角菌(麥角);玉米(玉米圓斑病菌)、穀類(例如圓葉槐,異形體:根腐病菌)和水稻(例如葉斑病,異形體:稻瘟病)的旋孢腔菌(異形體:兩極線蟲);在棉花、玉米(例如大草鶯屬:炭疽病莖腐爛)、軟水果、馬鈴薯(例如炭疽病菌:黑點)、豆類(例如豆刺盤孢)和大豆(例如平頭刺盤孢或膠孢炭病菌)上的炭疽菌(異形體:小叢殼屬)(炭疽病);大米上的伏革菌屬,例如紋枯病(鞘枯病);大豆和觀賞植物上的葉斑;橄欖樹上的雀斑病;果樹、葡萄藤(例如鵝掌藤屬,有性型,黑腳病)和觀賞植物上的柱孢屬(果樹潰瘍病或幼年藤蔓衰退,異形體:壞死或初生孢子);大豆上的脫毒植物(變形蟲:薔薇屬)壞死菌(根和莖腐爛);大豆上的菜豆輪斑病菌;玉米、穀物如大麥(如圓柱菌、網斑病)和小麥(如小麥:褐斑病)、大米和草坪上的內臍蠕孢屬(蠕蟲孢子,遠距形成層:核孔蟲);葡萄藤上由蟻生(層孔菌)、馬鞭草、地黃、厚垣褐指藻(早熟的厚垣褐指藻)、嗜綠指藻和/或鈍頂芽孢桿菌引起的回枯;梨果、軟果(炭疽病)和藤本植物(炭疽病)上的痂囊腔菌屬病;稻子上的稻黑腫病;小麥黑黴病;甜菜(甜菜黑黴病)、蔬菜(如豌豆),如葫蘆(如菊苣)、捲心菜、油菜(如十字花科植物)上的白粉病;果樹、藤蔓和觀賞林上的白樺上的頂枯病(無性潰瘍或枯梢病,無性生殖:胞孢菌。瞼球菌);在玉米(例如薑黃)上的寄生蟲;各種植物上的鐮刀菌(萎蔫、根腐或莖腐),如穀類(例如小麥或大麥)上的禾本科或倉鼠(根腐、痂或頭疫),番茄上的氧化孢子菌,茄上的茄子枯萎病菌(現為甘氨酸桿菌)。病毒型和圖庫曼原蟲和巴西原蟲分別在大豆上引起猝死綜合症,和玉米上引起輪狀芽孢桿菌;禾穀類作物(如小麥或大麥)和玉米上引起禾本科芽孢桿菌; 在穀類作物上(如玉米屬)和水稻上(巴卡那病)的赤黴菌屬;葡萄、柚子和其他植物上的扣帶小球藻;棉花上的棉鈴蟲;水稻上的禾本科複合體;葡萄上的吉格納氏菌(黑腐病);薔薇科植物和杜松上的裸子孢子菌,例如梨上的莎比納(鏽菌);玉米、穀物和水稻上的蠕蟲孢子菌;咖啡上的駝孢鏽菌屬,如咖啡鏽菌(咖啡葉鏽);葡萄騰上的枝孢黴;大豆和棉花上的巨噬細胞病(根和莖腐爛);穀類(例如小麥或大麥)上的小孢子菌(粉色雪黴);大豆上的小孢子菌(白粉病);結石水果和其他薔薇科植物上的鏈核盤菌屬,例如開花和嫩枝枯萎病,褐腐病;在穀類、香蕉、軟水果和碎堅果上的葉斑病,比如小麥上的麥粒可樂(變形體:小麥紋枯病菌,殼針孢葉斑病)或香蕉上的斐濟黴菌(黑穗病);甘藍(例如甘藍)、油菜(例如寄生蟲)、洋蔥(例如破壞磷)、煙草(煙粉虱)和大豆(例如滿洲青黴)上的霜黴屬(霜黴);大豆上的大豆鏽;葡萄上(如氣管線蟲)和大豆(如灰黴莖腐病)的瓶黴屬;油菜和捲心菜上的根朽病(根腐和莖腐),甜菜上的蛇眼病菌(根腐、葉斑和阻尼);向日葵、葡萄藤(葡萄霜黴病和葉斑病)和大豆(莖腐病:赤小豆,有性型:大豆莖潰瘍病菌)上的擬莖點黴屬;玉米上的麥芽疫黴(褐斑);各種植物上的疫黴(枯萎病、根、葉、果和莖根),如辣椒和葫蘆(如辣椒疫黴),大豆(如巨豆疫黴,同源物)大豆疫黴、馬鈴薯和番茄(例如晚疫病)和闊葉樹(例如櫟樹疫黴:突然死亡);甘藍、油菜、蘿蔔和其他植物上的甘藍(球根)瘧原蟲;等離子體寄生蟲,例如葡萄上的玻璃體瘧原蟲(葡萄霜黴),向日葵上的哈氏瘧原蟲;薔薇科植物、酒花、石榴和軟果上的叉絲單囊殼屬(白粉病),例如蘋果上的白背飛虱;多黏菌,例如穀類,如大麥和小麥(多黏菌)和甜菜(甜菜蛇眼病)和傳播病毒病;禾穀類,如小麥或大麥上的假小尾孢屬;各種植物上的假單孢菌(霜黴病),如葫蘆上的楔形芽孢桿菌或啤酒花上的腐黴;在葡萄上氣管假單孢菌(紅火病或輪蟲病,變形體:瓶黴屬);各種植物上的柄鏽菌屬(鏽),例如小麥(棕色或葉鏽)、條鏽菌(條鏽或黃鏽)、矮生銹菌(矮生銹)、禾本科鏽菌(莖或黑鏽)或禾本科鏽菌(褐色或葉鏽),例如小麥、大麥或黑麥、甘蔗和蘆筍上屈恩柄鏽菌(橙鏽);小麥上的焦粒病菌(變形體:內臍蠕孢屬),小麥赤黴病菌(褐斑病)或大麥上的赤黴病菌(網斑病);稻穀上的稻瘟病菌(遠形:稻瘟)和大米上的稻瘟病菌(稻瘟),草坪、水稻、玉米、小麥、棉花、葡萄、向日葵、大豆、甜菜、蔬菜和各種其他植物(例如極致疫黴或無疫黴)上的稻瘟病菌(阻尼);柱隔孢屬,如大麥上的葉斑(生理葉斑)和甜菜上的灰白斑長隔孢黴;棉花、水稻、馬鈴薯、草坪、玉米、油菜、馬鈴薯、甜菜、蔬菜以及各種其他植物上的絲核菌屬,例如大豆上的立枯絲核菌(根莖腐爛)、水稻上的立枯絲核菌(紋枯病)或小麥或大麥上的麥子紋枯病(紋枯病);黑黴、胡蘿蔔、捲心菜、藤蔓和番茄上的匍匐根黴(黑黴、軟腐病);大麥、黑麥和小黑麥上的大麥雲紋病菌(燙傷)樣;水稻上的稻瘟病菌和稀疏鏈球菌(鞘腐);蔬菜和大田作物上的菌核病菌(莖腐或白黴),如油菜、向日葵(例如菌核病菌)和大豆(例如羅氏菌核病菌);各種植物上的殼針孢屬,如大豆上的甘氨酸鏈球菌(褐斑)、小麥上的小麥斑點桿菌(殼針孢斑點葉枯病)和穀物上的殼多胞菌屬;葡萄藤上的鉤絲殼屬(變形體:白粉病)和板口線蟲屬(白粉病,無性型:粉孢屬);玉米(如薑黃,同源異株.葉蠕孢菌)和草坪上的葉枯病菌;玉米(如玉米絲黑穗病菌:絲黑穗病)、高粱和甘蔗上的軸黑粉菌屬(黑穗病);葫蘆上的球形孢菌(粉狀黴);馬鈴薯上的海綿孢菌(粉狀疥瘡),從而傳播病毒疾病;穀物類上的殼多胞菌屬,如小麥上的穎枯殼針孢(殼多胞菌屬,有性型:小球腔菌屬)[異形體:鉤端螺旋體];馬鈴薯上的內生合胞體(馬鈴薯疣病);例如桃上的變形桿菌(葉捲曲病)和李子上的李外囊菌(李袋);煙草、柚子、蔬菜、大豆和棉花上的根串珠黴(黑根腐爛),例如根黑腐病(變形體.雅致暗內孢);穀物上的腥黑粉菌屬(普通茴香或臭黑穗病),如小麥上的小麥腥黑粉菌(異形體.小麥光腥黑穗病)和小麥矮腥黑穗病菌(矮腥黑穗病);大麥或小麥上的肉孢核瑚菌(灰雪黴病);條黑粉菌屬,如黑麥上的莖黑穗病;蔬菜,如豆類(菜豆鏽菌)和甜菜上的單胞鏽菌屬(銹病);穀物類(如,黑穗病)、玉米(如,玉米黑粉菌:玉米黑穗病)和甘蔗上的黑粉菌屬;蘋果(如,黑星病)和梨上的黑星菌屬(瘡痂病);以及各種植物,如水果、觀賞植物、葡萄藤、軟性水果、蔬菜和大田作物上的黃萎病(枯萎病),例如草莓、油菜、馬鈴薯和番茄上的大麗輪枝菌。The compounds of formula I and their compositions are particularly suitable for controlling the following plant diseases: (White rust) on ornamental plants, vegetables (eg Candida) and sunflowers (eg chafer); vegetables, rape (canola or brassica), beets (Alternaria alternata), fruits, rice, soybeans, potatoes (eg Alternaria alternata), tomatoes (eg Alternaria alternata) and Alternaria on wheat; Phytophthora on sugar beets and vegetables; Mycoplasma on grains and vegetables, for example, wheat on wheat Gibberella (anthracnose) and ryegrass on barley; Helminthosporium spp. and Helminthosporium spp. (alien: Coelospora), such as southern leaf blight on corn/cereals (corn ash Phytophthora infestans) or corn leaf spot (Coleops oryzae), such as leaf spot on wheat (wheat root rot) and rice blast on rice and turf; powdery mildew on cereal crops (such as wheat or barley) ( Formerly powdery mildew) Gramineae (powder mildew); Botrytis cinerea on fruits and berries (eg strawberries), vegetables (eg lettuce, carrots, celery and cabbage), rapeseed, flowers, grapes, forestry plants and rapeseed ( Alien: Botrytis cinerea: Grey mold) wheat; downy mildew on lettuce; long beak shells on broadleaf trees and evergreen plants, such as inchworms on the elm tree (Dutch elm disease); on corn (such as gray spots: Corn-corn leaf spot), rice, sugar beet (eg betel nut), sugar cane, vegetables, coffee, soybean (eg soybean spot chicory) and purple spot disease on rice; cladosporium on tomato and cereals (eg leaf mold) ), such as Streptomyces graminis (smut) on wheat; ergot fungus (ergot) on cereals; corn (corn rot disease), cereals (eg locust, heteromorphism: root rot fungus) and rice Coelospora (e.g. leaf spot disease, aliens: rice blast) Cochlea spores (alien: bipolar nematodes); in cotton, corn (e.g. large warbler: anthracnose stem rot), soft fruits, potatoes (e.g. anthracnose: Black dots), anthracnose (alien: small cluster genus) on beans (e.g. discospora sphaeroides) and soybeans (e.g. discospora sphaeroides or spores) (Anthracnose); Fusarium spp. on rice Genus, such as sheath blight (sheath blight); leaf spots on soybeans and ornamental plants; freckles on olive trees; fruit trees, grapevines (eg, Schefflera, sexual type, blackfoot) and ornamental plants Cylindrosporium (fruit tree ulcer disease or juvenile vine decline, aliens: necrosis or primary spores); detoxified plants (amoeba: Rosa genus) necrotic bacteria (root and stem rot) on soybean; kidney bean wheel on soybean Spot pathogens; corn, grains such as barley (eg Cylindrosporium, net spot disease) and wheat (eg wheat: brown spot), rice and turf helminths (worm spores, long-range formation: nuclear pores) Insects); on the vines caused by ant colonies (Sphaeropsis), Verbena, Rehmannia glutinosa, Phaeodactylum brevis (precocious Phellinus vulgaris), Phaeodactylum aurantia and/or Bacillus platensis Withering; Scabies on pear, soft fruit (anthracnose) and liana (anthracnose); rice swollen disease on rice; wheat black mold; sugar beet (beet black mold), vegetables ( Such as peas), such as powdery mildew on gourds (such as chicory), cabbage, and rape (such as cruciferous plants); on fruit trees, vines, and white birch on ornamental forests The top blight (asexual ulcer or blight, asexual reproduction: Cytospora. Chrysococcus); parasites on corn (eg turmeric); Fusarium (wilting, root rot or stem rot) on various plants, such as gramineae or hamsters (root rot, scab) on cereals (eg wheat or barley) Or Phytophthora infestans), oxidizing spore bacteria on tomato, Fusarium oxysporum on eggplant (now Glycinebacteria). Viral and Tucummania and Brazilian protozoa cause sudden death syndrome on soybeans, and Bacillus rota on corn; cereal crops (such as wheat or barley) and Bacillus graminis on corn; on cereal crops Gibberella spp. on corn (such as corn) and rice (bakana disease); Chlorella cingulata on grapes, grapefruits, and other plants; cotton bollworm on cotton; gramineous complex on rice; grape on Gignerella (black rot); Gymnosporium on Rosaceae and Juniper, such as Sabina (rust fungus) on pears; Helminthospores on corn, grain and rice; Coffee on Camellia rust, such as coffee rust (coffee leaf rust); Cladosporium on grapevine; Macrophage disease (root and stem rot) on soybeans and cotton; small on cereals (such as wheat or barley) Spore fungus (Snowy mildew); Microspore fungus on soybean (powdery mildew); Streptococcus spp. on stone fruits and other Rosaceae, such as flowering and twig blight, brown rot; in cereals, bananas , Leaf spot on soft fruits and crushed nuts, such as cola on wheat (amyloid: Rhizoctonia solani, spore leaf spot) or Fiji mould on banana (smut); cabbage ( For example, downy mildew (downy mildew) on soybeans (eg cabbage) (eg parasites), onions (eg destroying phosphorus), tobacco (eg Bemisia tabaci), and soybeans (eg Penicillium manchurianum); soybean rust on soybeans; grapes ( Such as gas pipeworms) and soybeans (such as Botrytis cinerea); root rot (root rot and stem rot) on rape and cabbage, snake eye pathogens (root rot, leaf spot and damping) on sugar beet ; Pseudomonas spp. on sunflowers, vines (grass downy mildew and leaf spot) and soybeans (stalk rot: red bean, sexual type: soybean stem ulcer); Phytophthora malaria (brown) on corn Phytophthora infestans (fusarium wilt, roots, leaves, fruit and stem roots) on various plants, such as peppers and gourds (eg Phytophthora capsici), soybeans (eg Phytophthora infestans, homologs), Phytophthora sojae, Potatoes and tomatoes (e.g. late blight) and broad-leaved trees (e.g. Phytophthora oak: sudden death); Plasmodium oleracea (bulb) on cabbage, rape, radish and other plants; plasma parasites, such as vitreous malaria on grapes Protozoa (Grape downy mildew), Plasmodium harzianum on sunflowers; Cyanospora (powdery mildew) on Rosaceae, hops, pomegranates and soft fruits, such as white-backed planthoppers on apples; many Slime molds, such as cereals, such as barley and wheat (polymyxa) and sugar beets (beet snake eye disease) and transmitted virus diseases; cereals, such as wheat or barley Pseudocercospora; Pseudomonas on various plants ( Downy mildew), such as Wedge-shaped Bacillus on gourds or Pythium on hops; Pseudomonas trachea on grapes (red fire disease or rotifer disease, deformed body: Bottle mold); Puccinia on various plants Genus (rust), such as wheat (brown or leaf rust), stripe rust fungus (stripe rust or yellow rust), dwarf rust fungus (dwarf rust), gramineous rust fungus (stem or black rust) or gramineous rust fungus (Brown or leaf rust), for example, rust fungus (orange rust) on wheat, barley or rye, sugar cane and asparagus; sclerotium on wheat (deformed body: Helminthosporium), Fusarium head blight (brown spot disease) or Fusarium head blight (barley spot) on barley; Magnaporthe grisea on rice (distant form: rice blast) and Magnaporthe grisea on rice (rice blast), lawn, rice , Magnaporthe grisea (damping) on corn, wheat, cotton, grapes, sunflowers, soybeans, sugar beets, vegetables, and various other plants (such as Phytophthora infestans or Phytophthora infestans); Cercospora, such as leaf spots on barley (Physiological leaf spot) and M. grisea on sugar beets; Rhizoctonia spp. on cotton, rice, potato, lawn, corn, rape, potato, beet, vegetable, and various other plants, such as Rhizoctonia solani Rhizoctonia solani (rhizome rot), Rhizoctonia solani on rice (sheath blight) or wheat sheath blight on wheat or barley (sheath blight ); black mold, carrots, cabbage, vines, and creeping tomatoes Rhizopus (black mold, soft rot); barley, rye and triticale barley moth (scald) samples; rice blast fungus and sparse streptococcus (sheath rot) on rice; vegetables and field crops Sclerotium sclerotiorum (stalk rot or white mold), such as rape, sunflower (e.g. sclerotium sclerotiorum) and soybean (e.g. Sclerotinia sclerotiorum); C. spp. on various plants, such as glycine streptococcus (brown spot) on soybean ), Mycobacterium spp. on wheat (Neurospora phyllostachium blight) and Sphaeropsis spp. on grains; Erysiphe spp. (deformation: powdery mildew) on vines and Nematodes spp. (powdery mildew) , Asexual type: Mycospora); corn (such as turmeric, homologous. Helminthosporium) and leaf blight on lawns; corn (such as corn smut: smut), sorghum and Trichoderma spp. (smut) on sugarcane; Sphaeropsis sphaeroides (powder mold) on gourds; Sponge spores (powder scabies) on potatoes, thereby spreading viral diseases; Clams on grains Bacteria, such as Trichosporium esculentum on wheat (Hymenopsora spp., Sexual type: Glomus spp.) [Alien: Leptospira]; Endogenous syncytia on potato (potato wart disease) ); for example Proteus on peach (leaf curl disease) and Exocystic plum on plum (plum bag); Streptococcus rhizogenes (black root rot) on tobacco, grapefruit, vegetables, soybeans and cotton, such as root black rot Disease (deformation. Elegant dark endospores); smutella (common fennel or stinky smut) on cereals, such as smutty wheat smut on wheat (alien body. wheat smut) Wheat dwarf smut (dwarf smut); Sclerotinia sclerotiorum (grey snow mold) on barley or wheat; Sphaerotheca spp., such as stem smut on rye; vegetables, such as Trichomonas spp. on beans (Phaseolus vulgaris) and sugar beet (rust); cereals (eg, smut), corn (eg, smut: corn smut), and smut on sugarcane Genus; Cercospora (crustosis) on apples (eg, scab) and pears; and Verticillium wilt (wilt) on various plants, such as fruits, ornamental plants, vines, soft fruits, vegetables, and field crops Disease), such as Verticillium dahliae on strawberries, rape, potatoes and tomatoes.

在一個實施方案中,本發明提供用式(I)的化合物及其組合物控制和/或預防由下列病原菌引起的植物疾病的用途:稻瘟病菌,立枯絲核菌,灰葡萄孢,茄病菌,炭疽病菌,棒孢菌,茄殼針孢菌,黃色鐮刀菌,馬鈴薯晚疫病菌,大豆鏽菌,白粉病菌,黃瓜霜黴病菌,葉鏽菌,葉枯病菌,晚疫病菌,霜黴病菌和葡萄鉤絲殼菌。In one embodiment, the present invention provides the use of compounds of formula (I) and compositions thereof to control and/or prevent plant diseases caused by the following pathogens: Magnaporthe grisea, Rhizoctonia solani, Botrytis cinerea, Solanum Pathogens, anthracnose, coryneform bacteria, needle shell fungi, Fusarium yellow, Phytophthora infestans, soybean rust, powdery mildew, cucumber downy mildew, leaf rust, leaf blight, late blight, downy mildew Pathogens and Rhizoctonia grape.

根據本發明的處理方法還可以用於保護儲藏品或收穫物免受真菌和微生物的侵襲。The treatment method according to the invention can also be used to protect stored goods or harvests from fungi and microorganisms.

根據本發明,術語“儲藏品”應理解為表示植物或動物來源的天然物質及其加工形式,其取自自然生命週期並且需要長期保護。農作物來源的儲存物,如植物或其部分(如莖,葉,塊莖,種子,果實或穀物),可以以新鮮收穫的狀態或加工形式保護,例如烘乾,濕潤,粉碎,研磨,壓榨或烤制,這種過程也稱為收穫後處理。木材(無論是原木形式,如建築木材,電塔和柵欄,還是成品,如傢俱或木製品)也同樣屬於儲存物的定義範疇。動物來源的存儲產品包括獸皮、皮革、毛皮、毛髮等。根據本發明的組合可以防止諸如腐爛、變色或黴菌的不利影響。優選地,“儲存物”應理解為表示植物來源的天然物質及其加工形式,更優選的為水果及其加工形式,例如梨果、核果、軟果和柑橘類水果及其加工形式。According to the invention, the term "storage" should be understood to mean natural substances of plant or animal origin and their processed forms, which are taken from the natural life cycle and require long-term protection. Crop-derived storage, such as plants or parts (eg stems, leaves, tubers, seeds, fruits or grains), can be protected in a freshly harvested state or processed form, such as drying, wetting, crushing, grinding, pressing or roasting This process is also called post-harvest processing. Wood (whether in the form of logs, such as construction timber, electrical towers and fences, or finished products, such as furniture or wood products) also belongs to the definition of storage. Storage products of animal origin include animal skin, leather, fur, hair, etc. The combination according to the present invention can prevent adverse effects such as rot, discoloration, or mold. Preferably, "storage" is understood to mean natural substances of plant origin and their processed forms, more preferably fruits and their processed forms, such as pear, stone, soft and citrus fruits and their processed forms.

式I化合物及其組合物可分別用於改善植物的健康。本發明還涉及通過分別用有效量的式(I)化合物及其組合物處理植物、其繁殖材料和/或植物生長或將要生長的場所來改善植物健康的方法。The compounds of formula I and their compositions can be used to improve the health of plants, respectively. The invention also relates to a method for improving plant health by treating plants, their propagation material and/or the place where plants are growing or will grow with effective amounts of compounds of formula (I) and compositions thereof.

術語“植物健康”應理解為表示植物和/或其產品的狀況,其由單獨的指標或幾個指標結合測定,這些指標有產量(例如增加的生物量和/或增加的有價值成分的含量)、植物活力(例如植物的生長更好和/或葉子更綠(“綠化效果”))、品質(例如改善的某些成分的含量或組成)和對非生物和/或生物脅迫的耐受性等。以上確定的植物健康狀況指標可能是相互依賴的,也可能是相互產生的。The term "plant health" should be understood to mean the condition of the plant and/or its products, which is determined by a single indicator or a combination of several indicators that have yields (eg increased biomass and/or increased content of valuable ingredients ), plant vitality (eg better plant growth and/or greener leaves ("greening effect")), quality (eg improved content or composition of certain ingredients) and tolerance to abiotic and/or biological stress Sex and so on. The above-determined plant health status indicators may be interdependent or may be generated from each other.

術語“種子”包括各種種子和植物繁殖體,包括但不限於真正的種子、種子塊、吸根、玉米、球莖、果實、塊莖、穀粒、根莖、插條、切枝等,在優選的實施方案中為真正的種子。The term "seed" includes various seeds and plant propagules, including but not limited to real seeds, seed blocks, sucker roots, corn, bulbs, fruits, tubers, grains, rhizomes, cuttings, cuttings, etc., in preferred implementations The real seed in the plan.

本發明還包括含有式(I)化合物或用式(I)化合物處理或包覆的種子。The present invention also includes seeds containing or treated or coated with a compound of formula (I).

術語“用......塗覆或處理和/或含有......”通常表示:根據使用方法的不同,儘管在施用時活性成分或多或少可滲透到種子材料中,但活性成分大部分在種子表面上。當(再)種植所述種子產品時,它可以吸收活性成分。在一個實施方案中,本發明提供了一種附有式(I)化合物的植物繁殖材料。由此本發明進一步提供了包含用式(I)化合物處理的植物繁殖材料的組合物。The term "coated or treated with and/or containing..." generally means: depending on the method of use, although the active ingredient is more or less permeable to the seed material at the time of application, But most of the active ingredients are on the surface of the seeds. When (re)planting the seed product, it can absorb the active ingredient. In one embodiment, the present invention provides a plant propagation material to which the compound of formula (I) is attached. The invention thus further provides a composition comprising plant propagation material treated with a compound of formula (I).

種子處理包括本領域已知的所有合適的種子處理技術,例如拌種、種子包衣、種子撒粉、種子浸泡和種子制粒。作為優選的施用方法,用式I化合物處理種子可以通過任何已知的方法進行,例如在播種之前或播種/種植種子期間對種子噴灑或撒粉。Seed treatment includes all suitable seed treatment techniques known in the art, such as seed dressing, seed coating, seed dusting, seed soaking, and seed granulation. As a preferred method of application, the treatment of the seeds with the compound of formula I can be carried out by any known method, such as spraying or dusting the seeds before sowing or during sowing/planting of the seeds.

合適的目標植物主要有穀物,例如小麥、大麥、黑麥、燕麥、大米、玉米或高粱;甜菜,如糖用甜菜或飼用甜菜;水果,例如梨果、核果,或軟果,如蘋果、梨、李子、桃子、杏仁、櫻桃,或漿果,例如草莓、覆盆子或黑莓;豆科植物,如豆類、扁豆、豌豆或大豆;油料植物,如油菜、芥菜、罌粟、橄欖、向日葵、椰子、蓖麻、可哥或碎堅果;葫蘆類,如南瓜、黃瓜或甜瓜;纖維植物,如棉花、亞麻、大麻或黃麻;柑橘類水果,如柳丁、檸檬、葡萄柚或橘子;蔬菜,如菠菜、生菜、蘆筍、捲心菜、胡蘿蔔、洋蔥、番茄、土豆或青椒;樟科,如鱷梨、肉桂或樟腦;還有煙草、堅果、咖啡、茄子、甘蔗、茶葉、胡椒、葡萄藤、啤酒花、車前草、乳膠植物和觀賞植物(如花卉、草坪草或草坪)。在一個實施方案中,植物選自穀類、玉米、大豆、大米、甘蔗、蔬菜和油料植物。Suitable target plants are mainly cereals such as wheat, barley, rye, oats, rice, corn or sorghum; sugar beets such as sugar beets or fodder beets; fruits such as pears, stone fruits, or soft fruits such as apples, Pears, plums, peaches, almonds, cherries, or berries, such as strawberries, raspberries, or blackberries; legumes, such as beans, lentils, peas, or soybeans; oil plants, such as canola, mustard, poppy, olive, sunflower, coconut, Castor, cocoa or ground nuts; cucurbits such as pumpkin, cucumber or melon; fibrous plants such as cotton, flax, hemp or jute; citrus fruits such as orange, lemon, grapefruit or orange; vegetables such as spinach , Lettuce, asparagus, cabbage, carrots, onions, tomatoes, potatoes, or green peppers; Cinnamomum, such as avocado, cinnamon, or camphor; tobacco, nuts, coffee, eggplant, sugar cane, tea, pepper, vines, hops, plantain , Latex plants and ornamental plants (such as flowers, lawn grass or lawn). In one embodiment, the plant is selected from cereals, corn, soybeans, rice, sugar cane, vegetables, and oil plants.

“植物”應理解為還包括通過使用重組DNA技術轉化的植物,它們能夠合成一種或多種選擇性作用毒素,例如已知的產生毒素的細菌,尤其是芽孢桿菌屬的細菌,以及已經選擇或雜交以保持和/或獲得所需特性,例如抵禦昆蟲、真菌和/或線蟲抗性。可由這些轉基因植物表達的毒素包括,例如,來自蠟狀芽孢桿菌或芽孢桿菌的殺蟲蛋白;或來自蘇雲金芽孢桿菌的殺蟲蛋白質,例如8-內毒素,如Cry1Ab,Cry1Ac,Cry1F,Cry1Fa2,Cry2Ab,Cry3A,Cry3Bb1或Cry9C,或營養性殺蟲蛋白(Vip),例如,Vip1,Vip2,Vip3或Vip3A;或者用於定殖線蟲的細菌的殺蟲蛋白,例如發光桿菌屬或致病桿菌屬,如發光桿菌、嗜線蟲致病桿菌;動物產生的毒素,如蠍毒素、蜘蛛毒素、黃蜂毒素和其他昆蟲特有的神經毒素;由真菌產生的毒素,如鏈黴菌毒素、植物凝集素,如豌豆凝集素、大麥凝集素或雪花蓮凝集素;凝集素;蛋白酶抑制劑,如胰蛋白酶抑制劑、絲氨酸蛋白酶抑制劑、馬鈴薯糖蛋白、胱抑素、木瓜蛋白酶抑制劑;核糖體失活蛋白(RIP),如蓖麻毒素、玉米-RIP、相思蛋白、松脂、皂草素或苔蘚甙;類固醇代謝酶,如3-羥基類固醇氧化酶、蛻皮激素-二磷酸尿核苷-糖基轉移酶、膽固醇氧化酶、蛻皮激素抑制劑、HMG-COA-還原酶、離子通道阻滯劑,如鈉或鈣通道阻滯劑、保幼激素酯酶、利尿激素受體、二苯乙烯合成酶、聯苄合酶、幾丁質酶和葡聚糖酶。在本發明的上下文中,需要瞭解8-內毒素,例如Cry1Ab、Cry1Ac、Cry1F、Cry1Fa2、Cry2Ab、Cry3A、Cry3Bb1或Cry9C,或營養性殺蟲蛋白(Vip),例如Vip1,Vip2,Vip3或Vip3A,明確來說也是混合毒素、截短的毒素和改進的毒素。通過這些蛋白質的不同結構域的新組合重組產生雜合毒素(參見,例如,WO 02/15701)。截短的毒素,例如截短的Cry1Ab,是已知的。在改進的毒素中,天然存在的毒素的一個或多個氨基酸被替換。在這種氨基酸置換中,優選將非天然存在的蛋白酶識別序列插入毒素中,例如,在Cry3A055的情況下,將組織蛋白酶-G識別序列插入Cry3A毒素中(參見WO 03/018810)。能夠合成這種毒素或轉基因植物的實例已被公開,例如在EP-A-0 374 753、WO 93/07278、WO 95/34656、EP-A-0 427 529、EP-A-451 878和WO 03/052073中。製備這種轉基因植物的方法通常是本領域技術人員已知的,並且描述於例如上述出版物中。Cry1型去氧核糖核酸及其製備是已知的,例如在WO 95/34656,EP-A-0 367474,EP-A-0 401 979和WO 90/13651中。Cry1型去氧核糖核酸及其製備從WO 95/34656、EP-A-0 367474、EP-A-0 401 979和WO 90/13651就可知。轉基因植物中含有的毒素賦予植物對有害昆蟲的耐受性。這種昆蟲可以出現在昆蟲的任何分類群中,但特別常見於甲蟲(鞘翅目)、雙翅昆蟲(雙翅目)和蝴蝶(鱗翅目)。含有一個或多個編碼殺蟲抗性的基因的轉基因植物表達一種或多種毒素是已知的,並且它們中的一些是可商購的。此類植物的實例是:YieldGard(表達Cry1Ab毒素的玉米品種);YieldGardRootworm®(表達Cry3Bb1毒素的玉米品種);YieldGardPlus®(表達Cry1Ab和Cry3Bb1毒素的玉米品種);Starlink®(表達Cry9C毒素的玉米品種);HerculexI®(玉米品種,表達Cry1Fa2毒素和酶膦絲菌素N-乙醯轉移酶(PAT),以實現對除草劑草丁膦銨的耐受性);NuCOTN33B®(表達Cry1Ac毒素的棉花品種);BollgardI®(表達Cry1Ac毒素的棉花品種);BollgardII®(表達Cry1Ac和Cry2Ab毒素的棉花品種);VipCot®(表達Vip3A和Cry1Ab毒素的棉花品種);Newleaf®(表達Cry3A毒素的馬鈴薯品種);NatureGard®,25Agrisure®GTAdvantage(GA21草甘膦耐性性狀),Agrisure®CBAdvantage(Bt11玉米螟(CB)性狀)和Protecta®。此類轉基因植物的其他實例是:i)來自先正達種子公司的Bt11玉米,Chemin de l'Hobit 27,F-31 790 St.Sauveur,France,登記號C/FR/96/05/10。基因改進的玉米通過轉基因表達截短的Cry1Ab毒素而對歐洲玉米螟(歐洲玉米螟和蛀莖夜蛾)的攻擊具有抗性。Bt11玉米還轉基因表達PAT酶以實現對除草劑草丁膦銨的耐受性;ii)來自先正達種子公司的Bt176玉米,Chemin de l'Hobit 27,F-31 790 St. Sauveur,France,註冊號C/FR/96/05/10。基因改進的玉米通過轉基因表達Cry1Ab毒素而對歐洲玉米螟(歐洲玉米螟和蛀莖夜蛾)的攻擊具有抗性。Bt176玉米還轉基因表達PAT酶以實現對除草劑草丁膦銨的耐受性;iii)來自先正達種子公司的MIR604玉米,Chemin de l'Hobit 27,F-31 790 St. Sauveur,France,註冊號C/FR/96/05/10。通過轉基因表達改進的Cry3A毒素使玉米具有抗蟲性的玉米。該毒素是通過插入組織蛋白酶-G-蛋白酶識別序列而改進的Cry3A055。這種轉基因玉米植物的製備在WO 03/018810有描述;iv)MON 863玉米,來自孟山都公司S.A. 270-272 Avenue de Tervuren,B-1150 Brussels,Belgium,註冊號C/DE/02/9。MON 863表達Cry3Bb1毒素並對某些鞘翅目昆蟲具有抗性; v)來自孟山都公司S.A. 270-272 Avenue de Tervuren的IPC 531 棉花,B-1150 Brussels,Belgium,註冊號C/ES/96/02;vi)1507玉米,來自Pioneer Overseas Corporation,Avenue Tedesco,7 B-1160 Brussels,Belgium,註冊號C/NL/00/10。基因改進的玉米,用於表達蛋白Cry1F以實現對某些鱗翅目昆蟲和PAT蛋白的抗性,以實現對除草劑草丁膦銨的耐受性;vii)來自孟山都公司的NK603 x MON 810玉米270-272 Avenue de Tervuren,比利時布魯塞爾B-1150,註冊號C/GB/02/M3/03。通過雜交轉基因品種的常規品種雜交玉米品種的成分NK603和MON 810。NK603×MON 810玉米轉基因表達從土壤桿菌屬菌株CP4獲得的蛋白質CP4 EPSPS,其賦予除草劑Roundup®(含有草甘膦)以及從蘇雲金芽孢桿菌亞種獲得的Cry1Ab毒素的耐受性,對某些鱗翅目包括歐洲玉米螟產生耐受性。"Plants" are understood to also include plants transformed by using recombinant DNA technology, which are capable of synthesizing one or more selective acting toxins, such as known toxin-producing bacteria, especially bacteria of the genus Bacillus, and have been selected or crossed To maintain and/or obtain desired characteristics, such as resistance to insects, fungi and/or nematodes. Toxins that can be expressed by these transgenic plants include, for example, insecticidal proteins from Bacillus cereus or Bacillus; or insecticidal proteins from Bacillus thuringiensis, such as 8-endotoxins, such as Cry1Ab, Cry1Ac, Cry1F, Cry1Fa2, Cry2Ab , Cry3A, Cry3Bb1 or Cry9C, or vegetative insecticidal protein (Vip), for example, Vip1, Vip2, Vip3 or Vip3A; or insecticidal proteins for bacteria that colonize nematodes, such as the genus Photobacterium or the pathogenic Bacillus, Such as photobacterium, nematode pathogenic bacillus; toxins produced by animals, such as scorpion toxin, spider toxin, wasp toxin, and other neurotoxins unique to insects; toxins produced by fungi, such as streptomycin, phytohemagglutinin, such as pea agglutinin Lectin, barley lectin or snowdrop lectin; lectin; protease inhibitors such as trypsin inhibitor, serine protease inhibitor, potato glycoprotein, cystatin, papain inhibitor; ribosome inactivating protein (RIP) , Such as ricin, corn-RIP, acacia, rosin, saponin, or bryoside; steroid metabolizing enzymes, such as 3-hydroxysteroid oxidase, ecdysone-uridine diphosphate-glycosyltransferase, cholesterol oxidation Enzymes, ecdysone inhibitors, HMG-COA-reductase, ion channel blockers such as sodium or calcium channel blockers, juvenile hormone esterases, diuretic hormone receptors, stilbene synthase, bibenzyl synthase , Chitinase and glucanase. In the context of the present invention, it is necessary to understand 8-endotoxins, such as Cry1Ab, Cry1Ac, Cry1F, Cry1Fa2, Cry2Ab, Cry3A, Cry3Bb1 or Cry9C, or nutritional insecticidal proteins (Vip), such as Vip1, Vip2, Vip3 or Vip3A, Specifically, it is a mixture of toxins, truncated toxins, and improved toxins. Hybrid toxins are produced by recombinant combinations of different domains of these proteins (see, for example, WO 02/15701). Truncated toxins, such as truncated CrylAb, are known. In the improved toxin, one or more amino acids of the naturally occurring toxin are replaced. In this amino acid substitution, it is preferable to insert a non-naturally occurring protease recognition sequence into the toxin, for example, in the case of Cry3A055, insert the cathepsin-G recognition sequence into the Cry3A toxin (see WO 03/018810). Examples of the ability to synthesize such toxins or transgenic plants have been disclosed, for example in EP-A-0 374 753, WO 93/07278, WO 95/34656, EP-A-0 427 529, EP-A-451 878 and WO 03/052073. Methods for preparing such transgenic plants are generally known to those skilled in the art and are described in, for example, the aforementioned publications. Cry1 type deoxyribonucleic acid and its preparation are known, for example, in WO 95/34656, EP-A-0 367474, EP-A-0 401 979 and WO 90/13651. Cry1 type deoxyribonucleic acid and its preparation are known from WO 95/34656, EP-A-0 367474, EP-A-0 401 979 and WO 90/13651. The toxins contained in the transgenic plants give the plants tolerance to harmful insects. This insect can appear in any taxa of insects, but it is particularly common in beetles (Coleoptera), diptera (Diptera) and butterflies (Lepidoptera). It is known that transgenic plants containing one or more genes encoding insecticidal resistance express one or more toxins, and some of them are commercially available. Examples of such plants are: YieldGard (maize variety expressing Cry1Ab toxin); YieldGardRootworm® (maize variety expressing Cry3Bb1 toxin); YieldGardPlus® (maize variety expressing Cry1Ab and Cry3Bb1 toxin); Starlink® (maize variety expressing Cry9C toxin) ); HerculexI® (maize variety, expressing Cry1Fa2 toxin and the enzyme phosphinothricin N-acetyltransferase (PAT) to achieve tolerance to the herbicide glufosinate ammonium); NuCOTN33B® (cotton expressing Cry1Ac toxin Varieties); BollgardI® (cotton varieties expressing Cry1Ac toxin); BollgardII® (cotton varieties expressing Cry1Ac and Cry2Ab toxin); VipCot® (cotton varieties expressing Vip3A and Cry1Ab toxin); Newleaf® (potato varieties expressing Cry3A toxin) ; NatureGard®, 25Agrisure® GT Advantage (GA21 glyphosate tolerance trait), Agrisure® CBAdvantage (Bt11 corn borer (CB) trait) and Protecta®. Other examples of such transgenic plants are: i) Bt11 corn from Syngenta Seed Company, Chemin de l'Hobit 27, F-31 790 St. Sauveur, France, registration number C/FR/96/05/10. Genetically modified maize is resistant to attack by European corn borers (European borer and borer) by transgenic expression of truncated Cry1Ab toxin. Bt11 corn is also transgenic to express the PAT enzyme to achieve tolerance to the herbicide glufosinate; ii) Bt176 corn from Syngenta Seed Company, Chemin de l'Hobit 27, F-31 790 St. Sauveur, France, Registration number C/FR/96/05/10. Genetically modified maize is resistant to attacks by European corn borers (European borer and borer) by transgenic expression of Cry1Ab toxin. Bt176 corn is also transgenic to express PAT enzyme to achieve tolerance to the herbicide glufosinate; iii) MIR604 corn from Syngenta Seed Company, Chemin de l'Hobit 27, F-31 790 St. Sauveur, France, Registration number C/FR/96/05/10. The improved Cry3A toxin through transgene expression makes corn resistant to insects. The toxin is Cry3A055 modified by inserting a cathepsin-G-protease recognition sequence. The preparation of this transgenic corn plant is described in WO 03/018810; iv) MON 863 corn from Monsanto S.A. 270-272 Avenue de Tervuren, B-1150 Brussels, Belgium, registration number C/DE/02/9. MON 863 expresses Cry3Bb1 toxin and is resistant to certain coleoptera insects; v) IPC 531 cotton from Monsanto SA 270-272 Avenue de Tervuren, B-1150 Brussels, Belgium, registration number C/ES/96/02; vi) 1507 corn, from Pioneer Overseas Corporation, Avenue Tedesco, 7 B-1160 Brussels, Belgium, registration number C/NL/00/10. Genetically modified corn used to express the protein Cry1F to achieve resistance to certain lepidopteran insects and PAT proteins to achieve tolerance to the herbicide glufosinate; vii) NK603 x MON 810 corn from Monsanto 270-272 Avenue de Tervuren, Brussels B-1150, Belgium, registration number C/GB/02/M3/03. The components of hybrid corn varieties NK603 and MON 810, which are conventional varieties through hybridization of transgenic varieties. The NK603×MON 810 corn transgene expresses the protein CP4 EPSPS obtained from the Agrobacterium strain CP4, which confers tolerance to the herbicide Roundup® (containing glyphosate) and the Cry1Ab toxin obtained from Bacillus thuringiensis subspecies, to some Lepidoptera, including European corn borers, developed tolerance.

式(I)的化合物可以以不同的晶體變體存在,其生物活性可能不同,它們同樣是本發明的主題。The compounds of formula (I) may exist in different crystal variants, their biological activities may be different, and they are also the subject of the present invention.

式(I)的化合物可以原樣或以組合物的形式使用,通過用殺真菌有效量的活性物質處理真菌或植物、植物繁殖材料,如種子、土壤、表面、材料或空間來防止真菌侵襲。施用可以在植物和植物繁殖材料(種子、土壤、表面、材料或空間等)被真菌感染之前和之後進行。The compounds of formula (I) can be used as such or in the form of compositions to prevent fungal attack by treating fungi or plants, plant propagation materials such as seeds, soil, surfaces, materials or spaces with fungicidally effective amounts of active substances. Application can be carried out before and after the infection of plants and plant propagation materials (seeds, soil, surfaces, materials or spaces, etc.) by fungi.

植物繁殖材料可以在種植或移植時或之前用式(I)化合物本身或包含至少一種式(I)化合物的組合物進行保護性處理。The plant propagation material may be treated protectively with the compound of formula (I) itself or a composition containing at least one compound of formula (I) at or before planting or transplantation.

本發明還涉及包含一種助劑和至少一種本發明的式(I)化合物的農業化學組合物。The invention also relates to an agrochemical composition comprising an adjuvant and at least one compound of the formula (I) according to the invention.

在一個實施方案中,本發明提供了一種農業化學組合物,其包含殺真菌有效量的式(I)化合物。術語“有效量”表示足以控制栽培植物或待保護材料上的有害真菌並且不會對被處理的植物造成實質性損害的式(I)的組合物或式(I)化合物的量。 這樣的量可以在很大的範圍內變化,並且受各種因素(例如待控制的真菌物種、待處理的栽培植物或材料、氣候條件和所使用的具體的式(I)的化合物)的影響。In one embodiment, the present invention provides an agrochemical composition comprising a fungicidally effective amount of a compound of formula (I). The term "effective amount" refers to an amount of the composition of formula (I) or the compound of formula (I) sufficient to control harmful fungi on cultivated plants or materials to be protected and not cause substantial damage to the treated plants. Such amounts can vary within wide limits and are influenced by various factors such as fungal species to be controlled, cultivated plants or materials to be treated, climatic conditions and the specific compounds of formula (I) used.

式I化合物、它們的氧化物和鹽可以轉化成常規類型的農業化學組合物,如溶液、乳液、懸浮液、粉劑、粉末、糊劑、顆粒、壓製劑、膠囊及其混合物。組合物類型的實例有懸浮液(例如SC、OD、FS)、可乳化濃縮物(例如EC)、乳液(例如EW、EO、ES、ME)、膠囊(例如CS、ZC)、糊劑、錠劑、可濕性粉劑或粉劑(例如WP、SP、WS、DP、DS)、壓製劑(例如BR、TB、DT)、顆粒(例如WG、SG、GR、FG、GG、MG)、殺蟲製品(例如LN),以及用於處理植物繁殖材料如種子(例如GF)的凝膠製劑。這些和其他組合物類型在《農藥製劑類型和國際編碼系統》(技術專論第2號.61h版. 2008年5月.國際作物生命協會)有定義。The compounds of formula I, their oxides and salts can be converted into conventional types of agrochemical compositions, such as solutions, emulsions, suspensions, powders, powders, pastes, granules, compressed preparations, capsules and mixtures thereof. Examples of composition types are suspensions (eg SC, OD, FS), emulsifiable concentrates (eg EC), emulsions (eg EW, EO, ES, ME), capsules (eg CS, ZC), pastes, tablets Agents, wettable powders or powders (eg WP, SP, WS, DP, DS), compressed preparations (eg BR, TB, DT), granules (eg WG, SG, GR, FG, GG, MG), insecticides Products (eg LN), and gel formulations for treating plant propagation materials such as seeds (eg GF). These and other composition types are defined in "Types of Pesticide Formulations and International Coding System" (Technical Monograph No. 2. 61h edition. May 2008. International Crop Life Association).

該組合物以已知的方式製備,製備方法在例如莫列特和格魯伯貝恩(Mollet and Grube mann)的《製劑技術》(Wiley VCH出版社,魏因海姆,2001);或諾爾斯(Knowles)的《作物保護產品製劑的新發展》(Agrow Reports DS243,T&F lnforma,倫敦,2005)中有描述。The composition is prepared in a known manner, for example in "Molet and Grube mann" "Formulation Technology" (Wiley VCH Press, Weinheim, 2001); or Knowles ( Knowles) "New Developments in Crop Protection Product Formulations" (Agrow Reports DS243, T&F Informa, London, 2005).

合適的助劑有溶劑、液體載體、固體載體或填料、表面活性劑、分散劑、乳化劑、濕潤劑、佐劑、增溶劑、滲透促進劑、保護膠體、黏合劑、增稠劑、保濕劑、驅蟲劑、引誘劑、餵食興奮劑、增容劑、殺菌劑、抗-凍結劑、消泡劑、著色劑、增黏劑和黏合劑。Suitable auxiliaries are solvents, liquid carriers, solid carriers or fillers, surfactants, dispersants, emulsifiers, wetting agents, adjuvants, solubilizers, penetration enhancers, protective colloids, adhesives, thickeners, humectants , Insect repellent, attractant, feeding stimulant, compatibilizer, fungicide, anti-freezing agent, defoamer, colorant, tackifier and adhesive.

合適的溶劑和液體載體有水和有機溶劑,例如中沸點至高沸點的礦物油餾分,例如煤油、柴油;植物油或動物油;脂族、環狀和芳族烴,例如甲苯、石蠟、四氫化萘、烷基化萘;醇類,例如乙醇、丙醇、丁醇、苯甲醇、環己醇;乙二醇;二甲基亞碸;酮類,例如環己酮;酯類,例如乳酸、碳酸酯、脂肪酸酯、γ-丁內酯;脂肪酸;膦酸酯;胺;醯胺類,例如N-甲基吡咯烷酮、脂肪酸二甲基醯胺;及其混合物。Suitable solvents and liquid carriers are water and organic solvents, such as medium- to high-boiling mineral oil fractions, such as kerosene, diesel; vegetable or animal oils; aliphatic, cyclic, and aromatic hydrocarbons, such as toluene, paraffin, tetralin, Alkylated naphthalene; alcohols, such as ethanol, propanol, butanol, benzyl alcohol, cyclohexanol; ethylene glycol; dimethyl sulfoxide; ketones, such as cyclohexanone; esters, such as lactic acid, carbonate , Fatty acid esters, γ-butyrolactone; fatty acids; phosphonates; amines; amides, such as N-methylpyrrolidone, fatty acid dimethyl amide; and mixtures thereof.

合適的固體載體或填料有礦物土,例如,矽酸鹽、矽膠、滑石、高嶺土、石灰石、石灰、白堊、黏土、白雲石、矽藻土、膨潤土、硫酸鈣、硫酸鎂、氧化鎂;多糖,例如纖維素、澱粉;肥料,例如硫酸銨、磷酸銨、硝酸銨、脲;植物來源的產品,例如穀物粉、樹皮粉、木粉,堅果殼粉及其混合物。Suitable solid carriers or fillers are mineral soils such as silicates, silica gels, talc, kaolin, limestone, lime, chalk, clay, dolomite, diatomaceous earth, bentonite, calcium sulfate, magnesium sulfate, magnesium oxide; polysaccharides, For example, cellulose, starch; fertilizers, such as ammonium sulfate, ammonium phosphate, ammonium nitrate, urea; plant-derived products, such as cereal flour, bark flour, wood flour, nut shell flour, and mixtures thereof.

合適的表面活性劑有表面活性化合物,例如陰離子,陽離子,非離子和兩性表面活性劑,嵌段聚合物,聚電解質及其混合物。這些表面活性劑可用作乳化劑,分散劑,增溶劑,潤濕劑,滲透增強劑,保護膠體或佐劑。表面活性劑的實例列於麥克卡森(McCutcheon),第1卷:乳化劑和洗滌劑,《麥克卡森目錄》(McCutcheon's Directories),格蘭岩市,美國,2008(國際版或北美版)中。Suitable surfactants are surface-active compounds such as anionic, cationic, nonionic and amphoteric surfactants, block polymers, polyelectrolytes and mixtures thereof. These surfactants can be used as emulsifiers, dispersants, solubilizers, wetting agents, penetration enhancers, protective colloids or adjuvants. Examples of surfactants are listed in McCutcheon, Volume 1: Emulsifiers and Detergents, McCutcheon's Directories, Gran Rock, USA, 2008 (International or North American Edition) in.

合適的陰離子表面活性劑有磺酸鹽、硫酸鹽、磷酸鹽、羧酸鹽及其混合物的鹼金屬、鹼土金屬或銨鹽。磺酸鹽的實例有烷基芳基磺酸鹽、二苯基磺酸鹽、α-烯烴磺酸鹽、木質素磺酸鹽、脂肪酸和油的磺酸鹽、乙氧基化烷基酚的磺酸鹽、烷氧基化芳基酚的磺酸鹽、縮合萘的磺酸鹽、十二烷基和十三烷基苯磺酸鹽、萘磺酸鹽和烷基萘、磺基琥珀酸鹽或磺基琥珀醯胺酸鹽。硫酸鹽的實例有脂肪酸和油的硫酸鹽、乙氧基化烷基酚、醇、乙氧基化醇或脂肪酸酯的硫酸鹽。磷酸酯的實例有磷酸酯。羧酸鹽的實例有烷基羧酸鹽和羧化醇或烷基酚乙氧基化物。Suitable anionic surfactants are the alkali metal, alkaline earth metal or ammonium salts of sulfonates, sulfates, phosphates, carboxylates and mixtures thereof. Examples of sulfonates are alkyl aryl sulfonates, diphenyl sulfonates, α-olefin sulfonates, lignin sulfonates, sulfonates of fatty acids and oils, ethoxylated alkylphenols Sulfonates, alkoxylated arylphenol sulfonates, condensed naphthalene sulfonates, dodecyl and tridecylbenzene sulfonates, naphthalene sulfonates and alkyl naphthalenes, sulfosuccinic acid Salt or sulfosuccinamide. Examples of sulfates are sulfates of fatty acids and oils, sulfates of ethoxylated alkylphenols, alcohols, ethoxylated alcohols or fatty acid esters. Examples of phosphate esters are phosphate esters. Examples of carboxylates are alkyl carboxylates and carboxylated alcohols or alkylphenol ethoxylates.

合適的非離子表面活性劑有烷氧基化物,N-取代的脂肪酸醯胺、氧化胺、酯、糖基表面活性劑、聚合物表面活性劑,以及它們的混合物。 烷氧基化物的實例有1至50當量烷氧基化醇類、烷基酚類、胺類、醯胺類、芳基酚類、脂肪酸或脂肪酸酯化合物。環氧乙烷和/或環氧丙烷可用於烷氧基化,優選環氧乙烷。N-取代的脂肪酸醯胺的實例有脂肪酸葡糖醯胺或脂肪酸鏈烷醇醯胺。酯的實例有脂肪酸酯,甘油酯或甘油單酯。糖基表面活性劑的實例有脫水山梨糖醇,乙氧基化脫水山梨糖醇、蔗糖和葡萄糖酯或烷基聚葡糖苷。聚合物表面活性劑的實例有乙烯基吡咯烷酮、乙烯醇或乙酸乙烯酯的均聚物或共聚物。Suitable nonionic surfactants are alkoxylates, N-substituted fatty acid amides, amine oxides, esters, sugar-based surfactants, polymer surfactants, and mixtures thereof. Examples of alkoxylates are 1 to 50 equivalents of alkoxylated alcohols, alkylphenols, amines, amides, arylphenols, fatty acids or fatty acid ester compounds. Ethylene oxide and/or propylene oxide can be used for alkoxylation, preferably ethylene oxide. Examples of N-substituted fatty acid amides are fatty acid glucosamine or fatty acid alkanolamide. Examples of esters are fatty acid esters, glycerides or monoglycerides. Examples of sugar-based surfactants are sorbitan, ethoxylated sorbitan, sucrose and glucose esters or alkyl polyglucosides. Examples of polymer surfactants are homopolymers or copolymers of vinylpyrrolidone, vinyl alcohol or vinyl acetate.

合適的陽離子表面活性劑有季銨表面活性劑,例如具有一個或兩個疏水基團的季銨化合物,或長鏈伯胺的鹽。合適的兩性表面活性劑有烷基甜菜堿和咪唑啉。合適的嵌段聚合物有包含聚環氧乙烷和聚環氧丙烷嵌段的A-B或A-B-A型嵌段聚合物,或包含鏈烷醇、聚環氧乙烷和聚環氧丙烷的A-B-C型嵌段聚合物。Suitable cationic surfactants are quaternary ammonium surfactants, for example quaternary ammonium compounds with one or two hydrophobic groups, or salts of long-chain primary amines. Suitable amphoteric surfactants are alkyl beets and imidazolines. Suitable block polymers are AB or ABA type block polymers containing blocks of polyethylene oxide and polypropylene oxide, or ABC type embedded blocks containing alkanol, polyethylene oxide and polypropylene oxide Segment polymer.

合適的聚電解質有多元酸或多元醇。多元酸的實例有聚丙烯酸或聚酸梳狀聚合物的堿鹽。多堿的實例有聚乙烯胺或聚乙烯胺。Suitable polyelectrolytes are polyacids or polyalcohols. Examples of polyacids are polyacrylic acid or polyacid comb polymers. Examples of dopamine are polyvinylamine or polyvinylamine.

合適的佐劑為本身幾乎沒有殺蟲活性能夠提高式(I)化合物對目標的生物性能的化合物。實例有表面活性劑、礦物質或植物油以及其他助劑。其他例子列於諾爾斯的《佐劑和添加劑》(Agrow報告DS256, T&F lnforma英國,2006年,第5章)。Suitable adjuvants are compounds which themselves have little insecticidal activity and can enhance the biological performance of the compound of formula (I) against the target. Examples are surfactants, mineral or vegetable oils and other auxiliary agents. Other examples are listed in Knowles’ Adjuvants and Additives (Agrow Report DS256, T&F Informa UK, 2006, Chapter 5).

合適的增稠劑有多糖(例如黃原膠、羧甲基纖維素)、無機黏土(有機改性或未改性的)、多羧酸鹽和矽酸鹽。Suitable thickeners are polysaccharides (eg xanthan gum, carboxymethyl cellulose), inorganic clay (organically modified or unmodified), polycarboxylates and silicates.

合適的殺菌劑有溴硝醇和異噻唑啉酮衍生物,例如烷基異噻唑啉酮和苯並異噻唑啉酮。Suitable fungicides are bronopol and isothiazolinone derivatives, such as alkyl isothiazolinone and benzisothiazolinone.

合適的防凍劑有乙二醇、丙二醇、尿素和甘油。合適的消泡劑有矽氧烷、長鏈醇和脂肪酸鹽。合適的著色劑(如紅色、藍色或綠色)有低水溶性顏料和水溶性染料。實例是無機著色劑(如氧化鐵、氧化鈦、六氰基鐵酸鐵)和有機著色劑(如茜素-、偶氮-和酞菁著色劑)。Suitable antifreeze agents are ethylene glycol, propylene glycol, urea and glycerin. Suitable defoamers are silicones, long-chain alcohols and fatty acid salts. Suitable colorants (such as red, blue or green) are low water-soluble pigments and water-soluble dyes. Examples are inorganic colorants (such as iron oxide, titanium oxide, iron hexacyanoferrate) and organic colorants (such as alizarin-, azo-, and phthalocyanine colorants).

合適的增黏劑或黏合劑有聚乙烯吡咯烷酮、聚乙酸乙烯酯、聚乙烯醇、聚丙烯酸酯、生物或合成蠟和纖維素醚。Suitable tackifiers or binders are polyvinylpyrrolidone, polyvinyl acetate, polyvinyl alcohol, polyacrylates, biological or synthetic waxes and cellulose ethers.

組合物類型及其製備的實例有: i) 水溶性濃縮物 (SL, LS) 將重量比為10-60%的式(I)化合物和重量比為5-15%的潤濕劑(例如醇烷氧基化物)溶解在重量比為100%的水和/或水溶性溶劑(例如醇)中。活性物質在用水稀釋即溶解。 ii) 分散性濃縮物 (DC) 將重量比為5-25%的式(I)化合物和重量比為1-10%的分散劑(例如聚乙烯吡咯烷酮)溶解在重量比為100%的有機溶劑(例如環己酮)中。用水稀釋得到分散性濃縮物。 iii) 可乳化濃縮物 (EC) 將重量比為15-70%的式(I)化合物和重量比為5-10%的乳化劑(例如十二烷基苯磺酸鈣和蓖麻油乙氧基化物)溶解在重量比為100%的水不溶性有機溶劑(例如芳族烴碳)中。用水稀釋得到乳液。 iv) 乳液 (EW, EO, ES) 將重量比為5-40%的式(I)化合物和重量比為1-10%的乳化劑(例如十二烷基苯磺酸鈣和蓖麻油乙氧基化物)溶解在重量比為20-40%的水不溶性有機溶劑(例如芳烴)中。通過乳化機將該混合物溶在重量比為100%的水中並製成均相乳液。用水稀釋得到乳液。 v) 懸浮液 (SC, OD, FS) 在攪拌球磨機中,將重量比為20-60%的式(I)化合物粉碎,加入重量比為2-10%的分散劑和潤濕劑(例如木質素磺酸鈉和醇乙氧基化物),重量比為0.1-2%的增稠劑(例如,黃原膠)和重量比為100%的水,得到細活性物質懸浮液。 用水稀釋得到活性物質的穩定懸浮液。對於FS型組合物,加入重量比高達40%的黏合劑(例如聚乙烯醇)。 vi) 水分散性顆粒和水溶性顆粒 (WG, SG) 將重量比為50-80%的式(I)化合物粉碎,加入重量比為100%的分散劑和潤濕劑(例如木質素磺酸鈉和醇乙氧基化物),並通過技術器具(例如擠壓、噴霧塔、流化床)作為水分散性或水溶性顆粒製備。用水稀釋可得穩定的具有活性物質的分散體或溶液。 vii) 水分散性粉末和水溶性粉末 (WP, SP, WS) 將重量比為50-80%的式(I)化合物在轉子-定子磨機中研磨並添加重量比為1-5%的分散劑(例如木質素磺酸鈉)、重量比為1-3%的潤濕劑(例如醇乙氧基化物)和重量比為100%固體載體(例如矽膠)。用水稀釋得到穩定的具有活性物質的分散體或溶液。 viii) 凝膠 (GW, GF) 在攪拌球磨機中,將重量比為5-25%的式(I)化合物粉碎,加入重量比為3-10%分散劑(例如木質素磺酸鈉),重量比為1-5%增稠劑(例如羧甲基纖維素)和重量比為100%的水,得到有活性物質的細懸浮液。用水稀釋得到有活性物質的穩定懸浮液。 ix) 微乳劑 (ME) 將重量比為5-20%的式(I)化合物加入到重量比為5-30%的有機溶劑混合物(例如脂肪酸二甲基醯胺和環己酮),重量比為10-25%的表面活性劑混合物(例如醇乙氧基化物和芳基酚乙氧基化物),和重量比為100%的水。將該混合物攪拌1小時,自發產生熱力學穩定的微乳液。 x) 微膠囊 (CS) 將其含有重量比為5-50%的式(I)化合物、重量比為0-40%的水不溶性有機溶劑(例如芳烴)、重量比為2-15%的丙烯酸單體(例如甲基丙烯酸甲酯,甲基丙烯酸和二-或將三丙烯酸酯)油相分散在保護膠體(例如聚乙烯醇)的水溶液中。自由基聚合形成聚(甲基)丙烯酸酯微膠囊。或者,將含有重量比為5-50%的根據本發明的式(I)的化合物,重量比為0-40%的水不溶性有機溶劑(例如芳烴)和異氰酸酯單體(例如二苯基甲烷-4,4'-二異氰酸酯)的油相分散到保護膠體(例如聚乙烯醇)的水溶液中。加入多胺(例如六甲基苯二胺)形成聚脲微膠囊。單體量占重量的1-10%。wt%為占微膠囊組合物總重量百分比。 xi) 可撒粉的粉末 (DP, DS) 將重量比為1-10%的式(I)化合物細碎研磨並與重量比為100%的固體載體(例如細碎的高嶺土)充分混合。 xii) 顆粒 (GR, FG) 將重量比為0.5-30%的式(I)化合物細碎研磨並與重量比為100%的固體載體(例如矽酸鹽)混合。通過擠制加工,噴霧乾燥或流化床實現造粒。 xiii) 超低量液 (UL) 將重量比為1-50%的式(I)化合物溶於重量比為100%的有機溶劑(例如芳烴)中。Examples of composition types and their preparation are: i) Water-soluble concentrate (SL, LS) Dissolve the compound of formula (I) in a weight ratio of 10-60% and a wetting agent (for example, alcohol alkoxylate) in a weight ratio of 5-15% in water and/or a water-soluble solvent in a weight ratio of 100% ( For example, alcohol). The active substance dissolves upon dilution with water. ii) Dispersible concentrate (DC) A compound of formula (I) in a weight ratio of 5-25% and a dispersant (for example, polyvinylpyrrolidone) in a weight ratio of 1-10% are dissolved in an organic solvent (for example, cyclohexanone) in a weight ratio of 100%. Dilute with water to obtain a dispersible concentrate. iii) Emulsifiable concentrate (EC) Dissolve the compound of formula (I) in a weight ratio of 15-70% and an emulsifier in a weight ratio of 5-10% (eg calcium dodecylbenzenesulfonate and castor oil ethoxylate) in a weight ratio of 100% Of water-insoluble organic solvents (such as aromatic hydrocarbon carbon). Dilute with water to get an emulsion. iv) Emulsion (EW, EO, ES) Dissolve the compound of formula (I) in a weight ratio of 5-40% and emulsifier in a weight ratio of 1-10% (for example calcium dodecylbenzenesulfonate and castor oil ethoxylate) in a weight ratio of 20- 40% of water-insoluble organic solvents (such as aromatic hydrocarbons). The mixture was dissolved in water with a weight ratio of 100% by an emulsifier and made into a homogeneous emulsion. Dilute with water to get an emulsion. v) Suspension (SC, OD, FS) In a stirred ball mill, the compound of formula (I) with a weight ratio of 20-60% is pulverized, and a dispersant and a wetting agent with a weight ratio of 2-10% are added (for example, sodium lignosulfonate and alcohol ethoxylate) , A thickener (for example, xanthan gum) in a weight ratio of 0.1-2% and water in a weight ratio of 100% to obtain a fine active substance suspension. Dilute with water to obtain a stable suspension of the active substance. For the FS type composition, a binder (for example, polyvinyl alcohol) of up to 40% by weight is added. vi) Water-dispersible particles and water-soluble particles (WG, SG) Pulverize the compound of formula (I) with a weight ratio of 50-80%, add a dispersant and a wetting agent with a weight ratio of 100% (such as sodium lignosulfonate and alcohol ethoxylate), and pass through a technical appliance (such as Extrusion, spray tower, fluidized bed) are prepared as water-dispersible or water-soluble particles. Dilute with water to obtain a stable dispersion or solution with active substances. vii) Water-dispersible powder and water-soluble powder (WP, SP, WS) The compound of formula (I) with a weight ratio of 50-80% is ground in a rotor-stator mill and a dispersant with a weight ratio of 1-5% (eg sodium lignosulfonate) is added with a weight ratio of 1-3% The wetting agent (such as alcohol ethoxylate) and the weight ratio of 100% solid carrier (such as silicone). Dilute with water to obtain a stable dispersion or solution with active substance. viii) Gel (GW, GF) In a stirred ball mill, crush the compound of formula (I) in a weight ratio of 5-25%, add a dispersant (for example, sodium lignosulfonate) in a weight ratio of 3-10%, and a thickener in a weight ratio of 1-5% (For example, carboxymethyl cellulose) and water with a weight ratio of 100% to obtain a fine suspension of active substance. Dilute with water to obtain a stable suspension with active substance. ix) Microemulsion (ME) The compound of formula (I) with a weight ratio of 5-20% is added to an organic solvent mixture with a weight ratio of 5-30% (such as fatty acid dimethyl amide and cyclohexanone) with a weight ratio of 10-25% on the surface Active agent mixture (for example, alcohol ethoxylate and arylphenol ethoxylate), and 100% by weight of water. The mixture was stirred for 1 hour, and a thermodynamically stable microemulsion was generated spontaneously. x) Microcapsule (CS) It contains 5-50% by weight of compound of formula (I), 0-40% by weight of water-insoluble organic solvent (such as aromatic hydrocarbons), and 2-15% by weight of acrylic monomer (such as methacrylic acid) Methyl ester, methacrylic acid and di-or triacrylate) oil phase are dispersed in an aqueous solution of protective colloid (eg polyvinyl alcohol). Free radical polymerization forms poly(meth)acrylate microcapsules. Alternatively, it will contain a compound of formula (I) according to the invention in a weight ratio of 5-50%, a water-insoluble organic solvent (eg aromatic hydrocarbon) and an isocyanate monomer (eg diphenylmethane- 4,4'-diisocyanate) oil phase dispersed in an aqueous solution of protective colloid (such as polyvinyl alcohol). Polyamines (such as hexamethylphenylenediamine) are added to form polyurea microcapsules. The amount of monomer accounts for 1-10% by weight. wt% is the percentage of the total weight of the microcapsule composition. xi) Dustable powder (DP, DS) The compound of formula (I) in a weight ratio of 1-10% is finely ground and thoroughly mixed with a solid carrier in a weight ratio of 100% (eg finely divided kaolin). xii) Granules (GR, FG) The compound of formula (I) in a weight ratio of 0.5-30% is finely ground and mixed with a solid carrier in a weight ratio of 100% (eg silicate). Granulation is achieved by extrusion processing, spray drying or fluidized bed. xiii) Ultra Low Volume Liquid (UL) The compound of formula (I) in a weight ratio of 1-50% is dissolved in an organic solvent (for example, aromatic hydrocarbon) in a weight ratio of 100%.

i)至xiii)的組合物可任選地包含其他助劑,例如重量比為0.1-1%的殺菌劑,重量比為5-15%的防凍劑,重量比為0.1-1%的消泡劑和重量比為0.1-1%的著色劑。The composition of i) to xiii) may optionally contain other adjuvants, such as fungicides in a weight ratio of 0.1-1%, antifreeze in a weight ratio of 5-15%, and defoaming in a weight ratio of 0.1-1% The agent and the coloring agent with a weight ratio of 0.1-1%.

農業化學組合物通常包含重量比為0.01至95%,優選0.1至90%,特別是0.5至75%的活性物質。Agrochemical compositions generally contain active substances in a weight ratio of 0.01 to 95%, preferably 0.1 to 90%, in particular 0.5 to 75%.

活性物質的純度為90%至100%,優選95%至100%(根據NMR光譜)。The purity of the active substance is 90% to 100%, preferably 95% to 100% (according to NMR spectrum).

處理植物繁殖材料(特別是種子)時,常使用種子處理溶液(LS)、懸浮乳液(SE)、可流動濃縮物(FS)、乾燥處理粉末(DS)、漿液處理用水分散性粉末(WS)通常使用水溶性粉末(SS)、乳液(ES)、可乳化濃縮物(EC)和凝膠(GF)。在二至十倍稀釋後,所述組合物在即用製劑中產生重量比為0.01至60%,優選0.1至40%的活性物質濃度。施用可在播種前或播種期間進行。將式(I)化合物及其組合物分別施用到植物繁殖材料(特別是種子)上的方法包括敷料、包覆、造粒、撒粉和浸泡以及犁溝施用方法。優選地,分別通過拌種、造粒、包覆和撒粉這些不誘導發芽的方法將式(I)化合物或其組合物施用於植物繁殖材料上。When processing plant propagation materials (especially seeds), seed treatment solutions (LS), suspension emulsions (SE), flowable concentrates (FS), drying treatment powders (DS), slurry treatment water dispersible powders (WS) are often used Generally, water-soluble powder (SS), emulsion (ES), emulsifiable concentrate (EC) and gel (GF) are used. After a two- to ten-fold dilution, the composition produces an active substance concentration of 0.01 to 60% by weight in the ready-to-use preparation, preferably 0.1 to 40%. Application can be carried out before or during sowing. Methods of applying the compound of formula (I) and its composition to plant propagation materials (especially seeds) include dressing, coating, granulation, dusting and soaking, and furrow application methods. Preferably, the compound of formula (I) or a combination thereof is applied to plant propagation material by methods such as seed dressing, granulation, coating and dusting which do not induce germination.

當用於植物保護時,根據所需效果,施用的活性物質的量為每公頃0.1至2.5千克,優選每公頃0.5至1.5千克,更優選每公頃0.35至1千克(特別是每公頃0.2至0.75千克)。When used for plant protection, depending on the desired effect, the amount of active substance applied is 0.1 to 2.5 kg per hectare, preferably 0.5 to 1.5 kg per hectare, more preferably 0.35 to 1 kg per hectare (particularly 0.2 to 0.75 per hectare kilogram).

在處理(例如,通過撒粉、塗覆或浸透種子)植物繁殖材料如種子時,活性物質的量為每100千克植物繁殖材料(優選為種子)0.1至1000克,優選1至750克,更優選10至500克,最優選100至250克。When processing (for example, by dusting, coating, or drenching seeds) plant propagation material such as seeds, the amount of active substance is 0.1 to 1000 grams per 100 kilograms of plant propagation material (preferably seeds), preferably 1 to 750 grams, more It is preferably from 10 to 500 grams, most preferably from 100 to 250 grams.

當用於材料或儲藏品的保護時,所施加的活性物質的量取決於施用的類型和所需的效果。通常用於保護材料的量為每立方米經處理的材料施用0.01g至2kg,優選0.05g至1kg活性物質。When used for the protection of materials or storage items, the amount of active substance applied depends on the type of application and the desired effect. The amount generally used for protecting the material is 0.01 g to 2 kg, preferably 0.05 g to 1 kg of active substance per cubic meter of treated material.

可以將各種類型的油、濕潤劑、佐劑、肥料或微量營養素以及其他農藥(例如除草劑、殺蟲劑、殺真菌劑、生長調節劑、安全劑、生物殺蟲劑)添加到活性物質或包含它們的組合物中作為預混物,或者如果合適的話使用前再加(罐裝混合)。這些試劑可以按照本發明的組合物以1:100至100:1,優選1:10至10:1的重量比混合。Various types of oils, wetting agents, adjuvants, fertilizers or micronutrients, and other pesticides (eg herbicides, insecticides, fungicides, growth regulators, safeners, biological insecticides) can be added to the active substance or The composition containing them is used as a premix, or if appropriate, added before use (mixed in cans). These agents can be mixed in a weight ratio of 1:100 to 100:1, preferably 1:10 to 10:1, according to the composition of the present invention.

殺蟲劑通常是化學或生物製劑(例如殺蟲活性成分、化合物、組合物、毒素、細菌、抗微生物劑或消毒劑),通過其效果阻止,使害蟲喪失能力、殺死或以其他方式阻止害蟲。目標害蟲可包括昆蟲、植物病原體、雜草、軟體動物、鳥類、哺乳動物、魚類、線蟲(蛔蟲)和破壞財產、引起滋擾、傳播疾病或是疾病傳播媒介的微生物。術語“農藥”還包括改變植物預期生長、開花或繁殖率的植物生長調節劑;導致葉子或其他葉子從植物上掉落的落葉劑(通常是為了促進收穫);促進活組織(如不需要的植物頂部)乾燥的乾燥劑;啟動植物生理學以防禦某些害蟲的植物啟動劑;減少殺蟲劑對作物植物不必要的除草活性的安全劑;以及影響植物生理學以增加作物植物的可收穫物的植物生長、生物量、產量或任何其他品質參數的植物生長促進劑。Insecticides are usually chemical or biological agents (eg insecticidal active ingredients, compounds, compositions, toxins, bacteria, antimicrobial agents or disinfectants), which are prevented by their effects, disabling the pests, killing or otherwise preventing Pests. Target pests can include insects, plant pathogens, weeds, mollusks, birds, mammals, fish, nematodes (roundworms) and microorganisms that destroy property, cause nuisance, spread disease, or vectors of disease. The term "pesticide" also includes plant growth regulators that change the expected growth, flowering or reproduction rate of plants; deciduous agents that cause leaves or other leaves to fall from the plant (usually to promote harvest); promote living tissue (if not needed) Plant tops) Dry desiccants; plant initiators that activate plant physiology to protect against certain pests; safeners that reduce the unnecessary herbicidal activity of pesticides on crop plants; and affect plant physiology to increase the harvestability of crop plants Plant growth promoters for plant growth, biomass, yield, or any other quality parameter.

生物殺蟲劑被定義為基於微生物(細菌、真菌、病毒、線蟲等)或天然產物(化合物,如代謝物,蛋白質或生物或其他天然來源的提取物)的農藥形式(美國環境保護局:http://www.epa.gov/pesticides/biopesticides/)。生物殺蟲劑通常通過栽培和濃縮天然存在的生物和/或其代謝物(包括細菌和其他微生物、真菌、病毒、線蟲、蛋白質等)來產生。它們通常被認為是有害生物綜合治理(IPM)計畫的重要組成部分。Biopesticides are defined as pesticides based on microorganisms (bacteria, fungi, viruses, nematodes, etc.) or natural products (compounds, such as metabolites, proteins, or extracts of biological or other natural sources) (US EPA: http : //Www.epa.gov/pesticides/biopesticides/). Bioinsecticides are usually produced by cultivating and concentrating naturally occurring organisms and/or their metabolites (including bacteria and other microorganisms, fungi, viruses, nematodes, proteins, etc.). They are generally considered to be an important part of the integrated pest management (IPM) program.

生物農藥分為兩大類,即微生物農藥和生化農藥: 1. 微生物殺蟲劑由細菌、真菌或病毒組成(通常包括細菌和真菌產生的代謝物)。雖然昆蟲病原線蟲是多細胞的,但是它們也被歸類為微生物殺蟲劑。 2. 生化農藥是天然存在的可控制害蟲或提供如下定義的其他作物保護用途,但對哺乳動物相對無毒的物質。Biological pesticides are divided into two categories, namely microbial pesticides and biochemical pesticides: 1. Microbial pesticides consist of bacteria, fungi or viruses (usually including metabolites produced by bacteria and fungi). Although entomopathogenic nematodes are multicellular, they are also classified as microbial insecticides. 2. Biochemical pesticides are naturally occurring substances that can control pests or provide other crop protection uses as defined below, but are relatively non-toxic to mammals.

使用者通常從預劑量裝置、背負式噴霧器、噴霧罐、噴霧飛機或灌溉系統施用根據本發明的組合物。通常,農業化學組合物由水、緩衝劑和/或其它助劑配製成所需的施用濃度,從而獲得即用型噴霧液或根據本發明的農業化學組合物。通常,每公頃農業有用區域施用20至2000升,優選50至750升即用型噴霧液。The user usually applies the composition according to the invention from a pre-dose device, a backpack sprayer, a spray can, a spray airplane or an irrigation system. Generally, the agrochemical composition is formulated with water, buffers and/or other adjuvants to the desired application concentration to obtain a ready-to-use spray liquid or the agrochemical composition according to the present invention. Generally, 20 to 2000 liters, preferably 50 to 750 liters of ready-to-use spray liquid is applied per hectare of agriculturally useful area.

在一個實施方案中,本發明提供用於控制有害微生物的組合物,其包含至少一種式(I)的化合物和一種或多種惰性載體。惰性載體為農業上合適的助劑、溶劑、稀釋劑、表面活性劑和/或增量劑等。In one embodiment, the present invention provides a composition for controlling harmful microorganisms, which comprises at least one compound of formula (I) and one or more inert carriers. The inert carrier is agriculturally suitable auxiliary, solvent, diluent, surfactant and/or extender, etc.

在另一個實施方案中,式(I)化合物的濃度為占組合物總重量的10至90%,占組合物總重量的30至70%。In another embodiment, the concentration of the compound of formula (I) is 10 to 90% of the total weight of the composition and 30 to 70% of the total weight of the composition.

在另一個實施方案中,本發明提供了用於控制有害微生物的組合,其包含至少一種式(I)的化合物和/或一種或多種選自殺真菌劑、殺菌劑、殺蟎劑、殺蟲劑、殺線蟲劑、除草劑、生物殺蟲劑、植物生長調節劑、抗生素、肥料和/或其混合物的活性相容化合物。In another embodiment, the present invention provides a combination for controlling harmful microorganisms comprising at least one compound of formula (I) and/or one or more selected from fungicides, fungicides, acaricides, insecticides , Nematicides, herbicides, biological insecticides, plant growth regulators, antibiotics, fertilizers and/or mixtures of active compatible compounds.

通常,本發明化合物以含有載體的組合物(例如製劑)的形式使用。本發明化合物及其組合物可以以各種形式使用,例如氣溶膠噴罐、膠囊懸浮液、冷霧濃縮物、粉劑、可乳化濃縮物、農藥水乳劑、油乳劑、膠囊粒劑、細顆粒、可流動濃縮物。用於種子處理,氣體(加壓)、產氣劑、顆粒、熱霧劑、大顆粒、微粒、油分散性粉末、油溶性可流動濃縮物、油溶性液體、糊狀物、植物小棒、種子處理粉末、種衣劑、可溶液劑、可溶性粉末、種子處理液、懸浮濃縮液(可流動濃縮液)、超低容量(ulv)液體、超低容量懸浮液、水分散顆粒或片劑、水分散性漿料處理粉、水溶性顆粒或片劑、用於種子處理的水溶性粉末和可濕性粉劑。Generally, the compounds of the invention are used in the form of compositions (eg, formulations) containing carriers. The compounds of the present invention and their compositions can be used in various forms, such as aerosol spray cans, capsule suspensions, cold mist concentrates, powders, emulsifiable concentrates, pesticide aqueous emulsions, oil emulsions, capsule granules, fine particles, Mobile concentrate. Used for seed treatment, gas (pressurized), gas generating agent, granules, hot aerosol, large particles, microparticles, oil-dispersible powder, oil-soluble flowable concentrate, oil-soluble liquid, paste, plant sticks, Seed treatment powder, seed coating agent, soluble agent, soluble powder, seed treatment liquid, suspension concentrate (flowable concentrate), ultra low volume (ulv) liquid, ultra low volume suspension, water dispersible granules or tablets, Water-dispersible slurry treatment powder, water-soluble granules or tablets, water-soluble powder for seed treatment and wettable powder.

製劑通常包含液體或固體載體和任選的一種或多種常規配製助劑,其可以是固體或液體助劑,例如未環氧化或環氧化的植物油(例如環氧化椰子油、菜籽油或大豆油)、消泡劑(例如矽油、防腐劑、黏土、無機化合物)、黏度調節劑、表面活性劑、黏合劑和/或增黏劑。該組合物還可以進一步包含肥料、微量營養素供體或影響植物生長的其他製劑,以及包含含有本發明化合物與一種或多種其他生物活性劑(如殺菌劑、殺真菌劑、殺線蟲劑、植物啟動劑、殺蟎劑和殺蟲劑)的組合。The formulations generally include a liquid or solid carrier and optionally one or more conventional formulation aids, which may be solid or liquid aids, such as unepoxidized or epoxidized vegetable oils (such as epoxidized coconut oil, rapeseed oil, or soybean oil) ), defoamers (such as silicone oil, preservatives, clay, inorganic compounds), viscosity modifiers, surfactants, adhesives and/or tackifiers. The composition may further contain fertilizers, micronutrient donors or other preparations that affect plant growth, as well as containing compounds of the present invention and one or more other biologically active agents (such as fungicides, fungicides, nematicides, plant starters Agents, acaricides and insecticides).

因此,本發明還可製備包含本發明化合物和農學載體以及任選的一種或多種常規配製助劑的組合物。Therefore, the present invention can also prepare a composition comprising the compound of the present invention and an agronomic carrier and optionally one or more conventional formulation aids.

該組合物可通過技術人員已知的方式在加入助劑的情況下製備,例如通過研磨、篩分和/或壓制本發明的固體化合物並在至少一種助劑存在下,例如用輔助劑緊密混合和/或研磨本發明化合物。在本發明的固體化合物的情況下,化合物的研磨/碾磨是為了確保特定的細微性。這些製備組合物的方法和本發明化合物用於製備這些組合物的用途也是本發明的主題。The composition can be prepared in a manner known to the skilled person with the addition of auxiliary agents, for example by grinding, sieving and/or compressing the solid compound of the invention and intimately mixed in the presence of at least one auxiliary agent, for example with auxiliary agents And/or grinding compounds of the invention. In the case of the solid compound of the present invention, the grinding/grinding of the compound is to ensure specific fineness. These methods for preparing compositions and the use of the compounds of the present invention for preparing these compositions are also the subject of the present invention.

通常,組合物包含0.1至99%(特別是0.1至95%)的本發明化合物和1至99.9%(特別是5至99.9%)的至少一種固體或液體載體(通常組合物的0至25%,特別是0.1至20%是表面活性劑)(在每種情況下%表示重量百分比)。儘管濃縮組合物往往優選用於商品,但最終消費者通常使用具有顯著較低濃度的活性成分的稀釋組合物。Generally, the composition comprises 0.1 to 99% (particularly 0.1 to 95%) of the compound of the present invention and 1 to 99.9% (particularly 5 to 99.9%) of at least one solid or liquid carrier (typically 0 to 25% of the composition) , In particular 0.1 to 20% are surfactants) (in each case% means weight percent). Although concentrated compositions are often preferred for commercial products, end consumers often use diluted compositions with significantly lower concentrations of active ingredients.

用於預混組合物的葉面製劑類型的實例是:

Figure 108129373-A0304-0001
Examples of types of foliar formulations used in premix compositions are:
Figure 108129373-A0304-0001

而用於預混組合物的種子處理製劑類型的實例有:

Figure 108129373-A0304-0002
Examples of types of seed treatment formulations used in premix compositions are:
Figure 108129373-A0304-0002

適用於桶混組合物的配方類型的實例是溶液、稀釋乳液,懸浮液或其混合物和粉劑。Examples of types of formulations suitable for tank mix compositions are solutions, diluted emulsions, suspensions or mixtures thereof and powders.

與製劑的性質一樣,根據預期目標和主要情況可以選擇葉面、浸漬、噴霧、霧化、撒粉、散佈、塗覆或澆注等施用方法。As with the nature of the formulation, application methods such as foliar, dipping, spraying, atomizing, dusting, spreading, coating, or pouring can be selected according to the intended target and main situation.

罐混物組合物通常通過用溶劑(例如水)稀釋一種或多種含有不同農藥的預混組合物和任選的其它助劑來製備。合適的載體和佐劑可以是固體或液體,並且是製劑技術中通常使用的物質,例如,天然或再生礦物質、溶劑、分散劑、潤濕劑、增黏劑、增稠劑、黏合劑或肥料。The tank mix composition is generally prepared by diluting one or more premix compositions containing different pesticides and optional other adjuvants with a solvent (eg, water). Suitable carriers and adjuvants can be solid or liquid, and are substances commonly used in formulation technology, for example, natural or regenerated minerals, solvents, dispersants, wetting agents, tackifiers, thickeners, binders or fertilizers .

通常,用於葉面或土壤施用的罐混配方包含0.1至20%(優選0.1至15%)的所需成分,和99.9至80%(優選99.9至85%)的固體或液體助劑(比如水等溶劑),根據桶混配方其中助劑可以是0至20%(優選0.1至15%)的表面活性劑。通常,用於葉面施用的預混合製劑包含0.1至99.9%(優選1至95%)的所需成分,和99.9至0.1%(優選99至5%)的固體或液體佐劑(包括例如,基於預混配方,助劑可以是0至50%,優選0.5至40%的表面活性劑)。Generally, tank mix formulations for foliar or soil application contain 0.1 to 20% (preferably 0.1 to 15%) of the desired ingredients, and 99.9 to 80% (preferably 99.9 to 85%) solid or liquid additives (such as Water and other solvents), according to the tank mixing formula, the auxiliary agent may be 0 to 20% (preferably 0.1 to 15%) surfactant. Generally, pre-mixed formulations for foliar application contain 0.1 to 99.9% (preferably 1 to 95%) of the desired ingredients, and 99.9 to 0.1% (preferably 99 to 5%) solid or liquid adjuvant (including, for example, Based on the premixed formulation, the adjuvant may be 0 to 50%, preferably 0.5 to 40% surfactant).

通常,用於種子處理應用的罐混配方包含0.25至80%(優選1至75%)的所需成分,和99.75至20%(優選99至25%)的固體或液體助劑(比如水等溶劑),其中基於桶混配方助劑可以是0至40%(優選0.5至30%)的表面活性劑。Generally, tank mix formulations for seed treatment applications contain 0.25 to 80% (preferably 1 to 75%) of the desired ingredients, and 99.75 to 20% (preferably 99 to 25%) of solid or liquid additives (such as water etc.) Solvent), wherein the tank-based formulation aid may be 0 to 40% (preferably 0.5 to 30%) surfactant.

通常,用於種子處理應用的預混合製劑包含0.5至99.9%(優選1至95%)的所需成分,以及99.5至0.1%(優選99至5%)的固體或液體佐劑(包括,例如溶劑比如水),其中基於預混配方助劑可以是0至50%(優選0.5至40%)的表面活性劑,而商業產品優選配製成濃縮物(例如,預混合組合物(配方)),最終用戶通常使用稀釋製劑(例如桶混組合物)。Typically, pre-mixed formulations for seed treatment applications contain 0.5 to 99.9% (preferably 1 to 95%) of the desired ingredients, and 99.5 to 0.1% (preferably 99 to 5%) solid or liquid adjuvants (including, for example Solvents such as water), where the pre-mix formulation-based adjuvant may be 0 to 50% (preferably 0.5 to 40%) surfactant, while the commercial product is preferably formulated as a concentrate (eg, pre-mix composition (formulation)) , End users usually use dilute formulations (such as tank mixes).

優選的種子處理預混配方是含水懸浮濃縮物。可以使用常規處理技術和機器將製劑施用於種子,例如流化床技術、輥磨法、旋轉靜態種子處理器和鼓式塗料器。其他方法,例如噴射床也可能是有用的。可以在塗覆之前預先確定種子的大小。塗覆後,通常將種子乾燥,然後轉移到漿紗機中進行施膠。這些方法在本領域中是已知的。本發明的化合物特別適用於土壤和種子處理。The preferred seed treatment premix formulation is an aqueous suspension concentrate. The formulation can be applied to the seeds using conventional processing techniques and machines, such as fluidized bed technology, roller milling, rotating static seed processors, and drum coaters. Other methods, such as jet beds, may also be useful. The size of the seed can be predetermined before coating. After coating, the seeds are usually dried and then transferred to a sizing machine for sizing. These methods are known in the art. The compounds of the present invention are particularly suitable for soil and seed treatment.

通常,本發明的預混組合物含有0.5%至99.9%,優選1至95%,更有選1%至50%的所需成分,以及99.5%至0.1%,優選99至5%(品質)的固體或液體佐劑(包括溶劑,比如水),其中根據預混合配方的品質助劑(或佐劑)可以是品質占比為0至50%,優選0.5至40%的表面活性劑。Generally, the premix composition of the present invention contains 0.5% to 99.9%, preferably 1 to 95%, more preferably 1% to 50% of the desired ingredients, and 99.5% to 0.1%, preferably 99 to 5% (quality) Solid or liquid adjuvant (including solvent, such as water), wherein the quality adjuvant (or adjuvant) according to the pre-mixed formulation may be a surfactant with a quality ratio of 0 to 50%, preferably 0.5 to 40%.

在優選實施方案中,獨立於任何其他實施方案,式(I)化合物的形式是植物繁殖材料處理(或保護)組合物,其中所述植物繁殖材料保護組合物可另外包含著色劑。植物繁殖材料保護組合物或混合物還可包含至少一種來自水溶性和水分散性成膜聚合物的聚合物,其改善活性成分與處理過的植物繁殖材料的黏附性,該聚合物通常具有平均至少10,000到約100,000的分子量。In a preferred embodiment, independent of any other embodiment, the compound of formula (I) is in the form of a plant propagation material treatment (or protection) composition, wherein the plant propagation material protection composition may additionally comprise a colorant. The plant propagation material protection composition or mixture may further comprise at least one polymer derived from water-soluble and water-dispersible film-forming polymers, which improves the adhesion of the active ingredient to the treated plant propagation material, the polymer generally having an average of at least Molecular weight from 10,000 to about 100,000.

本發明化合物及其組合物的施用方法的實例(即控制農業中害蟲的方法)有噴霧、霧化、撒粉、刷塗、敷料、撒布或澆注——根據現行的預期目標來選擇。Examples of methods of application of the compounds of the present invention and their compositions (ie, methods of controlling pests in agriculture) are spraying, atomization, dusting, brushing, dressing, spreading, or pouring-selected based on current expected goals.

在農業中應用的一種方法是施用於植物的葉子(葉面施用),可以根據害蟲或真菌的危險選來擇施用的頻率和速率。或者,活性成分可通過根系統(全身作用)到達植物,通過將化合物施用於植物所在地,例如通過將化合物的液體組合物施用到土壤中(通過浸透),或通過將固體形式的化合物以顆粒形式施用於土壤(土壤施用)。在水稻植物的情況下,可以將這種顆粒計量加入淹水稻田中。將本發明化合物施用於土壤是優選的施用方法。One method used in agriculture is to apply to the leaves of plants (foliar application), and the frequency and rate of application can be selected according to the danger of pests or fungi. Alternatively, the active ingredient can reach the plant through the root system (systemic action), by applying the compound to the locus of the plant, for example by applying a liquid composition of the compound to the soil (by soaking), or by applying the solid form of the compound in the form of granules Apply to soil (soil application). In the case of rice plants, such particles can be metered into flooded rice fields. The application of the compounds of the invention to the soil is the preferred method of application.

每公頃的典型施用量通常是每公頃1-5000克活性成分。Typical application rates per hectare are usually 1-5000 grams of active ingredient per hectare.

本發明的化合物及其組合物也適用於保護植物繁殖材料,例如種子(如果實、塊莖或果仁)或苗圃植物,以防止上述害蟲的侵擾。繁殖材料(例如種子)可以在種植前用化合物處理。或者,可以通過將種子仁浸泡在液體組合物中或施加一層固體組合物。也可以在將繁殖材料種植到施用地點(例如將所述材料種植到種子溝中)時施用所述組合物。這些用於植物繁殖材料的處理方法和由此處理的植物繁殖材料是本發明的進一步主題。典型的處理率取決於要防控的植物和害蟲/真菌,通常為每100kg種子1至1000克,優選每100kg種子10至500克,例如每100kg種子100至250克。將本發明化合物施用於種子是優選的施用方法。The compounds of the present invention and their compositions are also suitable for protecting plant propagation materials, such as seeds (if fruit, tubers or nuts) or nursery plants, to prevent the infestation of the above-mentioned pests. Propagating materials (eg seeds) can be treated with compounds before planting. Alternatively, it is possible to soak the seed kernel in the liquid composition or apply a layer of solid composition. The composition may also be applied when planting propagation material to the application site (eg planting the material into a seed ditch). These treatment methods for plant propagation material and the plant propagation material treated thereby are a further subject of the invention. A typical treatment rate depends on the plants and pests/fungi to be controlled, and is usually 1 to 1000 g per 100 kg of seed, preferably 10 to 500 g per 100 kg of seed, for example 100 to 250 g per 100 kg of seed. The application of the compounds of the invention to seeds is the preferred method of application.

通過添加例如一種或多種殺蟲、殺蟎、殺線蟲和/或殺真菌活性劑可以顯著擴大本發明組合物的活性,並使其適應於主要環境。式(I)化合物與其它殺蟲、殺蟎、殺線蟲和/或殺真菌活性劑的組合也可具有進一步令人驚訝的優點,例如,植物的更好的耐受性,降低的植物毒性,可以在它們的不同發育階段中控制害蟲或真菌或在它們的生產過程(例如在研磨或混合期間、儲存或使用期間)中有更好的表現。By adding, for example, one or more insecticidal, acaricidal, nematicidal and/or fungicidal active agents, the activity of the composition of the invention can be significantly expanded and adapted to the main environment. The combination of the compound of formula (I) with other insecticidal, acaricidal, nematicidal and/or fungicidal active agents may also have further surprising advantages, for example, better tolerance of plants, reduced phytotoxicity, Pests or fungi can be controlled in their different developmental stages or perform better in their production process (for example during grinding or mixing, during storage or use).

下列是可以與本發明的化合物一起使用的殺蟲劑清單,旨在舉例說明可能的組合。The following is a list of pesticides that can be used with the compounds of the present invention, intended to illustrate possible combinations.

式(I)化合物與其它活性化合物的下列組合是選自如下所述的由(A)至(O)類的所有命名的混合搭檔體組成的物質的佐劑,如果它們的官能團允許(即使在每種情況下沒有特別提及),能隨意地與合適的堿形成鹽或與酸表現為立體異構體,或表現為多晶型物。它們也應被理解為包括在本發明的範圍。這些例子是:The following combinations of compounds of formula (I) and other active compounds are adjuvants selected from the group consisting of all named mixed partners of (A) to (O) as described below, if their functional groups allow (even if In each case, there is no special mention), can optionally form a salt with a suitable compound or with acid as a stereoisomer, or as a polymorph. They should also be understood to be included within the scope of the present invention. These examples are:

A)麥角甾醇生物合成的抑制劑,例如(A01)醛亞胺、(A02)阿紮康唑、(A03)聯苯三唑醇、(A04)溴康唑、(A05)環丙唑醇、(A06)二氯丁唑、(A07)苯醚甲環唑、(A08)烯唑醇、(A09)烯唑醇、(A10)多嗎啉、(A11)醋酸多嗎啉、(A12)環氧唑、(A13)埃康唑、(A13)乙錐唑、(A13)烯康唑、(A14)菲萘咪唑、(A15)芬丁唑、(A15)苯丁唑、(A15)芬丁丁唑、(A15)芬丁丁腈、(A16)芬甲醯醯、(A17)粉鏽啶、(A19)氟喹唑、(A20)氟喹環唑、(A20)氟尿嘧啶、(A21)氟矽唑、(A22)粉唑醇(A23)氟康唑、(A24)呋醚唑、(A25)己唑醇、(A26)抑黴唑、(A27)抑黴唑、(A28)咪康唑、(A29) 種菌唑、(A30)甲環唑,(A31)腈菌唑、(A32)萘替芬、(A33)氟苯嘧啶醇、(A34)奧昔康唑、(A35)多效唑、(A36)培菲拉唑、(A37)戊康唑、(A38)呱啶、(A39)咪唑、(A40)丙環唑、(A41)丙硫康唑、(A42)稗草畏、(A43)啶斑肟、(A44)喹康唑、(A45)西咪康唑,(A46)螺胺、(A47)替布康唑、(A48)特比萘芬、(A49)氟醚唑、(A50)三唑酮、(A51)三唑、(A52)三苯並咪唑、(A53)三氟咪唑、(A54)三福林、(A55)滅菌唑、(A56)烯康唑、(A57)唏效唑(A58)烯霜苄唑、(A59)伏立康唑、(A60)1-(4-氯苯基)-2-(1H-1,2,4-三唑-1-基)環庚醇、(A61)甲基1-(2,2-二甲基-2,3-二氫-1H--茚-1-基)-1H-咪唑-5-羧酸酯、(A62)N'-{5-(二氟甲基)-2-甲基-4-[3-(三甲基甲矽烷基)丙氧基]苯基}-N-乙基-N-甲基亞氨基甲醯胺、(A63)N-乙基-N-甲基-N'-{2-甲基-5-(三氟甲基)-4-[3-(三甲基甲矽烷基)丙氧基]苯基}亞氨基甲醯胺、(A64)O-[1-(4-甲氧基苯氧基)-3,3-二甲基丁-2-基]-1H-咪唑-1-硫代甲酸酯、(A65)啶菌唑,(A66)2-{[3-(2-氯苯基)-2-(2,4-二氟苯基)環氧乙烷-2-基]甲基}-2,4-二氫-3H-1,2,4-三唑-3-硫酮、(A67)1-{[3-(2-氯苯基)-2-(2,4-二氟苯基)環氧乙烷-2-基]甲基}-1H-1,2,4-三唑-5-基硫氰酸酯、(A68)5-(烯丙基硫基)-1-{[3-(2-氯苯基)-2-(2,4-二氟苯基)環氧乙烷-2-基]甲基}-1H-1,2,4-三唑、(A69)2-[1-(2,4-二氯苯基)-5-羥基-2,6,6-三甲基庚-4-基]-2,4-二氫-3H-1,2,4-三唑-3-硫酮、(A70)2-{[rel(2R,3S)-3-(2-氯苯基)-2-(2,4-二氟苯基)環氧乙烷-2-基]甲基}-2,4-二氫-3H-1,2,4-三唑-3-硫酮、(A71)2-{[rel(2R,3R)-3-(2-氯苯基)-2-(2,4-二氟苯基)環氧乙烷-2-基]甲基}-2,4-二氫-3H-1,2,4-三唑-3-硫酮、(A72)1-{[rel(2R,3S)-3-(2-氯苯基)-2-(2,4-二氟苯基)環氧乙烷-2-基]甲基}-1H-1,2,4-三唑-5-基硫氰酸酯、(A73)1-{[rel(2R,3R)-3-( 2-氯苯基)-2-(2,4-二氟苯基)環氧乙烷-2-基]甲基}-1H-1,2,4-三唑-5-基硫氰酸酯、(A74)5-(烯丙基硫基)-1-{ [REL(2R,3S)-3-(2-氯苯基)-2-(2,4-二d (氟代苯基)環氧乙烷-2-基]甲基}-1H-1,2,4-三唑、(A75)5-(烯丙基硫基)-1-{[rel(2R,3R)-3-(2-氯苯基)-2-(2,4-二氟苯基)環氧乙烷-2-基]甲基}-1H-1,2,4-三唑、(A76)2-[(2S,4S,5S)-1-(2,4-二氯苯基)-5-羥基-2,6,6-三甲基庚-4-基]-2,4-二氫-3H-1,2,4-三唑-3-硫酮、(A77)2-[(2R,4S,5 S)-1-(2,4-二氯苯基)-5-羥基-2,6,6-三甲基庚-4-基]-2,4-二氫-3H-1,2,4-三唑-3-硫酮、(A78)2-[(2R,4R,5R)-1-(2,4-二氯苯基)-5-羥基-2,6,6-三甲基庚-4-基]-2,4-二氫-3H-1,2,4-三唑-3-硫酮、(A79)2-[(2S,4R,5R)-1-(2,4-二氯苯基)-5-羥基-2,6,6-三甲基庚-4-基]-2,4-二氫-3H-1,2,4-三唑-3-硫酮、(A80)2-[(2S,4S,5R)-1-(2,4-二氯苯基)-5-羥基-2,6,6-三甲基庚-4-基]-2,4-二氫-3H-1,2,4-三唑-3-硫酮、(A81)2-[(2R,4S,5R)-1-(2,4-二氯苯基)-5-羥基-2,6,6-三甲基庚-4-基]-2,4-二氫-3H-1,2,4-三唑-3-硫酮、(A82)2-[(2R,4R,5S)-1-(2,4-二氯苯基)-5-羥基-2,6,6-三甲基庚-4-基]-2,4-二氫-3H-1,2,4-三唑-3-硫酮、(A83)2-[(2S,4R,5S)-1-(2,4-二氯苯基)-5-羥基-2,6,6-三甲基庚-4-基]-2,4-二氫-3H-1,2,4-三唑-3-硫酮、(A84)2-[4-(4-氯苯氧基)-2-(三氟甲基)苯基]-1-(1H-1,2, 4-三唑-1-基)丙-2-醇、(A85)2-[4-(4-氯苯氧基)-2-(三氟甲基)苯基]-1-(1H-1,2,4-三唑-1)-)丁-2-醇,(A86)2-[4-(4-氯苯氧基)-2-(三氟甲基)苯基]-1-(1H-1,2,4-三唑-1-基)戊烷-2-醇、(A87)2-[2-氯-4-(4-氯苯氧基)苯基]-1-(1H-1,2,4-三唑-1-基)丁-2-醇、(A88) 2-[2-氯-4-(2,4-二氯苯氧基)苯基]-1-(1H-1,2,4-三唑-1-基)丙-2-醇、(A89)(2R)-2-(1-氯環丙基)-4-[(1R)-2,2-二氯環丙基]-1-(1H-1,2,4-三唑-1-基)丁-2-醇、(A90)(2R)-2-(1-氯環丙基)-4-[(1S)-2,2-二氯環丙基]-1-(1H-1,2,4-三唑-1-基)丁-2-醇、(A91)( 2S)-2-(1-氯環丙基)-4-[(1S)-2,2-二氯環丙基]-1-(1H-1,2,4-三唑-1-基)丁-2-醇、(A92) )(2S)-2-(1-氯環丙基)-4-[(1R)-2,2-二氯環丙基]-1-(1H-1,2,4-三唑-1-基)丁-2-醇、(A93)(1S,2R,5R)-5-(4-氯苄基)-2-(氯甲基)-2-甲基-1-(1H-1,2,4-三唑-1-酮)基甲基)環戊醇、(A94)(1R,2S,5S)-5-(4-氯苄基)-2-(氯甲基)-2-甲基-1-(1H-1,2,4-三唑-1-基甲基)環戊醇、(A95) 5-(4-氯苄基)-2-(氯甲基)-2-甲基-1-(1H-1,2,4-三唑-1-基甲基)環戊醇,其他甾醇生物合成抑制劑:(A96)氯苯肟唑、(A97)三唑類殺菌劑。A) Inhibitors of ergosterol biosynthesis, such as (A01) aldimine, (A02) azaconazole, (A03) bifentriazole, (A04) broconazole, (A05) cyproconazole , (A06) dichlorobutazole, (A07) difenoconazole, (A08) enazolol, (A09) enazolol, (A10) polymorpholine, (A11) polymorpholine acetate, (A12) Epoxazole, (A13) Econazole, (A13) Epiconazole, (A13) Enconazole, (A14) Phenimidazole, (A15) Fenbutazole, (A15) Phenidazole, (A15) Fen Tebuconazole, (A15) Fenbutyronitrile, (A16) Fenformamide, (A17) Fenpyridine, (A19) Fluoroquinazole, (A20) Fluquineconazole, (A20) Fluorouracil, (A21) Fluorosilicone Azole, (A22) fluconazole (A23) fluconazole, (A24) furoconazole, (A25) hexaconazole, (A26) imazalil, (A27) imazalil, (A28) miconazole, (A29) Strainarazole, (A30) Meconazole, (A31) Myclobutanil, (A32) Naftifine, (A33) Fluazimidol, (A34) Oxiconazole, (A35) Paclobutrazol, (A36) ) Pefiprazole, (A37) penticonazole, (A38) pyridine, (A39) imidazole, (A40) propiconazole, (A41) prothioconazole, (A42) barnyard grass, (A43) pyridine Spot oxime, (A44) quinconazole, (A45) simiconazole, (A46) spiroamine, (A47) tebuconazole, (A48) terbinafine, (A49) fluribenazole, (A50) Triazolone, (A51) triazole, (A52) tribenzimidazole, (A53) trifluoroimidazole, (A54) trifolin, (A55) sterazole, (A56) enconazole, (A57) Azole (A58) dimethoxazole, (A59) voriconazole, (A60) 1-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-yl) cycloheptanol, ( A61) Methyl 1-(2,2-dimethyl-2,3-dihydro-1H-inden-1-yl)-1H-imidazole-5-carboxylate, (A62) N'-{5 -(Difluoromethyl)-2-methyl-4-[3-(trimethylsilyl)propoxy]phenyl}-N-ethyl-N-methyliminocarboxamide, ( A63) N-ethyl-N-methyl-N'-{2-methyl-5-(trifluoromethyl)-4-[3-(trimethylsilyl)propoxy]phenyl} Iminocarboxamide, (A64) O-[1-(4-methoxyphenoxy)-3,3-dimethylbut-2-yl]-1H-imidazole-1-thiocarbamate , (A65) Myclobutanil, (A66) 2-{[3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxirane-2-yl]methyl}- 2,4-dihydro-3H-1,2,4-triazole-3-thione, (A67)1-{[3-(2-chlorophenyl)-2-(2,4-difluorobenzene Group) ethylene oxide-2-yl]methyl}-1H-1,2 ,4-triazol-5-ylthiocyanate, (A68)5-(allylthio)-1-{[3-(2-chlorophenyl)-2-(2,4-difluoro Phenyl) ethylene oxide-2-yl]methyl}-1H-1,2,4-triazole, (A69) 2-[1-(2,4-dichlorophenyl)-5-hydroxy- 2,6,6-trimethylhept-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione, (A70) 2-{[rel(2R, 3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxirane-2-yl]methyl}-2,4-dihydro-3H-1,2 ,4-triazole-3-thione, (A71)2-{[rel(2R,3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl) ethylene oxide Alkan-2-yl]methyl}-2,4-dihydro-3H-1,2,4-triazole-3-thione, (A72)1-{[rel(2R,3S)-3-( 2-chlorophenyl)-2-(2,4-difluorophenyl)oxirane-2-yl]methyl}-1H-1,2,4-triazol-5-ylthiocyanate , (A73) 1-{[rel(2R, 3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl) oxirane-2-yl]methyl}- 1H-1,2,4-triazol-5-ylthiocyanate, (A74)5-(allylthio)-1-{ [REL(2R,3S)-3-(2-chlorobenzene Group)-2-(2,4-did(fluorophenyl)oxirane-2-yl]methyl}-1H-1,2,4-triazole, (A75) 5-(allyl Thio)-1-{[rel(2R,3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxirane-2-yl]methyl} -1H-1,2,4-triazole, (A76) 2-[(2S, 4S, 5S)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-tri Methylhept-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione, (A77)2-[(2R, 4S, 5 S)-1-( 2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylhept-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3- Thione, (A78) 2-[(2R, 4R, 5R)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylhept-4-yl]- 2,4-dihydro-3H-1,2,4-triazole-3-thione, (A79)2-[(2S,4R,5R)-1-(2,4-dichlorophenyl)- 5-hydroxy-2,6,6-trimethylhept-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione, (A80) 2-[( 2S, 4S, 5R)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylhept-4-yl]-2,4-dihydro-3H-1 , 2,4-triazole-3-thione, (A81) 2-[(2R, 4S, 5R)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylhept-4-yl]-2,4 -Dihydro-3H-1,2,4-triazole-3-thione, (A82)2-[(2R, 4R, 5S)-1-(2,4-dichlorophenyl)-5-hydroxyl -2,6,6-trimethylhept-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione, (A83) 2-[(2S, 4R , 5S)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylhept-4-yl]-2,4-dihydro-3H-1,2, 4-triazole-3-thione, (A84) 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2, 4- Triazol-1-yl)propan-2-ol, (A85) 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2 ,4-triazole-1)-)butan-2-ol, (A86)2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H- 1,2,4-triazol-1-yl)pentane-2-ol, (A87) 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1-(1H-1 ,2,4-triazol-1-yl)butan-2-ol, (A88) 2-[2-chloro-4-(2,4-dichlorophenoxy)phenyl]-1-(1H- 1,2,4-triazol-1-yl)propan-2-ol, (A89)(2R)-2-(1-chlorocyclopropyl)-4-[(1R)-2,2-dichloro Cyclopropyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol, (A90)(2R)-2-(1-chlorocyclopropyl)-4-[ (1S)-2,2-dichlorocyclopropyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol, (A91)( 2S)-2-(1 -Chlorocyclopropyl)-4-[(1S)-2,2-dichlorocyclopropyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol, ( A92)) (2S)-2-(1-chlorocyclopropyl)-4-[(1R)-2,2-dichlorocyclopropyl]-1-(1H-1,2,4-triazole- 1-yl) butan-2-ol, (A93) (1S, 2R, 5R)-5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-1-(1H-1 ,2,4-triazol-1-one)ylmethyl)cyclopentanol, (A94)(1R,2S,5S)-5-(4-chlorobenzyl)-2-(chloromethyl)-2 -Methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol, (A95) 5-(4-chlorobenzyl)-2-(chloromethyl)-2 -Methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol, other sterol biosynthesis inhibitors: (A96) chlorobenzoxazole, (A97) triazoles Agent.

B)複合體I或II上的呼吸鏈抑制劑,例如(B01)聯苯吡菌胺、(B02) 啶醯菌胺、(B03) 萎鏽靈、(B04) 環丙醯胺、(B05) 二氟林、(B06) 甲呋醯苯胺、(B07) 氟吡、(B08) 氟醯胺、(B09) 氟唑菌醯胺、(B10) 呋吡菌胺、(B11) 拌種胺、(B12) 異吡嗪(同向異構外消旋體1RS、4SR、9RS與反向異構外消旋體1RS、4SR、9SR的混合物)、(B13) 異吡嗪(抗差向異構體1Rs,4Sr,9Sr),(B14) 異吡嗪(抗差向異構體1R,4S,9S)、(B15)異吡嗪(抗差向異構體1S,4R,9R)、(B16) 異吡嗪(對映異構體外消旋體1RS,4SR,9RS)、(B17) 異吡嗪(對映異構體外消旋體1R,4S,9R)、(B18) 異吡嗪(對映異構體外消旋體1S,4R,9S)、(B19)擔菌寧、(B20) 氧化萎鏽靈、(B21) 氟唑菌苯胺、(B22)吡噻菌胺、(B23)氟唑菌醯羥胺、(B24) 環丙吡、(B25)噻呋醯胺、(B26)1-甲基-N-[2-(1,1,2,2-四氟乙氧基)苯基]-3-(三氟甲基)-1H-吡唑-4-甲醯胺、(B27)3-(二氟甲基)-1-甲基-N-[2-(1,1,2,2-四氟乙氧基)苯基]-1H-吡唑-4-甲醯胺、(B28)3-(二氟甲基)-N-[4-氟-2-(1),1,2,3,3,3-六氟丙氧基)苯基]-1-甲基-1H-吡唑-4-甲醯胺、(B29)N-[1-(2,4-二氯苯基)-1-甲氧基丙烷-2-yl]-3-(二氟甲基)-1-甲基-1H-吡唑-4-甲醯胺、(B30)5,8-二氟-N-[2-(2-氟-4-{[4-(三氟甲基)吡啶]-2-基]氧基}苯基)乙基]喹唑啉-4-胺、(B31)苯並吲哚基吡啶、(B32)N-[(1S,4R)-9-(二氯亞甲基)-1,2,3,4-四氫-1,4-甲基萘-5-基]-3-(二氟甲基)-1-甲基-1H-吡唑-4-甲醯胺、(B33)N-[(1R,4S)-9-(二氯亞甲基)-1,2,3,4-四氫-1,4-亞甲基萘-5-基]-3-(二氟甲基)-1-甲基-1H-吡唑-4-甲醯胺、(B34)3-(二氟甲基)-1-甲基-N-(1,1,3-三甲基-2,3-二氫-1H-茚-4-基)-1H-吡唑-4-甲醯胺、(B35)1,3,5-三甲基-N-(1,1) ,3-三甲基-2,3-二氫1H-茚-4-基)-1H-吡唑-4-甲醯胺、(B36)1-甲基-3-(三氟甲基)-N-(1,1,3-三甲基-2,3-二氫-1H-茚-4-基)-1H-吡唑-4-甲醯胺、(B37)1-甲基-3-(三氟甲基)-N-[(3R)-1,1,3-三甲基-2,3-二氫-1H-茚-4-基]-1H-吡唑-4-甲醯胺、(B38)1-甲基-3-(三氟甲基)-N-[(3S)-1,1,3-三甲基-2,3-二氫-1H--茚-4-基]-1H-吡唑-4-甲醯胺、(B39)3-(二氟甲基)-1-甲基-N-[(3S)-1,1,3-三甲基-2,3-二氫-1H-茚-4-基]-1H-吡唑-4-甲醯胺、(B40)3-(二氟甲基)-1-甲基-N-[(3R)-1,1,3-三甲基-2,3-二氫-1H-茚-4-基]-1H-吡唑-4-甲醯胺、(B41)1,3,5-三甲基-N-[(3R)-1,1,3-三甲基-2,3-二氫-1H-茚-4-基]-1H-吡唑-4-甲醯胺、( B42)1,3,5-三甲基-N-[(3S)-1,1,3-三甲基-2,3-二氫-1H-茚-4-基]-1H-吡唑-4-甲醯胺、(B43))苯並脲、(B44)2-氯-N-(1,1,3-三甲基-2,3-二氫-1H-茚-4-基)吡啶-3-甲醯胺、(B45)異噻唑、(B46)1-甲基-3-(三氟甲基)-N-[2'-(三氟甲基)聯苯-2-基]-1H-吡唑-4-甲醯胺、(B47)N-(4'-氯聯苯-2-基)-3-(二氟甲基)-1-甲基-1H-吡唑-4-甲醯胺、(B48)N-(2',4'-二氯聯苯-2-基)-3-(二氟甲基)-1-甲基-1H-吡唑-4-甲醯胺、(B49)3-(二氟甲基)-1-甲基-N-[4'-(三氟甲基)聯苯-2-基]-1H-吡唑-4-甲醯胺、(B50)N-(2', 5'-二氟聯苯-2-基)-1-甲基-3-(三氟甲基)-1H-吡唑-4-甲醯胺、(B51)3-(二氟甲基)-1-甲基-N-[4'-(丙-) 1-炔-1-基)聯苯-2-基]-1H-吡唑-4-甲醯胺、(B52)5-氟-1,3-二甲基-N-[4'-(丙-1-炔-1)-)聯苯-2-基]-1H-吡唑-4-甲醯胺、(B53)2-氯-N-[4'-(丙-1-炔-1-基)聯苯-2-基]煙醯胺、(B54)3-(二氟甲基)-N-[4'-(3,3-二甲基丁-1-炔-1-基)聯苯-2-基]-1-甲基-1H-吡唑-4-甲醯胺、(B55)N-[4'-(3,3-二甲基丁-1-炔-1-基)聯苯-2-15-氟-1,3-二甲基-1H-吡唑-4-甲醯胺、(B56)3-(二氟甲基)-N-(4'-乙炔基聯苯-2-基)-1-甲基-1H-吡唑-4-甲醯胺、(B57)N-(4'-乙炔基聯苯-2-基)-5-氟-1,3-二甲基-1H-吡唑-4-甲醯胺、(B58)2-氯-N-(4'-乙炔基聯苯)-2-基)煙醯胺、(B59)2-氯-N-[4'-(3,3-二甲基丁-1-炔-1-基)聯苯-2-基]煙醯胺、(B60)4-(二氟甲基)-2-甲基-N-[4'-(三氟甲基)聯苯-2-基]-1,3-噻唑-5-甲醯胺、(B61)5-氟-N-[4'-(3-羥基-3-甲基丁-1-炔-1-基)聯苯-2-基]-1,3-二甲基-1H-吡唑-4-甲醯胺、(B62)2-氯-N-[4'-(3-羥基)-3-甲基丁-1-炔-1-基)聯苯-2-基]煙醯胺、(B63)3-(二氟甲基)-N-[4'-(3-甲氧基-3-甲基丁-1-炔-1)-基]聯苯-2-基]-1-甲基-1H-吡唑-4-甲醯胺、(B64)5-氟-N-[4'-(3-甲氧基-3-甲基丁-1-炔-1-) ()聯苯-2-基]-1,3-二甲基-1H-吡唑-4-甲醯胺、(B65)2-氯-N-[4'-(3-甲氧基-3-甲基丁-1-炔-1)-)聯苯-2-基]煙醯胺、(B66)1,3-二甲基-N-(1,1,3-三甲基-2,3-二氫-1H-茚-4-基)-1H-吡唑-4-甲醯胺、(B67)1,3-二甲基-N-[(3R)-1,1,3-三甲基-2,3-二氫-1H-茚-4-基]-1H-吡唑-4-羧基醯胺、(B68)1,3-二甲基-N-[(3S)-1,1,3-三甲基-2,3-二氫-1H-茚-4-基]-1H-吡唑-4-甲醯胺、( B69)3-(二氟甲基)-N-甲氧基-1-甲基-N-[1-(2,4,6-三氯苯基)丙烷-2-基]-1H-吡唑-4-甲醯胺、(B70)3-(二氟甲基)-N-(7-氟-1,1,3-三甲基-2,3-二氫-1H-茚-4-基)-1-甲基-1H-吡唑-4-甲醯胺、(B71)3-(二氟甲基)-N-[(3,R)-7-氟-1,1,3-三甲基-2,3-二氫-1H-茚-4-基]-1-甲基-1H-吡唑-4--羧醯胺、(B72)3-(二氟甲基-1)-N-[(3S)-7-氟-1,1,3-三甲基-2,3-二氫-1H-茚-4-基]-1-甲基--1H-吡唑-4-甲醯胺。B) Respiratory chain inhibitors on complexes I or II, such as (B01) bifenamid, (B02) fenpropan, (B03) chloramphenicol, (B04) cyproteron, (B05) Diflulin, (B06) Metofuranil, (B07) Fluopyril, (B08) Fluopamidil, (B09) Fluoxacin, (B10) Fluopyram, (B11) Seeding amine, ( B12) Isopyrazine (a mixture of isomeric racemates 1RS, 4SR, 9RS and reverse isomeric racemates 1RS, 4SR, 9SR), (B13) isopyrazine (anti-epimer 1Rs, 4Sr, 9Sr), (B14) isopyrazine (anti-epimer 1R, 4S, 9S), (B15) isopyrazine (anti-epimer 1S, 4R, 9R), (B16) Isopyrazine (enantiomer racemate 1RS, 4SR, 9RS), (B17) isopyrazine (enantiomer racemate 1R, 4S, 9R), (B18) isopyrazine (enantiomer Isomers in vitro racemates 1S, 4R, 9S), (B19) benzoicin, (B20) Oxytetracycline, (B21) fluoxacin anilide, (B22) pyrithazone, (B23) fluoxacin Acetylhydroxylamine, (B24) cypropyridine, (B25) thiofuramide, (B26) 1-methyl-N-[2-(1,1,2,2-tetrafluoroethoxy)phenyl]- 3-(trifluoromethyl)-1H-pyrazole-4-carboxamide, (B27)3-(difluoromethyl)-1-methyl-N-[2-(1,1,2,2 -Tetrafluoroethoxy)phenyl]-1H-pyrazole-4-carboxamide, (B28)3-(difluoromethyl)-N-[4-fluoro-2-(1), 1,2 ,3,3,3-Hexafluoropropoxy)phenyl]-1-methyl-1H-pyrazole-4-carboxamide, (B29)N-[1-(2,4-dichlorophenyl )-1-Methoxypropane-2-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide, (B30)5,8-difluoro-N -[2-(2-fluoro-4-{[4-(trifluoromethyl)pyridine]-2-yl]oxy}phenyl)ethyl]quinazolin-4-amine, (B31)benzo Indolylpyridine, (B32) N-[(1S,4R)-9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methylnaphthalen-5-yl] -3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide, (B33)N-[(1R,4S)-9-(dichloromethylene)-1, 2,3,4-tetrahydro-1,4-methylenenaphthalene-5-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide, (B34 ) 3-(difluoromethyl)-1-methyl-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)-1H-pyrazole-4 -Formamide, (B35) 1,3,5-trimethyl-N-(1,1), 3-trimethyl-2,3-dihydro 1H-indene-4 -Yl)-1H-pyrazole-4-carboxamide, (B36) 1-methyl-3-(trifluoromethyl)-N-(1,1,3-trimethyl-2,3-di Hydrogen-1H-inden-4-yl)-1H-pyrazole-4-carboxamide, (B37) 1-methyl-3-(trifluoromethyl)-N-[(3R)-1,1, 3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide, (B38) 1-methyl-3-(trifluoromethyl)- N-[(3S)-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide, (B39)3- (Difluoromethyl)-1-methyl-N-[(3S)-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole- 4-carboxamide, (B40) 3-(difluoromethyl)-1-methyl-N-[(3R)-1,1,3-trimethyl-2,3-dihydro-1H-indene -4-yl]-1H-pyrazole-4-carboxamide, (B41) 1,3,5-trimethyl-N-[(3R)-1,1,3-trimethyl-2,3 -Dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide, (B42) 1,3,5-trimethyl-N-[(3S)-1,1,3- Trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide, (B43)) benzourea, (B44) 2-chloro-N-(1 ,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)pyridine-3-carboxamide, (B45)isothiazole, (B46)1-methyl-3-(tri Fluoromethyl)-N-[2'-(trifluoromethyl)biphenyl-2-yl]-1H-pyrazole-4-carboxamide, (B47)N-(4'-chlorobiphenyl-2 -Yl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide, (B48)N-(2',4'-dichlorobiphenyl-2-yl) -3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide, (B49)3-(difluoromethyl)-1-methyl-N-[4'-( Trifluoromethyl)biphenyl-2-yl]-1H-pyrazole-4-carboxamide, (B50)N-(2', 5'-difluorobiphenyl-2-yl)-1-methyl -3-(trifluoromethyl)-1H-pyrazole-4-carboxamide, (B51)3-(difluoromethyl)-1-methyl-N-[4'-(propyl-) 1- Alkyn-1-yl)biphenyl-2-yl]-1H-pyrazole-4-carboxamide, (B52) 5-fluoro-1,3-dimethyl-N-[4'-(prop-1 -Yne-2)-)biphenyl-2-yl]-1H-pyrazole-4-carboxamide, (B53)2-chloro-N-[4'-(prop-1-yn-1-yl) Biphenyl-2-yl] nicotinamide, (B54) 3-(difluoromethyl)-N-[4'-(3,3-dimethylbut-1-yn-1-yl)biphenyl- 2-yl]-1-methyl-1H-pyrazole-4-carboxamide, (B55)N -[4'-(3,3-Dimethylbut-1-yn-1-yl)biphenyl-2-15-fluoro-1,3-dimethyl-1H-pyrazole-4-carboxamide , (B56) 3-(difluoromethyl)-N-(4'-ethynylbiphenyl-2-yl)-1-methyl-1H-pyrazole-4-carboxamide, (B57) N- (4'-ethynylbiphenyl-2-yl)-5-fluoro-1,3-dimethyl-1H-pyrazole-4-carboxamide, (B58)2-chloro-N-(4'- Ethynylbiphenyl)-2-yl) nicotinamide, (B59) 2-chloro-N-[4'-(3,3-dimethylbut-1-yn-1-yl)biphenyl-2- Group] nicotinamide, (B60) 4-(difluoromethyl)-2-methyl-N-[4'-(trifluoromethyl)biphenyl-2-yl]-1,3-thiazole-5 -Carboxamide, (B61) 5-fluoro-N-[4'-(3-hydroxy-3-methylbut-1-yn-1-yl)biphenyl-2-yl]-1,3-di Methyl-1H-pyrazole-4-carboxamide, (B62) 2-chloro-N-[4'-(3-hydroxy)-3-methylbut-1-yn-1-yl)biphenyl- 2-yl] nicotinamide, (B63) 3-(difluoromethyl)-N-[4'-(3-methoxy-3-methylbut-1-yne-1)-yl]biphenyl -2-yl]-1-methyl-1H-pyrazole-4-carboxamide, (B64) 5-fluoro-N-[4'-(3-methoxy-3-methylbutan-1- Alkyne-1-) ()biphenyl-2-yl]-1,3-dimethyl-1H-pyrazole-4-carboxamide, (B65)2-chloro-N-[4'-(3- Methoxy-3-methylbut-1-yne-1)-)biphenyl-2-yl] nicotinamide, (B66) 1,3-dimethyl-N-(1,1,3-tri Methyl-2,3-dihydro-1H-inden-4-yl)-1H-pyrazole-4-carboxamide, (B67) 1,3-dimethyl-N-[(3R)-1, 1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxyamide, (B68) 1,3-dimethyl-N-[( 3S)-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide, (B69) 3-(difluoromethyl )-N-methoxy-1-methyl-N-[1-(2,4,6-trichlorophenyl)propane-2-yl]-1H-pyrazole-4-carboxamide, (B70 ) 3-(difluoromethyl)-N-(7-fluoro-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)-1-methyl-1H- Pyrazole-4-carboxamide, (B71) 3-(difluoromethyl)-N-[(3,R)-7-fluoro-1,1,3-trimethyl-2,3-dihydro -1H-inden-4-yl]-1-methyl-1H-pyrazole-4-carboxamide, (B72)3-(difluoromethyl-1)-N-[(3S)-7- Fluorine-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1-methyl-- 1H-pyrazole-4-carboxamide.

C)複合物III的呼吸鏈抑制劑,例如(C01)阿美托辛、(C02)阿米索溴姆、(C03)氟唑司汀、(C04)氰唑胺、(C05)苯甲氧基司汀、(C06)苯甲氧基司汀、(C07)二羥司汀、(C08)依諾司汀、(C08)法莫司汀、(C09)法莫司汀、(C10)非那明、(C11)非那明、(C12)氟諾司汀、(C13)氟索司汀、(C14)克瑞索昔-甲基、(C15)美托司汀、(C16)甘露糖苷、(C17)肟醚菌胺、(C18)啶氧菌酯、(C19)唑菌胺酯、(C20)唑胺菌酯、(C21)唑菌酯、(C22)吡菌苯威、(C23)氯啶菌酯、(C24)肟菌酯、(C25)(2E)-2-(2-{[6-(3-氯-2-甲基苯氧基)-5-氟嘧啶-4-基]氧基}苯基)-2-(甲氧基亞氨基)-N-甲基乙醯胺、(C26)(2E)-2-(甲氧基亞氨基)-N-甲基-2-(2-{[({1E)-1-[3-(三氟甲基)苯基]亞乙基}氨基)氧基]甲基}苯基)乙醯胺 、(C27)(2E)-2-(甲氧基亞氨基)-N-甲基-2-{2-[(E)-({1-[3-(三氟甲基)苯基]乙氧基}亞氨基)甲基]苯基}乙醯胺、(C28)(2E)-2-{2-[({[(1E)-1-(3-{[(E)-1-氟-2-苯基乙烯基]氧基}苯基)亞乙基]氨基}氧基)甲基 ]苯基}-2-(甲氧基亞氨基)-N-甲基乙醯胺、(C29)芬那托林、(C30)5-甲氧基-2-甲基-4-(2-{[({(1E)-1-[3-(三氟甲基))苯基]亞乙基}氨基)氧基]甲基}苯基)-2,4-二氫-3H-1,2,4-三唑-3-酮、(C31)甲基(2E)-2-{2-[({ 環丙基[(4-甲氧基苯基)亞氨基]甲基}硫烷基)甲基]苯基}-3-甲氧基丙烯酸酯、(C32)N-(3-乙基-3,5,5-三甲基環己基)-3-甲醯胺基-2-羥基苯甲醯胺、(C33)2-{2-[(2,5-二甲基苯氧基)甲基]苯基}-2-甲氧基-N-甲基乙醯胺、(C34)2-{2-[(2,5-二甲基苯氧基)甲基]苯基}-2-甲氧基-N-甲基乙醯胺、(C35)(2E,3Z)-5-{[1-(4-氯苯基))-1H-吡唑-3-基]氧基}-2-(甲氧基亞氨基)-N,3-二甲基戊-3-烯醯胺。C) Respiratory chain inhibitors of complex III, such as (C01) Ametoxine, (C02) Amisombrom, (C03) Fluzolastine, (C04) Cyanazolamide, (C05) Benzomethoxy Statin, (C06) benzyloxystein, (C07) dihydroxyustine, (C08) enoxastine, (C08) famustine, (C09) famustine, (C10) phenamine, (C11) phenamine, (C12) flunostatin, (C13) fluoxetine, (C14) crisoxi-methyl, (C15) metoplastine, (C16) mannoside, (C17 ) Diclofenac, (C18) Diclofenac, (C19) Diclofenac, (C20) Diclofenac, (C21) Diclofenac, (C22) Pyraclostrobin, (C23) Diclofenac Bacitracin, (C24) Oximetocin, (C25)(2E)-2-(2-{[6-(3-chloro-2-methylphenoxy)-5-fluoropyrimidin-4-yl]oxy Yl}phenyl)-2-(methoxyimino)-N-methylacetamide, (C26)(2E)-2-(methoxyimino)-N-methyl-2-(2 -{[({1E)-1-[3-(trifluoromethyl)phenyl]ethylene}amino)oxy]methyl}phenyl)acetamide, (C27)(2E)-2- (Methoxyimino)-N-methyl-2-{2-[(E)-({1-[3-(trifluoromethyl)phenyl]ethoxy}imino)methyl]benzene Base} acetamide, (C28)(2E)-2-{2-[({[(1E)-1-(3-{[(E)-1-fluoro-2-phenylvinyl]oxy }Phenyl)ethylene]amino}oxy)methyl]phenyl}-2-(methoxyimino)-N-methylacetamide, (C29)fenatoline, (C30)5- Methoxy-2-methyl-4-(2-{[({(1E)-1-[3-(trifluoromethyl))phenyl]ethylene}amino)oxy]methyl}benzene Group)-2,4-dihydro-3H-1,2,4-triazol-3-one, (C31)methyl (2E)-2-{2-[({ cyclopropyl[(4-methyl Oxyphenyl)imino]methyl}sulfanyl)methyl]phenyl}-3-methoxyacrylate, (C32)N-(3-ethyl-3,5,5-trimethyl Cyclohexyl)-3-carboxamido-2-hydroxybenzamide, (C33)2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}-2-methyl Oxy-N-methylacetamide, (C34) 2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methylethyl Acetamide, (C35) (2E, 3Z)-5-{[1-(4-chlorophenyl))-1H-pyrazol-3-yl]oxy}-2-(methoxyimino)- N,3-dimethylpent-3-enamide.

D)有絲分裂和細胞分裂的抑制劑,例如(D01)苯菌靈、(D02)多菌靈、(D03)氯噠唑、(D04)乙氧苄卡布、(D05)乙胺、(D06)氟吡菌胺、(D07)菲立唑、(D08)戊菌隆、(D09)噻苯達唑、(D10)苯硫脲-甲基、(D11)苯硫脲、(D12)唑醯胺、(D13)5-氯-7-(4-甲基呱啶-1-基)-6-(2,4,6-三氟苯基)[1,2,4]三唑並[1,5-a]嘧啶、(D14) 3-氯-5-(6-氯吡啶-3-基)-6-甲基-4-(2,4,6-三氟苯基)噠嗪、(D15)3-氯-4-(2,6-二氟苯基)-6-甲基-5-苯基-噠嗪、(D16)3-氯-6-甲基-5-苯基-4-(2,4,6-三氟苯基)噠嗪、(D17)N-乙基-2-[(3-炔基-8-甲基-6-喹啉基)氧基]丁醯胺、(D18)N-乙基-2-[(3-乙炔基-8-甲基-6-喹啉基)氧基]-2-甲基硫烷基-乙醯胺、(D19)2-[(3-乙炔基-8-甲基-6-喹啉基)氧基]-N-(2-氟乙基)丁醯胺、(D20)2-[(3-乙炔基-8-甲基-6-喹啉基)氧基]-N-(2-氟乙基)-2-甲氧基-乙醯胺、(D21)2-[(3-乙炔基-8-甲基-6-喹啉基)氧基]-N-丙基-丁醯胺、(D22)2-[(3-乙炔基-8-甲基-6-喹啉基)氧基]-2-甲氧基-N-丙基-乙醯胺、(D23)2-[(3-乙炔基-8-甲基-6-喹啉基)氧基]-2-甲基硫烷基-N-丙基-乙醯胺、(D24)2-[(3-乙炔基-8-甲基-6-喹啉基)氧基]-N-(2-氟乙基)-2-甲硫基-乙醯胺、(D25)4-(2-)溴-4-氟-苯基)-N-(2-氯-6-氟-苯基)-2,5-二甲基吡唑-3-胺、(D26) 氨基吡唑;D) Inhibitors of mitosis and cell division, such as (D01) benomyl, (D02) carbendazim, (D03) chlorpyrazole, (D04) ethoxybenzcarb, (D05) ethylamine, (D06) Fluopyram, (D07) Fiprazole, (D08) Pentimidazole, (D09) Thiabendazole, (D10) Phenylthiourea-methyl, (D11) Phenylthiourea, (D12) Pyrazamide , (D13) 5-chloro-7-(4-methylpyridin-1-yl)-6-(2,4,6-trifluorophenyl)[1,2,4]triazolo[1, 5-a]pyrimidine, (D14) 3-chloro-5-(6-chloropyridin-3-yl)-6-methyl-4-(2,4,6-trifluorophenyl)pyridazine, (D15 ) 3-chloro-4-(2,6-difluorophenyl)-6-methyl-5-phenyl-pyridazine, (D16) 3-chloro-6-methyl-5-phenyl-4- (2,4,6-trifluorophenyl)pyridazine, (D17) N-ethyl-2-[(3-alkynyl-8-methyl-6-quinolinyl)oxy]butyramide, (D18) N-ethyl-2-[(3-ethynyl-8-methyl-6-quinolinyl)oxy]-2-methylsulfanyl-acetamide, (D19)2-[ (3-ethynyl-8-methyl-6-quinolinyl)oxy]-N-(2-fluoroethyl)butyramide, (D20)2-[(3-ethynyl-8-methyl -6-quinolinyl)oxy]-N-(2-fluoroethyl)-2-methoxy-acetamide, (D21) 2-[(3-ethynyl-8-methyl-6- Quinolinyl)oxy]-N-propyl-butylamide, (D22)2-[(3-ethynyl-8-methyl-6-quinolinyl)oxy]-2-methoxy- N-propyl-acetamide, (D23) 2-[(3-ethynyl-8-methyl-6-quinolinyl)oxy]-2-methylsulfanyl-N-propyl-ethyl Acetamide, (D24) 2-[(3-ethynyl-8-methyl-6-quinolinyl)oxy]-N-(2-fluoroethyl)-2-methylthio-acetamide, (D25) 4-(2-)bromo-4-fluoro-phenyl)-N-(2-chloro-6-fluoro-phenyl)-2,5-dimethylpyrazol-3-amine, (D26 ) Aminopyrazole;

E)能夠具有多位點作用的化合物,例如(E01)波爾多液混合物、(E02)敵菌丹、(E03)克菌丹、(E04)百菌清、(E05)氫氧化銅、(E06)環烷酸銅、(E07)氧化銅、(E08)氯氧化銅、(E09)硫酸銅(2+) 、(E10)二氯呋喃、(E11)二噻農、(E12)多果定、(E13)多果定游離堿、(E14)福美鐵、(E15)氟代聚酯、(E16)滅菌丹、(E17)雙胍鹽、(E18)醋酸雙胍鹽、(E19)亞氨基辛二丁、(E20)亞氨基辛二酸二乙酸酯、(E21)亞氨基辛二乙酸酯、(E22)代森錳銅、(E23)代森錳鋅、(E24)代森錳、(E25)代森聯、(E26)代森聯鋅、(E27)喹啉銅、(E28)丙脒、(E29)丙炔、(E30)硫和硫製劑、包括多硫化鈣、(E31)福美雙、(E32)甲苯磺醯胺、(E33)代森鋅、(E34)福美鋅、(E35)敵菌靈、(E36) 二甲基甲酮。E) Compounds capable of having multiple sites of action, such as (E01) Bordeaux mixture, (E02) triamcinolone, (E03) clotrimazole, (E04) chlorothalonil, (E05) copper hydroxide, (E06) Copper naphthenate, (E07) Copper oxide, (E08) Copper oxychloride, (E09) Copper sulfate (2+), (E10) Dichlorofuran, (E11) Dithianon, (E12) Dogodine, ( E13) Dowedine free radical, (E14) Formamite, (E15) fluorinated polyester, (E16) Sterile Dan, (E17) biguanide salt, (E18) biguanide acetate, (E19) iminooctanedione, (E20) imino suberic acid diacetate, (E21) imino suberic acid diacetate, (E22) mancozeb, (E23) mancozeb, (E24) mancozeb, (E25) Daisenlian, (E26) Daisenlian zinc, (E27) copper quinoline, (E28) propionamidine, (E29) propyne, (E30) sulfur and sulfur preparations, including calcium polysulfide, (E31) Famex, (E32) Toluenesulfonamide, (E33) Daisenzinc, (E34) Fomezine, (E35) Dimethalin, (E36) Dimethyl ketone.

F)能夠誘導宿主防禦的化合物,例如(F01)噻二唑素-S-甲基、(F02)異噻菌胺、(F03)噻菌靈、(F04)噻醯菌胺、(F05)海帶多糖、(F06)4-環丙基-N-(2,4-二甲氧基苯基)噻二唑-5羧基醯胺。F) Compounds capable of inducing host defense, such as (F01) thiadiazolin-S-methyl, (F02) isotianil, (F03) thiabendazole, (F04) thiazamide, (F05) kelp Polysaccharide, (F06) 4-cyclopropyl-N-(2,4-dimethoxyphenyl) thiadiazole-5 carboxyamide.

G)氨基酸和/或蛋白質生物合成的抑制劑,例如(G01) 安多普林、(G02) 滅瘟素、(G03) 嘧菌環胺,(G04)春日黴素,(G05)鹽酸春日黴素水合物, (G06) 嘧菌胺、(G07) 嘧黴胺、(G08) 3-(5-氟-3,3,4,4-四甲基-3,4-二氫異喹啉-1-基)喹啉、(G09)土黴素,(G10)鏈黴素。G) Inhibitors of amino acid and/or protein biosynthesis, such as (G01) Andopram, (G02) Pyricidin, (G03) Pyrimethanil, (G04) Kasugamycin, (G05) Kasuga Element hydrate, (G06) pyrimethanil, (G07) pyrimethanil, (G08) 3-(5-fluoro-3,3,4,4-tetramethyl-3,4-dihydroisoquinoline- 1-yl) quinoline, (G09) oxytetracycline, (G10) streptomycin.

H)ATP產生的抑制劑,例如(H01)乙酸芬太尼、(H02)氯化鐵、(H03)氫氧化釩、(H04)矽噻菌胺。H) Inhibitors of ATP production, such as (H01) fentanyl acetate, (H02) ferric chloride, (H03) vanadium hydroxide, and (H04) silicotianil.

I)細胞壁合成的抑制劑,例如 (I01) 苯噻菌胺、(I02) 烯醯嗎啉、(I03) 氟嗎啉、(I04) 異丙菌、(I05) 雙炔醯菌、(I06) 多氧黴素、(I07) 保粒黴素、(I08) 有效黴素A、(I09) 纈菌胺、(I10) 多氧黴素B、(I11) (2E)-3-(4-叔丁基苯基)-3-(2-氯吡啶-4-基)-1-(嗎啉-4-基)丙-2-烯-1-酮、(I12)(2Z)基)-3-(4-叔丁基苯基)-3-(2-氯吡啶-4-基)-1-(嗎啉-4-基)丙-2-烯-1-酮。I) Inhibitors of cell wall synthesis, such as (I01) fenothiamide, (I02) enilmorpholine, (I03) flumorpholine, (I04) isoproteobacteria, (I05) diacetylenia, (I06) Oxytetracycline, (I07) Paenomycin, (I08) Effective Amycin, (I09) Valeramide, (I10) Polyoxin B, (I11) (2E)-3-(4-tert Butylphenyl)-3-(2-chloropyridin-4-yl)-1-(morpholin-4-yl)prop-2-en-1-one, (I12)(2Z)yl)-3- (4-tert-butylphenyl)-3-(2-chloropyridin-4-yl)-1-(morpholin-4-yl)prop-2-en-1-one.

J)脂質和膜合成的抑制劑,例如(J01)聯苯、(J02)氯酮、(J03)二烯、(J04)克瘟散、(J05)土菌靈、(J06)碘卡波、(J07)異稻瘟淨、(J08)異丙硫脲、(J09)霜黴威、(J10)鹽酸丙胺卡、(J11)丙硫菌、(J12)吡唑磷、(J13)五氯硝基苯、(J14)四氯硝基苯、(J15)托洛夫司-甲基。J) Inhibitors of lipid and membrane synthesis, such as (J01) biphenyl, (J02) ketone, (J03) diene, (J04) Kewensan, (J05) termicide, (J06) iodocarb, (J07) Isoprothrin, (J08) isopropylthiourea, (J09) fenprocarb, (J10) propylamine card hydrochloride, (J11) prothiobacillus, (J12) pyrazolate, (J13) pentachloronitrate Benzene, (J14) tetrachloronitrobenzene, (J15) Tolovs-methyl.

K)黑色素生物合成的抑制劑,例如(K01)環丙醯菌胺、(K02)雙氯氰菌胺、(K03)稻瘟醯胺、(K04)苯酞、(K05)咯喹酮、(K06)氨基甲酸酯、(K07)三環唑。K) Inhibitors of melanin biosynthesis, such as (K01) cyproteron, (K02) diclofenac, (K03) rice blast amide, (K04) phthalide, (K05) roquiquinone, ( K06) Carbamate, (K07) Tricyclazole.

L)核酸合成的抑制劑,例如(L01)苯霜靈、(L02)苯霜靈-M(精苯霜靈)、(L03)乙嘧酚磺酸酯、(L04)氯氮平、(L05)二甲嘧酚、(L06)乙嘧酚、(L07)呋霜靈、(L08)惡黴靈、(L09)甲霜靈、(L10)甲霜靈-M(甲霜靈)、(L11)呋醯胺、(L12)惡二唑基、(L13)氧代酸、(L14)辛基苯酮。L) Inhibitors of nucleic acid synthesis, such as (L01) Benaxyl, (L02) Benxyl-M (fine benxyl), (L03) pyrimethoxine sulfonate, (L04) clozapine, (L05 ) Dimethymol, (L06) Pyrimol, (L07) Furaxyl, (L08) Oxytetracycline, (L09) Metalaxyl, (L10) Metalaxyl-M (Metalaxyl), (L11 ) Furamide, (L12) oxadiazolyl, (L13) oxo acid, (L14) octyl benzophenone.

M)信號轉導的抑制劑,例如(M01)氯嗪酸鹽、(M02)拌種咯、(M03)咯菌腈、(M04)撲海因、(M05)腐黴利、(M06)喹喔啉、(M07)乙烯菌核利、(M08)丙氧喹啉。M) Inhibitors of signal transduction, such as (M01) chlorazate, (M02) seed dressing, (M03) fludioxonil, (M04) prochlorin, (M05) procymidone, (M06) quinoline Oxoline, (M07) vinyl sclerotin, (M08) propoxyquinoline.

N)能夠用作解偶聯劑的化合物,例如(N01)二萘嵌苯、(N02)敵蟎普、(N03)嘧菌腙、(N04)氟啶胺、(N05)消蟎多。N) Compounds that can be used as uncoupling agents, such as (N01) perylene, (N02) difenprop, (N03) pyrimethanil, (N04) fluazinam, and (N05) mite elimination.

O)其他化合物,例如(O01)苯噻唑、(O02)倍他嗪、(O03)凱西黴素、(O04)香芹酮、(O05)甲殼胺、(O06)吡咯烷酮(氯紮芬酮)、(O07)立方芬、(O08)氟氰胺、(O09)環莫沙尼,(O10)環丙磺醯胺,(O11)達唑胺、(O12)地巴卡布、(O13)二氯苯並咪唑、(O14)二氯苯並咪唑、(O15)二氯甲烷、(O16)二苯醌、(O17)二苯醌甲硫代硫酸酯、(O18)二苯胺、(O19)生態伴侶、(O20)芬吡嗪、(O21)芬格雷、(O22)氟甲醚、(O23)氟醯亞胺、(O24)氟磺醯胺、(O25)氟替尼、(O26)磷醯鋁,(O27)磷醯鈣,(O28)磷醯鈉,(O29)六氯苯,(O30)伊魯黴素,(O31)異硫苯,(O32)甲磺酸甲酯,(O33)異硫氰酸甲酯,(O34)甲苯酮,(O35)米地黴素,(O36)納他黴素,(O37)二甲基二硫代氨基甲酸鎳,(O38)硝基異丙基,(O39)草胺卡布、(O40)氧芬啶、(O41)五氯酚和鹽、(O42)酚苷、(O43)皮卡布唑(O44)磷酸及其鹽、(O45)丙氨酚-膦酸酯、(O46)丙烷-鈉、(O47)嘧啶、(O48)吡嗪氟醯胺(O49)吡咯腈、(O50)替布洛喹、(O51)替洛芬、(O5)2)托尼非尼、(O53)三嗪、(O54)三醯胺、(O55)紮里拉胺、(O56)(3S,6S,7R,8R)-8-苄基-3-[({3-[(異丁醯氧基)甲氧基]-4-甲氧基吡啶-2-基}羰基)氨基]-6-甲基-4-, 9-二氧代-1,5-二氧雜環戊烷-7-基2-甲基丙酸酯、(O57)1-(4-{4-[(5R)-5-(2,6-二氟苯基)-4,5-二氫-1-1,2-惡唑-3-基]-1,3-噻唑-2-基}呱啶-1-基)-2-[5-甲基-3-(三氟甲基)-1H-吡唑-1-基]乙酮、(O58)1-(4-{4-[(5S)-5-(2,6-二氟苯基)-4,5-二氫-1,2-惡唑-3-基]-1,3-噻唑-2-呱啶-1-基)-2-[5-甲基-3-(三氟甲基)-1H-吡唑-1-基]乙酮、(O59)二氯苯噠嗪、(O60)1-(4-甲氧基苯氧基)-3-,3-二甲基丁-2-基-1H-咪唑-1-羧酸酯、(O61)2,3,5,6-四氯-4-(甲基磺醯基)吡啶、(O62)2,3-二丁基-6-氯噻吩並[2,3-d]嘧啶-4(3H)-酮、(O63)2,6-二甲基-1H,5H-[1,4]二硫雜環己烯[2,3-c:5,6-c']二吡咯-1,3,5,7(2H,6H)-雌酮、(O64)2-[5-甲基-3-(三氟甲基)-1H-吡唑-1-基]-1-(4-{4-[( 5R)-5-苯基-4,5-二氫-1,2-惡唑-3-基]-1,3-噻唑-2-基}呱啶-1-基)乙酮、(O65)2-[5-甲基-3-(三氟甲基)-1H-吡唑-1-基]-1-(4-{4-[(5S)-5-苯基-4,5-二氫-1,2-惡唑-3-基]-1,3-噻唑-2-基}呱啶-1-基)乙酮、(O66)2-[5-甲基-3-(三氟甲基)-1H-吡唑-]-基]-1-{4-[4-(5-苯基-4,5-二氫-1,2-惡唑-3-基)-1,3-噻唑2-基]呱啶-1-基}乙酮、(O67)2-丁氧基-6-碘-3-丙基-4H-苯並吡喃-4-酮、(O68)2-氯-5-[2-氯-1-(2,6-二氟-4-甲氧基苯基)-4-甲基-1H-咪唑-5-基]吡啶、(O69)2-苯基苯酚和鹽、(O70)3-(4,4,5-三氟)-3,3-二甲基-3,4-二氫異喹啉-1-基)喹啉、(O71)3,4,5-三氯吡啶-2,6-二腈、(O72)3-氯-5-(4-氯苯基)-4-(2,6-二氟苯基)-6-甲基噠嗪、(O73)4-(4-氯苯基)-5-(2,6-二氟苯基)-3,6-二甲基噠嗪、(O74)3-氯-4-(2,6-二氟苯基)-6-甲基-5-苯基噠嗪、(O75)5-氨基-1,3,4-噻二唑-2-硫醇、(O76)5-氯-N'-苯基-N'-(丙-2-炔-1-基)噻吩-2-磺醯肼、(O77)5-氟-2-[(4-氟苄基)氧基]嘧啶-4-胺、(O78)5-氟-2-[(4-甲基苄基)氧基]嘧啶-4-胺、(O79)5-甲基-6-辛基[1,2,4]三唑並[1,5]-a]嘧啶-7-胺、(O80)乙基(2Z)-3-氨基-2-氰基-3-苯基丙烯酸酯、(O81)N'-(4-{[3-(4-氯苄基)-1, 2,4-噻二唑-5-基]氧基}-2,5-二甲基苯基)-N-乙基-N-甲基亞胺甲醯胺、(O82)N-(4-氯苄基)-3-[3-甲氧基-4-(丙醇)-2-yn-1-基氧基)苯基]丙醯胺、(O83)N-[(4-氯苯基)(氰基)甲基]-3-[3-甲氧基-4-(丙-2-炔-1-基氧基)苯基]丙醯胺、(O84)N-[(5-溴-3-氯吡啶-2-基)甲基]-2,4-二氯煙醯胺、(O85)N-[1-(5-溴-3-氯吡啶-2)-(甲基)乙基]-2,4-二氯煙醯胺、(O86)N-[1-(5-溴-3-氯吡啶-2-基)乙基]-2-氟-4-碘煙醯胺、(O87)N-{(E)-[(環丙基甲氧基)亞氨基] [6-(二氟甲氧基)]-2,3-二氟苯基]甲基}-2-苯基乙醯胺、(O88)N-{(Z)-[(環丙基甲氧基)亞氨基] [6-(二氟甲氧基)-2,3-二氟苯基]甲基}-2-苯基乙醯胺、(O89)N'-{4-[(3-叔丁基-4-氰基-1,2-噻唑-5-基)氧基]-2-氯-5-甲基苯基}-N-乙基-N-甲基亞胺甲醯胺、(O90)N-甲基-2-(1-{[5-甲基-3-(三氟甲基)-1H-吡唑-1-基]乙醯基}呱啶-4-基)-N-(1,2,3) ,4-四氫萘-1-基)-1,3-噻唑-4-甲醯胺、(O91)N-甲基-2-(1-{[5-甲基-3-(三氟甲基)-1H-吡唑-1-(乙基)呱啶-4-基)-N-[(1R)-1,2,3,4-四氫萘-1-基]-1,3-噻唑-4-甲醯胺、(O92)N-甲基-2-(1-{[5-甲基-3-(三氟甲基)-1H-吡唑-1-基]乙醯基}呱啶-4-基)-N-[(1S)-1,2,3,4-四氫化萘-1-基]-1,3-噻唑-4-甲醯胺、(O93)戊基{6-[({[(1-甲基-1H-四唑-5-基)(苯基)亞甲基]氨基}氧基)甲基]吡啶-2-基}氨基甲酸酯、(O94)吩嗪-1-羧酸、(O95)喹啉-8-醇、(O96)喹啉-8-醇硫酸鹽(2:1)、(O97)叔丁基{6-[({[(1-甲基-1H-四唑)-5-基)(苯基)亞甲基]氨基}氧基)甲基]吡啶-2-基}氨基甲酸酯、(O98)(5-溴-2-甲氧基-4-甲基吡啶-3-基)(2,3,4)-三甲氧基-6-甲基苯基)甲酮、(O99)N-[2-(4-{[3-(4-氯苯基)丙-2-炔-1-基]氧基}-3-甲氧基苯基)甲基]-N2-(甲基磺醯基)纈氨醯胺、(O100)4-氧代-4-[(2-苯基乙基)氨基]丁酸、(O101)丁-3-炔-1-基{6-[({[(Z)-(1-甲基-1H-四唑-5-基)(苯基)亞甲基]氨基}氧基)甲基]吡啶-2-基}氨基甲酸酯、(O102)4-氨基-5-氟嘧啶-2-醇(互變異構形式:4-氨基-5-氟嘧啶-2(1H)-酮)、(O103)丙基3,4,5-三羥基苯甲酸酯、(O104)[3-(4-氯-2-氟苯基)-5-(2,4-二氟苯基)-1,2-惡唑-4-基](吡啶-3-基)甲醇、(O105)(S)-[3-(4-氯-2-氟苯基)-5-(2,4-二氟苯基)-1,2-惡唑-4-基](吡啶-3-基)甲醇、(O106)(R)-[3-(4-氯-2-氟苯基)-5-(2,4-二氟苯基)-1,2-惡唑-4-基](吡啶-3-基)甲醇、(O107)2-氟-6-(三氟甲基) )-N-(1,1,3-三甲基-2,3-二氫-1H-茚-4-基)苯甲醯胺、(O108)2-(6-苄基吡啶-2-基)喹唑啉、(O109)2-[6-(3-氟-4-甲氧基苯基)-5-甲基吡啶-2-基]喹唑啉、(O110)3-(4,4-二氟-3,3-二甲基-3,4-二氫異喹啉-1-基) )喹啉、(O111)脫落酸、(O112)N'-[5-溴-6-(2,3-二氫-1H-茚-2-基氧基)-2-甲基吡啶-3-基]-N-乙基-N-甲基亞胺甲醯胺、(O113)N'-{5-溴-6-[1-(3,5-二氟苯基)乙氧基]-2-甲基吡啶-3-基}-N-乙基-N-甲基亞胺甲醯胺、(O114) )N'-{5-溴-6-[(1R)-1-(3,5-二氟丙基) (苯基)乙氧基]-2-甲基吡啶-3-基}-N-乙基-N-甲基亞胺甲醯胺、(O115)N'-{5-溴-6-[(1S)-1-(3,5-二氟苯基)乙氧基]-2-甲基吡啶-3-基}-N-乙基-N-甲基亞胺甲醯胺、(O116)N'-{5-溴-6-[(順式-4-異丙基環己基)氧基]-2-甲基吡啶-3-基-N-乙基-N-甲基亞胺甲醯胺、(O117)N'-{5-溴-6-[(反式-4-異丙基環己基)氧基]-2-甲基吡啶-3-基}-N-乙基-N-甲基咪唑甲醯胺、(O118)N-環丙基-3-(二氟甲基)-5-氟-N-(2-異丙基苄基)-1-甲基-1H-吡唑-4-甲醯胺、(O119)N-環丙基-N-(2-環丙基苄基)-3-(二氟甲基)-5-氟-1-甲基-1H-吡唑-4-甲醯胺、(O120)N-(2-叔丁基苄基)-N-環丙基-3-(二氟甲基)-5-氟-1-甲基-1H-吡唑-4-甲醯胺、(O121)N-(5-氯-2-乙基苄基)-N-環丙基-3-(二氟甲基)-5-氟-1-甲基-1H-吡唑-4-甲醯胺、(O122)N-(5-氯-2-異丙基苄基)-N-環丙基-3-(二氟甲基)-5-氟-1-甲基-1H-吡唑-4-甲醯胺、(O123)N-環丙基-3-(二氟甲基)-N-(2-乙基5-氟苄基)-5-氟-1-甲基-1H-吡唑-4-甲醯胺、(O124)N-環丙基-3-(二氟甲基)-5-氟-N-(5-氟-2-異丙基苄基)-1-甲基-1H-吡唑-4-甲醯胺、(O125)N-環丙基-N-(2-環丙基-5-氟苄基)-3-(二氟甲基)-5-氟-1-甲基-1H-吡唑-4-甲醯胺、(O126)N-(2-環戊基-5-氟苄基)-N-環丙基-3-(二氟甲基)-5-氟-1-甲基-1H-吡唑-4-甲醯胺、(O127)N-環丙基-3-(二氟甲基)-5-氟-N-(2-氟-6-異丙基苄基)-1-甲基-1H-吡唑-4-甲醯胺、(O128)N-環丙基-3-(二氟甲基)-N-(2-乙基-5-甲基苄基)-5-氟-1-甲基-1H-吡唑-4-甲醯胺、(O129)N-環丙基-3-(二氟甲基)-5-氟-N-(2-異丙基-5-甲基苄基)-1-甲基-1H-吡唑-4-甲醯胺、(O130)N-環丙基-N-(2-環丙基-5-甲基苄基)-3-(二氟甲基)-5-氟-1-甲基-1H-吡唑-4-甲醯胺、(O131)N-(2-叔丁基-5-甲基苄基)-N-環丙基-3-(二氟甲基)-5-氟-1-甲基-1H-吡唑-4-甲醯胺、(O132)N-[5-氯-2-(三氟甲基)苄基]-N-環丙基-3-(二氟甲基)-5-氟-1-甲基-1H-吡唑-4-甲醯胺、(O133)N-環丙基-3-(二氟甲基)-5-氟-1-甲基-N-[5-甲基-2-(三氟甲基)苄基]-1H-吡唑-4-甲醯胺、(O134)N-[2-氯-6-(三氟甲基)苄基]-N-環丙基-3-(二氟甲基)-5-氟-1-甲基-1H-吡唑-4-甲醯胺、(O135)N-[3-氯-2-氟-6-(三氟甲基))苄基]-N-環丙基-3-(二氟甲基)-5-氟-1-甲基-1H-吡唑-4-甲醯胺、(O136)N-環丙基-3-(二氟甲基)-N-(2-乙基-4,5-二甲基苄基)-5-氟-1-甲基-1H-吡唑-4-甲醯胺、(O137)N-環丙基-3-(二氟甲基)-5-氟-N-(2-異丙基苄基)-1-甲基-1H-吡唑-4-硫代甲醯胺、(O138)N'-(2,5-二甲基-4-苯氧基苯基)-N-乙基-N-甲基亞胺甲醯胺、(O139)N'-{4-[(4,5)-二氯-1,3-噻唑-2-基)氧基]-2,5-二甲基苯基}-N-乙基-N-甲基亞胺甲醯胺、(O140)N-(4-氯-2,6-二氟苯基)-4-(2-氯-4-氟苯基)-1,3-二甲基-1H-吡唑-5-一個礦、(O141)9-氟-2,2-二甲基-5-(喹啉-3-基)-2,3-二氫-1,4-苯並氧氮雜、(O142)2-{2-氟-6-[(8-氟-2-甲基喹啉-3-基)氧基]苯基}丙-2-醇、(O143)2-{2-[(7,8-二氟-2-甲基喹啉-3-基))氧基]-6-氟苯基}丙-2-醇、(O144)4-(2-氯-4-氟苯基)-N-(2-氟苯基)-1,3-二甲基-1H-吡唑-5-胺、(O145)4-(2-氯-4-氟苯基)-N-(2,6-二氟苯基)-1,3-二甲基-1H-吡唑-5-胺、(O146)4-(2-氯-4-氟苯基)-N-(2-氯-6-氟苯基)-1,3-二甲基-1H-吡唑-5-胺、(O147)4-(2-溴-4-氟苯基)-N-(2-氯-6-氟苯基)-1,3-二甲基-1H-吡唑-5-胺、(O148)N-(2-溴-6-氟苯基)-4-(2-氯-4-氟苯基)-1 ,3-二甲基-1H-吡唑-5-胺、(O149)4-(2-溴-4-氟苯基)-N-(2-溴苯基)-1,3-二甲基-1H-吡唑-5-胺、 (O150)4-(2-溴-4-氟苯基)-N-(2-溴-6-氟苯基)-1,3-二甲基-1H-吡唑-5-胺、(O151)4-(2-溴)-4-氟苯基)-N-(2-氯苯基)-1,3-二甲基-1H-吡唑-5-胺、(O152)N-(2-溴苯基)-4-(2-氯-4-氟苯基)-1,3-二甲基-1H-吡唑-5-胺、(O153)4-(2-氯-4-氟苯基)-N-(2-氯苯基)-1,3-二甲基-1H-吡唑-5-胺、(O154)4-(2-溴-4-氟苯基)-N-(2,6-二氟苯基)-1,3-二甲基-1H-吡唑-5-胺、(O155)4-(2-溴-4-氟苯基)-N-(2-氟苯基)-1,3-二甲基-1H-吡唑-5-胺、(O156)N'-(4-{3-[(二氟甲基)硫烷基]苯氧基}-2,5-二甲基苯基)-N-乙基-N-甲基亞胺甲醯胺、(O157)N'-(2,5-二甲基-4)-{3-[(1,1,2,2-四氟乙基)硫烷基]苯氧基}苯基)-N-乙基-N-甲基亞胺甲醯胺、(O158)N'-(2,5-二甲基-4-{3-[(2,2,2-三氟乙基)硫烷基]苯氧基}苯基)-N-乙基-N-甲基亞胺甲醯胺、(O159)N'-(2,5-二甲基-4-{3-[(2,2,3,3-四氟丙基)硫烷基]苯氧基}苯基)-N-乙基-N-甲基亞胺甲醯胺、(O160)N'-(2,5-二甲基-4-{3-[(五氟乙基)硫烷基]苯氧基}苯基)-N-乙基-N-甲基亞胺甲醯胺、(O161)N'-(4-{[3-(二氟甲氧基)苯基]硫烷基}-2,5-二甲基苯基)-N-乙基-N-甲基亞胺甲醯胺、(O162)N'-(2,5-二甲基-4-{[3-(1,1,2,2-四氟乙氧基)苯基]硫烷基}苯基)-N-乙基-N-甲基亞胺甲醯胺、(O163)N'-(2,5-二甲基-4-{[3-(2,2,2-三氟乙氧基)苯基]硫烷基}苯基)-N-乙基-N-甲基亞胺甲醯胺、(O164)N'-(2,5-二甲基-4-{[3-( 2,2,3,3-四氟丙氧基)苯基]硫烷基}苯基)-N-乙基-N-甲基亞胺甲醯胺、(O165)N'-( 2,5-二甲基-4-{[3-(五氟乙氧基)苯基]硫烷基}苯基)-N-乙基-N-甲基咪唑胺、(O166)2-[3,5-雙(二氟甲基)-1H-吡唑-1基]-1-[4-(4-{5-[2-(丙-2-炔-1-基氧基)苯基]-4,5-二氫-1,2-惡唑-3-基}-1,3-噻唑-2-基)呱啶-1-基]乙酮、(O167)2-[3,5-雙(二氟甲基)-1H-吡唑-1-基]-1-[4-(4-{ 5-[2-氟-6-(丙-2-炔-1-基氧基)苯基]-4,5-二氫-1,2-惡唑-3-基}-1,3-噻唑-2-基)呱啶-1-基]乙酮、(O168)2-[3,5-雙(二氟甲基)-1H-吡唑-1-基]-1-[4-(4-{5-[2-氯-6-] (丙-2-炔-1-基氧基)苯基]-4,5-二氫-1,2-惡唑-3-基}-1,3-噻唑-2-基)呱啶-1-基]乙酮、( O169)2-{3-[2-(1-{[3,5-雙(二氟甲基)-1H-吡唑-1-基]乙醯基}呱啶-4-基)-1,3-噻唑-4-基]-4,5-二氫-1,2-惡唑-5-基}苯基甲磺酸鹽、(O170)2-{3-[2-(1-{[3,5-雙(二氟甲基)-1H-吡唑-1-基]乙醯基}呱啶-4-基)-1,3-噻唑-4-基]-4,5-二氫-1,2-惡唑-5-基}-3-氯苯基甲磺酸鹽、(O171)2-[3,5-雙(二氟甲基)-1H-吡唑-1-基]-1-[4-(4-{(5S)-5-[2-(丙-2-炔-1--氧基)苯基]-4,5-二氫-1,2-惡唑-3-基}-1,3-噻唑-2-基)呱啶-1-基]乙酮、(O172)2-[3,5]雙(二氟甲基)-1H-吡唑-1-基]-1-[4-(4-{(5R)-5-[2-(丙-2-炔-1-基氧基)苯基]-4,5-二氫-1,2-oxazo1-3基}-1,3-噻唑-2-基)呱啶-1-基]乙酮、(O173)2-[3,5-雙(二氟甲基)-1H-吡唑-1-基]-1-[4-(4-{(5S)-5-[2-氟-6-(prop-2)-yn-1-基氧基)苯基]-4,5-二氫-1,2-惡唑-3-基}-1,3-噻唑-2-基)呱啶-1-基]乙酮、(O174)2-[3,5-雙(二氟甲基)-1H-吡唑-1-基]-1-[4-(4-{(5R)-5-[2-氟-6-(丙-2-炔-1-(氧基)苯基]-4,5-二氫-1,2-惡唑-3-基}-1,3-噻唑-2-基)呱啶-1-基]乙酮、(O175)2-[3,5-]雙(二氟甲基)-1H-吡唑-1-基]-1-[4-(4-{(5S)-5-[2-氯-6-(丙-2-炔-1-基氧基)苯基]-4,5-二氫-1,2-惡唑-3-基}-1,3-噻唑-2-基)呱啶-1-基]乙酮、(O176)2-[3,5-雙(二氟甲基)--1H-吡唑-1-基]-1-[4-(4-{(5R)-5-[2-氯-6-(丙-2-炔-1-基氧基)苯基]-4,5-二氫-1,2-惡唑-3-基}-1,3-噻唑-2-基)呱啶-1-基]乙酮、(O177)2-{(5S)-3-[2-(1-{[ 3,5-雙(二氟甲基)-1H-吡唑-1-基]乙醯基}呱啶-4-基)-1,3-噻唑-4-基]-4,5-二氫-1,2-惡唑-5--甲基磺酸苯酯、(O178)2-{(5R)-3-[2-(1-{[3,5-雙(二氟甲基)-1H-吡唑-1-基]乙醯基}呱啶-4-基)-1,3-噻唑-4-基]-4,5-二氫-1,2-惡唑-5-基甲基磺酸苯酯、(O179)2-{(5S)-3-[2-(1-{[3,5-雙(二氟甲基)-1H-吡唑-1-基]乙醯基}呱啶-4-基)-1,3-噻唑-4-基]-4,5-二氫-1,2-惡唑-5-基}-3-氯苯基甲磺酸酯、(O180)2-{(5R)-3-[2-(1-{[3,5-雙(二氟甲基)-1H-吡唑-1-基]乙醯基}呱啶-4-基)-1,3-噻唑-4-基]-4,5-二氫-1,2-惡唑-5-基}-3-氯苯基甲磺酸酯、(O181)(3S,6S,7R,8R)-8-苄基-3-{3-[(異丁醯氧基)甲氧基]-4-甲氧基吡啶醯氨基}-6-甲基-4,9-二氧代-1,5-二氧雜環戊烷-7-基異丁酸酯、(O182)N'-(4-(4-氯-3-三氟甲基-苯氧基)-2,5-二甲基-苯基)-N-乙基-N-甲基甲脒、(O183)N'-(4-(4-氟-3-三氟甲基-苯氧基)-2,5-二甲基-苯基)-N-乙基-N-甲基甲脒、(O184)N'-[4-[[3-[(4-氯苯基)甲基]-1,2,4-噻二唑-5-基]氧基]-2,5-二甲基-苯基]-N-乙基-N-甲基甲脒、(O185))N'-(5-溴-6-茚滿-2-基氧基-2-甲基-3-吡啶基)-N-乙基-N-甲基-甲脒、(O186)N'-[5-溴-6-[ 1-(3,5-二氟苯基)乙氧基]-2-甲基-3-吡啶基]-N-乙基-N-甲基甲脒、(O187)N'-[5-溴-6-(4-異丙基環己氧基)-2-甲基-3-吡啶基]-N-乙基-N-甲基-甲脒、(O188)N'-[5-溴-2]-甲基-6-(1-苯基乙氧基)-3-吡啶基]-N-乙基-N-甲基甲脒、(O189)N'-(2-甲基-5-三氟甲基-4-(3-三甲基矽烷基-丙氧基)苯基)-N-乙基-N-甲基甲脒、(O190)N'-(5-二氟甲基-2-甲基-4-(3-三甲基矽烷基-丙氧基)-苯基)-N-乙基-N-甲基甲脒、(O191)(N-乙基-N'-(4-(2-氟苯氧基)-2,5-二甲基苯基)-N-甲基甲醯亞胺、(O192)N'-(2-氯-4-(2-氟苯氧基)-5-(甲基苯基)-N-乙基-N-甲基甲醯亞胺、(O193)2-[2-[(7,8-二氟-2-甲基-3-喹啉基)氧基]-6-氟-苯基]丙-2-醇、(O194)2-[2-氟-6-[(8-氟-2-甲基-3-喹啉基)氧基]-苯基]丙-2-醇、(O195)喹諾芬、(O196)9-氟-2,2-二甲基-5-(3-喹啉基)-3H-1,4-苯並氧氮雜、(0197)2-(6-苄基-2-吡啶基)喹唑啉、(O198)2-[6-(3-氟-4-甲氧基-苯基)-5-甲基-2-吡啶基]喹唑啉、(O199)氟嘧啶、(O200)氟化皮醯胺、(O201) 氟噻唑吡乙酮。O) Other compounds, such as (O01) benzothiazole, (O02) betamethazine, (O03) kazemycin, (O04) carvone, (O05) chitosan, (O06) pyrrolidone (lozafenone) , (O07) cubic fenfen, (O08) fluorocyanamide, (O09) cyclomethanil, (O10) cyprosulfonamide, (O11) dalzolamide, (O12) debakab, (O13) di Chlorobenzimidazole, (O14) dichlorobenzimidazole, (O15) dichloromethane, (O16) dibenzoquinone, (O17) dibenzoquinone methylthiosulfate, (O18) diphenylamine, (O19) ecology Mate, (O20) Fenpyrazine, (O21) Fengreset, (O22) Fluoromethyl ether, (O23) Fluoroimide, (O24) Fluorosulfonamide, (O25) Flutinib, (O26) Phosphatide Aluminum, (O27) Calcium Phosphate, (O28) Sodium Phosphate, (O29) Hexachlorobenzene, (O30) Iluomycin, (O31) Isothiobenzene, (O32) Methyl Methanesulfonate, (O33) Methyl isothiocyanate, (O34) ketone, (O35) midenomycin, (O36) natamycin, (O37) nickel dimethyldithiocarbamate, (O38) nitroisopropyl , (O39) oxacarb, (O40) oxifene, (O41) pentachlorophenol and salts, (O42) phenol glycosides, (O43) picocazole (O44) phosphoric acid and its salts, (O45) alanine Phenol-phosphonate, (O46) propane-sodium, (O47) pyrimidine, (O48) pyrazine fluoroamide (O49) pyrronitrile, (O50) tebuproquine, (O51) teprofen, (O5) 2) Tonifenib, (O53) triazine, (O54) triamide, (O55) Zaliramide, (O56) (3S, 6S, 7R, 8R)-8-benzyl-3-[({3 -[(Isobutylamide)methoxy]-4-methoxypyridin-2-yl}carbonyl)amino]-6-methyl-4-, 9-dioxo-1,5-dioxo Heterocyclopentane-7-yl 2-methylpropionate, (O57) 1-(4-{4-[(5R)-5-(2,6-difluorophenyl)-4,5-di Hydrogen-1-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}pyridin-1-yl)-2-[5-methyl-3-(trifluoromethyl) -1H-pyrazol-1-yl]ethanone, (O58) 1-(4-{4-[(5S)-5-(2,6-difluorophenyl)-4,5-dihydro-1 ,2-oxazol-3-yl]-1,3-thiazol-2-pyridin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazole-1 -Yl] ethyl ketone, (O59) dichloropyridazine, (O60) 1-(4-methoxyphenoxy)-3-,3-dimethylbut-2-yl-1H-imidazole-1 -Carboxylate, (O61) 2,3,5,6-tetrachloro-4-(methylsulfonyl)pyridine, (O62) 2,3-dibutyl-6-chlorothieno[2,3 -d] pyrimidine-4 (3H)-one, (O63) 2,6-dimethyl-1H, 5 H-[1,4] dithiohexene [2,3-c: 5,6-c'] dipyrrole-1,3,5,7 (2H, 6H)-estrone, (O64) 2 -[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]-1-(4-{4-[( 5R)-5-phenyl-4,5-dihydro -1,2-oxazol-3-yl]-1,3-thiazol-2-yl}pyridin-1-yl)ethanone, (O65)2-[5-methyl-3-(trifluoromethyl Group)-1H-pyrazol-1-yl]-1-(4-{4-[(5S)-5-phenyl-4,5-dihydro-1,2-oxazol-3-yl]- 1,3-thiazol-2-yl}pyridin-1-yl)ethanone, (O66)2-[5-methyl-3-(trifluoromethyl)-1H-pyrazole-]-yl]- 1-{4-[4-(5-phenyl-4,5-dihydro-1,2-oxazol-3-yl)-1,3-thiazol-2-yl]pyridin-1-yl}ethyl Ketone, (O67) 2-butoxy-6-iodo-3-propyl-4H-benzopyran-4-one, (O68) 2-chloro-5-[2-chloro-1-(2, 6-difluoro-4-methoxyphenyl)-4-methyl-1H-imidazol-5-yl]pyridine, (O69) 2-phenylphenol and salts, (O70) 3-(4,4, 5-trifluoro)-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline, (O71) 3,4,5-trichloropyridine-2,6-dinitrile , (O72) 3-chloro-5-(4-chlorophenyl)-4-(2,6-difluorophenyl)-6-methylpyridazine, (O73) 4-(4-chlorophenyl) -5-(2,6-difluorophenyl)-3,6-dimethylpyridazine, (O74)3-chloro-4-(2,6-difluorophenyl)-6-methyl-5 -Phenylpyridazine, (O75) 5-amino-1,3,4-thiadiazole-2-thiol, (O76) 5-chloro-N'-phenyl-N'-(prop-2-yne -1-yl)thiophene-2-sulfonyl hydrazine, (O77) 5-fluoro-2-[(4-fluorobenzyl)oxy]pyrimidine-4-amine, (O78) 5-fluoro-2-[( 4-methylbenzyl)oxy]pyrimidin-4-amine, (O79) 5-methyl-6-octyl[1,2,4]triazolo[1,5]-a]pyrimidine-7- Amine, (O80) ethyl (2Z)-3-amino-2-cyano-3-phenyl acrylate, (O81) N'-(4-{[3-(4-chlorobenzyl)-1, 2,4-thiadiazol-5-yl]oxy}-2,5-dimethylphenyl)-N-ethyl-N-methylimine formamide, (O82)N-(4- Chlorobenzyl)-3-[3-methoxy-4-(propanol)-2-yn-1-yloxy)phenyl]propanamide, (O83)N-[(4-chlorophenyl ) (Cyano)methyl]-3-[3-methoxy-4-(prop-2-yn-1-yloxy)phenyl]propanamide, (O84)N-[(5-bromo -3-chloropyridin-2-yl)methyl]-2,4-dichloronicotinamide, (O85 ) N-[1-(5-Bromo-3-chloropyridine-2)-(methyl)ethyl]-2,4-dichloronicotinamide, (O86)N-[1-(5-bromo- 3-chloropyridin-2-yl)ethyl]-2-fluoro-4-iodonicotinamide, (O87)N-{(E)-[(cyclopropylmethoxy)imino][6-( Difluoromethoxy)]-2,3-difluorophenyl]methyl}-2-phenylacetamide, (O88)N-{(Z)-[(cyclopropylmethoxy)imino ] [6-(Difluoromethoxy)-2,3-difluorophenyl]methyl}-2-phenylacetamide, (O89)N'-{4-[(3-tert-butyl- 4-cyano-1,2-thiazol-5-yl)oxy]-2-chloro-5-methylphenyl}-N-ethyl-N-methylimine formamide, (O90)N -Methyl-2-(1-{[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]acetoyl}pyridin-4-yl)-N-(1 ,2,3),4-tetrahydronaphthalen-1-yl)-1,3-thiazole-4-carboxamide, (O91)N-methyl-2-(1-{[5-methyl-3 -(Trifluoromethyl)-1H-pyrazole-1-(ethyl)pyridin-4-yl)-N-[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl] -1,3-thiazole-4-carboxamide, (O92)N-methyl-2-(1-{[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl ]Ethlyl}pyridin-4-yl)-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]-1,3-thiazole-4-carboxamide, ( O93) Amyl {6-[({[(1-methyl-1H-tetrazol-5-yl)(phenyl)methylene]amino}oxy)methyl]pyridin-2-yl}carbamate Acid ester, (O94) phenazine-1-carboxylic acid, (O95) quinoline-8-ol, (O96) quinoline-8-ol sulfate (2:1), (O97) tert-butyl{6- [({[(1-methyl-1H-tetrazole)-5-yl)(phenyl)methylene]amino}oxy)methyl]pyridin-2-yl}carbamate, (O98) (5-Bromo-2-methoxy-4-methylpyridin-3-yl) (2,3,4)-trimethoxy-6-methylphenyl)methanone, (O99)N-[2 -(4-{[3-(4-chlorophenyl)prop-2-yn-1-yl]oxy}-3-methoxyphenyl)methyl]-N2-(methylsulfonyl) Valinamide, (O100) 4-oxo-4-[(2-phenylethyl)amino]butanoic acid, (O101)but-3-yn-1-yl{6-[({[(Z )-(1-methyl-1H-tetrazol-5-yl)(phenyl)methylene]amino}oxy)methyl]pyridin-2-yl}carbamate, (O102) 4-amino -5-fluoropyrimidine-2-ol (tautomeric form: 4-amino-5-fluoropyrimidine-2(1H)-one), (O103)propyl 3,4,5-trihydroxybenzoate, (O104) [3-(4-chloro-2-fluorobenzene Group)-5-(2,4-difluorophenyl)-1,2-oxazol-4-yl](pyridin-3-yl)methanol, (O105)(S)-[3-(4-chloro -2-fluorophenyl)-5-(2,4-difluorophenyl)-1,2-oxazol-4-yl](pyridin-3-yl)methanol, (O106)(R)-[3 -(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-1,2-oxazol-4-yl](pyridin-3-yl)methanol, (O107)2 -Fluoro-6-(trifluoromethyl))-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)benzamide, (O108) 2 -(6-benzylpyridin-2-yl)quinazoline, (O109)2-[6-(3-fluoro-4-methoxyphenyl)-5-methylpyridin-2-yl]quinazole Porphyrin, (O110) 3-(4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)) quinoline, (O111) abscisic acid, (O112) N'-[5-Bromo-6-(2,3-dihydro-1H-inden-2-yloxy)-2-methylpyridin-3-yl]-N-ethyl-N-methylmethylene Aminoamide, (O113) N'-{5-Bromo-6-[1-(3,5-difluorophenyl)ethoxy]-2-methylpyridin-3-yl}-N-ethyl -N-methylimine formamide, (O114)) N'-{5-bromo-6-[(1R)-1-(3,5-difluoropropyl) (phenyl)ethoxy ]-2-Methylpyridin-3-yl}-N-ethyl-N-methylimine formamide, (O115) N'-{5-bromo-6-[(1S)-1-(3 ,5-difluorophenyl)ethoxy]-2-methylpyridin-3-yl}-N-ethyl-N-methylimine formamide, (O116)N'-{5-bromo- 6-[(cis-4-isopropylcyclohexyl)oxy]-2-methylpyridin-3-yl-N-ethyl-N-methylimine formamide, (O117) N'- {5-Bromo-6-[(trans-4-isopropylcyclohexyl)oxy]-2-methylpyridin-3-yl}-N-ethyl-N-methylimidazolamide, ( O118) N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-isopropylbenzyl)-1-methyl-1H-pyrazole-4-carboxamide, ( O119) N-cyclopropyl-N-(2-cyclopropylbenzyl)-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, ( O120) N-(2-tert-butylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, ( O121) N-(5-chloro-2-ethylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide Amine, (O122) N-(5-chloro-2-isopropylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole- 4-carboxamide, (O123) N-ring Propyl-3-(difluoromethyl)-N-(2-ethyl5-fluorobenzyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (O124)N -Cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(5-fluoro-2-isopropylbenzyl)-1-methyl-1H-pyrazole-4-carboxamide, (O125) N-cyclopropyl-N-(2-cyclopropyl-5-fluorobenzyl)-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4- Formamide, (O126) N-(2-cyclopentyl-5-fluorobenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyridine Azole-4-carboxamide, (O127)N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-fluoro-6-isopropylbenzyl)-1-methyl -1H-pyrazole-4-carboxamide, (O128)N-cyclopropyl-3-(difluoromethyl)-N-(2-ethyl-5-methylbenzyl)-5-fluoro- 1-methyl-1H-pyrazole-4-carboxamide, (O129)N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-isopropyl-5-methyl Benzyl)-1-methyl-1H-pyrazole-4-carboxamide, (O130)N-cyclopropyl-N-(2-cyclopropyl-5-methylbenzyl)-3-( Difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (O131)N-(2-tert-butyl-5-methylbenzyl)-N-cyclopropyl Yl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (O132)N-[5-chloro-2-(trifluoromethyl)benzyl Group]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (O133)N-cyclopropyl-3-( Difluoromethyl)-5-fluoro-1-methyl-N-[5-methyl-2-(trifluoromethyl)benzyl]-1H-pyrazole-4-carboxamide, (O134)N -[2-chloro-6-(trifluoromethyl)benzyl]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-methyl Acetamide, (O135) N-[3-chloro-2-fluoro-6-(trifluoromethyl))benzyl]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1 -Methyl-1H-pyrazole-4-carboxamide, (O136)N-cyclopropyl-3-(difluoromethyl)-N-(2-ethyl-4,5-dimethylbenzyl )-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (O137)N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-iso Propylbenzyl)-1-methyl-1H-pyrazole-4-thiocarboxamide, (O138)N'-(2,5-dimethyl-4-phenoxyphenyl)-N- Ethyl-N-methylimine formamide, (O139) N'-{4-[(4,5)-dichloro-1,3-thiazol-2-yl)oxy]-2,5- Dimethylphenyl}-N-ethyl-N-methylimine formamide, (O140) N-(4-chloro-2 ,6-difluorophenyl)-4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-1H-pyrazole-5-one ore, (O141)9-fluoro-2, 2-dimethyl-5-(quinolin-3-yl)-2,3-dihydro-1,4-benzoxaza, (O142) 2-{2-fluoro-6-[(8- Fluoro-2-methylquinolin-3-yl)oxy]phenyl}propan-2-ol, (O143)2-{2-[(7,8-difluoro-2-methylquinoline-3 -Yl))oxy]-6-fluorophenyl}propan-2-ol, (O144) 4-(2-chloro-4-fluorophenyl)-N-(2-fluorophenyl)-1,3 -Dimethyl-1H-pyrazole-5-amine, (O145) 4-(2-chloro-4-fluorophenyl)-N-(2,6-difluorophenyl)-1,3-dimethyl Yl-1H-pyrazole-5-amine, (O146) 4-(2-chloro-4-fluorophenyl)-N-(2-chloro-6-fluorophenyl)-1,3-dimethyl- 1H-pyrazole-5-amine, (O147) 4-(2-bromo-4-fluorophenyl)-N-(2-chloro-6-fluorophenyl)-1,3-dimethyl-1H- Pyrazole-5-amine, (O148) N-(2-bromo-6-fluorophenyl)-4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-1H-pyrazole -5-amine, (O149) 4-(2-bromo-4-fluorophenyl)-N-(2-bromophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, ( O150) 4-(2-bromo-4-fluorophenyl)-N-(2-bromo-6-fluorophenyl)-1,3-dimethyl-1H-pyrazole-5-amine, (O151) 4-(2-bromo)-4-fluorophenyl)-N-(2-chlorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (O152)N-(2- Bromophenyl)-4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (O153) 4-(2-chloro-4-fluorobenzene Group)-N-(2-chlorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (O154)4-(2-bromo-4-fluorophenyl)-N-( 2,6-difluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (O155) 4-(2-bromo-4-fluorophenyl)-N-(2-fluoro Phenyl)-1,3-dimethyl-1H-pyrazole-5-amine, (O156)N'-(4-{3-[(difluoromethyl)sulfanyl]phenoxy}-2 ,5-dimethylphenyl)-N-ethyl-N-methylimine formamide, (O157)N'-(2,5-dimethyl-4)-{3-[(1, 1,2,2-Tetrafluoroethyl)sulfanyl]phenoxy}phenyl)-N-ethyl-N-methylimine formamide, (O158) N'-(2,5-di Methyl-4-{3-[(2,2,2-trifluoroethyl)sulfanyl]phenoxy}phenyl)-N-ethyl-N-methylimine formamide, (O159 ) N'-(2,5-dimethyl-4-{3-[(2,2,3,3 -Tetrafluoropropyl)sulfanyl]phenoxy}phenyl)-N-ethyl-N-methylimine formamide, (O160) N'-(2,5-dimethyl-4- {3-[(pentafluoroethyl)sulfanyl]phenoxy}phenyl)-N-ethyl-N-methylimine formamide, (O161)N'-(4-{[3- (Difluoromethoxy)phenyl]sulfanyl}-2,5-dimethylphenyl)-N-ethyl-N-methylimine formamide, (O162)N'-(2, 5-dimethyl-4-{[3-(1,1,2,2-tetrafluoroethoxy)phenyl]sulfanyl}phenyl)-N-ethyl-N-methylimine Acetamide, (O163) N'-(2,5-dimethyl-4-{[3-(2,2,2-trifluoroethoxy)phenyl]sulfanyl}phenyl)-N- Ethyl-N-methylimine formamide, (O164) N'-(2,5-dimethyl-4-{[3-( 2,2,3,3-tetrafluoropropoxy)benzene Group]sulfanyl}phenyl)-N-ethyl-N-methylimine formamide, (O165)N'-( 2,5-dimethyl-4-{[3-(pentafluoroethyl Oxy)phenyl]sulfanyl}phenyl)-N-ethyl-N-methylimidazolamide, (O166) 2-[3,5-bis(difluoromethyl)-1H-pyrazole-1 Yl]-1-[4-(4-{5-[2-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazole-3- Group}-1,3-thiazol-2-yl)pyridin-1-yl]ethanone, (O167)2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl] -1-[4-(4-{ 5-[2-fluoro-6-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazole- 3-yl}-1,3-thiazol-2-yl)pyridin-1-yl]ethanone, (O168)2-[3,5-bis(difluoromethyl)-1H-pyrazole-1- Group]-1-[4-(4-{5-[2-chloro-6-] (prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2- Oxazol-3-yl}-1,3-thiazol-2-yl)pyridin-1-yl]ethanone, (O169) 2-{3-[2-(1-{[3,5-bis( Difluoromethyl)-1H-pyrazol-1-yl]acetoyl}pyridin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxo Azole-5-yl}phenyl methanesulfonate, (O170) 2-{3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl] Acetyl}pyridin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorophenylmethanesulfonic acid Salt, (O171) 2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{(5S)-5-[2-(propylene -2-yne-1-oxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)qua Pyridin-1-yl]ethanone, (O172)2-[3,5]bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{(5R)- 5-[2-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazo1-3yl}-1,3-thiazol-2-yl) Xia Pyridin-1-yl]ethanone, (O173) 2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{(5S)- 5-[2-fluoro-6-(prop-2)-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3- Thiazol-2-yl)pyridin-1-yl]ethanone, (O174)2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-( 4-{(5R)-5-[2-fluoro-6-(prop-2-yn-1-(oxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl }-1,3-thiazol-2-yl)pyridin-1-yl]ethanone, (O175)2-[3,5-]bis(difluoromethyl)-1H-pyrazol-1-yl] -1-[4-(4-{(5S)-5-[2-chloro-6-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2 -Oxazol-3-yl}-1,3-thiazol-2-yl)pyridin-1-yl]ethanone, (O176) 2-[3,5-bis(difluoromethyl)--1H- Pyrazol-1-yl]-1-[4-(4-{(5R)-5-[2-chloro-6-(prop-2-yn-1-yloxy)phenyl]-4,5 -Dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)pyridin-1-yl]ethanone, (O177)2-{(5S)-3-[2 -(1-{[ 3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetoyl}pyridin-4-yl)-1,3-thiazol-4-yl]- 4,5-dihydro-1,2-oxazole-5-methylsulfonic acid phenyl ester, (O178) 2-{(5R)-3-[2-(1-{[3,5-bis( Difluoromethyl)-1H-pyrazol-1-yl]acetoyl}pyridin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxo Pyrazol-5-ylmethanesulfonate, (O179) 2-{(5S)-3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazole-1 -Yl]acetoyl}pyridin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorophenyl Mesylate, (O180) 2-{(5R)-3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetoyl} Pyridin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorophenyl methanesulfonate, (O181 ) (3S, 6S, 7R, 8R)-8-benzyl-3-{3-[(isobutylamide) Methoxy]-4-methoxypyridylamino}-6-methyl-4,9-dioxo-1,5-dioxolane-7-yl isobutyrate, (O182) N'-(4-(4-chloro-3-trifluoromethyl-phenoxy)-2,5-dimethyl-phenyl)-N-ethyl-N-methylformamidine, (O183) N'-(4-(4-fluoro-3-trifluoromethyl-phenoxy)-2,5-dimethyl-phenyl)-N-ethyl-N-methylformamidine, (O184) N'-[4-[[3-[(4-chlorophenyl)methyl]-1,2,4-thiadiazol-5-yl]oxy]-2,5-dimethyl-phenyl ]-N-ethyl-N-methylformamidine, (O185)) N'-(5-bromo-6-indan-2-yloxy-2-methyl-3-pyridyl)-N- Ethyl-N-methyl-formamidine, (O186)N'-[5-bromo-6-[ 1-(3,5-difluorophenyl)ethoxy]-2-methyl-3-pyridine Group]-N-ethyl-N-methylformamidine, (O187)N'-[5-bromo-6-(4-isopropylcyclohexyloxy)-2-methyl-3-pyridyl] -N-ethyl-N-methyl-formamidine, (O188) N'-[5-bromo-2]-methyl-6-(1-phenylethoxy)-3-pyridyl]-N -Ethyl-N-methylformamidine, (O189)N'-(2-methyl-5-trifluoromethyl-4-(3-trimethylsilyl-propoxy)phenyl)-N -Ethyl-N-methylformamidine, (O190)N'-(5-difluoromethyl-2-methyl-4-(3-trimethylsilyl-propoxy)-phenyl)- N-ethyl-N-methylformamidine, (O191) (N-ethyl-N'-(4-(2-fluorophenoxy)-2,5-dimethylphenyl)-N-methyl Methylformimide, (O192) N'-(2-chloro-4-(2-fluorophenoxy)-5-(methylphenyl)-N-ethyl-N-methylformimide , (O193) 2-[2-[(7,8-difluoro-2-methyl-3-quinolinyl)oxy]-6-fluoro-phenyl]propan-2-ol, (O194) 2 -[2-fluoro-6-[(8-fluoro-2-methyl-3-quinolinyl)oxy]-phenyl]propan-2-ol, (O195) quinofen, (O196) 9- Fluorine-2,2-dimethyl-5-(3-quinolinyl)-3H-1,4-benzoxaza, (0197)2-(6-benzyl-2-pyridyl)quinazole Porphyrin, (O198) 2-[6-(3-fluoro-4-methoxy-phenyl)-5-methyl-2-pyridyl]quinazoline, (O199) fluoropyrimidine, (O200) fluorination Dacrylamide, (O201) fluthiazolidinepyrone.

P)生長調節劑,例如脫落酸、醯胺氯、琥珀醯胺、6-苄氨基嘌呤、芸苔素內酯、丁醛、矮壯素、氯倍半氯、氯化膽鹼、環丙醯胺、丁醯肼、敵草克、噻節因、2,6-二甲基吡啶、乙烯利、氟甲醛、氟尿嘧啶、氟噻嗪、對氯苯脲、赤黴素、二苯醚、吲哚-3-乙酸、順丁烯醯肼、甲呱噻噸、美吡喹、甲呱喹、萘乙酸、N-6苄基腺嘌呤、多效唑、調環酸、調環酸鈣、茉莉酸誘導體、噻苯隆、抑芽唑、三丁基磷酸三硫代磷酸酯、2,3,5-三碘苯甲酸、抗倒酯和烯效唑。P) Growth regulators such as abscisic acid, amide chloride, succinamide, 6-benzylaminopurine, brassinolide, butyraldehyde, chlormequat chloride, sesquichloride, choline chloride, cyprochloride Amine, butyl hydrazine, diquat, thiophene, 2,6-lutidine, ethephon, fluoroformaldehyde, fluorouracil, fluorothiazide, p-chlorophenylurea, gibberellin, diphenyl ether, indole -3-acetic acid, cis-butene hydrazide, methamphetamine, mepraquine, mevaquine, naphthalene acetic acid, N-6 benzyladenine, paclobutrazol, prohexadione, prohexadione calcium, jasmonic acid inducer , Thidiazuron, imazalazole, tributyl phosphate trithiophosphate, 2,3,5-triiodobenzoic acid, trinexapac-ethyl and oxiconazole.

上面提到的活性物質,他們的製備和他們的活性,如對有害真菌的活性已知(參見:http://www.alanwood.net/pesticides/);這些物質是可商購的。化合物用IUPAC命名法描述的,它們的製備和它們的殺蟲活性也是已知的 (參見《加拿大植物科學雜誌》48(6), 587-94, 1968; EP-A 141 317, EP-A 152031, EP-A 226917, EP-A 243 970, EP-A 256503, EP-A 428941, EP-A 532022, EP-A 1028125, EP-A1035122, EP-A 1201648, EP-A 1122244, JP 2002316902, DE 19650197, DE 10021412, DE 102005009458, US 3,296,272, US 3,325,503, WO 98/46608, WO 99/14187, WO 99/24413, WO 99/27783, WO 00/29404, WO 00/46148, WO 00/65913, WO 01/54501, WO 01/56358, WO 02/22583, WO 02/40431, WO 03/10149, WO 03/11853, WO 03/14103, WO 03/16286, WO 03/53145, WO 03/61388, WO 03/66609, WO 03/74491, WO 04/49804, WO 04/83193, WO 05/120234, WO 05/123689, WO 05/123690, WO 05/63721, WO 05/87772, WO 05/87773, WO 06/15866, WO 06/87325, WO 06/87343, WO 07/82098, WO 07 /90624, WO 10/139271, WO 11 /028657, WO 12/168188, WO 07 /006670, WO 11/77514, WO 13/047749, WO 10/069882, WO 13/047441, WO 03/16303, WO 09/90181, WO 13/007767, WO 13/010862, WO 13/127704, WO 13/024009, WO 13/24010, WO 13/047441, WO 13/162072, WO 13/092224, WO 11/135833, CN 1907024, CN 1456054, CN 103387541, CN 1309897, WO 12/84812, CN 1907024, WO 09094442, WO 14/60177, WO 13/116251, WO 08/013622, WO 94/01546, EP 2865265, WO 07/129454, WO 12/165511, WO 11/081174, WO 13/47441)。The active substances mentioned above, their preparation and their activity, as known for their activity against harmful fungi (see: http://www.alanwood.net/pesticides/); these substances are commercially available. Compounds are described by the IUPAC nomenclature, their preparation and their insecticidal activity are also known (see Canadian Journal of Plant Science 48(6), 587-94, 1968; EP-A 141 317, EP-A 152031 , EP-A 226917, EP-A 243 970, EP-A 256503, EP-A 428941, EP-A 532022, EP-A 1028125, EP-A1035122, EP-A 1201648, EP-A 1122244, JP 2002316902, DE 19650197, DE 10021412, DE 102005009458, US 3,296,272, US 3,325,503, WO 98/46608, WO 99/14187, WO 99/24413, WO 99/27783, WO 00/29404, WO 00/46148, WO 00/65913, WO 01/54501, WO 01/56358, WO 02/22583, WO 02/40431, WO 03/10149, WO 03/11853, WO 03/14103, WO 03/16286, WO 03/53145, WO 03/61388, WO 03/66609, WO 03/74491, WO 04/49804, WO 04/83193, WO 05/120234, WO 05/123689, WO 05/123690, WO 05/63721, WO 05/87772, WO 05/87773, WO 06/15866, WO 06/87325, WO 06/87343, WO 07/82098, WO 07/90624, WO 10/139271, WO 11/028657, WO 12/168188, WO 07/006670, WO 11/77514, WO 13/047749, WO 10/069882, WO 13/047441, WO 03/16303, WO 09/90181, WO 13/007767, WO 13/010862, WO 13/127704, WO 13/024009, WO 13/24010, WO 13/047441, WO 13/162072, WO 13/092224, WO 11/135833, CN 1907024, CN 1456054, CN 103387541, CN 1309897, WO 12/84812, CN 1907024, WO 09094442, WO 14/60177, WO 13/116251, WO 08/013622, WO 94/01546, EP 2865265, WO 07/129454, WO 12 /165511, WO 11/081174, WO 13/47441).

如上所述,式(I)化合物可與一種或多種選自殺蟲劑/殺蟎劑/殺線蟲劑類的活性相容化合物混合,這些化合物在本文中通過其已知和描述的常用名稱指定,例如在《農藥手冊》第17版中。或者可以在互聯網(例如在www.alanwood.net/pesticides)上搜索。As mentioned above, the compound of formula (I) may be mixed with one or more active compatible compounds selected from the group of insecticides/acaricides/nematicides, which are designated herein by their common names known and described , For example, in the 17th edition of the Pesticide Handbook. Or you can search on the Internet (for example, www.alanwood.net/pesticides).

(1)乙醯膽鹼酯酶(AChE)抑制劑,例如氨基甲酸酯,例如阿拉尼卡、涕滅威、苯噻菌胺、苯呋喃甲酸丁酯、丁卡巴林、丁氧基甲醯胺、甲萘威、呋喃丹、硫丹、乙氧苄卡巴、非諾巴卡、異硫氰酸酯、異丙威、甲硫威、滅多威、甲氧苄胺、草醯胺、 抗蚜威、殘殺威、硫雙威、久效威、唑蚜威、混殺威、滅除威和滅殺威或有機磷、如乙醯甲胺磷、亞氮硫磷、乙基亞氮磷、甲基亞氮磷、芭樂、毒死蜱、毒殺芬磷、毒死蜱、香豆素、氰基磷、甲基去甲基葡萄糖、二嗪農、敵敵畏/敵敵畏、雙效磷、樂果、二甲基乙烯磷、乙拌磷、苯硫磷、乙硫磷、滅線磷、伐滅磷、苯線磷、殺螟硫磷、倍硫磷、噻唑磷、庚烯、新煙磷、異柳磷、異丙基O-(甲氧基硫代磷醯基磷醯基)水楊酸鹽、異惡唑磷、馬拉硫磷、滅蚜磷、甲胺磷、殺撲磷、速滅磷、久效磷、二溴磷、氧化樂果、碸吸磷-甲基、對硫磷、對硫磷-甲基、稻豐散、甲拌磷、伏殺硫磷、亞胺硫磷、磷胺、辛硫磷、甲基嘧啶磷、丙溴磷、強敵、丙硫磷、吡唑硫磷、噠嗪硫磷、喹硫磷、治螟磷、丁基嘧啶磷、雙硫磷、特丁硫磷、殺蟲畏、甲基乙拌、三唑磷、敵百蟲和蚜滅多。(1) Acetylcholinesterase (AChE) inhibitors, such as carbamates, such as alanicar, aldicarb, phenothicarb, butyl benzofuranate, tetracabarin, butoxymethan Amine, manacarb, furandan, endosulfan, ethoxybenzcarba, fenofacarb, isothiocyanate, isoprocarb, methiocarb, metoprolol, trimethoprim, oxalamide, anti-aphid Carbamazepine, carbendazim, thiodicarb, prolonged carbamazepine, carbamazepine, mixed carbamazepine, carbamazepine and carbamazepine or organophosphorus, such as acetofosin, phosmet, ethyl phosphazin, Methyl phosphazene, guava, chlorpyrifos, chlorfenapox, chlorpyrifos, coumarin, cyanophosphorus, methyl desmethylglucose, diazinon, dichlorvos/dichlorvos, double-effect phosphorus, dimethoate, dimethylethylene Phosphorus, ethyl phosphorus, phoxim, phoxim, methamidophos, valphos, fenfluphos, fenthion, fenthion, thiazophos, heptene, neofume, isoliphos, iso Propyl O-(Methoxythiophosphorylphosphorylphosphoryl) salicylate, isoxazosin, malathion, aphiphos, methamidophos, triflusfos, quick phosphorus, long-lasting Phosphorus, Dibromophosphorus, Dimethoate, Phosphorus-Methyl, Parathion, Parathion-Methyl, Rice Fengsan, Phosphatate, Phoxamate, Imiphos, Phosphatamine, Octane Thiophos, methylpyrimidine, profenofos, strong enemy, prothiophos, pyrazola, pyridazin, quinaphos, moth phosphorus, butyl pyrimidine, dithiophos, terbutafo, Insecticides, methoxazole, triazophos, trichlorfon and aphid are more effective.

(2)GABA-門控氯離子通道拮抗劑,例如環二烯有機氯,例如氯丹,以及硫丹或苯基吡唑,例如乙蟲清和氟蟲腈。(2) GABA-gated chloride ion channel antagonists, such as cyclodiene organochlorine, such as chlordane, and endosulfan or phenylpyrazole, such as ethachlor and fipronil.

(3)鈉通道調節劑/電壓依賴性鈉通道阻滯劑,例如擬除蟲菊酯,例如吖啶菊酯、丙烯菊酯、d-順反式丙烯菊酯、d-反式丙烯菊酯、聯苯菊酯、生物異亮氨酸、生物異亮氨酸、生物異亮氨酸S-環戊烯異構體、生物保護素、環丙菊酯、氟氯氰菊酯、β-氟氯菊酯、氟氯菊酯、λ-氯氰菊酯、氯氰菊酯、α-氯氰菊酯、β-氯氰菊酯、θ-氯氰菊酯、ζ-氯氰菊酯、氯氰菊酯[(1R)-反式異構體]、溴氰菊酯、戊菊酯[(EZ)-(1R)-異構體]、艾司芬戊菊酯、氰丙菊酯、氰戊菊酯、氰戊菊酯、氟氰菊酯、氟氯菊酯、t金氟戊酸鹽、氟苯丙酮、亞胺菊酯、卡地司林、嗎氟菊酯、氯菊酯、酚[(1R)-反式異構體]、除蟲菊酯、除蟲菊酯(除蟲菊酯)、氯菊酯、矽氟醚、四氟菊酯、四甲基菊酯[(1R)-異構體]、曲洛美菊酯和氟菊酯或DDT或甲氧氯。(3) Sodium channel regulators/voltage-dependent sodium channel blockers, such as pyrethroids, such as acrimethrin, acryl, d-cis-trans-acrythrin, d-trans-acrythrin , Bifenthrin, bioisoleucine, bioisoleucine, bioisoleucine S-cyclopentene isomer, bioprotectin, cypromethrin, cyfluthrin, β-flumethrin , Cypermethrin, λ-cypermethrin, cypermethrin, α-cypermethrin, β-cypermethrin, θ-cypermethrin, ζ-cypermethrin, cypermethrin [(1R)-trans isomer], deltamethrin, fenvalerate [ (EZ)-(1R)-isomer], esfenvalerate, cypermethrin, fenvalerate, fenvalerate, cyfluthrin, cyfluthrin, t-valproic acid Salt, fluorophenylacetone, iminthrin, cardesline, morphfluthrin, permethrin, phenol [(1R)-trans isomer], pyrethrin, pyrethrin (pyridin) Pyrethrin), permethrin, silaflurane, tetrafluthrin, tetramethrin [(1R)-isomer], trimethrin and flumethrin or DDT or methoxychlor.

(4)煙鹼乙醯膽鹼受體競爭性調節劑(如新煙鹼類),例如啶蟲脒,噻蟲胺,呋蟲胺,吡蟲啉,烯啶蟲胺,噻蟲啉和噻蟲嗪或尼古丁或啶蟲胺腈或氟吡啶酮。(4) Nicotinic Acetylcholine receptor competitive regulators (such as neonicotinoids), such as acetamiprid, clothianidin, clothianidin, imidacloprid, nitenpyram, clothianidin and thiamethoxam Or nicotine or acetamiprid or fluopyridone.

(5)煙鹼乙醯膽鹼受體變構調節劑,例如多殺菌素、乙基多殺菌素和多殺菌素。(5) Nicotinic acetylcholine receptor allosteric modulators, such as spinosyn, ethyl spinosyn and spinosyn.

(6)谷氨酸門控氯離子通道變構調節劑(如阿維菌素/米爾倍黴素),例如阿維菌素、甲氨基阿維菌素苯甲酸鹽、雷皮菌素和米爾貝菌素。(6) Glutamate-gated chloride channel allosteric modulators (eg avermectin/milbemycin), such as avermectin, emamectin benzoate, rapamycin and Milbemycin.

(7)幼年激素類似物,如幼年激素類似物,例如氫化腎上腺素、激肽和甲氧基腎上腺素或苯氧基碳或吡咯氧基苯。(7) Juvenile hormone analogues, such as juvenile hormone analogues, such as hydrogenated epinephrine, kinin and methoxyadrenaline or phenoxycarbon or pyrroleoxybenzene.

(8)具有未知或非特異性作用機理的活性化合物,例如烷基鹵化物,例如甲基溴和其他烷基鹵化物或氯化苦或氟化物或硼酸鹽或酒石酸催化劑或甲基異氰酸酯發生劑。(8) Active compounds with unknown or non-specific mechanisms of action, such as alkyl halides, such as methyl bromide and other alkyl halides or chloropicrin or fluoride or borate or tartaric acid catalysts or methyl isocyanate generators .

(9)脈絡膜器官TRPV通道調節劑,如吡啶偶氮甲胺衍生物,例如吡唑嗪和吡喹酮或氟尼康。(9) TRPV channel modulators of choroid organs, such as pyridine azomethine derivatives, such as pyrazosin and praziquantel or flunikon.

(10)蟎類生長抑制劑,例如氯芬太嗪、己噻唑和二氟維嗪或依託沙唑。(10) Mite growth inhibitors, such as clofenazine, hexthiazole, difluvizine, or etoxazole.

(11)昆蟲腸道中腸的微生物破壞劑,例如蘇雲金芽孢桿菌以色列亞種,蘇雲金芽孢桿菌亞種,蘇雲金芽孢桿菌亞種,蘇雲金芽孢桿菌亞種和球形芽孢桿菌和BT作物蛋白:Cry1Ab、Cry1Ac、Cry1Fa、Cry1A105、Cry2Ab、Vip3a、mCry3A、Cry3Ab、Cry3Bb、Cry34Ab1 / Cry35Ab1。(11) Microbial destroying agents in the midgut of insect intestines, such as Bacillus thuringiensis subspecies Israel, Bacillus thuringiensis subspecies, Bacillus thuringiensis subspecies, Bacillus thuringiensis subspecies and Bacillus sphaericus and BT crop protein: Cry1Ab, Cry1Ac, Cry1Fa, Cry1A105, Cry2Ab, Vip3a, mCry3A, Cry3Ab, Cry3Bb, Cry34Ab1/Cry35Ab1.

(12)線粒體ATP合成酶的抑制劑,如有機錫殺絲劑,例如氮環素、六氮雜環素、氧化芬丁丁、二苯磺隆、丙酮酸或四氫呋喃。(12) Inhibitors of mitochondrial ATP synthase, such as organotin silk killers, such as azacycline, hexaazacyclocycline, fenfenbutin, dibensulfuron, pyruvate, or tetrahydrofuran.

(13)通過破壞質子梯度而起作用的氧化磷酸化解偶聯劑,例如氯苯那吡、二硝甲酚和磺胺。(13) Oxidative phosphorylation decoupling agents that act by disrupting the proton gradient, such as chlorpheniride, dinitrocresol, and sulfonamide.

(14)煙鹼型乙醯膽鹼受體(nAChR)通道阻滯劑,如苯磺胺、卡他普-鹽酸鹽、硫環素和硫代硫酸鈉。(14) Nicotinic acetylcholine receptor (nAChR) channel blockers, such as benzene sulfonamide, catapult-hydrochloride, thiocycline and sodium thiosulfate

(15)0型幾丁質生物合成的抑制劑,如雙三氟,氯氟脲,除蟲脲,氟尿嘧啶,氟蟲脲,氟鈴脲,虱蟎脲,諾瓦龍,新氟脲,二硝甲酚和殺鈴脲。(15) Inhibitors of type 0 chitin biosynthesis, such as bistrifluoro, chlorofluorourea, diflubenzuron, fluorouracil, fipronil, fluflubenzuron, lofenil, novaron, neoflufen, Nitrocresol and triflumuron.

(16)1型幾丁質生物合成的抑制劑,例如噻嗪酮。(16) Inhibitors of type 1 chitin biosynthesis, such as thiazinone.

(17)蛻皮干擾物(特別是在雙翅目中),如環丙氨嗪。(17) Molt disturbing substances (especially in Diptera), such as cypromazine.

(18)蛻皮激素受體激動劑,例如環蟲醯肼,氯苯肼,甲氧蟲醯肼和蟲醯肼。(18) Ecdysone receptor agonists, such as cyclic chlorhydrazine, chlorophenylhydrazine, methoxyphenazide, and hydrazide.

(19)章魚胺受體激動劑,如雙甲脒。(19) Octopamine receptor agonists, such as biformamidine.

(20)線粒體複合物III電子傳遞抑制劑,如肼甲基農、無馬來醯基、氟丙烯嘧啶或聯苯那酯。(20) Mitochondrial complex III electron transport inhibitors, such as hydrazinium, non-maleimide, fluoropyrimidine, or bifenate.

(21)線粒體複合物I電子傳遞抑制劑,例如,METI殺蟎劑和殺蟲劑,例如芬那氮喹、苯吡肟、嘧啶芬、吡啶、替布芬吡喃和甲苯吡喃或魚藤酮。(21) Mitochondrial complex I electron transport inhibitors, for example, METI acaricides and insecticides, such as fenazinoquine, fenpyrazine, pyrimidin, pyridine, tebufenpyran, and tolupyran or rotenone.

(22)電壓依賴性鈉通道阻滯劑,如茚蟲威或氰氟蟲胺。(22) Voltage-dependent sodium channel blockers, such as indoxacarb or cyproteron.

(23)乙醯輔酶A羧化酶抑制劑,如四元酸和四元酸衍生物,例如螺地洛芬、螺美辛和螺替曲馬特。(23) Acetyl-CoA carboxylase inhibitors, such as tetrabasic acids and tetrabasic acid derivatives, such as spirodiprofen, spiromethacin, and spirotript.

(24)線粒體複合物IV電子傳遞抑制劑,例如磷化物,例如磷化鋁,磷化鈣,磷化鋅和磷化氫或氰化物。(24) Mitochondrial complex IV electron transport inhibitors, such as phosphides, such as aluminum phosphide, calcium phosphide, zinc phosphide, and phosphine or cyanide.

(25)線粒體複合物II電子傳遞抑制劑,如β-酮腈衍生物,例如氰基吡喃和氟氰菊酯或甲醯胺。(25) Mitochondrial complex II electron transport inhibitors, such as β-ketonitrile derivatives, such as cyanopyran and cyfluthrin or methamphetamine.

(26)魚尼丁受體調節劑如二醯胺,例如氯蟲苯甲醯胺,氰蟲醯胺,氟蟲雙醯胺,四硝基吡咯,(R)-3-氯-N-1-{2-甲基-4-[1,2,2,2-四氟-1-( 三氟甲基)乙基]苯基}-N2-(1-甲基-2-甲基磺醯基乙基)鄰苯二甲醯胺,(S)-3-氯-N1-{2-甲基-4-[1,2,2,2-四氟-1-(三氟甲基)乙基]苯基}-N2-(1-甲基-2-甲基磺醯基乙基)鄰苯二甲醯胺,甲基-2-[3,5-二溴-2-({[3-溴-1-(3-氯吡啶-2-)基)-1H-吡唑-5-基]羰基}氨基)苯甲醯基]-1,2-二甲基肼羧酸鹽,N-[4,6-二氯-2-[(二乙基λ-4硫烷基)氨基甲醯基]-苯基]-2-(3-氯-2-吡啶基)-5-(三氟甲基)吡唑-3-甲醯胺,N-[4-氯-2-[(二乙基λ-4硫烷基)氨基甲醯基]-6-甲基-苯基]-2-(3-氯-2-吡啶基)-5-(三氟甲基)吡唑-3-羧醯胺,N-[4-氯-2-[(二-2-丙基-λ-4-亞磺醯基)氨基甲醯基]-6-甲基-苯基]-2-(3-氯-2-吡啶基)-5-(三氟甲基)吡唑-3-甲醯胺,N-[4,6-二氯-2-[(二-2-丙基-λ-4-磺醯亞胺)氨基甲醯基]苯基]-2-(3-氯-2-吡啶基)-5-(三氟甲基)吡唑-3-甲醯胺,N-[4,6-二溴-2-[(二乙基-λ-4-硫烷基)氨基甲醯基]-苯基]-2-(3-氯-2-吡啶基)-5-(三氟甲基)吡唑-3-甲醯胺,N-[2-(5-氨基-1,3,4-噻二唑-2-基)-4-氯-6-甲基苯基]-3-溴-1-(3-氯-2-吡啶基)-1H-吡唑-5-甲醯胺;3-氯-1-(3-氯-2-吡啶基)-N-[2,4-二氯-6-[[(1-氰基-1-甲基乙基)氨基]羰基]苯基]-1H-吡唑-5-甲醯胺,3-溴-N-[2,4-二氯-6-(甲基氨基甲醯基)苯基]-1-(3,5-二氯-2-吡啶基)-1H-吡唑-5-甲醯胺,N-[4-氯-2-[[(1,1-二甲基乙基)氨基]羰基]-6-甲基苯基]-1-(3-氯-2-吡啶基)-3-(氟甲氧基)-1H-吡唑-5-甲醯胺和氰代二醯胺。(26) Fish nicotine receptor modulators such as diamidamide, such as chlorantraniliprole, cyanamide, fipronil, tetranitropyrrole, (R)-3-chloro-N-1 -{2-methyl-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]phenyl}-N2-(1-methyl-2-methylsulfonamide Ethyl) phthalamide, (S)-3-chloro-N1-{2-methyl-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl Yl]phenyl}-N2-(1-methyl-2-methylsulfonylethyl) o-xylylenediamine, methyl-2-[3,5-dibromo-2-({[3 -Bromo-1-(3-chloropyridin-2-)yl)-1H-pyrazol-5-yl]carbonyl}amino)benzyl]-1,2-dimethylhydrazine carboxylate, N- [4,6-Dichloro-2-[(diethylλ-4sulfanyl)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoro Methyl)pyrazole-3-carboxamide, N-[4-chloro-2-[(diethylλ-4sulfanyl)carbamoyl]-6-methyl-phenyl]-2- (3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide, N-[4-chloro-2-[(di-2-propyl-λ-4- Sulfenyl)carbamyl]-6-methyl-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide, N-[4,6-dichloro-2-[(di-2-propyl-λ-4-sulfonylimide)carbamoyl]phenyl]-2-(3-chloro-2-pyridyl )-5-(trifluoromethyl)pyrazole-3-carboxamide, N-[4,6-dibromo-2-[(diethyl-λ-4-sulfanyl)carbamoyl] -Phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide, N-[2-(5-amino-1,3,4 -Thiadiazol-2-yl)-4-chloro-6-methylphenyl]-3-bromo-1-(3-chloro-2-pyridyl)-1H-pyrazole-5-carboxamide; 3-chloro-1-(3-chloro-2-pyridyl)-N-[2,4-dichloro-6-[[(1-cyano-1-methylethyl)amino]carbonyl]phenyl ]-1H-pyrazole-5-carboxamide, 3-bromo-N-[2,4-dichloro-6-(methylcarbamoyl)phenyl]-1-(3,5-dichloro -2-pyridyl)-1H-pyrazole-5-carboxamide, N-[4-chloro-2-[[(1,1-dimethylethyl)amino]carbonyl]-6-methylbenzene Yl]-1-(3-chloro-2-pyridyl)-3-(fluoromethoxy)-1H-pyrazole-5-carboxamide and cyanodiamide.

(27)在未定義的靶點如氟尼康胺上的脊索器官調節劑。(27) Notochord organ modulators on undefined targets such as flunikonium.

具有未知或不確定作用模式的其他活性成分,如阿非吡喃酮、阿福唑啉、印楝素、苯並噻唑、苯甲醯肟、聯苯那酯、溴氰菊酯、溴丙酸酯、甲殼胺、冰晶石、環磷脂、環磷醯胺、氟二醯胺、二氯甲基偶氮唑、二氯殺蟎醇、二氟維嗪、氟美喹、氟氮卓嗪、氟磺酸、氟苯那林、氟苯氧氟脲、氟丙烷、氟己酮、氟吡喃、氟拉烷、氟甲醯胺、氟甲醯胺、氟脲嘧啶、氟脲嘧啶、呋喃噻嗪、胍基吡喃、庚氟蘇、吡咯烷、異丙酮、洛替蘭、甲氟蘇、止痛藥、吡哆醇、嘧啶核苷、sa丙烷、四甲基氟蘇氨酸、四苯乙烯基脯氨酸、四氯蒽醌基脯氨酸、噻唑嗪、三氟甲嘧啶和碘甲烷;此外,基於堅固芽孢桿菌(I-1582,BioNeem,Votivo)的製劑, 和以下已知的活性化合物:1-{2-氟-4-甲基-5-[(2,2,2-三氟乙基)亞磺醯基]苯基}-3-(三氟甲基)-1H-1,2,4-三唑-5-胺(從WO2006043635)、{1'-[(2E)-3-(4-氯苯基)丙-2-烯-1-基]-5-氟螺[吲哚-3,4'-呱啶]-1(2H)-基(2-氯吡啶-4-基)甲酮(從WO2003106457中已知)、2-氯-N-[2-{1-[(2E)-3-(4-氯苯基)丙-2-烯-1-基)]呱啶-4-基}-4-(三氟甲基)苯基]異煙醯胺(從WO2006003494中已知)、3-(2,5-二甲基苯基)-4-羥基-8-甲氧基-1,8-二氮雜螺[4.5] 3-en-2-one(從WO2009049851中已知)、3-(2,5-二甲基苯基)-8-甲氧基-2-氧代-1,8-二氮雜螺[4.5]癸-3-烯-4-基乙基碳酸酯(從WO2009049851中已知、4-(丁-2-炔-1-基氧基)-6-(3,5-二甲基呱啶-1-基)-5-氟嘧啶(已知自WO2004099160)、4-(但-2-中-1-基氧基)-6-(3-氯苯基)嘧啶(已知自WO2003076415)、PF1364(CAS-Reg.No.1204776-60-2)、甲基-2-[2-({[3-Bromo-1]-(3-氯吡啶-2-基)-1H-吡唑-5-基]羰基}氨基)-5-氯-3-甲基苯甲醯基]-2-甲基肼基羧酸酯(已知自WO2005085216)、甲基-2-[2-({[3-溴-1-(3-氯吡啶-2-基)-1H-吡唑-5-基]羰基}氨基)-5-氰基-3-甲基苯甲醯基] 2-乙基肼基羧酸酯(已知自WO2005085216)、甲基-2-[2-({[3-溴-1-(3-氯-吡啶-2-基)-1H-吡唑-5-基]羰基}氨基)-5-氰基-3-甲基苯甲醯基]-2-甲基肼基羧酸酯(已知自WO2005085216)、甲基-2-[3,5-二溴-2-({[3-溴-1-(3-氯-吡啶-2-酮)(1H-吡唑-5-基]羰基}氨基)苯甲醯基]-2-乙基肼基羧酸酯(已知自WO2005085216)、N-[2-(5-氨基-1,3,4-噻二唑-2-基)-4-氯-6-甲基苯基]-3-溴-1-(3-氯吡啶-2-基)-1H-吡唑-5-甲醯胺(已知CN102057925)、4-[5-(3,5-二氯苯基)-5-(三氟甲基)-4,5-二氫-1,2-惡唑-3-基]-2-甲基-N-(1-氧硫雜環丁烷-3-基)苯甲醯胺(已知自WO2009080250)、N-[(2E)-1-[(6-氯吡啶-3-基)甲基]吡啶-2(1H)-亞基]-2,2,2-三氟乙醯胺(公知自WO2012029672)、1-[(2-氯-1,3-噻唑-5-基)甲基]-4-氧代-3-苯基-4H-吡啶並[1,2-a]嘧啶-1-鎓-2-醇鹽(已知fr WO2009099929)、1-[(6-氯吡啶-3-基)甲基]-4-氧代-3-苯基-4H-吡啶並[1,2-a]嘧啶-1-鎓-2-醇鹽(已知自WO2009099929))、4-(3-{2,6-二氯-4-[(3,3-二氯丙-2-烯-1-基)氧基]苯氧基}丙氧基)-2-甲氧基-6-(三氟甲基)嘧啶(由CN101337940已知)、N-[2-(叔丁基氨基甲醯基)-4-氯-6-甲基苯基]-1-(3-氯吡啶-2-基)-3-(氟甲氧基)-1H-吡唑-5-甲醯胺(從WO2008134969中已知)、丁基-[2-(2,4-二氯苯基)-3-氧代-4-氧雜螺[4.5]癸-1-烯-1-基]碳酸酯(在CN102060818中公開)、3(E)-3-[1-[(6-氯-3-吡啶基)甲基]-2-吡啶基]-1,1,1-三氟丙-2-酮(已知自WO2013144213)、N-(甲基磺醯基)-6-[ 2-(吡啶-3-基)-1,3-噻唑-5-基]吡啶-2-甲醯胺(由WO2012000896已知)、N-[3-(苄基氨基甲醯基)-4-氯苯基]-1-甲基-3-(五氟乙基)-4-(三氟甲基)-1H-吡唑-5-甲醯胺(從WO2010051926中已知)。Other active ingredients with unknown or uncertain modes of action, such as amphiprone, aforazoline, azadirachtin, benzothiazole, benzoxime, bifenate, deltamethrin, bromopropionic acid Ester, chitosan, cryolite, cyclophospholipid, cyclophosphamide, fluorodiamide, dichloromethyl azozole, dicofol, difluvizine, flumequine, fluazoxazine, fluorine Sulfonic acid, fluorophenalin, fluorophenoxyfluorourea, fluoropropane, fluorohexanone, fluoropyran, flurane, fluoroformamide, fluoroformamide, fluorouracil, fluorouracil, furanthiazine , Guanidinopyran, hepflurane, pyrrolidine, isoacetone, lotiline, meflurane, analgesics, pyridoxine, pyrimidine nucleoside, sa propane, tetramethylfluorothreonine, tetrastyryl Proline, tetrachloroanthraquinone proline, thiazolazine, trifluoropyrimidine, and methyl iodide; in addition, formulations based on Bacillus firmus (I-1582, BioNeem, Votivo), and the following known active compounds: 1-{2-fluoro-4-methyl-5-[(2,2,2-trifluoroethyl)sulfinyl]phenyl]-3-}(trifluoromethyl)-1H-1,2 ,4-triazole-5-amine (from WO2006043635), {1'-[(2E)-3-(4-chlorophenyl)prop-2-en-1-yl]-5-fluorospiro[indole -3,4'-pyridinyl]-1(2H)-yl(2-chloropyridin-4-yl)methanone (known from WO2003106457), 2-chloro-N-[2-{1-[( 2E)-3-(4-chlorophenyl)prop-2-en-1-yl)]pyridin-4-yl}-4-(trifluoromethyl)phenyl]isonicotinamide (from WO2006003494 Known), 3-(2,5-dimethylphenyl)-4-hydroxy-8-methoxy-1,8-diazaspiro[4.5] 3-en-2-one (from WO2009049851 Known), 3-(2,5-dimethylphenyl)-8-methoxy-2-oxo-1,8-diazaspiro[4.5]dec-3-en-4-ylethane Carbonate (known from WO2009049851, 4-(but-2-yn-1-yloxy)-6-(3,5-dimethylpyridin-1-yl)-5-fluoropyrimidine (already Known from WO2004099160), 4-(but-2-in-1-yloxy)-6-(3-chlorophenyl)pyrimidine (known from WO2003076415), PF1364 (CAS-Reg. No. 1204776-60- 2). Methyl-2-[2-({[3-Bromo-1]-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)-5-chloro- 3-methylbenzyl]-2-methylhydrazinocarboxylate (known from WO2005085216), methyl-2-[2-({[3-bromo-1-(3-chloropyridine-2 -Yl)-1H-pyrazol-5-yl]carbonyl}amino)-5-cyano-3-methylbenzyl] 2-ethylhydrazinocarboxylate (known from WO2005085216), methyl -2- [2-({[3-Bromo-1-(3-chloro-pyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)-5-cyano-3-methylbenzoyl Yl]-2-methylhydrazinocarboxylate (known from WO2005085216), methyl-2-[3,5-dibromo-2-({[3-bromo-1-(3-chloro-pyridine- 2-keto) (1H-pyrazol-5-yl]carbonyl}amino)benzyl]-2-ethylhydrazinocarboxylate (known from WO2005085216), N-[2-(5-amino- 1,3,4-thiadiazol-2-yl)-4-chloro-6-methylphenyl]-3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazole-5 -Methamide (known CN102057925), 4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazole-3 -Yl]-2-methyl-N-(1-oxathiobutane-3-yl)benzamide (known from WO2009080250), N-[(2E)-1-[(6-chloro Pyridin-3-yl)methyl]pyridine-2(1H)-subunit]-2,2,2-trifluoroacetamide (well known from WO2012029672), 1-[(2-chloro-1,3-thiazole -5-yl)methyl]-4-oxo-3-phenyl-4H-pyrido[1,2-a]pyrimidin-1-ium-2-alkoxide (known fr WO2009099929), 1-[ (6-chloropyridin-3-yl)methyl]-4-oxo-3-phenyl-4H-pyrido[1,2-a]pyrimidin-1-ium-2-olate (known from WO2009099929 )), 4-(3-{2,6-dichloro-4-[(3,3-dichloroprop-2-en-1-yl)oxy]phenoxy}propoxy)-2- Methoxy-6-(trifluoromethyl)pyrimidine (known from CN101337940), N-[2-(tert-butylcarbamoyl)-4-chloro-6-methylphenyl]-1-( 3-chloropyridin-2-yl)-3-(fluoromethoxy)-1H-pyrazole-5-carboxamide (known from WO2008134969), butyl-[2-(2,4-dichloro Phenyl)-3-oxo-4-oxaspiro[4.5]dec-1-en-1-yl]carbonate (disclosed in CN102060818), 3(E)-3-[1-[(6- Chloro-3-pyridyl)methyl]-2-pyridyl]-1,1,1-trifluoropropan-2-one (known from WO2013144213), N-(methylsulfonyl)-6-[ 2-(pyridin-3-yl)-1,3-thiazol-5-yl]pyridine-2-carboxamide (known from WO2012000896), N-[3-(benzylcarbamoyl)-4- Chlorophenyl]-1-methyl-3-(pentafluoroethyl)-4-(trifluoromethyl)-1H-pyrazole-5-carboxamide (known from WO2010051926).

其他未知或不確定作用方式的殺蟲活性化合物:11-(4-氯-2,6-二甲基苯基)-12-羥基-1,4-二氧雜-9-氮雜螺[4.2.4.2]-十四碳-11-烯-10-酮、3-(4'-氟)-2,4-二甲基聯苯-3-基)-4-羥基-8-氧雜-1-氮雜螺[4.5]癸-3-烯-2-酮、1-[2-氟-4-甲基-5-[(2,2,2-三氟乙基)亞磺醯基]苯基]-3-(三氟甲基)-1H-1,2,4-三唑-5-胺、堅強芽孢桿菌;(E / Z)-N-[1-[(6-氯-3-吡啶基)甲基]-2-吡啶基]-2,2,2-三氟-乙醯胺;(E / Z)-N-[1-[(6-氯-5-氟-3-吡啶基)甲基]-2-吡啶亞基]-2,2,2-三氟-乙醯胺;(E / Z)-2,2,2-三氟-N-[1-[(6-氟-3-吡啶基)甲基]-2-吡啶亞基〕乙醯胺;(E / Z)-N-[1-[(6-溴-3-吡啶基)甲基]-2-吡啶亞基]-2,2,2-三氟乙醯胺;(E / Z)-N-[1-[1-(6-氯-3-吡啶基)乙基]-2-吡啶亞基]-2,2,2-三氟乙醯胺;(E / Z)-N-[1-[(6-氯-3-吡啶基)甲基]-2-吡啶亞基]-2,2-二氟-乙醯胺;(E / Z)-2-氯-N-[1-[(6-氯-3-吡啶基)甲基]-2-吡啶基]-2,2-二氟-乙醯胺;(E / Z)-N-[1-[(2-氯嘧啶-5-基)甲基]-2-吡啶亞基]-2,2,2-三氟-乙醯胺;(E / Z)-N-[1-[(6-氯-3-吡啶基)甲基]-2-吡啶亞基]-2,2,3,3,3-五氟-丙醯胺);N-[1-[(6-氯-3-吡啶基)甲基]-2-吡啶基]-2,2,2-三氟-硫代乙醯胺;N-[1-[(6-氯-3-吡啶基)甲基]-2-吡啶亞基]-2,2,2-三氟-N'-異丙基-乙脒;氟氮吲哚嗪;4-[5-(3,5-二氯苯基)-5-(三氟甲基)-4H-異惡唑-3-基]-2-甲基-N-(1-奧索替坦-3-基)苯甲醯胺;氟氮吲哚嗪;5-[3-[2,6-二氯-4-(3,3-二氯烯丙基氧基)苯氧基]丙氧基]-1H-吡唑;3-(苯甲醯甲氨基)-N-[2-溴-4-[1,2,2,3,3,3六氟-1-(三氟甲基)丙基]-6-(三氟甲基)苯基]-2-氟苯甲醯胺;3-(苯甲醯甲氨基)-2-氟-N-[2-碘-4-[1,2,2,2-四氟-1-(三氟甲基)乙基]-6-(三氟甲基)苯基]-苯甲醯胺;N-[3-[[[2-碘-4-[1,2,2,2-四氟-1-(三氟甲基)乙基]-6-(三氟甲基)苯基]氨基]羰基]苯基]-N-甲基苯甲醯胺;N-[3-[[[2-溴-4-[1,2,2,2-四氟-1-(三氟甲基)乙基]-6-(三氟甲基)苯基]氨基]羰基]-2-氟苯基]-4-氟-N-甲基苯甲醯胺;4-氟-N-[2-氟-3-[[[2-碘-4-[1,2,2,2-四氟-1-(三氟甲基)乙基]-6-(三氟甲基)苯基]氨基]羰基]苯基]-N-甲基-苯甲醯胺;3-氟代N-[2-氟-3-[[[2-碘-4-[1,2,2,2-四氟-1-(三氟甲基)乙基]-6-(三氟甲基)苯基]氨基]羰基]苯基基]-N-甲基-苯甲醯胺;2-氯-N-[3-[[[2-碘-4-[1,2,2,2-四氟-1-(三氟甲基)乙基]-6-(三氟甲基)苯基]氨基]羰基]苯基]-3-吡啶甲醯胺;4-氰基-N-[2-氰基-5-[[2,6-二溴-4-[1,2,2,3,3,3-六氟-1-(三氟甲基)丙基]苯基]氨基甲醯基]苯基]-2-甲基-苯甲醯胺;4-氰基-3-[(4-氰基-2-甲基-苯甲醯基)氨基]-N-[2,6-二氯-4-[-1,2,2,3,3-,3-六氟-1-(三氟甲基)丙基]苯基]-2-氟-苯甲醯胺;N-[5-[[2-氯-6-氰基-4-[1,2,2,3,3,3六氟-1-(三氟甲基)丙基]苯基]氨基甲醯基]-2-氰基-苯基]-4-氰基-2-甲基-苯甲醯胺;N-[5-[[2-溴-6-氯-4-[2,2,2-三氟-1-羥基-1-(三氟甲基)乙基]苯基]氨基甲醯基]-2-氰基-苯基]-4--氰基-2-甲基-苯甲醯胺;N-[5-[[2-溴-6-氯-4-[1,2,2,3,3,3-六氟-1-(三氟甲基)丙基]苯基]氨基甲醯基]-2-氰基-苯基]-4-氰基-2-甲基-苯甲醯胺;4-氰基-N-[2-氰基-5-[[2,6-二氯-4-[1,2,2,3,3,3六氟-1-(三氟甲基)丙基]苯基]氨基甲醯基]苯基]-2-甲基-苯甲醯胺;4-氰基-N-[2-氰基-5-[[2,6-二氯-4-[1,2,2,2-四氟-1-(三氟甲基)乙基]苯基]氨基甲醯基]苯基]-2-甲基-苯甲醯胺;N-[5-[[2-溴-6-氯-4-[1,2,2,2-四氟-1-(三氟甲基)乙基]苯基]氨基甲醯基]-2-氰基鄰苯基]-4-氰基-2-甲基-苯甲醯胺;2-(1,3-二惡烷-2-基)-6-[2-(3-吡啶基)-5-噻唑基]-吡啶;2-[6-[2-(5-氟-3-吡啶基)-5-噻唑基]-2-吡啶基]-嘧啶;2-[6-[2-(3-吡啶基)-5-噻唑基]-2-吡啶基]-嘧啶;的N-甲基磺醯基-6-[2-(3-吡啶基)噻唑-5-基]吡啶-2-甲醯胺;的N-甲基磺醯基-6-[2-(3-吡啶基)噻唑-5-基]吡啶-2-甲醯胺;N-乙基-N-[4-甲基-2-(3-吡啶基)噻唑-5-基]-3-甲硫基-丙醯胺;N-甲基-N-[4-甲基-2-(3-吡啶基)噻唑-5-基]-3-甲硫基丙醯胺;N,2-二甲基-N-[4-甲基-2-(3-吡啶基)基)噻唑-5-基]-3-甲基硫代丙醯胺;N-乙基-2-甲基-N-[4-甲基-2-(3-吡啶基)噻唑-5-基]-3-甲基硫代丙醯胺;N-[4-氯-2-(3-吡啶基)噻唑-5-基]-N-乙基-2-甲基-3-甲硫基-丙醯胺e;N-[4-氯-2-(3-吡啶基)噻唑-5-基]-N,2-二甲基-3-甲硫基丙醯胺;N-[4-氯-2-(3-吡啶基)噻唑-5-基]-N-甲基-3-甲硫基丙醯胺;N-[4-氯-2-(3-吡啶基)噻唑-5-基]-N-乙基-3-甲硫基丙醯胺;1-[(6-氯-3-吡啶基)甲基]-1,2,3,5,6,7-六氫-5-甲氧基-7-甲基-8-硝基咪唑並[1,2-a]吡啶1-[(6-氯吡啶-3-基)甲基]-7-甲基-8-硝基1,2,3,5,6,7-六氫[1,2-a]吡啶-5-醇;1-異丙基-N,5-二甲基-N-噠嗪-4-基吡唑-4-甲醯胺;1-(1,2-二甲基丙基)-N-乙基-5-甲基-N-噠嗪-4-基-吡唑-4-甲醯胺;N,5-二甲基-N-噠嗪-4-基-1-(2,2,2-三氟-1-甲基-乙基)吡唑-4-甲醯胺;1-[1-(1-氰基環丙基)乙基]-N-乙基-5-甲基-N-噠嗪-4-基吡唑-4-甲醯胺;N-乙基-1-(2-氟-1-甲基-丙基)-5-甲基-N-噠嗪-4-基吡唑-4-甲醯胺;1-(1,2-二甲基丙基)-N,5-二甲基-N-噠嗪-4-基吡唑-4-甲醯胺;1-[1-(1-氰基環丙基)乙基]-N,5-二甲基-N-噠嗪-4-基-吡唑-4-甲醯胺;N-甲基-1-(2-氟-1-甲基-丙基)-5-甲基-N-噠嗪-4-基-吡唑-4-甲醯胺;1-(4,4-二氟環己基)-N-乙基-5-甲基-N-噠嗪-4-基-吡唑-4-甲醯胺;1-(4,4-二氟環己基)-N,5-二甲基-N-噠嗪-4-基-吡唑-4-甲醯胺,N-( 1-甲基乙基)-2-(3-吡啶基)-2H-吲唑-4-甲醯胺;N-環丙基-2-(3-吡啶基)-2H-吲唑-4-甲醯胺;N-環己基-2-(3-吡啶基)-2H-吲唑-4-甲醯胺;2-(3-吡啶基)-N-(2,2,2-三氟乙基)-2H-吲唑-4-甲醯胺;2-(3-吡啶基)-N-[(四氫-2-呋喃基)甲基]-2H-吲唑-5-羧醯胺;2-[[2-(3-吡啶基)-2H-吲唑-5-基]羰基]肼甲酸甲酯;N-[(2,2-二氟環丙基)甲基]-2-(3-吡啶基)-2H-吲唑-5-羧醯胺;N-(2,2-二氟丙基)-2-(3-吡啶基)-2H-吲唑-5-羧醯胺;2-(3-吡啶基)N-(2-嘧啶基甲基)-2H-吲唑-5-甲醯胺;N-[(5-甲基-2-吡嗪基)甲基]-2-(3-吡啶基)-2H-吲唑-5-甲醯胺,N-[3-氯-1-(3-吡啶基)吡唑-4-基] N-乙基-3-(3,3,3-三氟丙基硫烷基))丙醯胺;N-[3-氯-1-(3-吡啶基)吡唑-4-基]-N-乙基-3-(3,3,3-三氟丙基亞磺醯基)丙醯胺;N-[3-氯-1-(3-吡啶基)吡唑-4-基]-3-[(2,2-二氟環丙基)甲基硫烷基]-N-乙基-丙醯胺;N-[3-氯-1-(3-吡啶基)吡唑-4-基]-3-[(2,2-二氟環丙基)甲基亞磺醯基]-N-乙基-丙醯胺;薩歐蘭那、洛替拉納、異囉唑啉、甲醯胺基吡唑。Other insecticidal active compounds of unknown or uncertain mode of action: 11-(4-chloro-2,6-dimethylphenyl)-12-hydroxy-1,4-dioxa-9-azaspiro[4.2 .4.2]-tetradec-11-en-10-one, 3-(4'-fluoro)-2,4-dimethylbiphenyl-3-yl)-4-hydroxy-8-oxa-1 -Azaspiro[4.5]dec-3-en-2-one, 1-[2-fluoro-4-methyl-5-[(2,2,2-trifluoroethyl)sulfinyl]benzene Group]-3-(trifluoromethyl)-1H-1,2,4-triazol-5-amine, Bacillus firmus; (E/Z)-N-[1-[(6-chloro-3- Pyridyl)methyl]-2-pyridyl]-2,2,2-trifluoro-acetamide; (E/Z)-N-[1-[(6-chloro-5-fluoro-3-pyridine Yl)methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide; (E/Z)-2,2,2-trifluoro-N-[1-[(6- Fluoro-3-pyridyl)methyl]-2-pyridylidene]acetamide; (E/Z)-N-[1-[(6-bromo-3-pyridyl)methyl]-2-pyridine Subunit]-2,2,2-trifluoroacetamide; (E/Z)-N-[1-[1-(1-chloro-3-pyridyl)ethyl]-2-pyridylidene] -2,2,2-trifluoroacetamide; (E/Z)-N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2- Difluoro-acetamide; (E/Z)-2-chloro-N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridyl]-2,2-difluoro- Acetamide; (E/Z)-N-[1-[(2-chloropyrimidin-5-yl)methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide; (E/Z)-N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2,3,3,3-pentafluoro-propionamide) ; N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridyl]-2,2,2-trifluoro-thioacetamide; N-[1-[(6 -Chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro-N'-isopropyl-acetamidine; fluoroazindolazine; 4-[5-( 3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-isoxazol-3-yl]-2-methyl-N-(1-oxotetan-3-yl)benzene Formamide; Fluazindolzine; 5-[3-[2,6-dichloro-4-(3,3-dichloroallyloxy)phenoxy]propoxy]-1H-pyridine Azole; 3-(benzylamino)-N-[2-bromo-4-[1,2,2,3,3,3hexafluoro-1-(trifluoromethyl)propyl]-6- (Trifluoromethyl)phenyl]-2-fluorobenzamide; 3-(benzylamino)-2-fluoro-N-[2-iodo-4-[1,2,2,2- Tetrafluoro-1-(trifluoromethyl)ethyl]-6-(trifluoromethyl)phenyl]-benzamide; N-[3-[[[2-iodo-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]-6-(trifluoromethyl)phenyl]amino ]Carbonyl]phenyl]-N-methylbenzamide; N-[3-[[[2-bromo-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl) Ethyl]-6-(trifluoromethyl)phenyl]amino]carbonyl]-2-fluorophenyl]-4-fluoro-N-methylbenzamide; 4-fluoro-N-[2-fluoro -3-[[[2-iodo-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]-6-(trifluoromethyl)phenyl]amino]carbonyl ]Phenyl]-N-methyl-benzamide; 3-fluoro N-[2-fluoro-3-[[[2-iodo-4-[1,2,2,2-tetrafluoro-1 -(Trifluoromethyl)ethyl]-6-(trifluoromethyl)phenyl]amino]carbonyl]phenyl]-N-methyl-benzamide; 2-chloro-N-[3- [[[2-Iodo-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]-6-(trifluoromethyl)phenyl]amino]carbonyl]phenyl ]-3-pyridylcarboxamide; 4-cyano-N-[2-cyano-5-[[2,6-dibromo-4-[1,2,2,3,3,3-hexafluoro -1-(trifluoromethyl)propyl]phenyl]carbamoyl]phenyl]-2-methyl-benzamide; 4-cyano-3-[(4-cyano-2- Methyl-benzyl)amino]-N-[2,6-dichloro-4-[-1,2,2,3,3-,3-hexafluoro-1-(trifluoromethyl)propane Yl]phenyl]-2-fluoro-benzamide; N-[5-[[2-chloro-6-cyano-4-[1,2,2,3,3,3hexafluoro-1- (Trifluoromethyl)propyl]phenyl]carbamoyl]-2-cyano-phenyl]-4-cyano-2-methyl-benzamide; N-[5-[[2 -Bromo-6-chloro-4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]carbamoyl]-2-cyano-phenyl ]-4--cyano-2-methyl-benzamide; N-[5-[[2-bromo-6-chloro-4-[1,2,2,3,3,3-hexafluoro -1-(trifluoromethyl)propyl]phenyl]carbamoyl]-2-cyano-phenyl]-4-cyano-2-methyl-benzamide; 4-cyano- N-[2-cyano-5-[[2,6-dichloro-4-[1,2,2,3,3,3hexafluoro-1-(trifluoromethyl)propyl]phenyl] Carboxamide]phenyl]-2-methyl-benzamide; 4-cyano-N-[2-cyano-5-[[2,6-dichloro-4-[1,2, 2,2-tetrafluoro-1-(trifluoromethyl)ethyl]phenyl]carbamoyl]phenyl]-2-methyl-benzamide; N-[5-[[2-bromo -6-chloro-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]phenyl]carbamoyl]-2-cyano-o-phenyl]-4- Cyano-2-methyl-benzamide; 2-(1,3-dioxan-2-yl)-6 -[2-(3-pyridyl)-5-thiazolyl]-pyridine; 2-[6-[2-(5-fluoro-3-pyridyl)-5-thiazolyl]-2-pyridyl]- Pyrimidine; 2-[6-[2-(3-pyridyl)-5-thiazolyl]-2-pyridyl]-pyrimidine; N-methylsulfonyl-6-[2-(3-pyridyl )Thiazol-5-yl]pyridine-2-carboxamide; N-methylsulfonyl-6-[2-(3-pyridyl)thiazol-5-yl]pyridine-2-carboxamide; N -Ethyl-N-[4-methyl-2-(3-pyridyl)thiazol-5-yl]-3-methylthio-propionamide; N-methyl-N-[4-methyl- 2-(3-pyridyl)thiazol-5-yl]-3-methylthiopropionamide; N,2-dimethyl-N-[4-methyl-2-(3-pyridyl)yl) Thiazol-5-yl]-3-methylthiopropionamide; N-ethyl-2-methyl-N-[4-methyl-2-(3-pyridyl)thiazol-5-yl]- 3-methylthiopropylamide; N-[4-chloro-2-(3-pyridyl)thiazol-5-yl]-N-ethyl-2-methyl-3-methylthio-propionamide Amine e; N-[4-chloro-2-(3-pyridyl)thiazol-5-yl]-N,2-dimethyl-3-methylthiopropionamide; N-[4-chloro-2 -(3-pyridyl)thiazol-5-yl]-N-methyl-3-methylthiopropylamide; N-[4-chloro-2-(3-pyridyl)thiazol-5-yl]- N-ethyl-3-methylthiopropylamide; 1-[(6-chloro-3-pyridyl)methyl]-1,2,3,5,6,7-hexahydro-5-methoxy Yl-7-methyl-8-nitroimidazo[1,2-a]pyridine1-[(6-chloropyridin-3-yl)methyl]-7-methyl-8-nitro1,2 ,3,5,6,7-hexahydro[1,2-a]pyridin-5-ol; 1-isopropyl-N,5-dimethyl-N-pyridazin-4-ylpyrazole-4 -Carboxamide; 1-(1,2-dimethylpropyl)-N-ethyl-5-methyl-N-pyridazin-4-yl-pyrazole-4-carboxamide; N, 5 -Dimethyl-N-pyridazin-4-yl-1-(2,2,2-trifluoro-1-methyl-ethyl)pyrazole-4-carboxamide; 1-[1-(1 -Cyanocyclopropyl)ethyl]-N-ethyl-5-methyl-N-pyridazin-4-ylpyrazole-4-carboxamide; N-ethyl-1-(2-fluoro- 1-methyl-propyl)-5-methyl-N-pyridazin-4-ylpyrazole-4-carboxamide; 1-(1,2-dimethylpropyl)-N,5-di Methyl-N-pyridazin-4-ylpyrazole-4-carboxamide; 1-[1-(1-cyanocyclopropyl)ethyl]-N,5-dimethyl-N-pyridazine -4-yl-pyrazole-4-carboxamide; N-methyl-1-(2-fluoro-1-methyl-propyl)-5-methyl-N-pyridazin-4-yl-pyridine Azole-4-carboxamide; 1-(4,4-difluorocyclohexyl)-N-ethyl-5-methyl-N-pyridazin-4-yl-pyrazole-4-carboxamide; 1 -(4,4-difluorocyclohexyl )-N,5-dimethyl-N-pyridazin-4-yl-pyrazole-4-carboxamide, N-(1-methylethyl)-2-(3-pyridyl)-2H- Indazole-4-carboxamide; N-cyclopropyl-2-(3-pyridyl)-2H-indazole-4-carboxamide; N-cyclohexyl-2-(3-pyridyl)-2H -Indazole-4-carboxamide; 2-(3-pyridyl)-N-(2,2,2-trifluoroethyl)-2H-indazole-4-carboxamide; 2-(3- Pyridyl)-N-[(tetrahydro-2-furyl)methyl]-2H-indazole-5-carboxamide; 2-[[2-(3-pyridyl)-2H-indazole-5 -Yl]carbonyl]hydrazinecarboxylic acid methyl ester; N-[(2,2-difluorocyclopropyl)methyl]-2-(3-pyridyl)-2H-indazole-5-carboxamide; N- (2,2-difluoropropyl)-2-(3-pyridyl)-2H-indazole-5-carboxamide; 2-(3-pyridyl)N-(2-pyrimidinylmethyl)- 2H-indazole-5-carboxamide; N-[(5-methyl-2-pyrazinyl)methyl]-2-(3-pyridyl)-2H-indazole-5-carboxamide, N-[3-chloro-1-(3-pyridyl)pyrazol-4-yl] N-ethyl-3-(3,3,3-trifluoropropylsulfanyl))propionamide; N -[3-chloro-1-(3-pyridyl)pyrazol-4-yl]-N-ethyl-3-(3,3,3-trifluoropropylsulfinyl)propionamide; N -[3-chloro-1-(3-pyridyl)pyrazol-4-yl]-3-[(2,2-difluorocyclopropyl)methylsulfanyl]-N-ethyl-propane Amine; N-[3-chloro-1-(3-pyridyl)pyrazol-4-yl]-3-[(2,2-difluorocyclopropyl)methylsulfinyl]-N-ethyl -Propylamide; Saurana, Lotirana, Isopazoline, Mepyrazole.

可以根據所需的效果選擇各種組合中任何兩種成分的品質比。通常,品質比將根據具體成分和組合中存在多少成分而變化。通常,本發明的任何組合中任何兩種成分之間的品質比彼此獨立地在100:1和1:100中間,包括從99:1, 98:2, 97:3, 96:4, 95:5, 94:6, 93:7, 92:8, 91:9, 90:10, 89:11, 88:12, 87:13, 86:14, 85:15, 84:16, 83:17, 82:18, 81:19, 80:20, 79:21, 78:22, 77:23, 76:24, 75:25, 74:26, 73:27, 72:28, 71:29, 70:30, 69:31, 68:32, 67:33, 66:34, 65:45, 64:46, 63:47, 62:48, 61:49, 60:40, 59:41, 58:42, 57:43, 56:44, 55:45, 54:46, 53:47, 52:48, 51:49, 50:50, 49:51, 48:52, 47:53, 46:54, 45:55, 44:56, 43:57, 42:58, 41:59, 40:60, 39:61, 38:62, 37:63, 36:64, 35:65, 34:66, 33:67, 32:68, 31:69, 30:70, 29:71, 28:72, 27:73, 26:74, 25:75, 24:76, 23:77, 22:78, 21:79, 20:80, 19:81, 18:82, 17:83, 16:84, 15:85, 14:86, 13:87, 12:88, 11:89, 10:90, 9:91, 8:92, 7:93, 6:94, 5:95, 4:96, 3:97, 2:98至1:99。The quality ratio of any two components in various combinations can be selected according to the desired effect. Generally, the quality ratio will vary depending on the specific ingredients and how many ingredients are present in the combination. Generally, the quality ratio between any two components in any combination of the present invention is independently between 100:1 and 1:100, including from 99:1, 98:2, 97:3, 96:4, 95: 5, 94:6, 93:7, 92:8, 91:9, 90:10, 89:11, 88:12, 87:13, 86:14, 85:15, 84:16, 83:17, 82:18, 81:19, 80:20, 79:21, 78:22, 77:23, 76:24, 75:25, 74:26, 73:27, 72:28, 71:29, 70: 30, 69:31, 68:32, 67:33, 66:34, 65:45, 64:46, 63:47, 62:48, 61:49, 60:40, 59:41, 58:42, 57:43, 56:44, 55:45, 54:46, 53:47, 52:48, 51:49, 50:50, 49:51, 48:52, 47:53, 46:54, 45: 55, 44:56, 43:57, 42:58, 41:59, 40:60, 39:61, 38:62, 37:63, 36:64, 35:65, 34:66, 33:67, 32:68, 31:69, 30:70, 29:71, 28:72, 27:73, 26:74, 25:75, 24:76, 23:77, 22:78, 21:79, 20: 80, 19:81, 18:82, 17:83, 16:84, 15:85, 14:86, 13:87, 12:88, 11:89, 10:90, 9:91, 8:92, 7:93, 6:94, 5:95, 4:96, 3:97, 2:98 to 1:99.

本發明的組合(即包含本發明化合物和一種或多種其它生物活性劑的組合)可以同時或依次施用。The combination of the invention (ie the combination comprising the compound of the invention and one or more other bioactive agents) can be administered simultaneously or sequentially.

在這種情況下,組合的成分依次施用(即,一個接一個地施用),成分在彼此的合理時間內(例如在幾小時或幾天內)順序施用以獲得生物學性能。施用組合中成分的順序(即,是否應首先施用式(I)化合物)對於實施本發明不是必需的。In this case, the combined ingredients are applied sequentially (ie, one after the other), and the ingredients are applied sequentially within a reasonable time of each other (eg, within hours or days) to obtain biological properties. The order in which the ingredients of the combination are applied (ie, whether the compound of formula (I) should be applied first) is not necessary to practice the present invention.

在本發明組合的成分同時施用的情況下,它們可以作為含有該組合的組合物施用,其中,(A)式(I)化合物和組合中的一種或多種其他成分可以從單獨的配方來源獲得並混合在一起(稱為罐混合物、即可施用、噴霧湯或漿液);(B)式(I)化合物和一種或多種其他成分可以是作為單一制劑混合物來源獲得(稱為預混合物、預混合物、濃縮物或配製產品)。In the case where the components of the combination of the present invention are applied simultaneously, they can be applied as a composition containing the combination, wherein (A) the compound of formula (I) and one or more other components of the combination can be obtained from separate formulation sources and Mixed together (called a tank mix, ready-to-apply, spray soup or slurry); (B) the compound of formula (I) and one or more other ingredients can be obtained as a single formulation mixture source (called a premix, premix, Concentrates or formulated products).

在一個獨立地實施方案中,根據本發明的化合物作為組合施用。因此,本發明還提供了一種組合物,其包含本文所述的本發明的化合物和一種或多種其他生物活性劑,以及任選的一種或多種常規配製助劑; 其可以是桶混或預混組合物的形式。In an independent embodiment, the compounds according to the invention are administered as a combination. Therefore, the present invention also provides a composition comprising the compound of the present invention described herein and one or more other biologically active agents, and optionally one or more conventional formulation aids; it may be tank-mixed or pre-mixed The form of the composition.

根據本發明的活性物質的混合物適合作為殺真菌劑,式(I)的化合物也合適的。它們的特點是對廣譜的植物致病真菌(特別是來自子囊菌綱、擔子菌綱、半知菌綱和卵菌綱具有突出的效果。另外,分別參考關於化合物和含有式(I)化合物的組合物的殺真菌活性的解釋。Mixtures of active substances according to the invention are suitable as fungicides, as are compounds of the formula (I). They are characterized by a broad spectrum of plant pathogenic fungi (especially from the Ascomycetes, Basidiomycetes, Semimycophytes, and Oomycetes. In addition, refer to the compounds and compounds containing formula (I), respectively The explanation of the fungicidal activity of the composition.

現在通過以下實施例進一步詳細說明本發明(這些實施例不對本發明施加任何限制)。The present invention will now be explained in further detail by the following examples (these examples do not impose any limitation on the present invention).

化學實例: 所有核磁共振(1 H-NMR)譜都記錄在各自指示的溶劑中,並且以內標四甲基矽烷(TMS)的低場δ單位報告化學位移。 質子間耦合常數以赫茲(Hz)表示,並且報告中化學位移以δ單位,為從內標四甲基矽烷(TMS)向低場的距離。質子間耦合常數以赫茲(赫茲)為單位。 Chemical example: All nuclear magnetic resonance ( 1 H-NMR) spectra were recorded in the respective indicated solvents, and chemical shifts were reported in the low-field δ units of the internal standard tetramethylsilane (TMS). The proton coupling constant is expressed in hertz (Hz), and the chemical shift in the report is in δ units, which is the distance from the internal standard tetramethylsilane (TMS) to the low field. The proton coupling constant is measured in Hertz (Hertz).

1 5- (苄基(甲基)氨基) -4- -3H-1,2- 二硫醇 -3- 酮( R1 = 甲基)(化合物 1 ): 在0℃下向攪拌的4,5-二氯-3H-1,2-二硫醇-3-酮(700mg,3.74mmol)的四氫呋喃(7mL)溶液中加入N-苄基甲胺(453mg,3.74mmol)和三乙胺(0.63mL,4.49mmol)。 將反應混合物在25℃下攪拌3小時。反應完成後,濃縮反應混合物並通過矽膠柱色譜法純化(洗脫液-己烷至 30%乙酸乙酯的己烷溶液),得到5-(苄基(甲基)氨基)-4-氯-3H-1,2-二硫醇-3-酮(457mg,1.68mmol,45%的產率)。 Example 1 : 5- (benzyl(methyl)amino) -4 -chloro- 3H-1,2 -dithiol- 3 -one ( R1= methyl) (Compound 1 ): stirred at 0°C To a solution of 4,5-dichloro-3H-1,2-dithiol-3-one (700mg, 3.74mmol) in tetrahydrofuran (7mL) was added N-benzylmethylamine (453mg, 3.74mmol) and triethylamine (0.63mL, 4.49mmol). The reaction mixture was stirred at 25°C for 3 hours. After the reaction was completed, the reaction mixture was concentrated and purified by silica gel column chromatography (eluent-hexane to 30% ethyl acetate in hexane) to obtain 5-(benzyl(methyl)amino)-4-chloro- 3H-1,2-dithiol-3-one (457 mg, 1.68 mmol, 45% yield).

2 3- ((( 4- -3- 氧代 -3H-1,2- 二硫醇 -5- 基)氨基)甲基)苄腈(化合物 87 ): 在0℃下向攪拌的4,5-二氯-3H-1,2-二硫醇-3-酮(500mg,2.67mmol)的四氫呋喃(10mL)溶液中加入3-(氨基甲基)苄腈(353mg,2.67mmol)和三乙胺(0.45mL,3.21mmol)。將反應混合物在25℃下攪拌3小時。將水加入到反應混合物中,用乙酸乙酯(50mL)萃取產物兩次。用鹽水(50mL)洗滌乙酸乙酯層,用無水硫酸鈉乾燥,過濾並減壓蒸發,得到粗產物。然後將粗產物通過矽膠柱色譜純化(洗脫液-己烷至50%乙酸乙酯的己烷溶液),得到3-(((4-氯-3-氧代-3H-1,2-二硫醇-5)-))氨基)甲基)苄腈(205mg,0.72mmol,27%的產率)。 Example 2 : 3- ((( 4- chloro- 3 -oxo- 3H-1,2 -dithiol -5- yl)amino)methyl)benzonitrile (Compound 87 ): stirring at 0°C To a solution of 4,5-dichloro-3H-1,2-dithiol-3-one (500 mg, 2.67 mmol) in tetrahydrofuran (10 mL), add 3-(aminomethyl)benzonitrile (353 mg, 2.67 mmol) and Triethylamine (0.45mL, 3.21mmol). The reaction mixture was stirred at 25°C for 3 hours. Water was added to the reaction mixture, and the product was extracted twice with ethyl acetate (50 mL). The ethyl acetate layer was washed with brine (50 mL), dried over anhydrous sodium sulfate, filtered and evaporated under reduced pressure to obtain a crude product. The crude product was then purified by silica gel column chromatography (eluent-hexane to 50% ethyl acetate in hexane) to give 3-(((4-chloro-3-oxo-3H-1,2-di Thiol-5)-))amino)methyl)benzonitrile (205 mg, 0.72 mmol, 27% yield).

3 3- ((( 4- -3- 氧代 -3H-1,2- 二硫醇 -5- 基)(甲基)氨基)甲基)苄腈(化合物 88 在0℃下向攪拌的4,5-二氯-3H-1,2-二硫醇-3-酮(500mg,2.67mmol)的四氫呋喃(10mL)溶液中加入3-((甲基氨基)甲基)苄腈(391mg,2.67mmol)和三乙胺(0.45mL,3.21mmol)。將反應在25℃下攪拌3小時。將水加入到反應混合物中,用乙酸乙酯(50mL)萃取產物兩次。用鹽水(50mL)洗滌乙酸乙酯層,用無水硫酸鈉乾燥,過濾並減壓蒸發,得到粗產物。然後將粗產物通過矽膠柱色譜純化(洗脫液-己烷至30%乙酸乙酯的己烷溶液),得到3-(((4-氯-3-氧代-3H-1,2-二硫醇-5)-(甲基)氨基)甲基)苄腈(455mg,1.53mmol,57%的產率)。 Example 3 : 3- ((( 4- chloro- 3 -oxo- 3H-1,2 -dithiol -5- yl)(methyl)amino)methyl)benzonitrile (Compound 88 ) at 0°C To a stirred solution of 4,5-dichloro-3H-1,2-dithiol-3-one (500 mg, 2.67 mmol) in tetrahydrofuran (10 mL) was added 3-((methylamino)methyl)benzonitrile (391mg, 2.67mmol) and triethylamine (0.45mL, 3.21mmol). The reaction was stirred at 25°C for 3 hours. Water was added to the reaction mixture, and the product was extracted twice with ethyl acetate (50 mL). The ethyl acetate layer was washed with brine (50 mL), dried over anhydrous sodium sulfate, filtered and evaporated under reduced pressure to obtain a crude product. The crude product was then purified by silica gel column chromatography (eluent-hexane to 30% ethyl acetate in hexane) to give 3-(((4-chloro-3-oxo-3H-1,2-di Thiol-5)-(methyl)amino)methyl)benzonitrile (455 mg, 1.53 mmol, 57% yield).

4 5- (( 3- 溴苄基)(甲基)氨基) -4- -3H-1,2- 二硫醇 -3- 酮(化合物 14 在0℃下向攪拌的4,5-二氯-3H-1,2-二硫醇-3-酮(750mg,4.01mmol)的四氫呋喃(20mL)溶液中加入1-(3-溴苯基)-N-甲基甲胺(800mg,4.01mmol)和三乙胺(0.67mL,4.81mmol)。將反應混合物在25℃下攪拌3小時。將水加入到反應混合物中,用乙酸乙酯(50mL)萃取產物兩次。用鹽水(50mL)洗滌乙酸乙酯層,用無水硫酸鈉乾燥,過濾並減壓蒸發,得到粗產物。然後將粗產物通過矽膠柱色譜純化(洗脫液-己烷至 50%二氯甲烷的己烷溶液),得到5-((3-溴苄基)(甲基)氨基)-4-氯-3H-1,2-二硫醇-3-酮(730mg,2.08mmol,52%的產率)。 Example 4 : 5- (( 3- bromobenzyl)(methyl)amino) -4 -chloro- 3H-1,2 -dithiol- 3 -one (Compound 14 ) was stirred at 0°C at 4, To a solution of 5-dichloro-3H-1,2-dithiol-3-one (750 mg, 4.01 mmol) in tetrahydrofuran (20 mL) was added 1-(3-bromophenyl)-N-methylmethylamine (800 mg , 4.01mmol) and triethylamine (0.67mL, 4.81mmol). The reaction mixture was stirred at 25°C for 3 hours. Water was added to the reaction mixture, and the product was extracted twice with ethyl acetate (50 mL). The ethyl acetate layer was washed with brine (50 mL), dried over anhydrous sodium sulfate, filtered and evaporated under reduced pressure to obtain a crude product. The crude product was then purified by silica gel column chromatography (eluent-hexane to 50% dichloromethane in hexane) to give 5-((3-bromobenzyl)(methyl)amino)-4-chloro- 3H-1,2-dithiol-3-one (730 mg, 2.08 mmol, 52% yield).

5 4- -5- (( 3,4- 二甲氧基苄基)(甲基)氨基) -3H-1,2- 二硫醇 -3- 酮(化合物 32 在0℃下向攪拌的4,5-二氯-3H-1,2-二硫醇-3-酮(500mg,2.67mmol)的四氫呋喃(5mL)溶液中加入1-(3,4-二甲氧基苯基)-N-甲基甲胺(484mg,2.67mmol)和三乙胺(0.56mL,4.01mmol)。將反應混合物在25℃下攪拌3小時。反應完成後,濃縮反應混合物並通過矽膠柱色譜法純化(洗脫液-己烷至50%乙酸乙酯的己烷溶液),得到4-氯-5-((3,4-二甲氧基基基)((甲基)氨基)-3H-1,2-二硫醇-3-酮(280mg,0.84mmol,32%的產率)。 Example 5 : 4- chloro -5- (( 3,4 -dimethoxybenzyl)(methyl)amino) -3H-1,2 -dithiol- 3 -one (Compound 32 ) at 0°C To a stirred solution of 4,5-dichloro-3H-1,2-dithiol-3-one (500 mg, 2.67 mmol) in tetrahydrofuran (5 mL) was added 1-(3,4-dimethoxyphenyl )-N-methylmethylamine (484 mg, 2.67 mmol) and triethylamine (0.56 mL, 4.01 mmol). The reaction mixture was stirred at 25°C for 3 hours. After the reaction was completed, the reaction mixture was concentrated and purified by silica gel column chromatography (eluent-hexane to 50% ethyl acetate in hexane) to give 4-chloro-5-((3,4-dimethoxy Group) ((methyl)amino)-3H-1,2-dithiol-3-one (280 mg, 0.84 mmol, 32% yield).

6 4- -5- (甲基( 2,4,6- 三氯苄基)氨基) -3H-1,2- 二硫醇 -3- 酮(化合物 8 在0℃下向攪拌的4,5-二氯-3H-1,2-二硫醇-3-酮(400mg,2.14mmol)的四氫呋喃(5mL)溶液中加入N-甲基-1-(2,4,6)-三氯苯基)甲胺(480mg,2.14mmol)和三乙胺(0.45mL,3.21mmol)。將反應混合物在25℃下攪拌3小時。反應完成後,濃縮反應混合物並用矽膠柱色譜法(洗脫液-己烷至20%乙酸乙酯的己烷溶液)純化,得到4-氯-5-(甲基(2,4,6-三氯苄基)氨基)-3H-1,2-二硫醇-3-酮(229mg,0.61mmol,29%的產率)。 Example 6 : 4- chloro -5- (methyl ( 2,4,6- trichlorobenzyl)amino) -3H-1,2 -dithiol- 3 -one (Compound 8 ) was stirred at 0°C To a solution of 4,5-dichloro-3H-1,2-dithiol-3-one (400mg, 2.14mmol) in tetrahydrofuran (5mL) was added N-methyl-1-(2,4,6)- Trichlorophenyl)methylamine (480mg, 2.14mmol) and triethylamine (0.45mL, 3.21mmol). The reaction mixture was stirred at 25°C for 3 hours. After the reaction was completed, the reaction mixture was concentrated and purified by silica gel column chromatography (eluent-hexane to 20% ethyl acetate in hexane) to obtain 4-chloro-5-(methyl (2,4,6-tri Chlorobenzyl)amino)-3H-1,2-dithiol-3-one (229 mg, 0.61 mmol, 29% yield).

7 4- -5- (( 1- 2,4- 二氯苯基)乙基)氨基) -3H-1,2- 二硫醇 -3- 酮(化合物 79 在0℃下向攪拌的1-(2,4-二氯苯基)乙-1-胺(508mg,2.67mmol)和三乙胺(0.56mL,4.01mmol)的四氫呋喃(10mL)溶液中加入4,5-二氯-3H-1,2-二硫醇-3-酮(500mg,2.67mmol)。將反應混合物在25℃下攪拌3小時。反應完成後,濃縮反應混合物並用矽膠柱色譜法(洗脫液-己烷至20%乙酸乙酯的己烷溶液)純化,得到4-氯-5-((1-(2,4-二氯苯基)乙基 )氨基)-3H-1,2-二硫醇-3-酮(200mg,0.59mmol,22%的產率)。 Example 7 : 4- chloro -5- (( 1- ( 2,4- dichlorophenyl)ethyl)amino) -3H-1,2 -dithiol- 3 -one (compound 79 ) at 0°C To a stirred solution of 1-(2,4-dichlorophenyl)ethyl-1-amine (508mg, 2.67mmol) and triethylamine (0.56mL, 4.01mmol) in tetrahydrofuran (10mL) was added 4,5-di Chloro-3H-1,2-dithiol-3-one (500mg, 2.67mmol). The reaction mixture was stirred at 25°C for 3 hours. After the reaction was completed, the reaction mixture was concentrated and purified by silica gel column chromatography (eluent-hexane to 20% ethyl acetate in hexane) to obtain 4-chloro-5-((1-(2,4-dichloro Phenyl)ethyl)amino)-3H-1,2-dithiol-3-one (200 mg, 0.59 mmol, 22% yield).

8 4- -5- (( 2- 羥基 -2- 苯基乙基)氨基) -3H-1,2- 二硫醇 -3- 酮(化合物 81 在0℃下向攪拌的4,5-二氯-3H-1,2-二硫醇-3-酮(500mg,2.67mmol)和三乙胺(0.56mL,4.01mmol)的四氫呋喃(200mL)溶液中加入2-氨基 加入1-苯基乙醇(367mg,2.67mmol)。將反應混合物在25℃下攪拌3小時。反應完成後,濃縮反應混合物並用矽膠柱色譜法(洗脫液-己烷至50%乙酸乙酯的己烷溶液)純化,得到4-氯-5-((2-羥基-2-苯基乙基)氨基)-3H-1,2-二硫醇-3-酮(210mg,0.73mmol,27%的產率)。 Example 8 : 4- chloro -5- (( 2- hydroxy -2 -phenylethyl)amino) -3H-1,2 -dithiol- 3 -one (Compound 81 ) was stirred at 0°C 4 ,5-dichloro-3H-1,2-dithiol-3-one (500mg, 2.67mmol) and triethylamine (0.56mL, 4.01mmol) in tetrahydrofuran (200mL) was added 2-amino added 1- Phenylethanol (367mg, 2.67mmol). The reaction mixture was stirred at 25°C for 3 hours. After the reaction was completed, the reaction mixture was concentrated and purified by silica gel column chromatography (eluent-hexane to 50% ethyl acetate in hexane) to obtain 4-chloro-5-((2-hydroxy-2-phenylethyl Group) amino)-3H-1,2-dithiol-3-one (210 mg, 0.73 mmol, 27% yield).

9 4- -5- (甲基(吡啶 -2- 基甲基)氨基) -3H-1,2- 二硫醇 -3- 酮(化合物 52 在0℃下向攪拌的4,5-二氯-3H-1,2-二硫醇-3-酮(700mg,3.74mmol)的四氫呋喃(10mL)溶液中加入N-甲基-1-(吡啶-4-基)甲胺(457mg,3.74mmol)和三乙胺(0.63mL,4.49mmol)。將反應混合物在25℃下攪拌3小時。反應完成後,濃縮反應混合物並用矽膠柱色譜法(洗脫液-己烷至70%乙酸乙酯的己烷溶液)純化,得到4-氯-5-(甲基(吡啶-4-基甲基)氨基)-3H-1,2-二硫醇-3-酮(370mg,1.36mmol,36%的產率)。 Example 9 : 4- chloro -5- (methyl(pyridin -2 -ylmethyl)amino) -3H-1,2 -dithiol- 3 -one (compound 52 ) was stirred at 0°C at 4, To a solution of 5-dichloro-3H-1,2-dithiol-3-one (700 mg, 3.74 mmol) in tetrahydrofuran (10 mL) was added N-methyl-1-(pyridin-4-yl)methylamine (457 mg , 3.74mmol) and triethylamine (0.63mL, 4.49mmol). The reaction mixture was stirred at 25°C for 3 hours. After the reaction was completed, the reaction mixture was concentrated and purified by silica gel column chromatography (eluent-hexane to 70% ethyl acetate in hexane) to obtain 4-chloro-5-(methyl(pyridin-4-ylmethyl )Amino)-3H-1,2-dithiol-3-one (370 mg, 1.36 mmol, 36% yield).

10 4- -5- (甲基(噻吩 -2- 基甲基)氨基) -3H-1,2- 二硫醇 -3- 酮(化合物 77 在0℃下向攪拌的4,5-二氯-3H-1,2-二硫醇-3-酮(700mg,3.74mmol)的四氫呋喃(12mL)溶液中加入N-甲基-1-(噻吩-2-基) 甲胺(476mg,3.74mmol)和三乙胺(0.63mL,4.49mmol)。將反應混合物在25℃下攪拌3小時。反應完成後,濃縮反應混合物並用矽膠柱色譜法(洗脫液-己烷至30%乙酸乙酯的己烷溶液)純化,得到4-氯-5-(甲基(噻吩-2-基甲基)氨基)-3H-1,2-二硫醇-3-酮(370mg,1.33mmol,36%的產率)。 Example 10 : 4- chloro -5- (methyl(thien -2 -ylmethyl)amino) -3H-1,2 -dithiol- 3 -one (compound 77 ) was stirred at 0°C at 4, To a solution of 5-dichloro-3H-1,2-dithiol-3-one (700mg, 3.74mmol) in tetrahydrofuran (12mL) was added N-methyl-1-(thiophen-2-yl) methylamine (476mg , 3.74mmol) and triethylamine (0.63mL, 4.49mmol). The reaction mixture was stirred at 25°C for 3 hours. After the reaction was completed, the reaction mixture was concentrated and purified by silica gel column chromatography (eluent-hexane to 30% ethyl acetate in hexane) to obtain 4-chloro-5-(methyl(thiophen-2-ylmethyl )Amino)-3H-1,2-dithiol-3-one (370 mg, 1.33 mmol, 36% yield).

11 4- -5- (甲基(嘧啶 -5- 基甲基)氨基) -3H-1,2- 二硫醇 -3- 酮(化合物 76 在0℃下向攪拌的4,5-二氯-3H-1,2-二硫醇-3-酮(650mg,3.47mmol)的四氫呋喃(12mL)溶液中加入N-甲基-1-(嘧啶-5-基)甲胺(428mg,3.47mmol)和三乙胺(0.58mL,4.17mmol)。將反應混合物在25℃下攪拌3小時。反應完成後,濃縮反應混合物並用矽膠柱色譜法(洗脫液-己烷至60%乙酸乙酯的己烷溶液)純化,得到4-氯-5-(甲基(嘧啶-5-基甲基)氨基)-3H-1,2-二硫醇-3-酮(205mg,0.75mmol,22%的產率)。 Example 11 : 4- chloro -5- (methyl(pyrimidin -5 -ylmethyl)amino) -3H-1,2 -dithiol- 3 -one (compound 76 ) was stirred at 0°C at 4, To a solution of 5-dichloro-3H-1,2-dithiol-3-one (650 mg, 3.47 mmol) in tetrahydrofuran (12 mL) was added N-methyl-1-(pyrimidin-5-yl)methylamine (428 mg , 3.47mmol) and triethylamine (0.58mL, 4.17mmol). The reaction mixture was stirred at 25°C for 3 hours. After the reaction was completed, the reaction mixture was concentrated and purified by silica gel column chromatography (eluent-hexane to 60% ethyl acetate in hexane) to obtain 4-chloro-5-(methyl(pyrimidin-5-ylmethyl )Amino)-3H-1,2-dithiol-3-one (205 mg, 0.75 mmol, 22% yield).

12 4- -5- (( 4- 羥基 -3- 甲氧基苄基)(甲基)氨基) -3H-1,2- 二硫醇 -3- 酮(化合物 26 在0℃下向攪拌的4,5-二氯-3H-1,2-二硫醇-3-酮(1.0g,5.35mmol)的四氫呋喃(20mL)溶液中加入2-甲氧基-4-((甲基氨基)甲基)苯酚(0.9g,5.35mmol)和三乙胺(1.12mL,8.02mmol)。將反應混合物在25℃下攪拌3小時。 反應完成後,濃縮反應混合物,用矽膠柱色譜法(洗脫液-己烷至60%乙酸乙酯的己烷溶液)純化,得到4-氯-5-((4-羥基-3-甲氧基苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮(650mg,2.04mmol,38%的產率)。 Example 12 : 4- chloro -5- (( 4- hydroxy- 3 -methoxybenzyl)(methyl)amino) -3H-1,2 -dithiol- 3 -one (Compound 26 ) at 0°C To a stirred solution of 4,5-dichloro-3H-1,2-dithiol-3-one (1.0 g, 5.35 mmol) in tetrahydrofuran (20 mL) was added 2-methoxy-4-((methyl Methylamino)methyl)phenol (0.9g, 5.35mmol) and triethylamine (1.12mL, 8.02mmol). The reaction mixture was stirred at 25°C for 3 hours. After the reaction was completed, the reaction mixture was concentrated and purified by silica gel column chromatography (eluent-hexane to 60% ethyl acetate in hexane) to obtain 4-chloro-5-((4-hydroxy-3-methoxy Benzyl)(methyl)amino)-3H-1,2-dithiol-3-one (650 mg, 2.04 mmol, 38% yield).

13 4- ((( 4- -3- 氧代 -3H-1,2- 二硫醇 -5- 基)(甲基)氨基)甲基) -2- 甲氧基苯基甲磺酸酯(化合物 30 在0℃下向攪拌的4-氯-5-((4-羥基-3-甲氧基苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮(600mg,1.89mmol)的二氯甲烷(12mL)溶液中加入三乙胺(0.58mL,4.15mmol)和甲磺醯氯(0.16mL,2.08mmol)。將反應混合物在25℃下攪拌3小時。反應完成後,濃縮反應混合物並用矽膠柱色譜法(洗脫液-己烷至60%乙酸乙酯的己烷溶液)純化,得到4-(((4-氯-3-氧代-3H-1,2)-二硫醇-5-基)(甲基)氨基)甲基)-2-甲氧基苯基甲磺酸酯(650mg,1.64mmol,87%的產率)。 Example 13 : 4- ((( 4- chloro- 3 -oxo- 3H-1,2 -dithiol -5- yl)(methyl)amino)methyl) -2- methoxyphenylmethanesulfonate The acid ester (Compound 30 ) was stirred at 0°C to 4-chloro-5-((4-hydroxy-3-methoxybenzyl)(methyl)amino)-3H-1,2-dithiol- To a solution of 3-one (600 mg, 1.89 mmol) in methylene chloride (12 mL) was added triethylamine (0.58 mL, 4.15 mmol) and mesylate (0.16 mL, 2.08 mmol). The reaction mixture was stirred at 25°C for 3 hours. After the reaction was completed, the reaction mixture was concentrated and purified by silica gel column chromatography (eluent-hexane to 60% ethyl acetate in hexane) to obtain 4-(((4-chloro-3-oxo-3H-1 ,2)-dithiol-5-yl)(methyl)amino)methyl)-2-methoxyphenyl methanesulfonate (650 mg, 1.64 mmol, 87% yield).

下表-1以非限制性方式舉了使用上述實施例中提到的類似方法製備的本發明化合物的例子。 在以下例子中,所選例子的l H-NMR(氫譜)資料是用l H-NMR-峰清單的形式書寫。表中列除了每個信號峰值以ppm為單位的δ值和的質子數(在圓括號中)。Table 1 below lists, in a non-limiting manner, examples of compounds of the present invention prepared using similar methods mentioned in the above examples. In the following examples, the l H-NMR (hydrogen spectrum) data of the selected example is written in the form of l H-NMR-peak list. The table lists the delta value and the number of protons (in parentheses) in ppm for each signal peak.

為了校準氫譜的化學位移,使用四甲基矽烷和/或各溶劑的化學位移(尤其是在二甲基亞碸中測量的頻譜的情況下)。因此,在NMR峰列表中,可發生四甲基矽烷峰(但不一定100%發生)。To calibrate the chemical shift of the hydrogen spectrum, the chemical shifts of tetramethylsilane and/or each solvent are used (especially in the case of the spectrum measured in dimethyl sulfoxide). Therefore, in the NMR peak list, a tetramethylsilane peak may occur (but not necessarily 100%).

表1-或表-2中的下列化合物是使用方案1-9或實施例中所述的類似方法獲得的。The following compounds in Table 1- or Table-2 were obtained using methods similar to those described in Schemes 1-9 or Examples.

1

Figure 108129373-A0304-0003
* 化合物名稱使用Chemdraw專業版17.1生成。 Table 1
Figure 108129373-A0304-0003
* The compound name is generated using Chemdraw Professional Edition 17.1.

2

Figure 108129373-A0304-0004
* 化合物名稱使用Chemdraw專業版17.1生成。 Table 2
Figure 108129373-A0304-0004
* The compound name is generated using Chemdraw Professional Edition 17.1.

如本文所述,通式(I)化合物顯示出極高的殺真菌活性,其對許多攻擊重要農作物的植物致病真菌發揮作用。下列試驗將評估本發明化合物的活性:生物測試實例 As described herein, the compounds of general formula (I) show extremely high fungicidal activity, which acts on many plant pathogenic fungi that attack important crops. The following tests will evaluate the activity of the compounds of the present invention: Examples of biological tests

1 稻瘟病菌 (稻瘟病): 將化合物溶解在0.3%的二甲基亞碸中,加入土豆葡萄糖瓊脂培養基中,然後將其放入皮氏培養皿中。將5ml培養基按要求濃度配製成60mm無菌皮氏培養皿。固化後,每片培養板播種5mm大小的菌絲盤,菌絲盤形成主動生長的毒力培養板皿的週邊。將培養皿在25℃溫度和60%相對濕度的生長室中溫育7天,並測量徑向生長。在這些測試中,與未處理的廣泛發的檢查相比,濃度為300ppm的化合物1 2 4 5 7 16 18 19 20 21 22 23 24 26 27 29 31 33 35 37 38 39 40 41 42 45 46 47 48 49 50 51 52 55 56 57 58 60 63 64 68 70 76 77 78 80 81 82 83 84 86 87 88 90 92 93 94 96 101 102 103 104 105 106 107 108 109 110 111 112 113 114 116 117 118 119 121 122 123 124 125 126 127 129 131 132 133 134 135 136 139 140 141 142 144 145 146 147 148 150 152 154 155 156 157 158 160 163 164 165 166 167 168 169 170 173 177 178 180 181 182 183 184 186 187 給予了超過70%的控制。 Example 1 : Magnaporthe grisea : (Magnaporthe grisea): The compound is dissolved in 0.3% dimethyl sulfoxide, added to potato dextrose agar medium, and then placed in a Petri dish. 5ml culture medium was prepared into 60mm sterile Petri dishes according to the required concentration. After curing, each culture plate is sown with a 5mm-sized hyphae disc, which forms the periphery of the actively growing virulence culture plate. The petri dishes were incubated in a growth chamber at a temperature of 25°C and a relative humidity of 60% for 7 days, and radial growth was measured. In these tests, the compound at a concentration of 300 ppm 1 2 4 5 7 16 18 19 20 21 22 23 24 26 27 29 31 33 35 37 38 39 40 41 42 45 46 47 48 compared to the untreated, widely distributed inspection 49 50 51 52 55 56 57 58 60 63 64 68 70 76 77 78 80 81 82 83 84 86 87 88 90 92 93 94 96 101 102 103 104 105 106 107 108 109 110 111 112 113 114 116 117 118 119 121 122 123 124 125 126 127 129 131 132 133 134 135 136 139 140 141 142 144 145 146 147 148 150 152 154 155 156 157 158 160 163 164 165 166 167 168 169 170 173 177 178 180 181 182 183 184 186 187 gave more than 70 %control.

2 立枯絲核菌 (水稻紋枯病/馬鈴薯黑屑病): 將化合物溶解在0.3%的二甲基亞碸中,加入土豆葡萄糖瓊脂培養基中,然後將其放入皮氏培養皿中。將5ml培養基按要求濃度配製成60mm無菌皮氏培養皿。固化後,每片培養板播種5mm大小的菌絲盤,菌絲盤形成主動生長的毒力培養板皿的週邊。將培養皿在25℃溫度和60%相對濕度的生長室中溫育7天,並測量徑向生長。在這些測試中,與未處理的廣泛發的檢查相比,濃度為300ppm的化合物 1 2 4 5 6 7 18 21 24 29 39 42 45 47 48 49 50 51 52 57 61 63 64 70 78 80 87 88 90 99 116 126 129 140 142 164 165 178 187 給予了超過70%的控制。 Example 2: Rhizoctonia solani (rice sheath blight / potato black psoriasis): The compound was dissolved in 0.3% dimethyl sulfoxide was added potato dextrose agar medium, then placed in a Petri dish in. 5ml culture medium was prepared into 60mm sterile Petri dishes according to the required concentration. After curing, each culture plate is sown with a 5mm-sized hyphae disc, which forms the periphery of the actively growing virulence culture plate. The petri dishes were incubated in a growth chamber at a temperature of 25°C and a relative humidity of 60% for 7 days, and radial growth was measured. In these tests, the compound at a concentration of 300 ppm 1 2 4 5 6 7 18 21 24 29 39 42 45 47 48 49 50 51 52 57 61 63 64 70 78 80 87 88 90 compared to the untreated, widely distributed inspection 99 116 126 129 140 142 164 165 178 187 gave more than 70% control.

3 灰黴菌 (灰黴病): 將化合物溶解在0.3%的二甲基亞碸中,加入土豆葡萄糖瓊脂培養基中,然後將其放入皮氏培養皿中。將5ml培養基按要求濃度配製成60mm無菌皮氏培養皿。固化後,每片培養板播種5mm大小的菌絲盤,菌絲盤形成主動生長的毒力培養板皿的週邊。將培養皿在22℃溫度和90%相對濕度的生長室中溫育7天,並測量徑向生長。在這些測試中,與未處理的廣泛發的檢查相比,濃度為300ppm的化合物 1 2 5 7 18 19 20 21 22 24 29 33 41 42 45 47 48 50 51 61 63 64 70 78 80 82 83 84 86 88 90 92 96 103 117 121 126 127 131 144 146 160 165 168 183 給予了超過70%的控制。 Example 3: Botrytis cinerea (gray mold): The compound was dissolved in 0.3% dimethyl sulfoxide was added potato dextrose agar medium, then placed in a Petri dish. 5ml culture medium was prepared into 60mm sterile Petri dishes according to the required concentration. After curing, each culture plate is sown with a 5mm-sized hyphae disc, which forms the periphery of the actively growing virulence culture plate. The petri dishes were incubated in a growth chamber at a temperature of 22°C and a relative humidity of 90% for 7 days, and the radial growth was measured. In these tests, the compound at a concentration of 300 ppm 1 2 5 7 18 19 20 21 22 24 29 33 41 42 45 47 48 50 51 61 63 64 70 78 80 82 83 84 86 compared to the untreated extensive test 88 90 92 96 103 117 121 126 127 131 144 146 160 165 168 183 gave more than 70% control.

4 鏈格孢菌 (番茄/馬鈴薯早疫病): 將化合物溶解在0.3%的二甲基亞碸中,加入土豆葡萄糖瓊脂培養基中,然後將其放入皮氏培養皿中。將5ml培養基按要求濃度配製成60mm無菌皮氏培養皿。固化後,每片培養板播種5mm大小的菌絲盤,菌絲盤形成主動生長的毒力培養板皿的週邊。將培養皿在25℃溫度和60%相對濕度的生長室中溫育7天,並測量徑向生長。在這些測試中,與未處理的廣泛發的檢查相比,濃度為300ppm的化合物 1 2 3 4 5 6 7 9 12 13 14 15 16 18 19 20 21 22 25 26 29 35 37 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 60 61 62 63 64 65 66 67 68 70 72 73 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 99 101 103 104 110 114 116 117 120 121 122 123 124 125 126 127 128 129 130 131 132 136 139 140 141 142 144 145 146 148 150 152 153 154 155 156 157 158 160 162 164 165 166 169 170 173 174 177 178 181 182 183 184 186 187 給予了超過70%的控制。 Example 4 : Alternaria alternata (tomato/potato early blight): The compound was dissolved in 0.3% dimethyl sulfoxide, added to potato dextrose agar medium, and then placed in a petri dish. 5ml culture medium was prepared into 60mm sterile Petri dishes according to the required concentration. After curing, each culture plate is sown with a 5mm-sized hyphae disc, which forms the periphery of the actively growing virulence culture plate. The petri dishes were incubated in a growth chamber at a temperature of 25°C and a relative humidity of 60% for 7 days, and radial growth was measured. In these tests, the compound with a concentration of 300 ppm 1 2 3 4 5 6 7 9 12 13 14 15 16 18 19 20 21 22 25 26 29 35 37 39 40 41 42 43 44 compared with the untreated extensive test 45 46 47 48 49 50 51 52 53 54 55 56 60 61 62 63 64 65 66 67 68 70 72 73 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 99 101 103 104 110 114 116 117 120 121 122 123 124 125 126 127 128 129 130 131 132 136 139 140 141 142 144 145 146 148 150 152 153 154 155 156 157 158 160 162 164 165 166 169 170 173 174 177 178 181 182 183 184 186 187 gave more than 70% control.

5 辣椒炭疽菌 (炭疽病): 將化合物溶解在0.3%的二甲基亞碸中,加入土豆葡萄糖瓊脂培養基中,然後將其放入皮氏培養皿中。將5ml培養基按要求濃度配製成60mm無菌皮氏培養皿。固化後,每片培養板播種5mm大小的菌絲盤,菌絲盤形成主動生長的毒力培養板皿的週邊。將培養皿在25℃溫度和60%相對濕度的生長室中溫育7天,並測量徑向生長。在這些測試中,與未處理的廣泛發的檢查相比,濃度為300ppm的化合物 1 2 5 7 15 16 18 19 20 21 22 24 26 27 29 37 39 40 41 42 45 47 48 49 50 51 63 64 68 70 78 79 80 82 88 92 93 96 98 99 101 102 103 104 106 108 110 111 112 114 115 116 117 118 121 122 123 126 127 129 131 140 141 142 144 145 146 148 150 154 155 156 157 158 160 164 165 166 169 170 177 179 181 182 183 184 187 給予了超過70%的控制。 Example 5: pepper Anthrax (anthrax): The compound was dissolved in 0.3% dimethyl sulfoxide was added potato dextrose agar medium, then placed in a Petri dish. 5ml culture medium was prepared into 60mm sterile Petri dishes according to the required concentration. After curing, each culture plate is sown with a 5mm-sized hyphae disc, which forms the periphery of the actively growing virulence culture plate. The petri dishes were incubated in a growth chamber at a temperature of 25°C and a relative humidity of 60% for 7 days, and radial growth was measured. In these tests, the compound at a concentration of 300 ppm 1 2 5 7 15 16 18 19 20 21 22 24 26 27 29 37 39 40 41 42 45 47 48 49 50 51 63 64 68 compared to the untreated, extensive inspection 70 78 79 80 82 88 92 93 96 98 99 101 102 103 104 106 108 110 111 112 114 115 116 117 118 121 122 123 126 127 129 131 140 141 142 144 145 146 148 150 154 155 156 157 158 160 164 165 166 169 170 177 179 181 182 183 184 187 gave more than 70% control.

6 番茄葉斑病 : 將化合物溶解在0.3%的二甲基亞碸中,加入土豆葡萄糖瓊脂培養基中,然後將其放入皮氏培養皿中。將5ml培養基按要求濃度配製成60mm無菌皮氏培養皿。固化後,每片培養板播種5mm大小的菌絲盤,菌絲盤形成主動生長的毒力培養板皿的週邊。將培養皿在25℃溫度和70%相對濕度的生長室中溫育7天,並測量徑向生長。在這些測試中,與未處理的廣泛發的檢查相比,濃度為300ppm的化合物1 2 3 4 16 27 45 47 48 49 50 51 52 60 63 64 67 68 70 78 80 82 84 88 92 93 101 103 116 117 121 129 131 140 142 144 148 155 157 160 164 177 給予了超過70%的控制。 Example 6 : Tomato leaf spot : The compound was dissolved in 0.3% dimethyl sulfoxide, added to potato dextrose agar medium, and then placed in a petri dish. 5ml culture medium was prepared into 60mm sterile Petri dishes according to the required concentration. After curing, each culture plate is sown with a 5mm-sized hyphae disc, which forms the periphery of the actively growing virulence culture plate. The petri dishes were incubated in a growth chamber at a temperature of 25°C and a relative humidity of 70% for 7 days, and the radial growth was measured. In these tests, the compound at a concentration of 300 ppm 1 2 3 4 16 27 45 47 48 49 50 51 52 60 63 64 67 68 70 78 80 82 84 88 92 93 101 103 116 compared to the untreated extensive test 117 121 129 131 140 142 144 148 155 157 160 164 177 gave more than 70% control.

7 黃色鐮刀菌 (穀物腐病): 將化合物溶解在0.3%的二甲基亞碸中,加入土豆葡萄糖瓊脂培養基中,然後將其放入皮氏培養皿中。將5ml培養基按要求濃度配製成60mm無菌皮氏培養皿。固化後,每片培養板播種5mm大小的菌絲盤,菌絲盤形成主動生長的毒力培養板皿的週邊。將培養皿在25℃溫度和60%相對濕度的生長室中溫育7天,並測量徑向生長。在這些測試中,與未處理的廣泛發的檢查相比,濃度為300ppm的化合物 1 5 18 21 29 47 48 50 51 52 64 給予了超過70%的控制。 Example 7 : Fusarium yellow (cereal rot): The compound was dissolved in 0.3% dimethyl sulfoxide, added to potato dextrose agar medium, and then placed in a Petri dish. 5ml culture medium was prepared into 60mm sterile Petri dishes according to the required concentration. After curing, each culture plate is sown with a 5mm-sized hyphae disc, which forms the periphery of the actively growing virulence culture plate. The petri dishes were incubated in a growth chamber at a temperature of 25°C and a relative humidity of 60% for 7 days, and radial growth was measured. In these tests, the compound 1 5 18 21 29 47 48 50 51 52 64 at a concentration of 300 ppm gave more than 70% control compared to the untreated extensive test.

8 致病疫黴 (馬鈴薯和番茄的晚疫病): 將化合物溶解在0.3%的二甲基亞碸中,加入土豆葡萄糖瓊脂培養基中,然後將其放入皮氏培養皿中。將5ml培養基按要求濃度配製成60mm無菌皮氏培養皿。固化後,每片培養板播種5mm大小的菌絲盤,菌絲盤形成主動生長的毒力培養板皿的週邊。將培養皿在18℃溫度和95%相對濕度的生長室中溫育7天,並測量徑向生長。在這些測試中,與未處理的廣泛發的檢查相比,濃度為300ppm的化合物 1 2 4 6 7 21 23 26 29 32 34 43 45 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 72 75 76 77 78 80 81 83 84 87 88 89 90 91 92 93 94 95 98 99 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 136 139 142 144 145 146 151 152 153 154 155 156 158 159 160 164 165 168 173 174 178 187 給予了超過70%的控制。 Example 8 : Phytophthora infestans (late blight of potato and tomato): Dissolve the compound in 0.3% dimethyl sulfoxide, add to potato dextrose agar medium, and place it in a Petri dish. 5ml culture medium was prepared into 60mm sterile Petri dishes according to the required concentration. After curing, each culture plate is sown with a 5mm-sized hyphae disc, which forms the periphery of the actively growing virulence culture plate. The petri dishes were incubated in a growth chamber at a temperature of 18°C and a relative humidity of 95% for 7 days, and radial growth was measured. In these tests, the compound at a concentration of 300 ppm 1 2 4 6 7 21 23 26 29 32 34 43 45 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 compared to the untreated extensive test 63 64 65 66 67 68 69 70 72 75 76 77 78 80 81 83 84 87 88 89 90 91 92 93 94 95 98 99 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 136 139 142 144 145 146 151 152 153 154 155 156 158 159 160 164 165 168 173 174 178 187 gave more than 70% control.

在參考某些優選方面描述本發明後,本領域技術人員應該很熟悉其他技術參數。對於本領域技術人員而言,可以在不脫離本發明範圍的情況下實施對材料和方法的許多修改。After describing the present invention with reference to certain preferred aspects, those skilled in the art should be familiar with other technical parameters. For those skilled in the art, many modifications to the materials and methods can be implemented without departing from the scope of the present invention.

no

no

Figure 108129373-A0101-11-0002-3
Figure 108129373-A0101-11-0002-3

Claims (15)

一種式(I)化合物,
Figure 03_image001
其中, R選自基團鹵素、羥基、氰基、硝基、C1 -C6 -烷基、C1 -C6 -鹵代烷基、C1 -C6 ­烷氧基、C3 -C6 -環烷基、C(=O)R3 、C(=O)OR3 和S(O)n R3 ; R1 選自氫、羥基、C1 -C6 -烷基、C2 -C6 -烯基、C2 -C6 -炔基、C2 -C6 -烯基-C1 -C3 -烷基、C2 -C6 -炔基-C1 -C3 -烷基、C1 -C6 -鹵代烷基、C2 -C8 -鹵代烯基、C1 -C6 ­烷氧基、C1 -C6 -鹵代烷氧基、C3 -C6 -環烷基、C3 -C6 -鹵代環烷基、C3 -C6 -環烷基-C1 -C3 -烷基、苄基、C(=O)R3 、C(=O)OR3 和S(O)n R3 基團; A代表O、NR1a 或S; R1a 選自氫、羥基、C1 -C6 -烷基、C1 -C6 ­烷氧基、C3 -C6 -環烷基、C3 -C6 -環烷基-C1 -C3 -烷基、苄基、C(=O)R3 、C(=O)OR3 和S(O)n R3 基團; R2a 和R2b 獨立地選自氫、鹵素、羥基、C1 -C6 -烷基、C1 -C6 ­烷氧基、C3 -C6 -環烷基、C3 -C6 -環烷基-C1 -C3 -烷基、C(=O)R3 、C(=O)OR3 和S(O)n R3 基團;或者 R2a 和R2b 與它們所連接的原子一起或與選自C、N、O和S的其他原子一起可以形成3-至5-元環,其本身可以被一個或多個R3 取代; R3 選自氫、羥基、C1 -C6 -烷基、C1 -C6 -鹵代烷基、C3 -C10 -環烷基、C3 -C10 -鹵代環烷基和 N(R6 R7 )基團; R6 和R7 獨立地選自氫、羥基、C1 -C6 -烷基、C1 -C6 -鹵代烷基、C3 -C10 -環烷基和 S(O)n R3 基團; R1 、R2 和R3 中定義的所有上述基團可帶有一個、兩個、三個或四個相同或不同的取代基,所述取代基選自鹵素、氰基、硝基、氨基、羥基、C1 -C6 -烷基、C1 -C6 -鹵代烷基、C1 -C6 ­烷氧基和C1 -C6 -鹵代烷氧基; Cy代表稠合或非稠合的C3 -C10 -碳環基或C3 -C10 -雜環基團,其可任選地被一個或多個R4 取代; R4 獨立地選自氫、鹵素、羥基、氰基、硝基、C1 -C6 -烷基、C2 -C8 -烯基、C2 -C8 -炔基、C1 -C6 -鹵代烷基、C2 -C8 -鹵代烯基、C1 -C6 -烷氧基、C2 -C8 -烯氧基、C2 -C8 -炔氧基、C1 -C6 -鹵代烷氧基、C2 -C8 -烯氧基、C2 -C8 -鹵代炔氧基、C1 -C6 -烷硫基、C2 -C8 -烯硫基、C2 -C8 -炔硫基、C1 -C6 -鹵代烷硫基、C2 -C8 -鹵代烯硫基、C3 -C10 -環烷基、C4 -C10 -環烯基、C3 -C10 -環烷氧基、C4 -C10 -環烯氧基、C3 -C10 -環烷硫基、C4 -C10 -環烯硫基、C3 -C10 -環烷基-C1 -C6 -烷基、C3 -C10 -環烷基-C1 -C6 -烷氧基、C3 -C10 -環烷基-C1 -C6 -烷硫基、C1 -C8 -烷基-S(O)n R3 、N(R6 R7 )、C(=O)R3 、C(=O)OR3 、S(O)n R3 、OS(O)n R3 、S(O)n -C6 -C10 -芳基、S(O)n- C7 -C19 -芳烷基、C6 -C10 -芳氧基、C6 -C10 -芳基和C3 -C10 -雜環基基團;上述所有基團可以被一個或多個選自鹵素R″、CN、OR″、SR″、N(R″)2 、Si(R″)3 、COOR″和CON(R″)2 的基團取代;或者 兩個R4 與它們所連接的原子一起或與其它選自C、N、O、S和任選地包括1至3個選自C(=O)、C(=S)、S(O)m 和Si(R′)2 的環成員的原子一起,可以形成3-至7-元環,其本身可以被一個或多個取代R5 ; R5 獨立地選自氫、鹵素、氰基、硝基、C1 -C6 -烷基、C2 -C8 -烯基、C2 -C8 -炔基、C1 -C6 -鹵代烷基、C2 -C8 -鹵代烯基、C2 -C8 -鹵代炔基、C3 -C6 -環烷基、C(=O)R″、C(=O)OR″、OR″、N(R″)2 和S(O)n R″基團; R″選自氫、C1 -C6 -烷基、C1 -C6 -鹵代烷基、C3 -C8 -環烷基和N(R′)2 基團;其中所述基團可任選被一個或多個選自鹵素、R′、CN、OR′、SR′、NR′2 、Si(R′)3 、COOR′、CONR′2 和C5 -C12 -芳基(其任選被一個或多個R′取代)的基團取代; R′選自氫、鹵素、C1 -C6 -烷基和C3 -C6 -環烷基基團; n和m代表整數,其中n= 0-2,m= 1-2; 或其農業上可接受的鹽、異構體/結構異構體、立體異構體、非對映異構體、對映異構體、互變異構體、多晶型物、金屬絡合物、S-氧化物或N-氧化物; 條件是:所述式(I)化合物不是5-(苄基氨基)-4-氯-3H-1,2-二硫醇-3-硫酮。
A compound of formula (I),
Figure 03_image001
Where R is selected from the group halogen, hydroxy, cyano, nitro, C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, C 1 -C 6 alkoxy, C 3 -C 6- Cycloalkyl, C(=O)R 3 , C(=O)OR 3 and S(O) n R 3 ; R 1 is selected from hydrogen, hydroxyl, C 1 -C 6 -alkyl, C 2 -C 6 -Alkenyl, C 2 -C 6 -alkynyl, C 2 -C 6 -alkenyl-C 1 -C 3 -alkyl, C 2 -C 6 -alkynyl-C 1 -C 3 -alkyl, C 1 -C 6 -haloalkyl, C 2 -C 8 -haloalkenyl, C 1 -C 6 alkoxy, C 1 -C 6 -haloalkoxy, C 3 -C 6 -cycloalkyl, C 3 -C 6 -halocycloalkyl, C 3 -C 6 -cycloalkyl-C 1 -C 3 -alkyl, benzyl, C(=O)R 3 , C(=O)OR 3 and S( O) n R 3 group; A represents O, NR 1a or S; R 1a is selected from hydrogen, hydroxyl, C 1 -C 6 -alkyl, C 1 -C 6 alkoxy, C 3 -C 6 -ring Alkyl, C 3 -C 6 -cycloalkyl-C 1 -C 3 -alkyl, benzyl, C(=O)R 3 , C(=O)OR 3 and S(O) n R 3 groups ; R 2a and R 2b are independently selected from hydrogen, halogen, hydroxy, C 1 -C 6 -alkyl, C 1 -C 6 alkoxy, C 3 -C 6 -cycloalkyl, C 3 -C 6- Cycloalkyl-C 1 -C 3 -alkyl, C(=O)R 3 , C(=O)OR 3 and S(O) n R 3 groups; or R 2a and R 2b to which they are attached The atoms together or together with other atoms selected from C, N, O, and S may form a 3- to 5-membered ring, which may itself be substituted with one or more R 3 ; R 3 is selected from hydrogen, hydroxyl, C 1- C 6 -alkyl, C 1 -C 6 -haloalkyl, C 3 -C 10 -cycloalkyl, C 3 -C 10 -halocycloalkyl and N(R 6 R 7 ) group; R 6 and R 7 is independently selected from hydrogen, hydroxyl, C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, C 3 -C 10 -cycloalkyl, and S(O) n R 3 groups; R 1 , R 2 and R 3 all of the above groups may have one, two, three or four same or different substituents selected from halogen, cyano, nitro, amino, hydroxyl , C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, C 1 -C 6 alkoxy and C 1 -C 6 -haloalkoxy; Cy represents fused or non-fused C 3- C 10 -Carbocyclyl or C 3 -C 10 -A heterocyclic group, which may be optionally substituted with one or more R 4 ; R 4 is independently selected from hydrogen, halogen, hydroxyl, cyano, nitro, C 1 -C 6 -alkyl, C 2- C 8 -alkenyl, C 2 -C 8 -alkynyl, C 1 -C 6 -haloalkyl, C 2 -C 8 -haloalkenyl, C 1 -C 6 -alkoxy, C 2 -C 8 -Alkenyloxy, C 2 -C 8 -alkynyloxy, C 1 -C 6 -haloalkoxy, C 2 -C 8 -alkenyloxy, C 2 -C 8 -haloalkynyloxy, C 1- C 6 -alkylthio, C 2 -C 8 -alkenylthio, C 2 -C 8 -alkynylthio, C 1 -C 6 -haloalkylthio, C 2 -C 8 -haloalkenylthio, C 3 -C 10 -cycloalkyl, C 4 -C 10 -cycloalkenyl, C 3 -C 10 -cycloalkoxy, C 4 -C 10 -cycloalkenyloxy, C 3 -C 10 -cycloalkylthio Group, C 4 -C 10 -cycloalkenylthio, C 3 -C 10 -cycloalkyl-C 1 -C 6 -alkyl, C 3 -C 10 -cycloalkyl-C 1 -C 6 -alkoxy Group, C 3 -C 10 -cycloalkyl-C 1 -C 6 -alkylthio, C 1 -C 8 -alkyl-S(O) n R 3 , N(R 6 R 7 ), C(= O)R 3 , C(=O)OR 3 , S(O) n R 3 , OS(O) n R 3 , S(O) n -C 6 -C 10 -aryl, S(O) n- C 7 -C 19 -aralkyl, C 6 -C 10 -aryloxy, C 6 -C 10 -aryl and C 3 -C 10 -heterocyclic groups; all of the above groups can be one or more A group selected from halogen R″, CN, OR″, SR″, N(R″) 2 , Si(R″) 3 , COOR″ and CON(R″) 2 ; or two R 4 and them The attached atoms are taken together or with others selected from C, N, O, S and optionally include 1 to 3 selected from C(=O), C(=S), S(O) m and Si(R′ ) The atoms of the ring members of 2 together may form a 3- to 7-membered ring, which may itself be substituted with one or more R 5 ; R 5 is independently selected from hydrogen, halogen, cyano, nitro, C 1- C 6 -alkyl, C 2 -C 8 -alkenyl, C 2 -C 8 -alkynyl, C 1 -C 6 -haloalkyl, C 2 -C 8 -haloalkenyl, C 2 -C 8- Haloalkynyl, C 3 -C 6 -cycloalkyl, C(=O)R″, C(=O)OR″, OR″, N(R″) 2 and S(O) n R″ groups ; R″ is selected from hydrogen, C 1 -C 6 -alkyl, C 1 -C 6 -Haloalkyl, C 3 -C 8 -cycloalkyl, and N(R′) 2 groups; wherein the group may be optionally selected from one or more of halogen, R′, CN, OR′, SR′ , NR′ 2 , Si(R′) 3 , COOR′, CONR′ 2 and C 5 -C 12 -aryl (which are optionally substituted by one or more R′) groups; R′ is selected from hydrogen , Halogen, C 1 -C 6 -alkyl and C 3 -C 6 -cycloalkyl groups; n and m represent integers, where n = 0-2, m = 1-2; or its agriculturally acceptable Salt, isomer/structural isomer, stereoisomer, diastereomer, enantiomer, tautomer, polymorph, metal complex, S-oxide or N -Oxide; provided that the compound of formula (I) is not 5-(benzylamino)-4-chloro-3H-1,2-dithiol-3-thione.
如請求項1所述的化合物,其中 A為O; R為鹵素; R2a 和R2b 獨立地選自氫、鹵素、C1 -C6 -烷基、C3 -C6 -環烷基和C3 -C6 -環烷基-C1 -C3 -烷基基團;或者 Cy為芳基,其可任選地被一個或多個R4 取代; R4 獨立地選自鹵素、羥基、氰基、硝基、C1 -C6 -烷基、C2 -C8 -烯基、C2 -C8 -炔基、C1 -C6 -鹵代烷基、C2 -C8 -鹵代烯基、C1 -C6 -烷氧基、C2 -C8 -烯氧基、C2 -C8 -炔氧基、C1 -C6 -鹵代烷氧基、C2 -C8 -烯氧基、C2 -C8 -鹵代炔氧基、C1 -C6 -烷硫基、C2 -C8 -烯硫基、C2 -C8 -炔硫基、C1 -C6 -鹵代烷硫基、C2 -C8 -鹵代烯硫基、C3 -C10 -環烷基、C4 -C10 -環烯基、C3 -C10 -環烷氧基、C4 -C10 -環烯氧基、C3 -C10 -環烷硫基、C4 -C10 -環烯硫基、C3 -C10 -環烷基-C1 -C6 -烷基、C3 -C10 -環烷基-C1 -C6 -烷氧基、C3 -C10 -環烷基-C1 -C6 -烷硫基、C1 -C8 -烷基-S(O)n R3 、N(R6 R7 )、C(=O)R3 、C(=O)OR3 、S(O)n R3 、OS(O)n R3 、OS(O)n R3 、S(O)n -C6 -C10 -芳基、S(O)n- C7 -C19 -芳烷基、C6 -C10 -芳氧基、C6 -C10 -芳基和C3 -C10 -雜環基基團;或者 兩個R4 與它們所連接的原子一起或與選自C、N、O、S的其他原子一起形成3-至5-元環,其本身可以被一個或多個R5 取代; m為1。The compound according to claim 1, wherein A is O; R is halogen; R 2a and R 2b are independently selected from hydrogen, halogen, C 1 -C 6 -alkyl, C 3 -C 6 -cycloalkyl and C 3 -C 6 -cycloalkyl-C 1 -C 3 -alkyl group; or Cy is an aryl group, which may be optionally substituted with one or more R 4 ; R 4 is independently selected from halogen, hydroxyl , Cyano, nitro, C 1 -C 6 -alkyl, C 2 -C 8 -alkenyl, C 2 -C 8 -alkynyl, C 1 -C 6 -haloalkyl, C 2 -C 8 -halo Alkenyl, C 1 -C 6 -alkoxy, C 2 -C 8 -alkenoxy, C 2 -C 8 -alkynoxy, C 1 -C 6 -haloalkoxy, C 2 -C 8- Alkenyloxy, C 2 -C 8 -haloalkynyloxy, C 1 -C 6 -alkylthio, C 2 -C 8 -alkenylthio, C 2 -C 8 -alkynylthio, C 1 -C 6 -haloalkylthio, C 2 -C 8 -haloalkenylthio, C 3 -C 10 -cycloalkyl, C 4 -C 10 -cycloalkenyl, C 3 -C 10 -cycloalkoxy, C 4 -C 10 -cycloalkenyloxy, C 3 -C 10 -cycloalkylthio, C 4 -C 10 -cycloalkenylthio, C 3 -C 10 -cycloalkyl-C 1 -C 6 -alkyl , C 3 -C 10 -cycloalkyl-C 1 -C 6 -alkoxy, C 3 -C 10 -cycloalkyl-C 1 -C 6 -alkylthio, C 1 -C 8 -alkyl- S(O) n R 3 , N(R 6 R 7 ), C(=O)R 3 , C(=O)OR 3 , S(O) n R 3 , OS(O) n R 3 , OS( O) n R 3 , S(O) n -C 6 -C 10 -aryl, S(O) n- C 7 -C 19 -aralkyl, C 6 -C 10 -aryloxy, C 6- C 10 -aryl and C 3 -C 10 -heterocyclyl groups; or two R 4 together with the atoms to which they are attached or together with other atoms selected from C, N, O, S form 3- to 5 -A member ring, which may itself be substituted with one or more R 5 ; m is 1. 如請求項1所述的化合物,其中 A為O; R為鹵素; R2a 和R2b 獨立地選自氫、鹵素、C1 -C6 -烷基、C3 -C6 -環烷基和C3 -C6 -環烷基-C1 -C3 -烷基基團;或者 Cy為C5 -C6 -雜環基團,其可任選地被一個或多個R4 取代; R4 獨立地選自鹵素、羥基、氰基、硝基、C1 -C6 -烷基、C2 -C8 -烯基、C2 -C8 -炔基、C1 -C6 -鹵代烷基、C2 -C8 -鹵代烯基、C1 -C6 -烷氧基、C2 -C8 -烯氧基、C2 -C8 -炔氧基、C1 -C6 -鹵代烷氧基、C2 -C8 -烯氧基、C2 -C8 -鹵代炔氧基、C1 -C6 -烷硫基、C2 -C8 -烯硫基、C2 -C8 -炔硫基、C1 -C6 -鹵代烷硫基、C2 -C8 -鹵代烯硫基、C3 -C10 -環烷基、C4 -C10 -環烯基、C3 -C10 -環烷氧基、C4 -C10 -環烯氧基、C3 -C10 -環烷硫基、C4 -C10 -環烯硫基、C3 -C10 -環烷基-C1 -C6 -烷基、C3 -C10 -環烷基-C1 -C6 -烷氧基、C3 -C10 -環烷基-C1 -C6 -烷硫基、C1 -C8 -烷基-S(O)n R3 、N(R6 R7 )、C(=O)R3 、C(=O)OR3 、S(O)n R3 、OS(O)n R3 、OS(O)n R3 、S(O)n -C6 -C10 -芳基、S(O)n- C7 -C19 -芳烷基、C6 -C10 -芳氧基、C6 -C10 -芳基和C3 -C10 -雜環基基團;或者 兩個R4 與它們所連接的原子一起或與選自C、N、O、S的其他原子一起形成3-至5-元環,其本身可以被一個或多個R5 取代; m為1。The compound according to claim 1, wherein A is O; R is halogen; R 2a and R 2b are independently selected from hydrogen, halogen, C 1 -C 6 -alkyl, C 3 -C 6 -cycloalkyl and C 3 -C 6 -cycloalkyl-C 1 -C 3 -alkyl group; or Cy is a C 5 -C 6 -heterocyclic group, which may be optionally substituted with one or more R 4 ; R 4 is independently selected from halogen, hydroxy, cyano, nitro, C 1 -C 6 -alkyl, C 2 -C 8 -alkenyl, C 2 -C 8 -alkynyl, C 1 -C 6 -haloalkyl , C 2 -C 8 -haloalkenyl, C 1 -C 6 -alkoxy, C 2 -C 8 -alkenoxy, C 2 -C 8 -alkynoxy, C 1 -C 6 -haloalkoxy Group, C 2 -C 8 -alkenyloxy, C 2 -C 8 -haloalkynyloxy, C 1 -C 6 -alkylthio, C 2 -C 8 -alkenylthio, C 2 -C 8- Alkynylthio, C 1 -C 6 -haloalkylthio, C 2 -C 8 -haloalkenylthio, C 3 -C 10 -cycloalkyl, C 4 -C 10 -cycloalkenyl, C 3 -C 10 -cycloalkoxy, C 4 -C 10 -cycloalkenyloxy, C 3 -C 10 -cycloalkylthio, C 4 -C 10 -cycloalkenylthio, C 3 -C 10 -cycloalkyl- C 1 -C 6 -alkyl, C 3 -C 10 -cycloalkyl-C 1 -C 6 -alkoxy, C 3 -C 10 -cycloalkyl-C 1 -C 6 -alkylthio, C 1 -C 8 -alkyl-S(O) n R 3 , N(R 6 R 7 ), C(=O)R 3 , C(=O)OR 3 , S(O) n R 3 , OS( O) n R 3 , OS(O) n R 3 , S(O) n -C 6 -C 10 -aryl, S(O) n- C 7 -C 19 -aralkyl, C 6 -C 10 -Aryloxy, C 6 -C 10 -aryl and C 3 -C 10 -heterocyclic groups; or two R 4 together with the atoms to which they are attached or selected from C, N, O, S Other atoms together form a 3- to 5-membered ring, which may itself be substituted with one or more R 5 ; m is 1. 如請求項1所述的化合物,其中所述式(I)的合物選自4-氯-5-((3,4-二甲基苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((3,5-二甲基苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2,5-)二氟苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((3-乙氧基-4-甲氧基苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(乙基(2-(三氟甲基)苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(乙基((3-甲基噻吩-2-基)甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(甲基(4-苯氧基苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2-氟-4-甲氧基苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、5-(((3-溴噻吩-2-基)甲基)(甲基)氨基)-4-氯-3H-1,2-二硫醇-3-酮、4-氯-5-(甲基(萘-1-基)甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(甲基(萘-2-基甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((3-甲基苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2-乙氧基苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2,4-二甲氧基苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮,5-(苄基(甲基)氨基)-4-氯-3H-1,2-二硫醇-3-酮、4-氯-5-((4-甲氧基苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((3,4-二氯苄基) )氨基)-3H-1,2-二硫醇-3-酮,5-(苄基氨基)-4-氯-3H-1,2-二硫醇-3-酮、4-氯-5-((1-(p-甲苯基)乙基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((4-氯苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((3-(三氟甲氧xy)苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(甲基(2,4,6-三氯苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((4-羥基苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2-氯-5-硝基苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(甲基(2-硝基苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-( (3-硝基苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(甲基(4-(甲硫基)苄基)氨基)-3H-1,2-二硫醇-3-酮, 5-((3-溴苄基)(甲基)氨基)-4-氯-3H-1,2-二硫醇-3-酮、4-氯-5-((2-氯苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮,5-((4-溴苄基)(甲基)氨基)-4-氯-3H-1,2-二硫醇-3-酮,5-((2-溴-4-)氟代苄基)(甲基)氨基)-4-氯-3H-1,2-二硫醇-3-酮、4-氯-5-((4-甲氧基苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((4-乙氧基苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((3-氯-4-甲氧基苄基) (甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((4-(2-羥基乙氧基)苄基)(甲基)氨基)-3H-1,2-二硫醇-3-one,4-氯-5-((4-甲氧基-3-甲基苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((4-羥基-3)-甲基苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((4-異丙氧基苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮 ,5-((3-溴-4-甲氧基苄基)(甲基)氨基)-4-氯-3H-1,2-二硫醇-3-酮、4-氯-5-((4-羥基-3-甲氧基苄基)基)(甲基)氨基)-3H--1,2-二硫醇-3-酮, 5-((4-丁氧基苄基)(甲基)氨基)-4-氯-3H-1,2-二硫醇-3-酮、4-氯-5-((4-羥基-3,5-二甲基苄基)(甲基))氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((3-氯-4-羥基苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮, 4-(((4-氯-3-氧代-3H-1,2-二硫醇-5-基)(甲基)氨基)甲基)-2-甲氧基苯基甲磺酸鹽,2-氯-4-(((4-氯)-3-氧代-3H-1,2-二硫醇-5-基)(甲基)氨基)甲基)苯基甲磺酸酯,4-氯-5-((3,4-二甲氧基苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((4-乙氧基-3-甲氧基苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2,5-二甲基苄基)氨基)-3H-1,2-二硫醇-3-酮,5-(苄基(異丁基)氨基)-4-氯-3H-1,2-二硫醇-3-酮,5-(苄基(丙-2-炔-1-基)氨基)-4-氯-3H-1,2-二硫醇-3-酮,5-(苄基(環丙基甲基)氨基)-4-氯-3H-1,2-二硫醇-3-酮,5-(苄基(環丙基)氨基)-4-氯-3H-1,2-二硫醇-3-酮,5-(苄基(乙基)氨基)-4-氯-3H-1,2-二硫醇-3-酮,5-(苄基(異丙基)氨基)-4-氯-3H-1,2-二硫醇-3-酮、4-氯-5-((3-氟-4-)我(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(甲基(4-甲基苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((4-(二甲基氨基)苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2,6-二氟苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((4-(二甲基氨基)苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮,5-(烯丙基(苄基))氨基)-4-氯-3H-1,2-二硫醇-3-酮、4-氯-5-((吡啶-2-基甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((吡啶-3-基甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((吡啶-4-基甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(甲基(吡啶-2-基甲基)氨基)-3H-1,2-二硫醇-3-酮, 4-氯-5-(甲基(吡啶-3-基甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(甲基(吡啶-4-基甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(((6-氯吡啶-3-基)甲基)(丙-2-炔-1-基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(((3-氯吡啶-4-基)甲基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(((3,5-二氯吡啶-4-基)甲基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(((2-氯吡啶-4-基)甲基) (甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((3-氯苄基)氨基)-3H-1,2-二硫醇-3-酮,5-((3-溴代苄基)氨基)-4-氯-3H-1,2-二硫醇-3-酮、4-氯-5-((3-氯-4-氟苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((3,5-二氟苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(((6-氯吡啶-3-基)甲基 )氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((3,5-二氯苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((3-氟苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((3-氟苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮, 4-氯-5-((4-氯-3-氟苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((3,4-二氟苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((3,4,5-三氟苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((3-(三氟甲基)苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2,6-二氟苄基)氨基)-3H-1,2-二硫醇-3-酮,4-氯-5-((3-氯苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2-氯-6-(三氟甲基)苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((3,5-二氟苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((3,5-二溴苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((3,5-二氯苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(甲基(3-(三氟甲基)苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(甲基(嘧啶-5-基甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(甲基(噻吩-2-基甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((吡嗪-2-基甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((1-(2,4-二氯苯基))乙基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((1-苯乙基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2-羥基-2-)苯乙基)氨基)-3H-1,2-二硫醇-3-酮,5-((2-溴-5-氟苄基)(甲基)氨基)-4-氯-3H-1,2-二硫醇-3-酮, 4-氯-5-((3-羥基苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮,5-((2-溴-3-羥基苄基)(甲基)氨基)-4-氯-3H-1,2-二硫醇-3-酮,3-(((4-氯-3-氧代-3H-1,2-二硫醇-5-基)(甲基)氨基)甲基)苯基甲磺酸鹽,2-溴-3-(((4-氯-3-氧代-3H-1,2-二硫醇-5-基)(甲基)氨基)甲基)苯基甲磺酸鹽,3-(((4-氯-3-氧代)-3H-1,2-二硫醇-5-基)氨基)甲基)苄腈,3-(((4-氯-3-氧代-3H-1,2-二硫醇-5-基)(甲基)氨基)甲基)苄腈,4-(((4-氯-3-氧代-3H-1,2-二硫醇-5-基)氨基)甲基)苄腈,4-(((4-氯-3-氧代-3H-1),2-二硫醇-5-基)(甲基)氨基)甲基)苄腈,4-氯-5-((3-甲氧基苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((3-甲氧基苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((4-氟苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((3-甲基苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((4-甲基苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((3,4-二甲基苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((4-氟-2-甲基苄基))氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((3,5-二甲基苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2-氟苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2,3-二甲基苄基)氨基)-3H-1,2-二硫醇-3-酮, 4-氯-5-(甲基(3-(三氟甲氧基)苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(乙基(3-(三氟甲氧基)苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(甲基(4-(三氟甲氧基)苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((4-(三氟甲氧基)苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((環丙基甲基)(3-(三氟甲氧基)苄基)氨基)-3H-1,2-二硫醇-3-酮,5-(烯丙基(3-(三氟甲氧基)苄基)氨基)-4-氯-3H-1,2-二硫醇-3-酮,5-((3-溴苄基)(環丙基甲基)氨基)-4-氯-3H-1,2-二硫醇-3-酮,5-(烯丙基(3-溴苄基)氨基)-4-氯-3H-1,2-二硫醇-3-酮,5-((3-溴苄基)(環丙基)氨基)-4-氯-3H-1,2-二硫醇-3-酮,5-((1-(3-溴苯基)乙基)(甲基)氨基)-4-氯-3H-1,2-二硫醇-3-酮,5-((1-(3-溴苯基)乙基)(乙基)氨基)-4-氯-3H-1,2-二硫醇-3-酮,5-(烯丙基)(1-(3-溴苯基)乙基)氨基)-4-氯-3H-1,2-二硫醇-3-酮,5-((1-(3-溴苯基)乙基)(環丙基甲基)氨基)-4-氯-3H-1,2-二硫醇-3-酮、4-氯-5-(甲基(3-((三氟甲氧基)基)硫基)苄基)氨基)-3H-1,2-二硫醇-3-酮, 4-氯-5-(乙基(3-((三氟甲基)硫代)苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(乙基(3-氟苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2,4-二甲氧基苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2,4-二氟苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((4-(三氟甲基)苄基)氨基)-3H-1,2-二硫醇-3-酮, 5-((4-溴苄基)氨基)-4-氯-3H-1,2-二硫醇-3-酮、4-氯-5-(乙基(4-甲氧基苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((4-(三氟甲氧基)苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2-氯-4-氟苄基))氨基)-3H-1,2-二硫醇-3-酮,5-((2-溴苄基)氨基)-4-氯-3H-1,2-二硫醇-3-酮、4-氯-5-((2-氯苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((3,4-二甲氧基苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2,5-二氟苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2,3-二氟苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((3,5-二甲氧基苄基)氨基)-3H-1,2-二硫醇-3-酮, 5-((苯並[d] [1,3]二氧雜環戊烯-5-基甲基)氨基)-4-氯-3H-1,2-二硫醇-3-酮、4-氯-5-((噻吩-2-) (甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2-甲基苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2,4-二氯苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2-甲氧基苄基)氨基)-3H-1,2-二硫醇-3-酮,4-氯-5-((2,3-二氯苄基)氨基)-3H-1,2-二硫醇-3-酮,5-((4-溴-2-氟苄基)氨基)-4-氯-3H-1,2-二硫醇-3-酮、4-氯-5-((2-甲氧基苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(乙基(2)-甲氧基苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2,4-二氟苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮, 4-氯-5-((2,4-二氟苄基)(乙基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(甲基(4-((三氟甲基)硫代)苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2,3-二甲氧基苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2-氯-6-氟苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2,5-二氯苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2,4-二甲基苯)zyl)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((4-(甲硫基)苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(乙基(4-((三氟甲基)硫代)苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((4-氯苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2,4-二氯苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((4-異丙基苄基)氨基)-3H-1,2-二硫醇-3-酮, 4-氯-5-((4-((三氟甲基)硫代)苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((4-乙氧基苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2-氯-3-氟苄基)氨基)-3H-1,2-二硫醇-3-酮,5-((2-溴苄基)(()氨基)-4-氯-3H-1,2-二硫醇-3-酮、4-氯-5-(((5-氯噻吩-2-基)甲基)(甲基)氨基)-3H-1, 2-二硫醇-3-酮、4-氯-5-((2,5-二甲氧基苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(甲基(( 3-甲基噻吩-2-基)甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2-氟-5-甲氧基苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((3-氯-5-氟苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((3-乙氧基苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2,6-二甲基苄基)(乙基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(甲基(2,3,6-三氯苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(乙基(2,3,6-三氯苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2,3-二氟苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(( 4-氟苄基)(甲基)氨基)-3H--1,2-二硫醇-3-酮、4-氯-5-((2,3-二氯苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((4-(三氟甲基)苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((4-甲氧基-2-甲基苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((3,4-二氯苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((4-異丙基苄基)(甲基)氨基)-3H--1,2-二硫醇-3-酮, 4-氯-5-(甲基(2,4,6-三甲基苄基)氨基)-3H-1,2-二硫醇-3-酮,5-((3,5-雙(三氟甲基)苄基)(甲基)氨基)-4-氯-3H-1,2-二硫醇-3-酮、4-氯-5-((4-氯-2-甲基苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2-氟-5-甲基苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2,6-二甲基苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((2-氯-6-氟苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(甲基(4-(三氟甲基)苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-((4-(乙基磺醯基)苄基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(乙基(3-(三氟甲基)苄基)氨基)-3H-1,2-二硫醇-3-酮,5-(([1,1'-聯苯基]-4-基甲基)(甲基)氨基)-4-氯-3H-1,2-二硫醇-3-酮、4-氯-5-((2,3-二氟苄基)(乙基)氨基)-3H-1 ,2-二硫醇-3-酮、4-氯-5-((4-乙基苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(乙基(4-)氟代苄基)氨基)-3H-1,2-二硫醇-3-酮,5-((4-(叔丁基)苄基)(甲基)氨基)-4-氯-3H-1,2-二硫醇-3-酮、4-氯-5-((2,6-二甲氧基苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮、4-氯-5-(甲基(2-甲基苄基)氨基)-3H-1,2-二硫醇-3-酮和4-氯-5-((2-氟苄基)(甲基)氨基)-3H-1,2-二硫醇-3-酮基團。The compound according to claim 1, wherein the compound of formula (I) is selected from 4-chloro-5-((3,4-dimethylbenzyl)(methyl)amino)-3H-1, 2-dithiol-3-one, 4-chloro-5-((3,5-dimethylbenzyl)(methyl)amino)-3H-1,2-dithiol-3-one, 4 -Chloro-5-((2,5-)difluorobenzyl)(methyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((3-ethoxy Yl-4-methoxybenzyl) (methyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-(ethyl(2-(trifluoromethyl)benzyl Group) amino)-3H-1,2-dithiol-3-one, 4-chloro-5-(ethyl((3-methylthiophen-2-yl)methyl)amino)-3H-1, 2-dithiol-3-one, 4-chloro-5-(methyl(4-phenoxybenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5 -((2-fluoro-4-methoxybenzyl)(methyl)amino)-3H-1,2-dithiol-3-one, 5-(((3-bromothiophen-2-yl) Methyl)(methyl)amino)-4-chloro-3H-1,2-dithiol-3-one, 4-chloro-5-(methyl(naphthalene-1-yl)methyl)amino)- 3H-1,2-dithiol-3-one, 4-chloro-5-(methyl(naphthalene-2-ylmethyl)amino)-3H-1,2-dithiol-3-one, 4 -Chloro-5-((3-methylbenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((2-ethoxybenzyl)(methyl )Amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((2,4-dimethoxybenzyl)(methyl)amino)-3H-1,2- Dithiol-3-one, 5-(benzyl(methyl)amino)-4-chloro-3H-1,2-dithiol-3-one, 4-chloro-5-((4-methoxy Benzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((3,4-dichlorobenzyl))amino)-3H-1,2-disulfide Alcohol-3-one, 5-(benzylamino)-4-chloro-3H-1,2-dithiol-3-one, 4-chloro-5-((1-(p-tolyl)ethyl )Amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((4-chlorobenzyl)amino)-3H-1,2-dithiol-3-one, 4 -Chloro-5-((3-(trifluoromethoxyxy)benzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-(methyl (2,4, 6-trichlorobenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((4-hydroxybenzyl)(methyl)amino)-3H-1,2 -Dithiol-3-one, 4-chloro-5-((2-chloro-5-nitrobenzyl)(methyl)amino)-3H-1,2-dithiol-3-one, 4 -Chloro-5-(methyl(2-nitrobenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-( (3-nitrobenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-(methyl(4-(methylthio)benzyl)amino)-3H- 1,2-dithiol-3-one, 5-((3-bromobenzyl)(methyl)amino)-4-chloro-3H-1,2-dithiol-3-one, 4-chloro -5-((2-chlorobenzyl)(methyl)amino)-3H-1,2-dithiol-3-one, 5-((4-bromobenzyl)(methyl)amino)-4 -Chloro-3H-1,2-dithiol-3-one, 5-((2-bromo-4-)fluorobenzyl)(methyl)amino)-4-chloro-3H-1,2- Dithiol-3-one, 4-chloro-5-((4-methoxybenzyl)(methyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5 -((4-ethoxybenzyl)(methyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((3-chloro-4-methoxybenzyl Group) (methyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((4-(2-hydroxyethoxy)benzyl)(methyl)amino) -3H-1,2-dithiol-3-one, 4-chloro-5-((4-methoxy-3-methylbenzyl)(methyl)amino)-3H-1,2-di Thiol-3-one, 4-chloro-5-((4-hydroxy-3)-methylbenzyl)(methyl)amino)-3H-1,2-dithiol-3-one, 4- Chloro-5-((4-isopropoxybenzyl)(methyl)amino)-3H-1,2-dithiol-3-one, 5-((3-bromo-4-methoxybenzyl Group) (methyl)amino)-4-chloro-3H-1,2-dithiol-3-one, 4-chloro-5-((4-hydroxy-3-methoxybenzyl)yl) ( Methyl)amino)-3H--1,2-dithiol-3-one, 5-((4-butoxybenzyl)(methyl)amino)-4-chloro-3H-1,2- Dithiol-3-one, 4-chloro-5-((4-hydroxy-3,5-dimethylbenzyl)(methyl))amino)-3H-1,2-dithiol-3- Ketone, 4-chloro-5-((3-chloro-4-hydroxybenzyl)(methyl)amino)-3H-1,2-dithiol-3-one, 4-(((4-chloro- 3-oxo-3H-1,2-dithiol-5-yl)(methyl)amino)methyl)-2-methoxyphenyl methanesulfonate, 2-chloro-4-(((( 4-chloro)-3-oxo-3H-1,2-dithiol-5-yl)(methyl)amino)methyl)phenyl methanesulfonate, 4-chloro-5-((3, 4-dimethoxybenzyl)(methyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((4-ethoxy-3-methoxybenzyl Group) (methyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((2,5-dimethylbenzyl)amino)-3H-1,2- Dithiol-3-one, 5-(benzyl(isobutyl)amino)-4-chloro-3H-1,2-dithiol-3-one, 5-(benzyl(prop-2-yn-1-yl)amino)-4-chloro-3H-1,2-dithiol-3-one, 5-(benzyl(cyclopropylmethyl)amino )-4-chloro-3H-1,2-dithiol-3-one, 5-(benzyl(cyclopropyl)amino)-4-chloro-3H-1,2-dithiol-3-one , 5-(benzyl(ethyl)amino)-4-chloro-3H-1,2-dithiol-3-one, 5-(benzyl(isopropyl)amino)-4-chloro-3H- 1,2-Dithiol-3-one, 4-chloro-5-((3-fluoro-4-)I(methyl)amino)-3H-1,2-dithiol-3-one, 4 -Chloro-5-(methyl(4-methylbenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((4-(dimethylamino)benzyl Group) amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((2,6-difluorobenzyl)(methyl)amino)-3H-1,2-di Thiol-3-one, 4-chloro-5-((4-(dimethylamino)benzyl)(methyl)amino)-3H-1,2-dithiol-3-one, 5-( Allyl (benzyl))amino)-4-chloro-3H-1,2-dithiol-3-one, 4-chloro-5-((pyridin-2-ylmethyl)amino)-3H- 1,2-dithiol-3-one, 4-chloro-5-((pyridin-3-ylmethyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5 -((Pyridin-4-ylmethyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-(methyl(pyridin-2-ylmethyl)amino)-3H -1,2-dithiol-3-one, 4-chloro-5-(methyl(pyridin-3-ylmethyl)amino)-3H-1,2-dithiol-3-one, 4- Chloro-5-(methyl(pyridin-4-ylmethyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-(((6-chloropyridin-3-yl )Methyl)(prop-2-yn-1-yl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-(((3-chloropyridin-4-yl) Methyl)(methyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-(((3,5-dichloropyridin-4-yl)methyl)(methyl Group) amino)-3H-1,2-dithiol-3-one, 4-chloro-5-(((2-chloropyridin-4-yl)methyl) (methyl)amino)-3H-1 ,2-dithiol-3-one, 4-chloro-5-((3-chlorobenzyl)amino)-3H-1,2-dithiol-3-one, 5-((3-bromo Benzyl)amino)-4-chloro-3H-1,2-dithiol-3-one, 4-chloro-5-((3-chloro-4-fluorobenzyl)amino)-3H-1,2 -Dithiol-3-one, 4-chloro-5-((3,5-difluorobenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-( ((6-chloropyridin-3-yl)methyl)amino)-3H-1,2-dithiol-3-one, 4 -Chloro-5-((3,5-dichlorobenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((3-fluorobenzyl)amino)- 3H-1,2-dithiol-3-one, 4-chloro-5-((3-fluorobenzyl)(methyl)amino)-3H-1,2-dithiol-3-one, 4 -Chloro-5-((4-chloro-3-fluorobenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((3,4-difluorobenzyl )Amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((3,4,5-trifluorobenzyl)amino)-3H-1,2-dithiol- 3-ketone, 4-chloro-5-((3-(trifluoromethyl)benzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((2, 6-difluorobenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((3-chlorobenzyl)(methyl)amino)-3H-1,2 -Dithiol-3-one, 4-chloro-5-((2-chloro-6-(trifluoromethyl)benzyl)(methyl)amino)-3H-1,2-dithiol-3 -Ketone, 4-chloro-5-((3,5-difluorobenzyl)(methyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((3 ,5-dibromobenzyl)(methyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((3,5-dichlorobenzyl)(methyl) Amino)-3H-1,2-dithiol-3-one, 4-chloro-5-(methyl(3-(trifluoromethyl)benzyl)amino)-3H-1,2-dithiol -3-one, 4-chloro-5-(methyl(pyrimidin-5-ylmethyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-(methyl ( Thiophen-2-ylmethyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((pyrazin-2-ylmethyl)amino)-3H-1,2 -Dithiol-3-one, 4-chloro-5-((1-(2,4-dichlorophenyl))ethyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((1-phenethyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((2-hydroxy-2-)phenethyl) Amino)-3H-1,2-dithiol-3-one, 5-((2-bromo-5-fluorobenzyl)(methyl)amino)-4-chloro-3H-1,2-disulfide Alcohol-3-one, 4-chloro-5-((3-hydroxybenzyl)(methyl)amino)-3H-1,2-dithiol-3-one, 5-((2-bromo-3 -Hydroxybenzyl)(methyl)amino)-4-chloro-3H-1,2-dithiol-3-one, 3-(((4-chloro-3-oxo-3H-1,2- Dithiol-5-yl)(methyl)amino)methyl)phenyl methanesulfonate, 2-bromo-3-(((4-chloro-3-oxo-3H-1,2-disulfide Alcohol-5-yl)(methyl)amino)methyl)phenyl methanesulfonate, 3-(((4-chloro-3-oxo)-3H-1,2 -Dithiol-5-yl)amino)methyl)benzonitrile, 3-(((4-chloro-3-oxo-3H-1,2-dithiol-5-yl)(methyl)amino )Methyl)benzonitrile, 4-(((4-chloro-3-oxo-3H-1,2-dithiol-5-yl)amino)methyl)benzonitrile, 4-(((4- Chloro-3-oxo-3H-1), 2-dithiol-5-yl) (methyl)amino) methyl) benzonitrile, 4-chloro-5-((3-methoxybenzyl) Amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((3-methoxybenzyl)(methyl)amino)-3H-1,2-dithiol- 3-ketone, 4-chloro-5-((4-fluorobenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((3-methylbenzyl) Amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((4-methylbenzyl)amino)-3H-1,2-dithiol-3-one, 4 -Chloro-5-((3,4-dimethylbenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((4-fluoro-2-methyl Benzyl))amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((3,5-dimethylbenzyl)amino)-3H-1,2-disulfide Alcohol-3-one, 4-chloro-5-((2-fluorobenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((2,3-di Methylbenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-(methyl(3-(trifluoromethoxy)benzyl)amino)-3H-1 ,2-dithiol-3-one, 4-chloro-5-(ethyl(3-(trifluoromethoxy)benzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-(methyl(4-(trifluoromethoxy)benzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((4-( Trifluoromethoxy)benzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((cyclopropylmethyl)(3-(trifluoromethoxy) Benzyl)amino)-3H-1,2-dithiol-3-one, 5-(allyl(3-(trifluoromethoxy)benzyl)amino)-4-chloro-3H-1, 2-dithiol-3-one, 5-((3-bromobenzyl)(cyclopropylmethyl)amino)-4-chloro-3H-1,2-dithiol-3-one, 5- (Allyl (3-bromobenzyl)amino)-4-chloro-3H-1,2-dithiol-3-one, 5-((3-bromobenzyl)(cyclopropyl)amino)- 4-chloro-3H-1,2-dithiol-3-one, 5-((1-(3-bromophenyl)ethyl)(methyl)amino)-4-chloro-3H-1,2 -Dithiol-3-one, 5-((1-(3-bromophenyl)ethyl)(ethyl)amino)-4-chloro-3H-1,2-dithiol-3-one, 5-(allyl)(1-(3-bromophenyl)ethyl)amino)-4-chloro-3H-1,2-dithiol-3-one, 5-((1-( 3-bromophenyl)ethyl)(cyclopropylmethyl)amino)-4-chloro-3H-1,2-dithiol-3-one, 4-chloro-5-(methyl(3-( (Trifluoromethoxy)yl)thio)benzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-(ethyl(3-((trifluoromethyl )Thio)benzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-(ethyl(3-fluorobenzyl)amino)-3H-1,2-di Thiol-3-one, 4-chloro-5-((2,4-dimethoxybenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-( (2,4-difluorobenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((4-(trifluoromethyl)benzyl)amino)-3H -1,2-dithiol-3-one, 5-((4-bromobenzyl)amino)-4-chloro-3H-1,2-dithiol-3-one, 4-chloro-5- (Ethyl(4-methoxybenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((4-(trifluoromethoxy)benzyl)amino )-3H-1,2-dithiol-3-one, 4-chloro-5-((2-chloro-4-fluorobenzyl))amino)-3H-1,2-dithiol-3- Ketone, 5-((2-bromobenzyl)amino)-4-chloro-3H-1,2-dithiol-3-one, 4-chloro-5-((2-chlorobenzyl)amino)- 3H-1,2-dithiol-3-one, 4-chloro-5-((3,4-dimethoxybenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((2,5-difluorobenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((2,3-difluorobenzyl )Amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((3,5-dimethoxybenzyl)amino)-3H-1,2-dithiol- 3-one, 5-((benzo[d] [1,3]dioxol-5-ylmethyl)amino)-4-chloro-3H-1,2-dithiol-3- Ketone, 4-chloro-5-((thiophen-2-) (methyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((2-methylbenzyl )Amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((2,4-dichlorobenzyl)amino)-3H-1,2-dithiol-3- Ketone, 4-chloro-5-((2-methoxybenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((2,3-dichlorobenzyl Group) amino)-3H-1,2-dithiol-3-one, 5-((4-bromo-2-fluorobenzyl)amino)-4-chloro-3H-1,2-dithiol- 3-ketone, 4-chloro-5-((2-methoxybenzyl)(methyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-(ethyl (2)-methoxybenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((2,4-difluorobenzyl Group) (methyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((2,4-difluorobenzyl)(ethyl)amino)-3H-1 ,2-dithiol-3-one, 4-chloro-5-(methyl(4-((trifluoromethyl)thio)benzyl)amino)-3H-1,2-dithiol-3 -Ketone, 4-chloro-5-((2,3-dimethoxybenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((2-chloro -6-fluorobenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((2,5-dichlorobenzyl)amino)-3H-1,2- Dithiol-3-one, 4-chloro-5-((2,4-dimethylbenzene) zyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5- ((4-(methylthio)benzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-(ethyl(4-((trifluoromethyl)thio) )Benzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((4-chlorobenzyl)(methyl)amino)-3H-1,2-disulfide Alcohol-3-one, 4-chloro-5-((2,4-dichlorobenzyl)(methyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5- ((4-isopropylbenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((4-((trifluoromethyl)thio)benzyl) Amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((4-ethoxybenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((2-chloro-3-fluorobenzyl)amino)-3H-1,2-dithiol-3-one, 5-((2-bromobenzyl)(()amino) -4-chloro-3H-1,2-dithiol-3-one, 4-chloro-5-(((5-chlorothiophen-2-yl)methyl)(methyl)amino)-3H-1 , 2-dithiol-3-one, 4-chloro-5-((2,5-dimethoxybenzyl)(methyl)amino)-3H-1,2-dithiol-3-one , 4-chloro-5-(methyl((3-methylthiophen-2-yl)methyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-(( 2-fluoro-5-methoxybenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((3-chloro-5-fluorobenzyl)amino)- 3H-1,2-dithiol-3-one, 4-chloro-5-((3-ethoxybenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro -5-((2,6-dimethylbenzyl)(ethyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-(methyl (2,3, 6-trichlorobenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-(ethyl(2,3,6-trichlorobenzyl)amino)-3H- 1,2-dithiol-3-one, 4-chloro-5-((2,3-difluorobenzyl)(methyl)amino)-3H-1, 2-dithiol-3-one, 4-chloro-5-((4-fluorobenzyl)(methyl)amino)-3H--1,2-dithiol-3-one, 4-chloro- 5-((2,3-dichlorobenzyl)(methyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((4-(trifluoromethyl) Benzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((4-methoxy-2-methylbenzyl)amino)-3H-1,2- Dithiol-3-one, 4-chloro-5-((3,4-dichlorobenzyl)(methyl)amino)-3H-1,2-dithiol-3-one, 4-chloro- 5-((4-isopropylbenzyl)(methyl)amino)-3H--1,2-dithiol-3-one, 4-chloro-5-(methyl (2,4,6- Trimethylbenzyl)amino)-3H-1,2-dithiol-3-one, 5-((3,5-bis(trifluoromethyl)benzyl)(methyl)amino)-4- Chloro-3H-1,2-dithiol-3-one, 4-chloro-5-((4-chloro-2-methylbenzyl)amino)-3H-1,2-dithiol-3- Ketone, 4-chloro-5-((2-fluoro-5-methylbenzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((2,6- Dimethylbenzyl)(methyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-((2-chloro-6-fluorobenzyl)(methyl)amino )-3H-1,2-dithiol-3-one, 4-chloro-5-(methyl(4-(trifluoromethyl)benzyl)amino)-3H-1,2-dithiol- 3-ketone, 4-chloro-5-((4-(ethylsulfonyl)benzyl)amino)-3H-1,2-dithiol-3-one, 4-chloro-5-(ethyl (3-(trifluoromethyl)benzyl)amino)-3H-1,2-dithiol-3-one, 5-(([1,1'-biphenyl]-4-ylmethyl) (Methyl)amino)-4-chloro-3H-1,2-dithiol-3-one, 4-chloro-5-((2,3-difluorobenzyl)(ethyl)amino)-3H -1,2-dithiol-3-one, 4-chloro-5-((4-ethylbenzyl)(methyl)amino)-3H-1,2-dithiol-3-one, 4 -Chloro-5-(ethyl(4-)fluorobenzyl)amino)-3H-1,2-dithiol-3-one, 5-((4-(tert-butyl)benzyl)(methyl Group) amino)-4-chloro-3H-1,2-dithiol-3-one, 4-chloro-5-((2,6-dimethoxybenzyl)(methyl)amino)-3H -1,2-dithiol-3-one, 4-chloro-5-(methyl(2-methylbenzyl)amino)-3H-1,2-dithiol-3-one and 4-chloro -5-((2-fluorobenzyl)(methyl)amino)-3H-1,2-dithiol-3-one group. 一種用於控制或預防植物病原微生物的組合物,其包含如請求項1所述的式(I)化合物、其N-氧化物、S-氧化物或農業上可接受的鹽和一種或多種惰性載體。A composition for controlling or preventing plant pathogenic microorganisms, which comprises the compound of formula (I) as described in claim 1, its N-oxide, S-oxide or agriculturally acceptable salt and one or more inerts Carrier. 如請求項5所述的組合物,其中所述組合物還可包含一種或多種選自殺真菌劑、殺蟲劑、殺線蟲劑、殺蟎劑、生物殺蟲劑、除草劑、植物生長調節劑、抗生素、營養素或肥料的活性相容化合物。The composition according to claim 5, wherein the composition may further comprise one or more selected from fungicides, insecticides, nematicides, acaricides, biological insecticides, herbicides, plant growth regulators , Antibiotics, nutrients or active compatible compounds of fertilizers. 如請求項5或6所述的組合物,其中式(I)化合物的濃度為占組合物總重量的10-90%,優選為占組合物總重量的30-70%。The composition according to claim 5 or 6, wherein the concentration of the compound of formula (I) is 10-90% by weight of the total composition, preferably 30-70% by weight of the total composition. 一種包含如請求項1所述的式(I)化合物、其N-氧化物、S-氧化物、農業上可接受的鹽和一種或多種選自殺真菌劑、殺蟲劑、殺線蟲劑、殺蟎劑、生物殺蟲劑、除草劑、植物生長調節劑、抗生素、營養素或肥料的活性相容化合物的組合。A compound comprising the compound of formula (I) according to claim 1, its N-oxides, S-oxides, agriculturally acceptable salts and one or more selected from fungicides, insecticides, nematicides, insecticides A combination of active compatible compounds of acaricides, biopesticides, herbicides, plant growth regulators, antibiotics, nutrients or fertilizers. 如請求項1或5或8所述的式(I)化合物、其N-氧化物、S-氧化物、農業上可接受的鹽、組合物或組合用於控制或保護農作物和/或園藝作物免受植物致病性微生物侵擾的用途。The compound of formula (I) as claimed in claim 1 or 5 or 8, its N-oxide, S-oxide, agriculturally acceptable salt, composition or combination for controlling or protecting agricultural crops and/or horticultural crops Use free from plant pathogenic microorganisms. 如請求項9所述的式(I)化合物的用途,其中農作物為谷類、玉米、大米、大豆和其他豆科植物、水果和果樹、堅果和堅果樹、柑橘和柑橘樹、任何園藝植物、葫蘆科植物、含油植物、煙草、咖啡、茶、可哥、甜菜、甘蔗、棉花、馬鈴薯、番茄、洋蔥、辣椒和其他蔬菜以及觀賞植物。The use of the compound of formula (I) according to claim 9, wherein the crops are cereals, corn, rice, soybeans and other legumes, fruits and fruit trees, nuts and nut trees, citrus and citrus trees, any horticultural plants, Cucurbitaceae, oily plants, tobacco, coffee, tea, cocoa, beets, sugar cane, cotton, potatoes, tomatoes, onions, peppers and other vegetables, and ornamental plants. 一種包含如請求項1所述的式(I)化合物、其N-氧化物或S-氧化物或農業上可接受的鹽的種子,其中通式(I)的化合物、其N-氧化物或S-氧化物或農業上可接受的鹽的量為每100kg種子0.1g至1kg。A seed containing the compound of formula (I), its N-oxide or S-oxide or an agriculturally acceptable salt as described in claim 1, wherein the compound of general formula (I), its N-oxide or The amount of S-oxide or agriculturally acceptable salt is 0.1 g to 1 kg per 100 kg of seeds. 一種控制或預防農業作物和/或園藝作物中植物致病微生物侵擾有用植物的方法,其中,如請求項1或5或8所述的式(I)化合物、其農業上可接受的鹽、組合物或組合施用於植物、其部分或其位元點。A method for controlling or preventing infestation of useful plants by plant pathogenic microorganisms in agricultural crops and/or horticultural crops, wherein the compound of formula (I) according to claim 1 or 5 or 8, its agriculturally acceptable salts, combinations The substance or combination is applied to the plant, its part or its locus. 一種控制或預防農業作物和/或園藝作物中植物致病微生物侵擾有用植物的方法,其中,如請求項1或5或8所述的式(I)化合物、農業上可接受的鹽、組合物或其組合施用於植物的種子。A method for controlling or preventing infestation of useful plants by plant pathogenic microorganisms in agricultural crops and/or horticultural crops, wherein the compound of formula (I), agriculturally acceptable salt, composition according to claim 1 or 5 or 8 Or a combination thereof is applied to the seeds of the plant. 一種使用如請求項1或5或8所述的式(I)化合物、其農業上可接受的鹽、組合物或組合控制或預防農作物和/或園藝作物中植物病原微生物的方法,包括施用有效劑量的化合物或組合物或組合的步驟,其量為每公頃農業和/或園藝作物100g至2.5kg。A method for controlling or preventing phytopathogenic microorganisms in crops and/or horticultural crops using a compound of formula (I) as described in claim 1 or 5 or 8 or an agriculturally acceptable salt, composition or combination thereof, including effective application The dosage of the compound or the composition or the steps of the combination is 100 g to 2.5 kg per hectare of agricultural and/or horticultural crops. 一種對抗植物致病真菌的方法,包括用如請求項1或5或8所述的式(I)化合物、其農業上可接受的鹽、組合物或組合處理待保護的植物、土壤、種子或材料。A method for combating phytopathogenic fungi, which comprises treating a plant, soil, seed or plant to be protected with a compound of formula (I) as described in claim 1 or 5 or 8 or an agriculturally acceptable salt, composition or combination thereof material.
TW108129373A 2018-08-17 2019-08-16 1,2-dithiolone compounds and use thereof TW202009235A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN201811030875 2018-08-17
IN201811030875 2018-08-17

Publications (1)

Publication Number Publication Date
TW202009235A true TW202009235A (en) 2020-03-01

Family

ID=67997664

Family Applications (1)

Application Number Title Priority Date Filing Date
TW108129373A TW202009235A (en) 2018-08-17 2019-08-16 1,2-dithiolone compounds and use thereof

Country Status (3)

Country Link
AR (1) AR115984A1 (en)
TW (1) TW202009235A (en)
WO (1) WO2020035826A1 (en)

Family Cites Families (113)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3325503A (en) 1965-02-18 1967-06-13 Diamond Alkali Co Polychloro derivatives of mono- and dicyano pyridines and a method for their preparation
US3296272A (en) 1965-04-01 1967-01-03 Dow Chemical Co Sulfinyl- and sulfonylpyridines
CH465314A (en) 1965-06-11 1968-11-15 Agripat Sa Methods and means of combating fungi
US3527867A (en) 1965-06-11 1970-09-08 Geigy Chem Corp Agents inhibiting fungus growth and method of controlling fungi therewith
FR2528843A2 (en) * 1981-08-11 1983-12-23 Rhone Poulenc Sante NOVEL DERIVATIVES OF DITHIOLE-1,2 YLIDENE-3 AMMONIUM, THEIR PREPARATION AND THE MEDICINAL PRODUCTS CONTAINING THE SAME
FR2541680B1 (en) 1983-02-24 1985-06-14 Rhone Poulenc Sante NEW AMINO-5 DITHIOLE-1,2 ONE-3 DERIVATIVES, THEIR PREPARATION AND THE MEDICINAL COMPOSITIONS CONTAINING THEM
DE3338292A1 (en) 1983-10-21 1985-05-02 Basf Ag, 6700 Ludwigshafen 7-AMINO-AZOLO (1,5-A) -PYRIMIDINE AND FUNGICIDES CONTAINING THEM
CA1249832A (en) 1984-02-03 1989-02-07 Shionogi & Co., Ltd. Azolyl cycloalkanol derivatives and agricultural fungicides
BR8600161A (en) 1985-01-18 1986-09-23 Plant Genetic Systems Nv CHEMICAL GENE, HYBRID, INTERMEDIATE PLASMIDIO VECTORS, PROCESS TO CONTROL INSECTS IN AGRICULTURE OR HORTICULTURE, INSECTICIDE COMPOSITION, PROCESS TO TRANSFORM PLANT CELLS TO EXPRESS A PLANTINIDE TOXIN, PRODUCED BY CULTURES, UNITED BY BACILLA
DE3545319A1 (en) 1985-12-20 1987-06-25 Basf Ag ACRYLIC ACID ESTERS AND FUNGICIDES THAT CONTAIN THESE COMPOUNDS
CN1015981B (en) 1986-05-02 1992-03-25 施托福化学公司 Fungicidal pyridyl imidates
ATE82966T1 (en) 1986-08-12 1992-12-15 Mitsubishi Chem Ind PYRIDINECARBOXAMIDE DERIVATIVES AND THEIR USE AS A FUNGICIDE.
US5169629A (en) 1988-11-01 1992-12-08 Mycogen Corporation Process of controlling lepidopteran pests, using bacillus thuringiensis isolate denoted b.t ps81gg
NZ231804A (en) 1988-12-19 1993-03-26 Ciba Geigy Ag Insecticidal toxin from leiurus quinquestriatus hebraeus
GB8910624D0 (en) 1989-05-09 1989-06-21 Ici Plc Bacterial strains
CA2015951A1 (en) 1989-05-18 1990-11-18 Mycogen Corporation Novel bacillus thuringiensis isolates active against lepidopteran pests, and genes encoding novel lepidopteran-active toxins
ES2074547T3 (en) 1989-11-07 1995-09-16 Pioneer Hi Bred Int LARVICID LECTINES, AND INDUCED RESISTANCE OF PLANTS TO INSECTS.
AU628229B2 (en) 1989-11-10 1992-09-10 Agro-Kanesho Co. Ltd. Hexahydrotriazine compounds and insecticides
JP2828186B2 (en) 1991-09-13 1998-11-25 宇部興産株式会社 Acrylate-based compounds, their preparation and fungicides
UA48104C2 (en) 1991-10-04 2002-08-15 Новартіс Аг Dna fragment including sequence that codes an insecticide protein with optimization for corn, dna fragment providing directed preferable for the stem core expression of the structural gene of the plant related to it, dna fragment providing specific for the pollen expression of related to it structural gene in the plant, recombinant dna molecule, method for obtaining a coding sequence of the insecticide protein optimized for corn, method of corn plants protection at least against one pest insect
EP1357189B1 (en) 1992-07-01 2011-04-13 Cornell Research Foundation Inc. Elicitor of the hypersensitive response in plants
US5530195A (en) 1994-06-10 1996-06-25 Ciba-Geigy Corporation Bacillus thuringiensis gene encoding a toxin active against insects
DE19650197A1 (en) 1996-12-04 1998-06-10 Bayer Ag 3-thiocarbamoylpyrazole derivatives
TW460476B (en) 1997-04-14 2001-10-21 American Cyanamid Co Fungicidal trifluoromethylalkylamino-triazolopyrimidines
ES2188016T3 (en) 1997-09-18 2003-06-16 Basf Ag DERIVAQDO DE BENZAMIDOXIMA, INTERMEDIATE PRODUCTS AND PROCEDURE FOR OBTAINING AND EMPLOYMENT AS FUNGICIDES.
DE19750012A1 (en) 1997-11-12 1999-05-20 Bayer Ag Isothiazole carboxamides
WO1999027783A1 (en) 1997-12-04 1999-06-10 Dow Agrosciences Llc Fungicidal compositions and methods, and compounds and methods for the preparation thereof
WO2000029404A1 (en) 1998-11-17 2000-05-25 Kumiai Chemical Industry Co., Ltd. Pyrimidinylbenzimidazole and triazinylbenzimidazole derivatives and agricultura/horticultural bactericides
IT1303800B1 (en) 1998-11-30 2001-02-23 Isagro Ricerca Srl DIPEPTID COMPOUNDS HAVING HIGH FUNGICIDE AND AGRICULTURAL USE.
JP3417862B2 (en) 1999-02-02 2003-06-16 新東工業株式会社 Silica gel highly loaded with titanium oxide photocatalyst and method for producing the same
AU770077B2 (en) 1999-03-11 2004-02-12 Dow Agrosciences Llc Heterocyclic substituted isoxazolidines and their use as fungicides
US6586617B1 (en) 1999-04-28 2003-07-01 Sumitomo Chemical Takeda Agro Company, Limited Sulfonamide derivatives
UA73307C2 (en) 1999-08-05 2005-07-15 Куміаі Кемікал Індастрі Ко., Лтд. Carbamate derivative and fungicide of agricultural/horticultural destination
DE10021412A1 (en) 1999-12-13 2001-06-21 Bayer Ag Fungicidal active ingredient combinations
JP4880161B2 (en) 2000-01-25 2012-02-22 シンジェンタ パーティシペーションズ アクチェンゲゼルシャフト Herbicidal formulation
US6376548B1 (en) 2000-01-28 2002-04-23 Rohm And Haas Company Enhanced propertied pesticides
IL167954A (en) 2000-02-04 2007-10-31 Sumitomo Chemical Co Pyrimidine derivatives
CN1114590C (en) 2000-02-24 2003-07-16 沈阳化工研究院 Unsaturated oximino ether bactericide
ES2243543T3 (en) 2000-08-25 2005-12-01 Syngenta Participations Ag HYBRIDS OF BACILLUS THURIGIENSIS CRYSTAL PROTEINS.
WO2002022583A2 (en) 2000-09-18 2002-03-21 E. I. Du Pont De Nemours And Company Pyridinyl amides and imides for use as fungicides
CN100438865C (en) 2000-11-17 2008-12-03 美国陶氏益农公司 Compounds having fungicidal activity and processes to make and use same
JP5034142B2 (en) 2001-04-20 2012-09-26 住友化学株式会社 Plant disease control composition
DE10136065A1 (en) 2001-07-25 2003-02-13 Bayer Cropscience Ag pyrazolylcarboxanilides
AR037228A1 (en) 2001-07-30 2004-11-03 Dow Agrosciences Llc ACID COMPOUNDS 6- (ARIL OR HETEROARIL) -4-AMYNOPYCOLINIC, HERBICIDE COMPOSITION THAT UNDERSTANDS AND METHOD TO CONTROL UNWANTED VEGETATION
FR2828196A1 (en) 2001-08-03 2003-02-07 Aventis Cropscience Sa New iodochromone derivatives, useful for the prevention or cure of plant fungal disorders, especially in cereals, vines, fruits, legumes or ornamental plants
WO2003016286A1 (en) 2001-08-17 2003-02-27 Sankyo Agro Company, Limited 3-phenoxy-4-pyridazinol derivative and herbicide composition containing the same
RU2004104638A (en) 2001-08-20 2005-07-10 Дайниппон Инк Энд Кемикалз, Инк. (Jp) TETRAZOILOXYM DERIVATIVE AND AGRICULTURAL CHEMICALS CONTAINING IT AS AN ACTIVE INGREDIENT
US7230167B2 (en) 2001-08-31 2007-06-12 Syngenta Participations Ag Modified Cry3A toxins and nucleic acid sequences coding therefor
AU2002361696A1 (en) 2001-12-17 2003-06-30 Syngenta Participations Ag Novel corn event
AU2002354251A1 (en) 2001-12-21 2003-07-09 Nissan Chemical Industries, Ltd. Bactericidal composition
TWI327462B (en) 2002-01-18 2010-07-21 Sumitomo Chemical Co Condensed heterocyclic sulfonyl urea compound, a herbicide containing the same, and a method for weed control using the same
DE10204390A1 (en) 2002-02-04 2003-08-14 Bayer Cropscience Ag Disubstituted thiazolylcarboxanilides
CA2477931C (en) 2002-03-05 2011-02-01 Josef Ehrenfreund O-cyclopropyl-carboxanilides and their use as fungicides
JP4186484B2 (en) 2002-03-12 2008-11-26 住友化学株式会社 Pyrimidine compounds and uses thereof
GB0213715D0 (en) 2002-06-14 2002-07-24 Syngenta Ltd Chemical compounds
GB0227966D0 (en) 2002-11-29 2003-01-08 Syngenta Participations Ag Organic Compounds
WO2004083193A1 (en) 2003-03-17 2004-09-30 Sumitomo Chemical Company, Limited Amide compound and bactericide composition containing the same
CN1201657C (en) 2003-03-25 2005-05-18 浙江省化工研究院 Methoxy methyl acrylate compounds as bactericidal agent
TWI312272B (en) 2003-05-12 2009-07-21 Sumitomo Chemical Co Pyrimidine compound and pests controlling composition containing the same
TWI355894B (en) 2003-12-19 2012-01-11 Du Pont Herbicidal pyrimidines
ES2526614T3 (en) 2004-03-05 2015-01-13 Nissan Chemical Industries, Ltd. Isoxazoline-substituted benzamide compound and harmful organisms control agent
AU2005221808B8 (en) 2004-03-10 2011-01-06 Basf Se 5,6-dialkyl-7-amino-triazolopyrimidines, method for their production, their use for controlling pathogenic fungi and agents containing said compounds
ATE473227T1 (en) 2004-03-10 2010-07-15 Basf Se 5,6-DIALKYL-7-AMINO-TRIAZOLOPYRIMIDINES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE FOR CONTROLLING HARMFUL FUNGI AND AGENTS CONTAINING SAME
WO2005120234A2 (en) 2004-06-03 2005-12-22 E.I. Dupont De Nemours And Company Fungicidal mixtures of amidinylphenyl compounds
WO2005123689A1 (en) 2004-06-18 2005-12-29 Basf Aktiengesellschaft 1-methyl-3-trifluoromethyl-pyrazole-4-carboxylic acid (ortho-phenyl)-anilides and to use thereof as fungicide
EP1761498A1 (en) 2004-06-18 2007-03-14 Basf Aktiengesellschaft 1-methyl-3-difluoromethyl-pyrazol-4-carbonic acid-(ortho-phenyl)-anilides, and use thereof as a fungicide
GB0414438D0 (en) 2004-06-28 2004-07-28 Syngenta Participations Ag Chemical compounds
GB0418048D0 (en) 2004-08-12 2004-09-15 Syngenta Participations Ag Method for protecting useful plants or plant propagation material
RU2394819C2 (en) 2004-10-20 2010-07-20 Кумиай Кемикал Индастри Ко., Лтд. Insecticide, acaricide and namatocide, containing 3-triazolylphenyl sulphide derivative as active component
DE102005007160A1 (en) 2005-02-16 2006-08-24 Basf Ag Pyrazolecarboxylic acid anilides, process for their preparation and compositions containing them for controlling harmful fungi
WO2006087325A1 (en) 2005-02-16 2006-08-24 Basf Aktiengesellschaft 5-alkoxyalkyl-6-alkyl-7-amino-azolopyrimidines, method for their production, their use for controlling pathogenic fungi and agents containing said substances
DE102005009458A1 (en) 2005-03-02 2006-09-07 Bayer Cropscience Ag pyrazolylcarboxanilides
BRPI0612637B1 (en) 2005-07-07 2016-08-02 Basf Ag n-thio anthranilamide compounds, processes for preparing such compounds and a composition, use of such compounds, methods for controlling insects, mites or nematodes, for protection from developing plants from attack or insect infestation, mites or nematodes, and compositions
CN1907024A (en) 2005-08-03 2007-02-07 浙江化工科技集团有限公司 Methoxyl group displacement methyl acrylate compound bactericidal agent
BR122015016965B8 (en) 2006-01-13 2022-06-28 Dow Agrosciences Llc 6-(POLYSUBSTITUTED ARYL)-4-AMINOPICOLINATES, HERBICIDAL COMPOSITION, AND METHOD FOR CONTROL OF UNDESIRABLE VEGETATION
US8124565B2 (en) 2006-02-09 2012-02-28 Syngenta Crop Protection, Inc. Method of protecting a plant propagation material, a plant, and/or plant organs
EP2017268B1 (en) 2006-05-08 2013-01-16 Kumiai Chemical Industry Co., Ltd. 1,2-benzisothiazole derivative, and agricultural or horticultural plant disease-controlling agent
WO2008013622A2 (en) 2006-07-27 2008-01-31 E. I. Du Pont De Nemours And Company Fungicidal azocyclic amides
WO2008134969A1 (en) 2007-04-30 2008-11-13 Sinochem Corporation Benzamide compounds and applications thereof
GB0720126D0 (en) 2007-10-15 2007-11-28 Syngenta Participations Ag Chemical compounds
TWI411395B (en) 2007-12-24 2013-10-11 Syngenta Participations Ag Insecticidal compounds
ES2632135T3 (en) 2008-01-15 2017-09-11 Bayer Intellectual Property Gmbh Pesticide composition comprising a tetrazolyl oxime derivative and an active substance pesticide or insecticide
EP2562162B1 (en) 2008-01-22 2015-08-19 Dow AgroSciences LLC N-cyano-4-amino-5-fluoro-pyrimidine derivatives as fungicides
TWI401023B (en) 2008-02-06 2013-07-11 Du Pont Mesoionic pesticides
CN101337940B (en) 2008-08-12 2012-05-02 国家农药创制工程技术研究中心 Nitrogen heterocyclic ring dichlorin allyl ether compounds with insecticidal activity
EP2184273A1 (en) 2008-11-05 2010-05-12 Bayer CropScience AG Halogen substituted compounds as pesticides
GB0823002D0 (en) 2008-12-17 2009-01-28 Syngenta Participations Ag Isoxazoles derivatives with plant growth regulating properties
CN101906075B (en) 2009-06-05 2012-11-07 中国中化股份有限公司 E-type phenyl acrylic acid ester compound containing substituted anilino pyrimidine group and applications thereof
US8470840B2 (en) 2009-09-01 2013-06-25 Dow Agrosciences, Llc. Synergistic fungicidal compositions containing a 5-fluoropyrimidine derivative for fungal control in cereals
BR112012015626B1 (en) 2009-12-22 2017-09-19 Mitsui Chemicals Agro, Inc COMPOSITION OF CONTROL OF PLANT DISEASE AND METHOD FOR CONTROLLING THE DISEASE BY THE APPLICATION OF THE SAME
NZ600926A (en) 2010-01-04 2013-07-26 Nippon Soda Co Nitrogen-containing heterocyclic compound and agricultural/horticultural germicide
ES2605490T3 (en) 2010-04-28 2017-03-14 Sumitomo Chemical Company, Limited Composition of plant disease control and its use
MX2013000188A (en) 2010-06-28 2013-01-28 Bayer Ip Gmbh Heteroaryl-substituted pyridine compounds for use as pesticides.
CU24170B1 (en) 2010-08-31 2016-03-31 Meiji Seika Pharma Co DERIVATIVES OF AMINA AND ITS SALTS FOR PEST CONTROL
IT1403275B1 (en) 2010-12-20 2013-10-17 Isagro Ricerca Srl HIGH-ACTIVITY INDANYLANILIDES FUNGICIDE AND THEIR PHYTOSANITARY COMPOSITIONS
CN102060818B (en) 2011-01-07 2012-02-01 青岛科技大学 Novel spirodiclofen compound and preparation method and application thereof
CN102057925B (en) 2011-01-21 2013-04-10 陕西上格之路生物科学有限公司 Insecticidal composition containing thiacloprid amide and biogenic insecticide
TWI583308B (en) 2011-05-31 2017-05-21 組合化學工業股份有限公司 Method for controlling rice disease
EP2532233A1 (en) 2011-06-07 2012-12-12 Bayer CropScience AG Active compound combinations
HUE027461T2 (en) 2011-07-13 2016-09-28 Basf Agro Bv Fungicidal substituted 2-[2-halogenalkyl-4-(phenoxy)-phenyl]-1-[1,2,4]triazol-1-yl-ethanol compounds
US9173402B2 (en) 2011-07-15 2015-11-03 Basf Se Fungicidal alkyl-substituted 2[2-chloro-4-(4-chioro-phenoxy)-phenyl]-1[1,2,4]triazol-1-yl-ethanol compounds
US20140179519A1 (en) 2011-08-12 2014-06-26 Basf Se N-thio-anthranilamide compounds and their use as pesticides
EA201400212A1 (en) 2011-08-12 2014-07-30 Басф Се N-THIOANTRANILAMIDE COMPOUNDS AND THEIR APPLICATION AS PESTICIDES
JP6005652B2 (en) 2011-09-26 2016-10-12 日本曹達株式会社 Agricultural / horticultural fungicide composition
JP5993860B2 (en) 2011-09-29 2016-09-14 三井化学アグロ株式会社 Method for producing 4,4-difluoro-3,4-dihydroisoquinoline derivative
DK2793579T6 (en) 2011-12-21 2018-05-28 Basf Se APPLICATION OF STROBILUR TYPE-COMPOUNDS TO COMBAT PHYTOPATHOGENIC Fungi RESISTANT TO QO INHIBITORS
TWI568721B (en) 2012-02-01 2017-02-01 杜邦股份有限公司 Fungicidal pyrazole mixtures
PE20190343A1 (en) 2012-02-27 2019-03-07 Bayer Ip Gmbh ACTIVE COMPOUND COMBINATIONS
MX2014011829A (en) 2012-03-30 2015-03-19 Basf Se N-substituted pyridinylidene compounds and derivatives for combating animal pests.
JP6107377B2 (en) 2012-04-27 2017-04-05 住友化学株式会社 Tetrazolinone compounds and uses thereof
CN103387541B (en) 2012-05-10 2016-02-10 中国中化股份有限公司 A kind of preparation method of substituted pyrazolecarboxylic ether compound
WO2014060177A1 (en) 2012-10-16 2014-04-24 Syngenta Participations Ag Fungicidal compositions
EP2865265A1 (en) 2014-02-13 2015-04-29 Bayer CropScience AG Active compound combinations comprising phenylamidine compounds and biological control agents

Also Published As

Publication number Publication date
AR115984A1 (en) 2021-03-17
WO2020035826A1 (en) 2020-02-20

Similar Documents

Publication Publication Date Title
CN108430986B (en) Fused bicyclic heterocyclic derivatives as pest control agents
CN107810188B (en) Fused bicyclic heterocyclic derivatives as pest control agents and intermediate products
CN110248941B (en) Aryl-or heteroaryl-substituted imidazopyridine derivatives and their use as pesticides
CN113166070A (en) Pesticidal compounds
JP7098630B2 (en) Heterocyclene derivative as a pest control agent
CN112004813B (en) Oxadiazole compounds for controlling phytopathogenic fungi
CN109689662B (en) Fused bicyclic heterocyclic derivatives as pest control agents
CN111741958A (en) Fused bicyclic heterocyclic derivatives as pest control agents
CN111433215A (en) Derivatives of heterocyclic compounds as pest control agents
TW201940470A (en) Novel heterocyclic compounds
CN110546152A (en) Bicyclic pesticidal compounds
TW202104197A (en) Oxadiazole compounds, applications of the same and methods of producing the same
CN111886238A (en) Fused bicyclic heterocyclic derivatives as pest control agents
CN113195483A (en) Novel oxadiazole compound
CN110637019B (en) 2- (hetero) aryl-substituted fused bicyclic heterocyclic derivatives as pest control agents
CN113454063A (en) 3-substituted phenylamidine compounds, preparation method and application thereof
BR112020009446A2 (en) derivatives of tetrazolium propyl and its use as a fungicide
CN110573513A (en) 2- (hetero) aryl-substituted fused bicyclic heterocyclic derivatives as pest control agents
CN113195461A (en) Novel oxadiazole compound
CN110678469B (en) Substituted pyrimidinium compounds and derivatives for combating animal pests
TW202104196A (en) Oxadiazole compounds, applications of the same and methods of producing the same
CN111670180A (en) Fluoroalkenyl compounds, process for their preparation and their use
US11524934B2 (en) Phenylamine compounds
TW202128679A (en) Novel oxadiazole compounds containing fused heterocyclyl rings for controlling or preventing phytopathogenic fungi
TW202009235A (en) 1,2-dithiolone compounds and use thereof